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ABSTRACT  
THE IMPACT OF THE 2010 AFFORDABLE CARE ACT ON REDUCING RACIAL/ETHNIC 
DISPARITIES IN PRIMARY CARE ACCESS AND THE DELIVERY OF DIABETES 
PREVENTIVE CARE IN THE UNITED STATES  
 
December 2019  
Adrianna Nava, B.S.N., Saint Francis Medical Center College of Nursing 
M.S.N., University of Pennsylvania  
Ph.D., University of Massachusetts Boston  
 
 
Directed by Professor Suzanne Leveille 
 A key focus of the 2010 Patient Protection and Affordable Care Act (ACA) was to improve 
access to healthcare services in the United States (U.S.) (Stolberg & Pear, 2010). The research 
purpose was to assess the impact of the ACA’s Medicaid expansion and insurance subsidies on 
reducing racial/ethnic disparities in coverage, access and the delivery of primary care services, 
specifically diabetes prevention. Diabetes disproportionately affects minority populations, with 
inequities reported in the delivery of diabetes care to minorities (Chow, Foster, Gonzalez & 
McIver, 2012). The Modified Quality Health Outcomes Model was used to guide this research. 
Statistical analyses were conducted by separately analyzing the 2012-2017 Behavioral Risk Factor 
Surveillance System (BRFSS) and the 2012 -2015 National Ambulatory Medical Care Survey 
(NAMCS). Multivariate logistic regression models found that the lowest income groups (<138% 
FPL) continued to have the lowest levels of insurance post-ACA. In addition, there was an overall 
1% gain in having a PCP, with narrowing of racial/ethnic disparities occurring post-ACA. Of 
interest, whites experienced declines in having a provider, despite gains in insurance. Hispanics 
v 
 
continued to have the lowest levels of having a provider post-ACA. High-risk Hispanics were 4 
times more likely to be screened than high-risk whites and high-risk adults were 96% more likely 
to receive diabetes prevention education than the low risk post-ACA. These results lay the 
groundwork for future research to address policy strategies to improve access to primary care 
providers and health system strategies to increase consumer awareness of their high-risk for 
diabetes status.    
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CHAPTER 1 
INTRODUCTION 
In order to promote high quality health care, access to the health care system is a 
prerequisite (Dilworth-Anderson, Pierre & Hilliard, 2012). High quality health care is defined as 
care that is safe, effective, patient-centered, timely, efficient, and equitable (Agency for 
Healthcare Research and Quality, 2016). In 2010, more than 1 in 6 Americans under the age of 
65 did not have health insurance coverage, which accounted for over 49 million Americans 
(Kaiser Family Foundation, 2012). Historically, racial and ethnic minorities have been more 
likely to be uninsured and face more barriers to accessing care with Hispanic-Americans being 
vastly overrepresented, when compared to non-Hispanic whites (Artiga, Foutz & Damico, 2018).  
Over 30% of the 50.5 million Hispanic-Americans in the United States (U.S.) were uninsured in 
2010 (Office of the Assistant Secretary for Planning and Evaluation, 2011; Passel, Cohn & Hugo 
Lopez, 2011). The large number of uninsured Hispanic-Americans was of concern as this 
population makes up the largest minority group in the U.S. and is rapidly growing. After the 
passage of the ACA, the uninsured rate among nonelderly adult minority groups decreased from 
26% to 17% (reduction of 4 million uninsured) for Hispanics, 17% to 12% (reduction of 1.8 
million uninsured) for blacks and from 15% to 8% (reduction of 0.9 million) for Asians. 
Nonelderly adult whites’ uninsured rate fell from 12% to 8%, but this group saw the largest 
decrease in the number of uninsured (reduction of 6.7 million) as a result of the larger population 
size (Artiga, et al., 2018).  
The overall purpose of this research was to assess the impact of the ACA on reducing 
health disparities in coverage, access and the delivery of primary care services, specifically 
diabetes prevention for minority adults and those at high risk of developing diabetes. Non-
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Hispanic black and minorities of Hispanic descent between the ages of 18 to 64 were the 
population of interest as this group has experienced poor health outcomes related to their low 
rate of health insurance coverage in the U.S. (Ortega, Rodriguez & Bustamante, 2015). The 
income threshold of interest includes individuals living between 100% to 400% of the federal 
poverty level (FPL) since this demographic was expected to benefit from the ACA’s coverage 
expansion by either state Medicaid expansion or a health insurance subsidy. Diabetes was the 
health condition of interest as diabetes disproportionately affects racial and ethnic minorities, 
with minorities being at greater risk of developing diabetes than non-Hispanic whites (American 
Diabetes Association, 2017). Coverage, access, and the delivery of diabetes prevention is vital to 
ensuring high quality diabetes preventive care is being delivered to high risk individuals. The 
Conceptual Model of Nursing and Health Policy (CMNHP), the Institute for Healthcare 
Improvement’s (IHI) Triple Aim and the Modified Quality Health Outcomes Model were used to 
understand how the ACA’s coverage expansion provisions impacted diabetes preventive care in 
the U.S. It was anticipated that national coverage expansion would lead to increased access and 
delivery of diabetes prevention for individuals at high risk; ultimately leading to a decrease in 
health disparities in diabetes care.  
Research Questions, Aims and Hypotheses 
1. To what extent did the ACA’s Medicaid expansion and insurance subsidies improve 
insurance coverage, access to primary care and the subsequent delivery of diabetes 
prevention for U.S. adults aged 18 to 64?  
2. Did increases in insurance coverage lead to a reduction in disparities in accessing primary 
care and the subsequent delivery of diabetes prevention for minority adults and adults at 
high risk of diabetes aged 18 to 64 in the U.S.?  
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Specific Aim #1: (Analyze with BRFSS Data 2012-2017) 
1a. To determine the impact of the ACA’s coverage expansion on the likelihood that an adult 
aged 18 to 64 has health insurance coverage in the U.S. by income category.  
• Hypothesis #1a: When compared to the pre-ACA period, ACA’s subsidy and Medicaid 
expansions will not only lead to an increase in the percentage of lower income adults 
gaining health insurance coverage, but at a faster rate than for higher income adults post-
ACA implementation.  
1b. To determine the differential impact of the ACA’s coverage expansion on the likelihood that 
an adult aged 18 to 64 has health care coverage between Medicaid expansion versus non-
expansion states by income category.   
• Hypothesis #1b: When compared to the pre-ACA period, ACA’s subsidy and Medicaid 
expansions will not only lead to an increase in the percentage of lower income adults 
gaining health care coverage, but at a faster rate within Medicaid expansion states than 
non-expansion states post-ACA implementation.   
Specific Aim #2: (Analyze with BRFSS Data 2012-2017) 
2a. To determine the impact of the ACA’s coverage expansion on the likelihood that an adult 
aged 18 to 64 has health care access (i.e. a primary care provider or visited a physician for a 
routine visit) in the U.S. by race, then by diabetes risk status.  
• Hypothesis #2a: When compared to the pre-ACA period, ACA’s subsidy and Medicaid 
expansions will lead to an overall increase in health care access among racial/ethnic 
minority adults and adults at high risk of developing diabetes when compared to non-
Hispanic whites and those at low risk respectively, post ACA implementation.  
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2b. To determine the differential impacts of the ACA’s coverage expansion on the likelihood 
that an adult aged 18 to 64 has health care access (i.e. a primary care provider or visited a 
physician for a routine visit) in a Medicaid expansion versus non-expansion states by race, then 
by diabetes risk status. 
• Hypothesis #2b: When compared to the pre-ACA period, ACA’s subsidy and Medicaid 
coverage expansions will lead to an overall increase in the reporting of health care access 
among racial/ethnic minority adults and adults at high risk of developing diabetes when 
compared to non-Hispanic whites and those at low risk respectively within Medicaid 
expansion states than non-expansion states. 
Specific Aim #3: (Analyze with NAMCS Data 2012 to 2015) 
3a. To determine if the ACA’s coverage expansion increased the rate of diabetes screening and 
diabetes prevention education for adults within Medicaid expansion versus non-expansion states.  
• Hypothesis #3a.1: When compared to the pre-ACA period, ACA’s subsidies and 
Medicaid expansions will lead to an increased rate of diabetes screening and counseling 
overall, with greater proportions of adults receiving diabetes prevention within Medicaid 
expansion states than in non-expansion states post-ACA implementation.  
3b. To determine if the ACA’s coverage expansion increased the rate of diabetes screening and 
diabetes prevention education within Medicaid expansion versus non-expansion states by 
race/ethnic, then by diabetes risk status.  
• Hypothesis #3b.1: When compared to the pre-ACA period, ACA’s subsidies and 
Medicaid expansions will lead to an increased rate of diabetes screening and counseling 
overall, with greater proportions of black, Hispanic and high-risk adults receiving 
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diabetes prevention within Medicaid expansion states than in non-expansion states post-
ACA implementation.  
Background and Significance 
Access, Quality and Costs on the U.S. Agenda 
Historically, changes to federal health policy have occurred incrementally. Leading up to 
2010, the need for a reformed health care system became apparent as health care costs were 
escalating, millions of Americans were without health insurance coverage, and individuals and 
families were facing poor health outcomes nationwide. In 2009, the Organization for Economic 
Co-operation and Development (OECD) reported that the U.S. spent $7,598 dollars per capita on 
healthcare, which was roughly 48% higher than Switzerland, the next highest spending 
industrialized country (Kaiser Family Foundation, 2012).  The dramatic increase in health care 
spending was associated with technological advances, an aging and chronically ill population, and 
heath service misuse and overuse (Cromwell, Healy, Seeley, Trebino & Cromwell, 2013). Despite 
the additional spending on health care in the U.S., increased spending did not result in efficient nor 
improved health outcomes. Overall, the Unites States ranks last among eleven industrialized 
countries when it comes to measures of healthcare quality, access, equity and health outcomes 
(Mahon & Fox, 2014).  
Despite developments in prevention and treatment regimens, the benefits of these 
advancements have not been shared equally across economic and racial/ethnic groups in the U.S. 
(Havranek, Mujahid, Barr, Blair, Cohen, Cruz-Flores, Davey-Smith, Dennison-Himmelfarb, 
Lockwood, Rosal & Yancy, 2015).  This is of concern as the census projects that the U.S. will 
become “minority white” by 2045, with Hispanics making up 25.6% of the minority population 
(Frey, 2018). Currently, ethnic minorities living in the U.S. report lower health-related quality of life 
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(HRQoL) than non-Hispanic whites, with health disparities being prominent among Hispanics and 
non-Hispanic whites (Laiteerapong, Karter, John, Schwillinger, Moffet, Liu, Adler, Chin & Huang, 
2013). To add to the existing disparities in care, America’s fragmented health care system has led 
uninsured low-income adults to be greater utilizers of the emergency room for routine care when 
compared to low-income adults with insurance options (Collins, Robertson, Garber & Doty, 2012). 
The passage of the ACA’s Medicaid expansion and Marketplace subsidies was the first step to 
making health care accessible to low-income uninsured adults within the U.S. 
Key ACA Coverage Expansion Provisions 
 Medicaid was the primary driver in expanding coverage among the uninsured as it was 
expected that two-thirds of the new population would qualify to be covered by Medicaid (Jacobs 
& Callagan, 2013). Medicaid is a jointly funded federal-state health insurance program and is the 
third largest domestic program in the federal budget after Medicare and Social Security (Robin, 
2016; Social Security Administration, n.d) This safety net program is responsible for ensuring 
affordable health care coverage for low-income adults and children in the U.S. and is the third 
largest domestic program in the federal budget after Medicare and Social Security (Robin, 2016).  
Medicaid itself is a major source of coverage for ethnic minority groups as these groups are more 
likely to be in low-income, low-wage jobs that provide limited access to employer-sponsored 
health care coverage despite having at least one family member working in a full-time position. 
Nearly two-thirds of uninsured blacks and Native Americans/Alaska Natives and over half of 
uninsured Hispanics had incomes below 138% of the federal poverty level (FPL) (Kaiser Family 
Foundation, 2013).  
 In 2009, 27% of Hispanics were covered by Medicaid, compared to 11% of non-Hispanic 
whites, making Medicaid a major source of coverage for this minority population (Kaiser Family 
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Foundation, 2011). The benefits of adequate access to coverage for uninsured Hispanics have 
been demonstrated with Medicaid state expansions that occurred before the ACA. Medicaid 
expansion in Oregon showed that Spanish-speaking Hispanics made major coverage gains as 
witnessed in the drop in the uninsured rate from 64.3% to 13.7% (Alcala, et al., 2017). Across all 
racial and ethnic groups, previous studies on Medicaid expansion were associated with positive 
health outcomes including: decreased rates of delayed care due to costs, increased rates of self-
reported health status of “excellent” or “very good”, and a significant reduction in adjusted all-
cause mortality. The reduction in mortality was the greatest among minorities, older adults and 
those with the lowest incomes (Sommers, Baicker, Epstein, 2012). Despite the benefits of 
Medicaid expansion, the success of improving coverage for newly eligible individuals was 
contingent upon the expansion of Medicaid across all states.  
Since the enactment of Medicaid in 1965, federal law required states to cover certain 
groups of people in order to receive matching federal funds. Before the ACA, the mandatory 
coverage groups included primarily pregnant women and children under 6 years old living at or 
below 133% of the FPL, children aged 6 to 18 with family incomes at or below 100% FPL, 
people with disabilities who qualify for Supplemental Security Income (SSI) benefits and 
caretaker relatives who meet the financial eligibility requirements for the former cash assistance 
program. Medicaid eligibility remained limited or nonexistent for working parents and non-
disabled, non-pregnant adults without dependent children. To increase coverage options for low-
income adults, the ACA required Medicaid participating states to cover nearly all individuals 
under the age of 65 who had incomes at or below 138% FPL (Kaiser Family Foundation, 2012). 
For low-income adults who did not meet Medicaid eligibility (< 138% FPL), a subsidized 
Marketplace was implemented on Oct. 1, 2013, making health insurance affordable for 
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individuals and families living between 100 to 400% FPL. (Green, 2013; Abdus, et al., 2015).  
The Marketplace was a health insurance exchange made up of health plans. Through the 
Marketplace individuals gained access to premium tax credits and cost-sharing subsidies either 
through the state or federal government (Kaiser Family Foundation, 2012).  It was estimated that 
60% of the uninsured would obtain coverage through one of the two ACA expansion provisions 
by 2019 (Brown & McBride, 2015).  In order to ensure individuals enrolled in coverage, the 
ACA also included an individual mandate which would require individuals to have health care 
coverage or pay a penalty beginning in 2014 (Kaiser Family Foundation, 2012).  
Even before the implementation of ACA’s coverage expansion, in 2011, the state of 
Florida, along with 25 other states filed a lawsuit challenging the constitutionality of the ACA’s 
Medicaid expansion in the Florida v. Department of Health and Human Services case which was 
rolled up into the National Federation of Independent Business (NFIB) v. Sebelius case (Kaiser 
Family Foundation, 2012; Smith, 2012). In the NFIB v. Sebelius case, the U.S. Supreme court 
reviewed the constitutionality of the health care subsidies, the individual mandate and the ability 
of the government to enforce Medicaid expansion.  Chief Justice John Roberts upheld the 
individual mandate and tax subsidies within the ACA (Liasson, Totenberg & Montagne, 2015). 
In June 2012, the U.S. Supreme Court ruled that the ACA could not enforce states to expand 
Medicaid as Chief Justice Roberts concluded that a federal condition on a grant to states was 
unconstitutionally coercive; as a result, expansion remained optional to states (Kaiser Family 
Foundation, 2012; Jacobs & Callagan, 2013).  
Beginning January 1, 2014, Medicaid expanded up to 138% FPL in states that chose to 
expand the program (Sommers, Gunja & Finegold, 2015). Full federal financing was available 
from 2014 through 2016, which would be reduced to 90% by 2020 for Medicaid expansion 
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states, allowing non-traditional Medicaid recipients (childless adults or very low-income parents) 
access to health care coverage through this program (Decker, Kostova, Kenney & Long, 2013; 
Herman & Cefalu, 2015). After 2016, the federal share (FMAP) varies by state, from a floor of 
50% to a high of 74%, depending on a state’s demographics (Rudowitz, 2016). From 2010 to 
2014, six states (California, Colorado, Connecticut, Minnesota, New Jersey and Washington) and 
the District of Columbia expanded Medicaid early, with a total of 31 states expanding Medicaid 
by mid-2016 (Kominski et al., 2017). As of January 2018, 33 states including D.C. expanded 
Medicaid (FamiliesUSA, 2018). States that did not expand Medicaid left at least 4 million 
American low-income adults with a coverage gap. (Herman & Cefalu, 2015). 
It is important to note that the ACA allowed for “qualified non-citizens” or green card 
holders to enroll in marketplace plans (Doty & Collins, 2017). There are no provisions 
addressing health care coverage for undocumented immigrants, although states could choose to 
provide coverage. For example, the state of California has allowed undocumented persons to 
participate in the insurance marketplace without subsidies (Alcala et al., 2017).  The lack of 
coverage options for undocumented immigrants has been of major concern for the Hispanic 
population as Hispanics of Mexican origin make up the majority of undocumented immigrants in 
the U.S. (Passel & Cohn, 2014).  
Access to Care post ACA  
The coverage provisions reduced income-related inequities within our current health care 
system as it allowed families and individuals in the bottom half of the income distribution equal 
access to the health care (Collins et al., 2012).  Focusing on Medicaid expansion and the 
reduction of socioeconomic disparities specifically, health care access for low-income 
individuals improved in both Medicaid expansion states and non-expansion states; with larger 
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gains in states that expanded (Griffith, Evans & Bor, 2017). Newly insured adults with Medicaid 
or Marketplace coverage reported high satisfaction with their coverage, physician options, 
affordability and access to care (Kominski et al., 2017). By 2016, the uninsured rate for 
nonelderly blacks reduced from 18.9 percent to 11.7 percent, with blacks having higher 
uninsured rates than whites (7.5%) and Asians (6.3%) (Bailey, Broaddus, Gonzalez & Hayes, 
2017). Current analyses among the remaining 19 non-expansion states show that adults with the 
highest uninsured rates under the current law continue to be individuals with less than a high 
school education (38.1%), the unemployed (32.5%) and Hispanics (26.8%) (Buettgens & 
Kenney, 2016). The high uninsured rates among Hispanics is of concern as Hispanics are the 
fastest growing population in the U.S., with 55.4 million people in 2014 self-identifying as 
Hispanic. By 2060, the number of Hispanics in the U.S. is expected to double, representing about 
a third of the U.S. population (Pew Research, 2015). Among the Hispanic population, it was 
estimated that 8 million (of the 10.2 million uninsured Hispanics) would qualify for Medicaid or 
a subsidized insurance plan via the Health Insurance Exchange (Ortega et al., 2015). 
Currently, 3 in 5 Hispanics live in a state that chose to expand Medicaid with large 
portions of Hispanics being newly eligible for insurance coverage by the Marketplace, with high 
subsidies (Abdus, et al., 2015). At the end of the ACA’s first open enrollment period, the 
uninsured rate for working-age Hispanic adults decreased from 36% to 23%, compared to 16% 
to 12% for non-Hispanic white adults. Hispanics continued to experience barriers to enrollment, 
such as language difficulties, a lack of awareness of current legislation and effects of state 
decisions to not expand Medicaid eligibility, leading to a number of Hispanics remaining 
uninsured (Doty, Blumenthal, Collins, 2014). Research on the first year of the ACA coverage 
expansion provisions has shown that approximately 1 in 3 Hispanics with a chronic disease 
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continued to lack coverage and access to care after ACA implementation (Torres, Poorman, 
Tadepalli, Schoettler, Ho Fung, Mushero, Campbell, Basu & McCormick, 2017). Among blacks, 
the second largest racial group to be uninsured, The Center on Budget and Policy Priorities 
estimates that about 806,000 African Americans would come out of the coverage gap if non-
expansion states expanded Medicaid (Bailey et al., 2017).  
Diabetes on the Rise in the United States 
 Diabetes and Access to Care. Diabetes is classified into two distinct categories, Type 1 
and Type 2. About 90 to 95% of the diabetes burden is related to Type 2 diabetes, which is a 
preventable health condition and the focus of this research. In Type 2 diabetes, insulin resistance 
leads muscle, fat and livers cells to not absorb glucose from the bloodstream. Insulin is a 
hormone produced in the pancreas and plays a major role in metabolism. As a result, higher 
levels of insulin are needed to move glucose into the cells. Research has shown that excess 
weight and physical inactivity are major contributors to the development of insulin resistance. 
Being overweight or obese, with excess abdominal fat, is a primary cause of insulin resistance 
(National Institute of Diabetes and Digestive and Kidney Diseases, 2009). The 2013-2014 
National Health and Nutrition Examination Survey (NHANES) found that more than 2 in 3 
adults or 70.2 percent were considered to be overweight (32.5%) or obese (37.7%) (National 
Institute of Diabetes and Digestive Kidney Diseases, 2017). Physical activity is important for 
overcoming insulin resistance as active muscles burn stored glucose for energy and refill 
reserves with glucose from the bloodstream, keeping blood glucose levels within the normal 
range. Additional factors found to affect insulin resistance include: ethnicity, certain diseases, 
hormones, steroid use, some medications, older age, sleep problems and cigarette smoking 
(National Institute of Diabetes and Digestive and Kidney Diseases, 2009).  
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Insulin resistance occurs overtime, with initial symptoms showing up as pre-diabetes, 
where individuals are asymptomatic. Studies have shown that individuals with prediabetes 
develop type 2 diabetes within 10 years if they do not change their lifestyle (National Institute of 
Diabetes and Digestive and Kidney Diseases, 2009). Pre-diabetes is defined as having impaired 
fasting glucose which is a fasting plasma blood glucose in the 100-125mg/dL or impaired 
glucose tolerance, which is a blood glucose of 140-199 mg/dL 2 hours after the administration of 
glucose, or a A1C of 5.7%-6.4% (Joslin Diabetes Center, 2017; American Diabetes Association, 
2017). Non-modifiable risk factors for type 2 diabetes or pre-diabetes include: age, 
race/ethnicity, family history, history of gestational diabetes and low birth weight. Modifiable 
risk factors include: Poor mental health status, inactivity, poor nutrition, hypertension, smoking 
and alcohol use, with increased body mass index (> or = 25) being one of the strongest risk 
factors for the development of diabetes (Deshpande, Harris-Hayes, Schootman, 2008).  
Even though the U.S. is home to about 6% of people living with diabetes, the U.S. 
accounts for nearly half of all global diabetes-related expenditures (Zeytinoglu & Huang, 2015). 
In fact, the U.S. spends 1 in 10 health care dollars on diabetes-related care, making diabetes one 
of the costliest chronic conditions to manage (Zeytinoglu & Huang, 2015). It was estimated that 
between 2011 and 2012, more than 13 million U.S. adults aged 19 to 64 were living with 
diagnosed diabetes, with almost 2 million of these individuals lacking health insurance. Being 
uninsured increases the rate of undiagnosed or poorly managed diabetes, which can lead to 
serious health conditions such as heart disease, stroke, kidney disease, hypertension, neuropathy 
and blindness (Brown & McBride, 2015). Among those with an existing diagnosis of diabetes, 
insurance coverage was associated with significantly lower hemoglobin A1C levels, indicating 
better management of diabetes (Hogan, Danaei, Ezzati, Clarke, Jha & Salomon, 2015).  
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Kaufman et al. (2015) conducted a study after the ACA coverage expansion which 
showed a 1.6% increase in newly identified diabetes cases across the U.S. In expansion states, 
Medicaid patients had a 23% increase in having newly identified diabetes, compared to a 0.4% 
increase in non-expansion states (Kaufman, Chen, Fonseca & McPhaul, 2015). This study 
highlighted the important role health care coverage plays in preventing and managing diabetes. 
Without adequate health insurance coverage, individuals with chronic disease do not have access 
to the health care system, leading to disparities in care. As the previously uninsured gained 
access to the health care system, an increased demand for primary care services was anticipated, 
especially among racial/ethnic minorities within Medicaid expansion states. Eight states 
(Oklahoma, Georgia, Texas, Louisiana, Arkansas, Nevada, North Carolina, and Kentucky) were 
expected to face the greatest challenges with Medicaid expansion since these states had weak 
primary care capacity before the passage of the ACA. This challenge could impact the quality of 
care delivered to newly insured and existing insured patients as newly insured populations 
demand more primary care services (Ku, Jones, Shin, Bruen & Hayes, 2011).  
Diabetes and Racial/Ethnic Health Disparities 
In 2003, the Institute of Medicine’s (IOM) Report “Unequal Treatment: Confronting 
Racial and Ethnic Disparities in Health Care” noted that African Americans, Hispanics and 
Native Americans experience a 50-100% higher burden of illness and mortality from diabetes 
than white Americans (Chow, Foster, Gonzalez & McIver, 2012).Type 2 diabetes 
disproportionally affects racial/ethnic groups that have historically made up a disproportionate 
share of the poor and uninsured in the U.S. This includes Blacks, Native Americans, Hispanics, 
Asians and Pacific Islanders (Alliance to Reduce Disparities in Diabetes, 2011). Figure A-1 
shows the U.S. poverty rates by race and ethnicity from 1961-2015.  In 2015, the poverty rate for 
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blacks was 24.1%, 21.4% for Hispanics, 11.4% of Asians, and 9.1% of whites. The overall 
poverty rate for the population was 13.5%. (Institute for Research and Poverty, 2016). Being of 
low socio-economic status increases one’s risk of developing diabetes as low-income 
populations tend to live in low-income neighborhoods with a lack of resources to healthy foods, 
safe neighborhoods and health care access. As a result, the environment, in conjunction with 
genetic factors, plays a major role in the higher rates of overweight and obesity in minority 
populations, predisposing these groups to an increased prevalence of diabetes (Alliance to 
Reduce Disparities in Diabetes, 2011). 
In addition to income, previous research has found significant associations between 
diabetes and age, educational attainment, marital status, health insurance, usual source of care, 
BMI, total dietary calories, and physical activity among Hispanics (O’Brien, et al., 2014). 
Among Hispanics, diabetes is the fifth leading cause of death with this population being 50% 
more likely to die from diabetes than non-Hispanic whites (Centers for Disease Control and 
Prevention, 2016). In practice, Hispanics frequently experience barriers to receiving better 
diabetes care which include: a lack of insurance coverage, linguistic, cultural, immigration status 
and socioeconomic barriers (Alcala, Chen, Langellier, Roby & Ortega, 2017). Among the U.S. 
Hispanic population, Mexican-Americans, the largest Hispanic subgroup, bear the largest 
diabetes burden when compared to non-Hispanic whites (20.1% vs. 11.0%, respectively) 
(O’Brien, Alos, Davey, Bueno & Whitaker, 2014). U.S.-born Hispanics tends to be less healthy 
than Hispanic immigrants and the expected increase in the older Hispanic population will be 
related to U.S. births rather than individuals from Spanish-speaking countries (PewResearch, 
2008). Before coverage expansion, more than one-fourth of Hispanic adults reported that they 
lacked a usual health care provider. In fact, when compared to blacks, Hispanics were twice as 
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likely to lack a regular health care provider; and three times as likely as Whites (Pew Research 
Center, 2008). This is problematic as diabetes prevention is most effective when a patient has a 
regular source of care. As a result, uninsured Hispanics are less likely to get recommended care 
for disease prevention and management, contributing to the health disparities seen in diabetes 
care (Agency for Healthcare Research and Quality, 2014).  
According to the Office of Minority Health (2017), an individual’s sex also plays a role 
in creating disparities in diabetes care. African American women have the highest rates of being 
overweight or obese when compared to other racial and ethnic groups in the U.S. African 
Americans were 1.4 times as likely to be obese than non-Hispanic whites. The Office of 
Minority Health estimates that four out of five black women are overweight or obese. In 2015, 
black women were 60% more likely to be obese than non-Hispanic white women (U.S. 
Department of Health and Human Services Office of Minority Health, 2017). Kieffer et al. 
(2001) found that disparities exist in women’s health among women aged 14 to 47 of 
childbearing age. In their study, 47% of black women and 37% of Latinas were overweight or 
obese, with 53% of black women and 38% of Latinas gaining excessive weight during 
pregnancy. Excessive weight gain during pregnancy is of concern given the risk of developing 
gestational diabetes. Hispanic women were found to be 2.5 times more likely than black women 
to develop gestational diabetes. Having gestational diabetes increases one’s risk of developing 
type 2 diabetes (Kieffer, Carman, Gillespie, Nolan, Worley & Guzman, 2001). Robbins et al. 
(2001) found that socioeconomic status was associated with type 2 diabetes prevalence among 
women, but not consistently among men using the National Health and Nutrition Examination 
Survey. Diabetes was found to be more strongly associated with poverty than education or work 
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status. The study found no significant associations between poverty, education, occupational 
status and diabetes for African American men (Robbins, Vaccarino, Zhang & Kasl, 2001).  
Interestingly, the Asian population is also rapidly growing and grew by 46% from 2000 
to 2010. Despite their rapid growth, limited population-based research exists about diabetes and 
Asian Americans (Joslin Diabetes Center, 2016; McNeely & Boyko, 2004). Similar to the 
Hispanic population, the Asian population is very diverse. This population is comprised of 
Chinese (24%), Filipino (18%), Asian Indian (16%), Vietnamese (11%), Korean (11%), Japanese 
(8%), and other Asian (13%) ancestry (McNeely & Boyko, 2004). The 2011-2012 National 
Health and Nutrition Examination Survey (NHANES) showed that 20.6% of Asians have Type 1 
& Type II diabetes; 32.2% of Asians have pre-diabetes; and 50.9% of Asians having 
undiagnosed diabetes. The percent of undiagnosed diabetes was higher than any other ethnic or 
racial group, meaning that one in two Asians in the U.S. will have diabetes or prediabetes.  
(Joslin Diabetes Center, 2016). The higher risk is most likely due to having less muscle and more 
abdominal fat, which increases insulin resistance. Asians, particularly men, have also been found 
to be higher users of tobacco products.  
While some Asian populations have a lower prevalence of being overweight or obese, or 
lower BMIs, they still have a greater number of people with diabetes when compared to non-
Hispanic whites (Asian Diabetes Prevention Initiative, n.d.). Overall, when adjusting for the 
lower BMI of Asians, the adjusted prevalence of diabetes is 60% higher for Asians than non-
Hispanic whites (McNeely & Boyko, 2004). A study by Karter et al. (2013) found the highest 
prevalence among racial and ethnic groups was among Pacific Islanders (18.3%), followed by 
Filipinos (16.1%) South Asians (15.9%), Latinos (14%), African Americans (13.7%), Native 
Americans (13.4%), Southeast Asians (10.5%), Japanese (10.3%), Vietnamese (9.9%), Koreans 
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(9.9%) and Chinese (8.2%) (Karter, Schillinger, Adams, Moffet, Liu, Adler & Kanaya, 2013). 
Native Hawaiian and Pacific Islanders (NHPI) tend to be the smallest ethnic group and in the 
2010 NHIS, this group had 42% of participants reporting obesity (Matias Bacong et al., 2016). 
When Pacific Islanders were aggregated with all Asian categories, the prevalence rate was 
12.3%. The prevalence rate for diabetes for Asians as an aggregate was 12.2%. Many national 
health surveys before the year 2000 classified Asians as “other race” or, if recognized, combined 
them with Pacific Islanders, making variations among subgroups difficult to distinguish (Karter 
et al., 2013).  
Native Americans over 18 years old have a high age-adjusted prevalence of diabetes 
(17.6%) (U.S. Department of Health and Human Services Office of Minority Health, 2016). 
Factors that contribute to a high rate of diabetes among this population include: genetic 
predisposition to insulin resistance, sedentary lifestyles, obesity and stress-producing 
environments. Throughout U.S. history, health care has been guaranteed to Native Americans in 
exchange for the millions of acres of lands that now make up the U.S. (National Congress of 
American Indians, 2018); yet Native Americans have experienced forced acculturation, warfare 
and severely underfunded health services through the Indian Health Services, leading to severe 
health disparities (Warne & Frizzell, 2014). From 1999 to 2003, the National Center for Health 
Statistics reported that Native adults are more likely to be obese than their white, black or Asian 
counterparts, with about 70% of Native adults being obese. When Schulz et al. (2006) compared 
the prevalence of obesity and type 2 diabetes in U.S. Pima Natives to individuals of Mexican 
descent, the natives had significantly higher rates of obesity and type 2 diabetes. The increase 
prevalence of obesity and diabetes was related to lower intake of dietary fiber, higher intake of 
dietary fat and less activity during work or leisure (McLaughlin, 2010).  
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Relationship between Health Disparities and Quality in Diabetes Care 
  One of the strongest predictors of health is socioeconomic status (SES) (Colen, Ramey, 
Cooksey & Williams, 2018). Link & Phelan’s (1995) Functional Cause Model highlights SES as 
the basic cause of health disparities as it has become increasingly common knowledge that social, 
economic and environmental factors influence an individual’s opportunities for developing good 
health behaviors (Heiman & Artiga, 2015). Although other conceptual models incorporate race 
when addressing health disparities, race itself is not considered a basic cause of health disparities in 
the functional model as previous research has closely linked socioeconomic status to race (Diez 
Roux, 2012). However, the association between SES and health is complex for certain minority 
groups. For instance, health disparities are often more prominent between African Americans and 
non-Hispanic whites with high SES than between the same groups with low SES. Upward mobility 
does not seem to improve health outcomes for African Americans as it does for whites. Among the 
Hispanic population, the association between SES and health is less pronounced when compared to 
non-Hispanic whites. Hispanics tend to experience better overall health outcomes given their low 
SES status (Colen et al, 2018).  
In 1999, the National Academy of Medicine, then, the Institute of Medicine (IOM) found 
scientific evidence that ethnic minorities receive poorer quality health care than whites in both 
simple treatments, as well as in the most technologically advanced services (Parks, 2016). The 
Agency for Healthcare Research and Quality (AHRQ) has also recognized racial and ethnic 
minorities, women, children, low-income groups, the elderly, rural residents and individuals with 
disabilities as priority groups for addressing health disparities (White, Beech & Miller, 2009).  
Racial and ethnic health disparities are defined as variations in the quality of health care that are 
not due to access-related factors or clinical needs, preferences, and appropriateness of an 
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intervention (Gold, 2014). Every year since 2003, AHRQ has documented that widespread 
disparities are persistent throughout the U.S. The National Healthcare Disparities Report, 
AHRQ (2003) defines a health disparity as differences among populations that are statistically 
significant with a difference from the reference group by at least 10% (LaVeist & Isaac, 2013).  
Despite the advantages of health insurance coverage in reducing disparities in access to 
care, disparities in health care delivery still exist, even among the insured. Through 2013, racial 
and ethnic minorities continued to receive less than optimal care for 40% of the quality measures 
assessed, with Asians receiving worse care for 20% of the measures (Maina, Belton, Ginzberg, 
Singh & Joshnson, 2018).The IOM report, Unequal Treatment, attributed health disparities to 
differences in the quality of care received within health care institutions (Peek, Cargill & Huang, 
2007).  Even when clinicians are aware that dietary and physical activity counseling are 
important parts of diabetes care, significantly fewer Hispanics, blacks, lower-income individuals 
and individuals with less than a high school education were told by their physician that they were 
overweight (White et al., 2009). Differential treatment of members of a specific group by 
individuals and social institutions has adverse effects on physical and mental health. There is 
scientific evidence that links racial discrimination to poor health, leading to psychological and 
physiological stress responses, unhealthy coping behaviors and lower health care utilization. In 
fact, racial minorities who deny that racism exists are at an increased risk for adverse health 
outcomes and lower health care utilization. Perceived racial discrimination in diabetes care 
among black men and women indicated an association between perceived discrimination and 
higher HbA1c levels for black men, but not black women (Assari, Lee, Nicklett, Lankarani, 
Piette & Aikens, 2017).  As IHI’s Chief Scientific Officer Emeritus and Senior Fellow Don 
Goldman quoted, “the uncomfortable truth is that we live in a society in which stereotypes about 
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groups of people are ubiquitous, and it follows that almost everyone has some implicit bias” 
(Institute for Healthcare Improvement, 2018).  
Provider bias manifests itself in two forms- explicit and implicit. Explicit biases are 
conscious attitudes which are measured through self-report but could easily be falsely reported in 
order to align with current societal beliefs and attitudes (Maina, et al., 2018). Implicit biases are 
unconscious and the provider may not be aware of these beliefs but these beliefs influence 
personal behavior and actions (Hayman & Worel, 2016; Maina et al., 2018). Implicit bias can be 
measured by the provider or through the patient’s experience of discrimination. Current research 
shows that when compared to non-Hispanic whites, minorities believe they would receive better 
care and respect from health care providers if they belonged to another racial group (Maina, et 
al., 2018).  It has been found that in some cases, minority individuals with higher levels of SES 
tend to report more instances of discrimination.  
Discrimination via implicit bias may result in lower-quality clinical interactions between 
clinicians and minority patients, leading minority patients to perceive biased treatment. In return, 
this perception of biased treatment has been associated with self-reports of poorer health status, 
self-care, adherence to treatment plans and the under-utilization of health care services (Hayman 
& Worel, 2016). Discrimination negatively influences the quality of clinical interactions between 
clinicians and patients, as well as a patient’s physical well-being. The perception of biased 
treatment (or discrimination) has been associated with self-reports of poorer health status, self-
care, adherence to treatment plans, the under-utilization of health care services, including 
elevated levels of stress in patient’s, meaning- individuals who endure discrimination over time 
are expected to have worse health outcomes than those with limited or less frequent stressors 
(Hayman & Worel, 2016; Colen et al., 2018).  
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Systemically, the federal government, insurance companies and health care systems have 
invested substantial resources on developing quality improvement programs to improve health 
outcomes and reduce disparities in care. For example, the Veterans Health Administration 
(VHA), which is the largest integrated health care system in the country, in 2004 reported 
measures of diabetes care and outcomes that were much higher than the national average due to 
the vast investment in quality improvement initiatives. Eye examinations were reported to be 
91% and HbA1c testing was 93%, with studies suggesting that improved quality improvement 
efforts have decreased racial and ethnic disparities in diabetes care among the veteran 
population. However, another study found that when VHA data is paired with Medicare claims 
data, health disparities among African Americans and Hispanics reemerged or worsened when 
compared to VHA-only data (Peek, Cargill & Huang, 2007). As the VA is not the sole provider 
for veteran care, disparities continued with access to non-VA data. From a system’s perspective, 
systemic differences in treatment, access and outcomes between individuals and across 
populations are problematic as inequities are the worst type of variation within a system. These 
variations in care are unjust as they are linked to forms of oppression that inhibit specific groups 
from achieving positive health outcomes (Institute for Healthcare Improvement, 2018).  
In order to promote positive health outcomes for racial/ethnic minorities, Weintraub et al. 
(2011) suggest that policy and environmental change is important to influence behavior’s shaped 
by an individual’s physical, social and cultural environments. A national policy change (such as 
the ACA) has the ability to improve the accessibility to health care coverage and primary care 
services for vulnerable populations, potentially leading to improvements in diabetes preventive 
care. National and state-level policies have been shown to reduce individual-specific behaviors 
and remove barriers for risk reduction and behavior change. In fact, research continues to 
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demonstrate that policy change is one of the most impactful ways to improve the health of large 
segments of the population (Weintraub et al. 2011). The ACA’s coverage expansion reduced the 
burden of being uninsured by increasing options for affordable health care for low-income 
adults, many of who were racial/ethnic minorities.   
Measuring the Quality of Diabetes Prevention and Management 
 Measuring Health Care Quality in Populations. The IOM (2013) reports lower levels of 
population health are a result of varying degrees of access to health care, unhealthy health 
behaviors, adverse economic and social conditions, environmental factors, social values and public 
policies that lead to these conditions. The health disadvantages are more pronounced among racial 
and ethnic minority groups and socioeconomically disadvantaged groups living within the U.S. 
(Institute of Medicine, 2013). To improve population health, interventions directed toward 
preventing disease and promoting, restoring and maintaining wellness are necessary to promote the 
highest quality of life for groups of people (Fawcett & Ellenbecker, 2015).  Although clinical 
guidelines are key to improving health care, care must also be individualized to the patient in order 
to promote optimal outcomes. As a result, efforts to improve population health require a 
combination of system-level and patient-level approaches and methods to track quality from a 
patient and system perspective (American Diabetes Association, 2017).  
 Health-related quality of life (HRQoL) goes beyond the direct measures of population health 
and focuses on the impact of health status on quality of life, from an individual’s perspective. There 
are several measures for HRQoL, but Health People 2010 focuses on three distinct measures: 
Patient-Reported Outcomes Measurement Information System (PROMIS) Measure of Global 
Health, Well-Being Measures and Participation Measures. NIH PROMIS Measures focus on self-
rated health, physical HRQoL, mental HRQoL and individual questions on fatigue, pain, emotional 
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distress, social activities and roles. Well-Being indicators focus on measuring when people feel very 
healthy and satisfied or content with life. Positive evaluations of life have been associated with a 
decreased risk of disease, illness and injury. Participation measures focuses on an individuals’ 
assessment of the impact their health has on their social participation (i.e. education, employment, 
civic, social and leisure activities) within their environment. These measures are important to 
understanding how a person with functional limitations views their quality of life, without assuming 
poor functional status is an indicator of poor quality of life (Office of Disease Prevention and 
Promotion, 2017).  
  Measuring Health Care Quality in Systems. Provider and institutional behavior became 
an issue of concern when hospitals gained nation-wide attention for poor performance in 1999, with 
the publication of the Institute of Medicine (IOM) Report, To Err is Human.  This report 
highlighted the alarming statistic that between 44,000 to 98,000 patients die in hospitals yearly due 
to preventable medical errors. This report was instrumental in increasing awareness around poor 
quality and the direct impact poor quality had on the lives of patients and families. This report also 
increased the awareness of the societal burden poor healthcare quality produced on costs by means 
of lost productivity of workers and lower levels of population health status (IOM, 1999). The 
American Diabetes Association has recognized that even when adjusting for barriers to care for 
certain segments of the population, young adults, patients with complex comorbidities, those who 
experience financial hardships and/or individuals with limited English proficiency continue to 
experience variability in the quality of diabetes care provided across providers and practice settings. 
This is an indication that substantial system level improvements are still needed within the health 
care system (American Diabetes Association, 2017).  
 Health care quality itself, is difficult to measure, especially within the U.S. health care 
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system where care is highly fragmented, with limited public health and primary care resources and a 
large uninsured population (Institute of Medicine, 2013). The IOM has defined quality as “the 
degree to which health services for individuals and populations increase the likelihood of desired 
health outcomes and are consistent with current professional knowledge” (Aron, 2014). Historically, 
quality was measured at the individual level (i.e. per procedure or per patient) and has now moved 
to evaluating system performance (Getzen, 2010). In order to evaluate system performance, metrics 
(or quality indicators) and clinical guidelines have been developed to track and reduce inappropriate 
variations in practice and to promote high quality care that is based on evidence (Thomas, 1999). 
Since the 1990’s, there have been landmark studies on diabetes that have changed the evidence over 
time and the results have informed the development of clinical practice guidelines by a variety of 
organizations with recommendations differing dependent on the interpretations of the inferences 
drawn from individual studies. Most quality measurement in diabetes care is focused within the 
ambulatory setting and includes measures of process and intermediate outcomes. Quality 
measurement includes having access to pertinent health information and data, which is easier to 
capture with the use of integrated health system technology (Aron, 2014). Health care organizations 
are motivated to focus on the health of populations and practicing continuous quality improvement 
efforts due to marketplace incentives to provide more efficient care, due to the mission of health 
professions to provide more effective care, and by the demands placed on providers by payers to 
demonstrate quality of care (Derose & Petitti, 2003).  
 Primary Care Measures for Diabetes Care within PCMH and ACOs. The ACA was 
also instrumental in improving the effectiveness of care coordination within primary care services 
through the creation of two new health system delivery models focusing on primary care- the 
patient-centered medical home (PCMH) and Accountable Care Organization (ACOs). Generally 
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speaking, PCMHs focus on providing the direct coordination of services, whereas ACOs provide 
the infrastructure and incentives for collaboration to occur across providers and organizations. The 
two main goals of care coordination are to transfer information (to and from the patient, as well as 
across providers and systems) and to establish accountability for a patient’s overall care (Agency for 
Healthcare Research and Quality, 2010). The creation of PCMHs and ACOs were essential to 
improving diabetes care as the Centers for Disease Control and Prevention (2010) has reported that 
among adults with prediabetes, only 11.6% were made aware by the physician of their health 
status. A greater exchange of health information and accountability was necessary to reduce 
disparities in care and improve health outcomes within the primary care setting.  
 As the demand for accurate and useful information has increased, the Centers for 
Medicare & Medicaid Services (CMS), Medicare and Medicaid managed care plans, purchasers, 
physicians and other care provider organizations have developed the Core Quality Measures 
Collaborative. This Collaborative developed a set of core measures to reduce variability in the 
selection of measures, collection of data, and cost across both commercial and government 
payers. Quality improvement in eight areas was the focus of CMS to provide more effective and 
efficient care. The eight areas include: (1) ACOs, PCMHs and Primary Care, (2) Cardiology, (3) 
Gastroenterology, (4) HIV and Hepatitis C, (5) Medical Oncology, (6) Obstetrics and 
Gynecology, (7) Orthopedics and (8) Pediatrics (Centers for Medicare & Medicaid Services, 
2017).  
 Within the first core measure (ACOs, PCMHs and Primary Care), there are eight focus 
areas which include: Cardiovascular Care, Diabetes, Care Coordination/Patient Safety, 
Prevention and Wellness, Utilization & Cost/Overuse, Patient Experience, Behavioral Health, 
and Pulmonary.  Within the Diabetes core measure, there are five measures which include 
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HbA1C control, HbA1C testing, eye exam, foot exam, and medical attention for nephropathy. 
Table 1 explains each measure in greater detail. The Diabetes core measure does not focus on 
pre-diabetes. The Core Quality Measures Collaborative was well aware of this and identified 
preventive diabetes measures (i.e. prediabetes) as an area for future metric development. The 
closest the core measure set comes to measuring pre-diabetes is under the prevention and 
wellness measure for Body Mass Index (BMI) Screening and Follow-up. This measure tracks the 
percentage of patients aged 18 and older with BMI documented in their chart during the visit or 
in the past 6 months. If the BMI is outside of normal range (i.e. Normal Parameters: Age 65 
years and older BMI >/ = 23 and < 30; Age 18 – 64 years BMI >/ = 18.5 and < 25) a follow-up 
plan is documented during the encounter or in the past 6 months (Centers for Medicare & 
Medicaid Services, 2017).  
Practice Guidelines for Diabetes Prevention and Management. Diabetes prevention is 
important to control the rising prevalence of diabetes, as it has been estimated that 79 million 
adults have pre-diabetes (Thorpe, 2012). As diabetes and obesity continue to effect individuals at 
younger ages, primordial and primary prevention across the lifespan are necessary (Weintraub, 
Daniels, Burke, Franklin, Goff, Hayman, Lloyd-Jones, Pandey, Sanchez, Parsons Schram & 
Whitsel, 2011). Preventive care includes: primordial, primary, secondary and tertiary prevention 
methods. Primordial prevention focuses on the prevention of the development of risk factors 
(Weintraub, et al., 2011). Primary prevention includes methods to prevent occurrence of disease; 
secondary prevention includes methods that identify and treat disease early; while tertiary 
prevention methods reduce the impact of a diagnosed disease and prevent complications (Centers 
for Disease Control and Prevention, n.d.). Previous research has shown that disparities exist by 
race/ethnicity and socioeconomic status in the use of preventative services, where minority 
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populations are less likely than whites to receive routine preventive care (Holden, Chen & 
Dagher, 2015). As a result, it is important to focus on disease prevention and ensuring that 
disparities do not exist at the point of care in order to decrease the prevalence of diabetes.  
The American Diabetes Association’s (ADA’s) Standards of Medical Care in Diabetes 
(2018) are new clinical guidelines with evidenced-based recommendations from an expert panel, 
with a focus on the primary care setting. Criteria for testing for diabetes or prediabetes in 
asymptomatic adults includes testing for overweight or obese (BMI >= 25kg/m2 or 23kg/m2 in 
Asian Americans) adults who have one or more of the following risk factors: A1C>=5.7%, 
impaired glucose tolerance, or impaired fasting glucose on previous testing, first degree relative 
with diabetes, high-risk race/ethnicity (including Hispanics), women diagnosed with gestational 
diabetes or polycystic ovary disease, history of cardiovascular disease, hypertension (>= 140/90 
mmHg or on therapy for HTN), HDL cholesterol level <35mg/dl and/or triglyceride level 
>250mg/dL, physical inactivity and other clinical conditions associated with insulin resistance 
including severe obesity or acanthosis nigricans.  
For all patients, testing is recommended at the age of 45. If results are normal, testing 
should be repeated at least every 3 years, but yearly in those with prediabetes or at high risk for 
diabetes (American Diabetes Association, 2018).  Diabetes prevention interventions such as 
screening and counseling are accessible to individuals who meet the testing criteria. The ACA 
mandated essential health benefits to be included in all health plans which included access to free 
diabetes preventive care in most states (American Association of Diabetes Educators, n.d.). The 
preventive care benefits important for diabetes prevention include: blood pressure screening, 
cholesterol screening for high risk adults, diabetes (Type 2) screening for adults with high blood 
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pressure, diet counseling for at risk adults, depression screening, obesity screening and counseling 
(Healthcare.gov, n.d.).  
Hogan et al. (2015) estimated that 1.5 million more people would be diagnosed with one 
or more chronic condition (diabetes, hypercholesterolemia or hypertension) if the rate of 
uninsured were reduced by half by the ACA. Criteria for the diagnosis of diabetes is a fasting 
glucose >= 126mg/dL or a 2 hour plasma glucose >= 200mg/dL during OGTT or A1C >= 6.5% 
or in a symptomatic patient experiencing hyperglycemia or hyperglycemic crisis, a random 
plasma glucose >= 200 mg/dL. For any patient at risk of diabetes or with a confirmed diagnosis 
of diabetes, lifestyle management and psychosocial care are the cornerstones of diabetes 
management (American Diabetes Association, 2018). In addition, patients should be referred for 
diabetes self-management education (DSME), diabetes self-management support (DSMS), 
medical nutrition therapy (MNT) and psychosocial health if needed (American Diabetes 
Association, 2018). 
 Diabetes prevention is an important component of diabetes care as the benefits of 
diabetes-related knowledge gives patients a sense of empowerment and improved quality of life 
(Bruce, Davis, Cull & Davis, 2003). In addition, identifying patients at risk of diabetes allows for 
the use of effective interventions. Previous studies have shown that health education provided to 
Hispanic patients with Type 2 diabetes significantly improved blood glucose control and health 
outcomes (Chukwueke & Cordero-MacIntyre, 2010).  Therefore, the benefits of diabetes 
knowledge extend beyond general improvements in knowledge and are a significant predictor of 
HbA1c levels (Bruce et al., 2003).  Patients with diabetes should also be appropriately screened 
for complications and comorbidities. Optimal diabetes management includes control of blood 
glucose levels, blood pressure and cholesterol control in order to prevent comorbidities. In 
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addition, frequent screening in patients with a diagnosis of diabetes is important to detect early 
complications of the eye and foot (Mitri & Gabbay, 2016).  Shi et al. (2016) projected that the 
eye examination rate among U.S. adults with diabetes would improve with coverage expansion. 
Overall, coverage expansion through the ACA was anticipated to improve access to and 
utilization of services and reduce diabetes-related complications (Brown & McBride, 2015). 
Research Value Added 
The ACA was instrumental in providing access to health insurance for low-income adults 
who were previously uninsured. In addition, we recognize the need to focus on diabetes 
prevention, especially among high risk groups, and ensuring that racial/ethnic minorities are 
receiving appropriate preventive care interventions in order to reduce health disparities. This 
research attempts to analyze the broader effects of the ACA on the health care system, including 
how the ACA’s coverage expansion impacted access to primary care services and the subsequent 
delivery of diabetes preventive care for three groups: (1) the general population; (2) racial/ethnic 
minorities; and (3) those at high risk of developing diabetes. Griffith et al. (2017) closely aligned 
with the baseline goals of this proposal, whereas we are interested in studying disparities by race 
and by diabetes risk status.   
Griffith et al. (2017) focused on socioeconomic disparities among individuals living in 
Medicaid expansion and non-expansion states. The 2011-2015 BRFSS dataset was used.  The 
authors used BRFSS to assess changes in health insurance coverage and access associated with 
the ACAs coverage expansion for people in different socioeconomic strata, comparing changes 
between Medicaid expansion and non-expansion states. The three measures of health care access 
included: insurance coverage, primary care provider, and avoided care due to cost. Analysis was 
stratified by respondents’ socioeconomic characteristics which were identified as: self-reported 
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house-hold income, educational attainment, employment status, and home ownership status. In 
order to identify income-related access gaps, people were placed into two groups, those with 
higher household incomes (>$75,000) and those with low incomes (<$25,000). To be considered 
a Medicaid expansion state, expansion needed to be implemented by mid-2015. Twenty-one out 
of forty-three states were categorized as expansion states. Final analysis contained a total of 
1,089,940 respondents from 43 states (Griffith et al., 2017). 
 In order to show disparities in access, an adjusted pre/post difference-in-difference model 
was used, stratifying by whether each state had expanded Medicaid. The year 2013 was used for 
pre and 2015 was used for post. The first regression model was used to assess time-based 
changes in health care access with ACA rollout. The models controlled for state level time trends 
from 2011-2015 and covariates: race, sex, age, pregnancy status, veteran status, education, home 
ownership, household size, household income, presence of children and state. In order to identify 
changes associated with Medicaid expansion, difference-in difference model was used. All 
regression models estimated as linear probability models with BRFSS sampling weights and 
standard errors clustered at the state level to account for intrastate correlation. Lastly, gaps in 
health care access (defined as absolute and relative changes over time in percentage-point 
differences in access between people in high vs. low SES strata) between 2013 and 2015 were 
assessed. Absolute changes were assessed in regression models by interacting the socioeconomic 
strata with the post-reform indicator (Griffith et al., 2017).  
The study found that in 2013, 90% of households with high incomes (>$75,000) were 
insured compared to 60% of households with incomes <$25,000 being insured. Medicaid 
expansion states had smaller proportions of blacks and higher average household incomes. In 
Medicaid expansion states, large increases in coverage for the poor, with little change in higher 
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incomes (which was expected). After adjusting for state-trends and covariates, in Medicaid 
expansion states, the poor gained 15.0 percentage points in insurance and 7.7 percentage points 
in having a primary care provider. The percentage of poor respondents avoiding care due to cost 
fell by 7.5 percentage points. Residents of non-expansion states also had increased access, but 
smaller gains than those in expansion states. Benefits of expansion were large among poor 
households (6.3 % points), the unemployed (11.00% points) and those who were not college 
graduates (3.2% points) and renters (2.8 % points). Medicaid expansion was associated with 
near-zero changes in coverage among non-poor respondents, college graduates, and the 
employed (Griffith et al., 2017).   
The Griffith et al. (2017) relates to the current study as it focuses on the ACA’s effect on 
insurance coverage by income, with a focus on socioeconomic disparities. This research study; 
however, is focused on racial/ethnic disparities, overall health disparities in diabetes care 
(between those at high risk vs. no/low risk patients) as well as socioeconomic disparities (to 
provide a baseline comparison). The target population in this proposal is narrower as the focus is 
on those at high risk of developing diabetes; as well as ethnic minorities. Griffith et al. (2017) 
also divided the population into two income groups (<$25,000 and >$75,000), whereas this study 
also includes a focus on individuals who benefited from the insurance subsidies (those within the 
100-400% FPL). Additionally, Griffith et al. (2017) took race into account, but left out those 
who identified as Hispanic ethnicity- which is interesting as Hispanics made major coverage 
gains and are a growing subset of the population. There was no focus on a health condition and 
even authors suggested future research should focus on improving health outcomes and reducing 
health disparities (Griffith et al., (2017).  This recommendation led to a review of the current 
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state of the science on the overall impact of the ACA’s coverage expansion in diabetes care for 
racial/ethnic minorities. 
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CHAPTER 2  
CURRENT STATE OF THE SCIENCE 
Conceptual Model of Nursing and Health Policy and IHI Triple Aim 
 The Conceptual Model of Nursing and Health Policy (CMNHP) (Russell & Fawcett, 2005) 
is a nursing discipline-specific model used to guide inquiry for nursing’s involvement in health 
policy (Figure C-1). The CMNHP was chosen as it guides inquiry through policy analysis, 
policy/program evaluation, and health service research. The CMNHP includes guidelines for 
analysis and evaluation of health policies (Fawcett & Russell, 2001). The model includes three 
sources of policies, three policy components and four increasing broad levels of nursing and policy 
focus and outcomes. The policy sources are public, organizational, and professional. For this study, 
the policy source is public, represented by the 2010 Patient Protection and Affordable Care Act 
(ACA) or HR 3590. The ACA coverage expansion provisions included the optional Medicaid 
expansion and the creation of health care subsidies through the federal insurance exchange 
(Marketplace) which was described in greater detail in chapter 1.  
 The policy components within the CMNHP include: healthcare services, healthcare 
personnel, and healthcare expenditures. The increase in health insurance coverage increased the 
ability of uninsured Americans to gain access to the health care system, making the policy 
component within this framework focused on health care services. The health care service of 
interest is access to high-quality diabetes prevention for adults at high risk within the primary care 
setting. This is measured by the 2012-2015 Behavioral Risk Factor Surveillance System (BRFSS) 
and the 2012-2015 National Ambulatory Medical Care Survey (NAMCS).  
The four levels of the CMNHP are level 1- efficacy of nursing processes, level-2 
effectiveness of nursing processes, effectiveness and efficiency of healthcare delivery subsystems, 
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level 3- equity of access to effective and efficient nursing processes and nursing delivery systems, 
(including equity in the distribution of costs and burdens of care delivery) and level 4- justice and 
social changes that address equity. Level III is the most relevant focus for this study as this level 
focuses on health system administrative practices. As the focus is on health system changes related 
to the 2010 Affordable Care Act, the Institute for Healthcare Improvement’s (IHI) Triple Aim 
framework is embedded within the Level III (Institute for Healthcare Improvement, 2017). In this 
level, focus is placed on the equity of access to effective and efficient processes and health care 
delivery systems (Russell & Fawcett, 2005).  
The theory behind the Triple Aim is that in order to improve the health care system, three 
dimensions must be considered: the per capita cost for the population, the health of a defined 
population and the experience of the individual. In order to meet these goals, focus is placed on 
individuals and families, redesigning primary care services and structures, focusing on 
prevention and health promotion, cost control and system integration in order to reduce 
inequitable variations in outcomes or undesirable variations in clinical practice. Each focus area 
has designated outcomes of interest that determine whether the system and health of a population 
has improved. The outcome of interest for per capita cost within the IHI framework is the total 
cost per member of the population per month and hospital and ED utilization rates. The four 
outcomes of interest for population health are: Health/functional status, risk status, disease 
burden and mortality. Lastly, the outcome of interest for patient experience is quality of care to 
determine if care is safe, effective, timely, efficient, equitable and patient-centered (Institute for 
Healthcare Improvement, 2009).  As the IHI Triple Aim framework suggests, in order to study 
the health of a population, a greater understanding of an individual experiences’ is important to 
optimize the performance of the health system. As a result, the Quality Health Outcomes Model 
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was also used as a framework to gain a deeper understanding of how socioeconomic and 
demographic characteristics (or health disparities) fit within health service research.    
Quality Health Outcomes Model 
In 1998, the Expert Panel on Quality Health Care of the American Academy of Nursing 
published the Quality Health Outcomes Model. The Quality Health Outcomes Model is an 
important conceptual guide for nursing and health service research as it provides a framework for 
multi-level analysis among four constructs: (1) system characteristics, (2) interventions, (3) client 
characteristics and (4) outcomes. These constructs were built on Donabedian’s (i.e. structure-
process-outcome) model and Holzemer’s (i.e. multi-level analysis of client, provider and setting) 
framework (Mitchell & Lang, 2004). The Quality Health Outcomes Model allows for the study of a 
policy intervention (ACA), to gain a better understanding of its effect on individuals, the health care 
system and outcomes of interest. Coverage expansion through the ACA was anticipated to 
decrease the number of uninsured Americans leading to a greater influx of patients utilizing the 
health care system.  
In the original version, the intervention in this model is a clinical process or activity that 
is delivered to a client or within a system (Mitchell, Ferketich, & Jennings, 1998). Since the 
focus of this proposal is on a federal health policy, the word intervention was changed to policy 
intervention to clarify that the intervention of interest (i.e. Medicaid expansion and the Insurance 
Marketplace) stems from an external governing body, instead of from within the health care 
system. As a result, the double arrows (in the original version) were changed to single-headed 
arrows to reinforce that the policy intervention was developed and implemented from catalysts 
(or individuals) outside the health care system and the policy intervention will not change 
because of the system or population. This is even truer with Medicaid expansion. Medicaid 
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expansion is a policy intervention in which policymakers have the power and choice to expand 
health care coverage within their states. The decision by Justice Roberts to allow states to opt-out 
of Medicaid expansion (Kaiser Family Foundation, 2012) highlights how policy can be 
implemented and reinforced irrespective of the needs of the health care system or population at 
risk. 
The policy intervention(s), if implemented, impact health care systems and individuals. 
The policy intervention impacts a population by providing a means (i.e. health care coverage) to 
access the health care system. Primary care clinics are the health system of focus as diabetes 
preventive care occurs in this setting. Radwin (2002) suggested a refined quality health outcomes 
model where the client, which referred to an individual, family or community, was bifurcated 
into client state characteristics and client trait characteristics. Client state characteristics refer to 
characteristics that can change over time. In Figure D-1, this refers to clients with pre-diabetes or 
individuals at high risk for pre-diabetes/diabetes. Diabetes is the health condition of interest as it 
is the precursor for other chronic conditions when left untreated or poorly managed and is 
currently on the rise. Being at risk for diabetes is a transient condition as behavior modification 
and preventive measures can prevent an individual from developing diabetes and therefore, 
reduce their risk. Client trait characteristics refer to stable characteristics that cannot be changed- 
such as age, race and gender. As a result, client trait characteristics can only be related to other 
factors unilaterally (Radwin, 2002).  With this refined model, health disparities and the 
variability in access to high quality diabetes care post ACA can be explored.  
The overall population health and health systems outcome of interest is to decrease the 
incidence of diabetes in the U.S. among adults aged 18 to 64 at high risk. In order to meet this 
goal from a health system perspective, the focus is on the delivery of diabetes preventative 
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services and ensuring variations in care due to race do not exist. Minimizing health disparities 
within the health care system is important to meeting the outcome goals of the IHI’s Triple Aim. 
From a population health perspective, the outcome of interest is to ensure the population has a 
means to access the health care system. Both access and utilization of primary care services will 
lead to an increase in the quality of diabetes preventive care delivered to patients at high risk, 
ultimately leading to a reduction in the incidence of diabetes (dotted arrows) in this population. 
A post-positivist lens was used to guide the review of literature as it is expected that multiple 
methodological studies are needed to gain a better understanding of how the passage of the ACA 
brought forth the opportunity to close the coverage cap for many uninsured Americans across the 
U.S., reducing barriers to high quality diabetes care for all (Welford, Murphy & Casey, 2011).   
Review of the Literature 
Search Strategy 
CINAHL, PubMed and Google Scholar were used to conduct a general review of literature 
on diabetes care post-ACA implementation. The search was limited to full-text, peer-reviewed 
journal articles published between the years of October 2013- March 2018.  This timeframe was 
chosen as coverage expansion was implemented in 2013 and the focus of this study is on diabetes-
related outcomes post ACA implementation. The key words for CINAHL were “diabetes” and 
“affordable care act” which yielded 79 results. The key words used for PubMed included: 
“diabetes” and “Affordable Care Act” which yielded 93 results. Since there were limited articles 
including the Insurance Marketplace, Google Scholar was used for a broader search. The key 
phrases included: “state insurance exchange” and “diabetes” which resulted in 6,560 results. The 
first 30 webpages from the Google Scholar search were reviewed as redundancy was noted soon 
after abstract retrieval (n=300). From all databases, 33 articles were downloaded and reviewed. 
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Two additional articles were retrieved from a reference list. Ultimately, seven research articles 
were included in this review. The PRISMA flow diagram (Figure E-1) is available in Appendix E.  
Inclusion criteria for the articles reviewed included: (1) Medicaid expansion or the 
insurance marketplace as the policy intervention, (2) a variable for race/ethnicity, (3) a variable 
for diabetes and (3) analysis of data post 2013. Non-empirical articles were not included in this 
review in order to focus on the current state of diabetes care and outcomes post-ACA 
implementation. The IHI Triple Aim framework was used as a guide to assess the current state of 
science.   
IHI Triple Aim Framework: Per Capita Cost  
Access to and Utilization of Health Care Services 
    National Coverage Expansion. In the literature reviewed, access to and 
utilization of health care improved nationally for uninsured adults, but disparities continued to 
exist among racial and ethnic minorities. Using data from the 2012-2015 Gallup-Healthways 
Well-Being Index (WBI), Sommers et al (2015) conducted a secondary data analysis designed to 
examine trends in self-reported coverage and access to care among adults aged 18 to 64 
(n=507,055). The WBI is a daily telephone survey of US adults in all 50 states and Washington, 
DC with a response rate of 5-10%. Using an interrupted time-series design, the study found that 
individuals who gained access to care post-ACA implementation were less likely to report the 
following: being uninsured (-7.9 percentage points [95% CI, -9.1 to -6.7]), not having a personal 
physician (-3.5 percentage points [95% CI, -4.8 to -2.2]), difficulty obtaining necessary 
medications (-2.4 percentage points [95% CI, -3.3 to -1.5]) and inability to afford medications (-
5.5 percentage points [95% CI, -6.7 to -4.2]) when compared to pre-ACA values (Sommers et 
al., 2015).  Sommers et al (2015) also found that the reduction in the rate of the uninsured was 
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greater among the Hispanic population (-11.9%, [95% CI, -15.3% to -8.5%]) than among Non-
Hispanic whites (-6.1%, [95% CI, -7.3% to -4.8%]).  
Despite the increase in coverage enrollment noted in the Sommers et al. (2015) study 
among Hispanic adults, Alcala et al (2017) found that disparities in access and utilization of 
healthcare existed within the Hispanic population. In fact, in a sample of adults aged 18 to 64 
from the 2011-2015 National Health Interview Survey (NHIS) (n=86,467), the authors found that 
Mexicans (OR 0.68) and Central Americans (OR 0.66) had lower odds of being insured 
compared to whites post-ACA implementation. Additionally, Mexicans (OR 0.83) and Puerto 
Ricans (0.86) saw a reduction in the odds of delaying necessary care, whereas Cubans (OR 1.33) 
and Central Americans (OR 1.28) saw poorer patterns in forgoing care. The odds of having a 
physician visit increased significantly among whites post-ACA, with few significant differences 
between Non-Hispanic whites and most Hispanic subgroups. Puerto Ricans had higher odds (OR 
1.42) of using emergency services compared to whites, while Mexicans had lower odds (OR 
0.83) of using emergency services as well as scheduling regular physician visits (OR 0.87) when 
compared to whites. As a result, this study highlighted the differences in access and utilization 
patterns within Hispanic subgroups. The differences were further complicated by language as 
participants who answered the NHIS survey in Spanish had lower odds of being insured (OR 
0.79), forgoing care (OR 0.86), using an emergency room (OR 0.62) and having a physician visit 
(OR 0.80) when compared to those who completed the survey in English (Alcala et al, 2017).  
  State-based Medicaid Expansion. Just as national coverage expansion decreased 
the rate of the uninsured, studies focusing solely on Medicaid expansion have also shown a 
decrease in the rate of the uninsured. Sommers et al. (2015), Sommers, et al. (2016) and Wherry 
& Miller (2016) conducted quasi-experimental difference-in-difference studies to explore 
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whether state based Medicaid expansions were associated with changes in access to and 
utilization of health care. Sommers et al. (2015) used the 2012-2015 Well-Being Index (WBI) 
database (n=86,188) to study adults aged 20 to 64, Sommers et al. (2016) administered a 
random-digit telephone survey to adults aged 19 to 64 (n=8,676), whereas Wherry & Miller 
(2016) used the 2010-2014 National Health Interview Survey (NHIS) (n=40,427) dataset to 
study adults aged 19 to 64. The three studies utilized a difference in difference study design to 
examine outcomes related to access and utilization of health care services.  
In comparing expansion states to non-expansion states, two studies showed that the 
uninsured rate declined for both groups with a significantly greater reduction seen among low-
income adults in Medicaid expansion states (Sommers et al. 2015; Wherry & Miller, 2016). 
Sommers et al. (2015) found that significant changes in coverage and access were more apparent 
in 2015 than 2014, with the net change in being uninsured between Medicaid expansion versus 
non-expansion states after the ACA declining by 5.2 percentage points (95% CI, -7.9 to -2.6). In 
addition, lacking a personal health care provider (-1.8 percentage points [95% CI, (-3.4 to -0.3)] 
and limited access to medications (-2.2 percentage points [95% CI, (-3.8 to -0.7) declined 
significantly in expansion states compared to non-expansion states (Sommers et al., 2015). 
Sommers et al., (2016) found that Medicaid expansion was associated with a decrease in 
the uninsured rate (-22.7 percentage-point, (95% CI, [-29.1 to -16.3])) when compared with the 
mean uninsured rate in expansion states in 2013 (mean = 41.0). Medicaid expansion, when 
compared to private insurance was also associated with increased access to primary care. 
Increased coverage options led to an increase in having a personal physician (12.1 percentage 
points (95% CI, [5.4 to 18.9])) an increase in the report of a usual source of care (10.8 percentage 
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points (95% CI, [3.5 to 18.1])) and a decrease in utilizing the ED as a usual source of care (-6.1 
percentage points, (95% CI, [-10.1 to 2.2]) (Sommers et al., 2016).  
  Health System Utilization. In terms of self-reported health system utilization, 
survey data showed that hospital inpatient stays and general physician visits increased in the first 
year post ACA in expansion states, with no statistical significance seen by year 2 (Wherry & 
Miller, 2016).  Sommers et al. (2016) also did not find any statistical significance in the net 
change between Medicaid expansion and private insurance in the utilization of office visits, ED 
visits or hospitalization in the past year. Statistical significance may be difficult to achieve with 
utilization data that is taken from self-reported information due to a reliance on patient recall. 
There were two articles that did utilize health system utilization records to assess the use of care. 
Literature using administrative data showed that coverage expansion resulted in increased 
utilization of health care services as individuals gained access to the health care system. 
However, questions remained as to where newly insured individuals would receive care. Sharma 
et al. (2017) studied changes in emergency room usage by uninsured Illinois residents who 
obtained coverage via Medicaid expansion or through the health insurance exchange. Data was 
obtained from the 2011-2015 Illinois Hospital Association Comparative Health Care and 
Hospital Data Reporting Services. The study found that total ER visits increased by 5.6% (p 
<0.001) in Illinois post-ACA with no change in hospital admissions. However, the percentage of 
emergency department visits decreased from 22.9% to 12.5% (p <0.001) for uninsured patients. 
Interestingly, the average number of monthly emergency department visits increased sharply for 
Medicaid patients (41.9%, p<0.001) compared to privately insured patients (10%). Among the 
insured, acute Ambulatory Care Sensitive Hospitalizations (ACSH) decreased from 4.9% to 
4.5% (p<0.001) while chronic ACSH increased from 10.5 to 11% (p<0.001). Among the 
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uninsured, the proportion of ACSH visits post-ACA decreased from 15.9% to 15% (p<0.001) 
with the decline being mostly for chronic conditions (Sharma et al., 2017).  
As care was expected to shift from acute care facilities, such as the ER and into the 
outpatient setting, Cole et al. (2017) analyzed the impact Medicaid expansion would have on 
federally funded community health centers. The study used data from 2011 to 2014 from the 
Uniform Data System, a database that feeds information to the Department of Health Resources 
and Services Administration (HRSA). The sample included 1,057 U.S. based community health 
centers and data was analyzed using a difference-in-differences analysis to compare outcomes 
among centers. The results showed that community health clinics within Medicaid expansion 
states saw a decrease in the uninsured rate and an increase in the number of individuals covered 
by Medicaid. The study found no significant difference among the number of unique patients 
served between centers in expansion and non-expansion states although there was growth over 
the study period. Unique patients were defined as the number of patients served who are different 
as to reflect the reach and capacity of the safety-net system and represents the number of 
otherwise underserved patients who have obtained care (Cole, et al., 2017). 
    Health Care Costs. Sommers et al. (2015) found that inability to afford care 
declined from 35.5 percentage points to 33.1 percentage points in Medicaid expansion states, but 
it was not found to be statistically significant. Medicaid expansion was associated with a 
decrease in the report of the following outcome related to costs: delaying care due to cost (-18.2 
percentage points (95% CI, [-25.4 to -11.1]), skipping medication due to cost (-11.6 percentage 
points, (95% CI, [-25.4 to -11.1]), and trouble paying medical bills (3.9 percentage points, (95% 
CI, [-4.0 to 11.9])) (Sommers et al., 2016). 
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Population Health: Disease Burden 
     Prevention and Detection of Undiagnosed Diabetes. Once the uninsured 
gained access to coverage, screening and the detection and diagnosis of diabetes also improved. 
Sommers et al. (2016) found that Medicaid expansion was associated with increased preventive 
care (i.e. check up in the past year, 16.1 percentage points [95% CI, (9.1 to 23), p<0.001] with 
higher diabetic glucose testing rates in a Medicaid expansion states compared to states that only 
had the private option available. In fact, in patients without diabetes, no statistical significance 
was found in obtaining a blood glucose check in the past year between Medicaid expansions and 
those states with only the private insurance option available. However, Medicaid expansion was 
associated with an increase of 10.7 percentage points (95% CI, [1.2 to 20.2]) in a patient with 
diabetes reporting a blood glucose check in 2015. Report of regular care for a chronic condition 
also increased by 12 percentage points (95% CI, [3.1 to 21]) by 2015 in Medicaid expansion 
states.  Chronic conditions were limited to at least 1 of the following conditions: hypertension, 
coronary artery disease, stroke, asthma/chronic obstructive pulmonary disease (COPD), kidney 
disease, depression, cancer, substance abuse and diabetes (Sommers et al., 2016). Wherry & 
Miller (2016) found a significant increase in the diagnosis of diabetes (4.0 percentage points, 
[95% CI, (1.2 to 6.8)] 1-year post -ACA among Medicaid recipients in expansion states This was 
attributed to the increase seen in preventive care visits over the ACA period. However, by year 2, 
the slight increase of 1.8 percentage points  in the increase of diabetes diagnosis was found to be 
statistically insignificant (Wherry & Miller, 2016).  
    Health/Functional Status. Wherry & Miller (2016) found no significant changes 
in health status or mental health between low-income adults in Medicaid expansion and non-
expansion states. Sommers et al. (2015) also found null results for improvements in health or 
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disability among Medicaid expansion and non-expansion groups; however nationally, the 
adjusted report of days with activities limited by poor health decreased by 1.7 percentage points 
(95% CI, -2.4 to -0.9. A limitation to finding significance between expansion and non-expansion 
states could be the unavailability of additional data post 2015 to measure changes in health and 
functional status.  
Patient Experience 
    Quality of Care. In the Cole et al. (2017) study, one of the outcomes of interest 
was to assess the quality of care provided to low-income adults who utilized community health 
centers in Medicaid expansion and non-expansion states. Quality care was defined as a 
hemoglobin A1c less than 9% among the low-income adults who utilized the community health 
centers.  No differences were found in the management of diabetes between Medicaid expansion 
versus non-expansion states, even among racial or ethnic minorities (Cole, et al., 2017). In year 2 
post ACA, Wherry & Miller (2016) found a decrease of 2.7 percentage points (95% CI, (-6.0 to 
0.5)] in the report of excellent or very good health, but it was found to not be statistically 
significant. However, Sommers et al. (2016) found that coverage expansion was associated with 
improved quality ratings of “excellent health” for individuals aged 19 to 64 years with incomes 
below 138% of the federal poverty level in Kentucky, Arkansas and Texas. Nationally, the adjusted 
report of fair/poor health decreased by 3.4 percentage points (95% CI, -4.6 to -2.2) (Sommers et 
al., 2015). 
  Additional Details. Appendices F and G have a summary of the literature reviewed with 
additional details.  
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Gap in the Literature 
 Through this review of literature, there was evidence that access to care improved as 
witnessed by dramatic drop in the rate of those who are uninsured, especially among the 
Hispanic population, with increased primary care access in Medicaid expansion states than in 
non-expansion states. Using the IHI Triple Aim as a guide, limited research was found on the 
impact of increased insurance coverage on diabetes preventive care. Only 7 articles were found 
to include diabetes in their analysis of ACA impacts. Commonly, diabetes was used as a control 
variable or outcome variable (i.e. newly diagnosed diabetes), rather than a predictor variable or 
sub-sample of interest. Current research has not focused on access to diabetes preventive care for 
high risk individuals, the effect of both the insurance subsidy and Medicaid expansion on high 
risk populations and the quality of the preventive services provided to high risk populations after 
ACA implementation. This is a novel area to explore as health care access and the quality of 
diabetes prevention among vulnerable populations continues to be a priority after ACA 
implementation. The recent literature primarily focused on identifying individuals with newly 
diagnosed diabetes and whether those with diabetes are receiving recommended diabetes care; 
which is important, but from population health perspective misses the opportunity to focus on 
primordial and primary prevention related research. Just as important to identifying diabetes, is 
identifying if the ACA led to (1) increased access to health insurance for individuals at high risk 
of diabetes, (2) increased access to health care services for individuals at high risk of diabetes 
and (3) the equitable delivery of diabetes prevention for minority adults (i.e. black and 
Hispanics) at high risk of developing diabetes.  
Additionally, limited research focuses on the impact the ACA has on reducing 
racial/ethnic disparities in diabetes care. Ensuring access to health insurance is the first step to 
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reducing racial/ethnic health disparities, as it ensures individuals have the ability to enter into the 
health care system to receive care. A limitation to the study of health disparities on this topic is 
that the time frame under examination is very short where population health changes may require 
additional years of analysis to detect improvements in diabetes preventive care for those at high 
risk.  In addition, many of the studies relied on self-reported data. If we truly want to measure 
health care quality, data must reflect the perspective of the patient (survey-based data), as well as 
from the health care system (administrative data) that delivers the care interventions. Lastly, 
another limitation to the study of diabetes preventive care in the U.S., is the inability to control 
for is the “culture” (or context) of the U.S. health care system when using secondary data. It is 
well-known that the U.S. health care system undervalues preventive care, so an individual 
gaining access to the U.S. health care system may not be enough to change individual preventive 
care behaviors (such as knowing to make a preventive care visit with a physician), especially 
among minority groups of low socioeconomic status as such a short study period (~6 years) is 
under study. From a nursing perspective, one way to encourage behavior change is to focus on 
the delivery of prevention education, in addition to screening individuals at high-risk. This is 
why the study of the delivery of diabetes preventive care is also important to investigate when 
attempting to reduce the incidence of diabetes in the U.S.  
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CHAPTER 3  
METHODOLOGY 
 In this chapter the datasets and methods used to conduct a secondary data analysis are 
presented. The research goal was to quantify the impact of the ACA, first, on the probability of 
having health care coverage, followed by quantifying the gain in health care access and the 
delivery of diabetes preventive care for low-income persons in the U.S. This initial analysis was 
run separately by race, then by diabetes risk status to determine the impact of the ACA’s 
coverage expansion on the two sub-groups. This quantitative analysis was based on two national 
CDC datasets: The 2012-2017 Behavioral Risk Factor Surveillance System (BRFSS) and the 
2012-2015 National Ambulatory Medical Care Survey (NAMCS). The state-based BRFSS 
dataset was chosen to study the impact of the ACAs coverage expansion on two specific 
outcomes: the likelihood of having health insurance coverage and the likelihood of having health 
care access (i.e. specific aims 1 and 2). This dataset was chosen over other national telephone 
surveys as it is the largest health-specific dataset focusing on health-related risk behaviors, 
chronic conditions and the use of preventive services (Centers for Disease Control and 
Prevention, 2018).  In order to study the delivery of diabetes preventive care (specific aim 3), the 
NAMCS dataset was added to this analysis. NAMCS is unique in that it provides data on 
services ordered and provided, including treatments for patients within the ambulatory care 
setting (CDC, 2017). The use of both datasets for this analysis was instrumental in understanding 
the broader picture of how ACA impacts coverage, access and care delivery. Each dataset is 
described in greater detail in sub-sections 3.1 and 3.2 prior to the methods used to test relevant 
parts of the regression path model.    
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Conceptually Linking ACA to Health Care Coverage, Access and Delivery 
Full Analytic Path Model 
Understanding the relationship between socioeconomic status (SES), race and health is 
important to addressing health disparities in diabetes care in the U.S. The complete analytic path 
model is shown in Figure 1, which includes all variables used to address specific aims 1-3 using 
both BRFSS and NAMCS. Plus and minus signs in the figure indicate hypothesized correlations 
between variables used in the regression analyses described in sub-sections 3.1 and 3.2. To 
simplify the model, sections of the full path model were broken down by specific aim and 
described in the text that follows. 
 
Figure 1. Analytic Path Model of the Impact of ACA on Reducing Disparities in the Coverage, 
Access and the Delivery of Diabetes Preventive Care to Adults aged 18 to 64 in the U.S. 
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SES is typically measured by educational level, income and occupation. It is expected 
that individuals with higher status occupations enjoy higher wages. One way to achieve a higher 
status occupation is to obtain advanced education. The association of SES with health becomes 
even more complex when race is added. Research has shown that even when income and 
educational levels are held constant, differences in health can be seen between blacks and whites 
(Barr, 2014). In the U.S., a long history of racism and discrimination has resulted in differences 
in health outcomes among racial and ethnic minorities (Isaacs & Schroeder, 2004). In fact, at any 
given income level, blacks die at a higher rate than whites and middle-income women. 
Discrimination is a form of social disadvantage that minorities face and has been found to be 
comparable with the disadvantage associated with being of low SES. An individual’s race (i.e. 
racial/ethnic minority) coupled with their standing in the social hierarchy (i.e. low class) for 
prolonged periods of time leads to both low SES and poor health outcomes (Barr, 2014).  
To simplify this otherwise complex relationship between race, SES and health, this 
analysis focused on education and income as an abridged proxy of SES. Race/Ethnicity (or 
minority status) is the central focus of this analysis, with age, gender, limited health status 
(described in the next section) and education being added to this model as controls. Additional 
relationships interacting with age, education, health status and being female exist but are not the 
central focus of this analysis. These four variables, including PCP supply, were removed from 
the figure and labeled as controls to narrow in on the path model of interest for each specific aim.   
Female was added as a control since it is positively associated with being low-income; 
whereas age is negatively associated with lower income in the 18-64-year-old population. 
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Education was added as a control since black and Hispanic minorities in the U.S. tend to 
obtain lower levels of education when compared to non-Hispanic whites. This leads to a negative 
association between minority status and education. Higher education levels has two positive 
paths to higher insurance coverage. First, more education makes it less likely to have an income 
below 400% FPL primarily because of higher wages. Also, with higher wages comes employer-
sponsored health insurance. Second, even holding a person’s income constant, higher education 
should make an individual more aware of the benefits of having health insurance and a primary 
care provider.   
Limited health status (LHS) plays a key role in the demand for health insurance as well as 
seeking a health care provider. Limited health status is an umbrella term and is represented by 
the following self-reported items in BRFSS: (1) chronic disease(s) and (2) self-reported health. 
These variables entered the model as control variables. Having limited health status is assumed 
to be positively correlated with age and minority status and negatively correlated with education 
level. Since high-risk for diabetes was one of the main predictor variables, it was studied 
separately from limited health status.  
Specific Aims 1 & 2 BRFSS Path Model 
Race/ethnicity is represented by the term Minority in this path model. Being of minority 
status is positively associated with being low-income (<400% FPL) as minorities tend to acquire 
lower wages when compared to non-Hispanic whites. Income level is an important variable 
within this model as the income to insurance path is interrupted by Medicaid expansion and the 
insurance subsidies through the ACA. Low-income is negatively associated with having health 
insurance as low-income individuals do not have the financial means to afford private insurance 
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coverage and/or have employment that provides insurance benefits, or the educational level to 
know that having insurance is an asset for their well-being. However, a host of government 
programs have been implemented in the U.S. to provide coverage options for low-income and 
vulnerable populations. These government programs include: Medicare, Medicaid, the Indian 
Health Service and the Department of Veterans Affairs. Despite these programs, a coverage gap 
still remained through 2013, as witnessed by the 49 million Americans who were uninsured 
before ACA implementation. Among the uninsured, racial and ethnic minorities and individuals 
with low-incomes (including Non-Hispanic whites) were overrepresented. As a result, low-
income status is important for this research as the ACA’s subsidies and Medicaid coverage 
expansions substantially benefited those living within 100 to 400% of the Federal Poverty Level 
(FPL). The introduction of the ACA (in red) provided insurance subsidies and federal cost-
sharing to states choosing to expand their Medicaid programs. The ACA is assumed to reduce 
the negative correlation between low income and insurance coverage. This might lead to zero 
correlation between the two variables post-ACA (Figure 2).   
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Figure 2. Specific Aim 1 Analytic Path Model of the Impact of the ACA on Reducing 
Disparities in Insurance Coverage.   
Individuals at risk for diabetes tend to be overweight with one or more risk factors 
identified by the American Diabetes Association, placing them at higher risk of developing 
diabetes in their lifetime. More education should reduce the risk of diabetes by living healthier 
lifestyles, including regular exercise, access to nutritious foods and less habitual smoking. 
Because racial and ethnic minorities tend to have lower levels of education, and less healthier 
lifestyles, they are hypothesized to have a higher probability of developing pre-diabetes/diabetes. 
A counter-argument to this hypothesis is that having “pre-diabetes” is often asymptomatic and 
may not evoke a need for insurance or a health provider. Additionally, individuals who were 
previously uninsured prior to the ACA may have been unaware of their diabetes risk status due 
to the cost of accessing a health care provider, discrimination in availability, or a personal under-
appreciation of primary care services.  
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Persons can have serious health conditions besides being pre-diabetic that encourage the 
purchase of health insurance and seeing a primary care provider. As a result, limited health status 
will be measured by the presence of chronic disease and self-reported health. Details on the 
chronic conditions controlled for in this analysis can be found within the BRFSS and NAMCS 
subsections that follow. Controlling for chronic disease is important because any of these 
conditions may “force” an individual to obtain health insurance that could lead to the 
“discovery” of their higher diabetes risk. Black and Hispanic minorities should exhibit greater 
health limitations, although they may be more likely to underreport or be unaware of their 
limitations which could produce an insignificant relationship. A limitation in this sense means 
individuals who report chronic disease.  
Self-reported health was also included as an indicator of limited health status. Perceived 
health status reflects biological, psychological and social dimensions that are inaccessible to an 
external observer. Perceived health has been shown to correlate with the occurrence of chronic 
illness and physicians’ ratings of health status in cross-sectional studies (Miilunpalo, Vuori, Oja, 
Pasanen & Urponen, 1997). In BRFSS, respondents rated their health as: (1) excellent, (2) very 
good, (3) good, (4) fair or (5) poor.  To note, Zajacova & Dowd (2011) found measurement error 
in self-reported health among U.S. adults, specifically for those with less education and 
racial/ethnic minorities. Individuals with low levels of education and minorities made up greater 
numbers of the uninsured pre-ACA. Decker et al. (2013) found that uninsured adults with 
hypertension, hypercholesterolemia or diabetes were less likely to be aware of their health status 
and less likely to have these conditions controlled when compared to those enrolled in Medicaid.   
The ACA’s insurance subsidies and Medicaid coverage expansions should expand 
coverage to low-income minorities who are at higher risk for diabetes and, holding their age and 
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education constant, who have experienced a limited health status more generally. We expected 
the ACA to show greater coverage to these two groups in “poorer” health, but without a casual 
link. Like with minorities in general, the ACA through its insurance features should “sweep up” 
those in poorer health by enhancing access to health insurance and health care. This would be an 
example of a (partially) intended spiller effect of public policy. Specific Aim 2 addresses this 
theory and is shown in Figure 3. 
 
Figure 3. Specific Aim 2 Analytic Path Model of the Impact of ACA on Reducing Disparities in 
Health Care Access.  
An important factor to consider in the Specific Aim 2 model is that BRFSS does not 
measure the primary care provider supply available within each state. Demographic, income, 
education, and health status measures were used to explain variation in a person’s demand for 
insurance and access to primary care. But only with an adequate supply of health care providers 
(per capita in a state) can the primary care setting meet the demand for increased primary care 
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services under expanded health insurance coverage. Health care access (or greater use of primary 
care services) will be measured two ways- by whether a BRFSS respondent has a primary care 
provider and/or had a routine checkup with a primary care provider within the last year. The 
National Center for Health Workforce Analysis, which is part of the U.S. Department of Health 
and Human Services (HHS) and the U.S. Health Resources and Services Administration 
(HRSA), provides updated projections of supply and demand for health workers (U.S. 
Department of Health and Human Services, 2016).  
Specific Aims 3 NAMCS Path Model 
BRFSS gives an estimate of the individuals who have access to the health care system. 
By adding NAMCS we go a step further to determine who is receiving diabetes preventive care. 
BRFSS and NAMCS, although separate analyses, conceptually are able to give a better 
understanding of how ACA impacts the delivery of diabetes preventive care for low-income 
adults (Figure 4). Diabetes preventive care was measured by receipt of diabetes screening or 
diabetes prevention education during a preventive care clinic visit. The ACA does not have a 
direct effect on the delivery of primary care services once a patient is at a clinic visit. In order to 
conceptually link ACA effects to the delivery of primary care, the BRFSS dataset was useful to 
understanding how the ACA worked through insurance coverage to health care access, leading to 
the likelihood that the patient would enter into a clinic to receive appropriate diabetes preventive 
care. 
 For the NAMCS analysis, the control variables included gender, age and chronic disease. 
Limited health status was updated to only reflect chronic disease as this is the only information 
available in NAMCS. Education level was not available in NAMCS, so was not used. PCP 
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supply was not used in this analysis as individuals already have a visit and the supply of PCPs 
should have no effect on visit content. It is assumed that everyone in the NAMCS dataset has 
health care access since they have a clinic visit. It was not assumed that everyone in the NAMCS 
dataset had health insurance coverage, so an arrow is added from high-risk for diabetes to health 
care access to represent the uninsured. In the literature review it was apparent that many who 
were previously uninsured were unaware they had diabetes, a condition where patients exhibit 
symptoms. Therefore, for those individuals with pre-diabetes or at high risk for diabetes (a 
condition that tends to be asymptomatic) and without insurance coverage, they would be less 
likely to access the health care system unless another health problem was present.   
 
Figure 4. Specific Aim 3 Analytic Path Model of the Impact of ACA on Reducing Disparities in 
the Delivery of Diabetes Preventive Care.  
An important factor to consider in the Specific Aim 3 path model is that NAMCS does 
not include a question on provider bias or a patient’s perception of being treated unfairly, which 
is important to studying the delivery of health care services. Previous research has linked 
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feelings of discrimination with minorities of higher SES status. If a patient is receiving or feels 
they are receiving different treatment than their white peers, then they will report discrimination 
which will decrease their trust with providers and/or with the health care system as a whole 
(Assari, et al., 2017). This may cause minority patients to forgo care leading to an increased 
probability of developing diabetes. Unfortunately, discrimination cannot be directly measured 
using the NAMCS dataset. For this analysis, focus was placed on determining if differences in 
the delivery of diabetes preventive care exist in the first place. Racial and ethnic disparities in 
diabetes screening or diabetes preventive education was measured by any statistically significant 
difference by at least 10% among each minority group versus non-Hispanics whites (LaVeist 
&Isaac, 2013), when controlling for other factors. This calculation will also be used to determine 
racial/ethnic health disparities in coverage and health care access. The description of these 
analyses will be presented in later sections.  
Experimental Design  
A Quasi-Experimental Design (QED) was chosen to estimate the impact of the ACA’s 
subsidy and Medicaid coverage expansion on improving access to health insurance coverage, 
primary care services and the delivery of diabetes preventive care for low-income adults across 
the U.S. Research using cross-sectional secondary data is observational since the data was 
originally collected for purposes other than the current research questions. When studying 
Medicaid expansion (specifically, the pre/post, study-control design) this study was considered 
an ACA experiment within an experiment due to the fact that the Supreme Court ruling deemed 
Medicaid expansion optional for states, creating a natural experiment. Survey respondents 
naturally had no short-run control over where they lived.  
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A QED difference-in difference approach was proposed, including an interrupted cross-
sectional time-series design with non-repetitive, independent annual samples. Cross-sectional 
data was merged for years 2012-2017 for BRFSS (for specific aims 1 and 2) and 2012-2015 for 
NAMCS (for specific aim 3). BRFSS and NAMCS are national federal datasets that do not 
follow the same individuals over time. The time-series was interrupted when the ACA 
introduced new coverage options for low-income adults at the end of 2013 (insurance subsidies) 
and the beginning of 2014 (Medicaid), which created an anticipated change in the trend line for 
the outcomes of interest by time. 
In cross-sectional study designs, data is typically collected for a population at a single point 
in time in order to study the relationship between two or more variables of interest. This type of 
design is helpful in assessing the burden of disease or the health needs of a given population. 
Since all variables are measured at roughly the same time through questionnaires, challenges 
arise when drawing conclusions about causality because it is difficult to tell which variable came 
first (Barratt & Kirwan, 2009). In order to overcome this, each database (BRFSS or NAMCS) 
was merged to itself over time by state to make comparisons before and after the ACA took 
effect. In addition, theory (using the analytic path models described above) was used to identify 
causality. For example, a person’s level of education was determined before they buy insurance 
and find a primary care provider.  
A limitation in using BRFSS and NAMCS samples is the inability to measure changes over 
time at the individual level. Admittedly, conducting a secondary data analysis using each of the 
two samples has weaker internal validity when compared to a study conducted using a 
randomized control trial. This happens because characteristics of individual respondents can 
change from year to year. While incomparability should be relatively small given very large 
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samples sizes, minor individual differences may still remain. Internal validity (the strength of the 
causal evidence) can be increased by restricting the inclusion criteria (Gurwitz, Sykora, 
Mamdani, Streiner, Garfinkel, Normand, Anderson & Rochon, 2005). This research was 
restricted to Non-Hispanic white, black and Hispanic individuals aged 18 to 64 years. In 
addition, potential confounders such as gender and age were controlled for to increase the 
validity of the study (Polit & Beck, 2017). Education level and health status to isolate 
race/ethnicity changes due to the ACA were also controlled for.  
The ACA’s impact on insurance coverage and primary care access worked through Medicaid 
expansion and the insurance subsidies of lower income persons. Systematic bias was expected 
when comparing results for Medicaid expansion and non-expansion states. Every state had an 
insurance exchange with financial subsidies available. However, only 34 states (including D.C.) 
expanded Medicaid as of 2018 (Kaiser Family Foundation, 2018). Because expansion and non-
expansion states vary systematically by standard of living, reported incomes were converted to a 
percentage of the federal poverty level (FPL), which is a nationally determined figure varying 
only by household size. Because respondents in “non-expansion” states such as Tennessee are 
poorer on average than persons living in California, we expect more of the former to be eligible 
for larger subsidies. Thus, the ACA may show greater percent changes in income groups 
between 138% and 400% in non-expansion states.  We predicted larger changes for race/ethnic 
groups in the former states. Because of disproportionate sampling and missing item responses 
(see next sections for details), all tabular and regression data were weighted to reflect national 
totals.   
Figure 4 provides a summary graphical structure that generated the hypothesized effects of 
the ACA’s coverage expansion on increasing health insurance coverage and access to primary 
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care in general; and the delivery of diabetes preventive care for individuals at high-risk of 
diabetes, in particular. The full QED model can be referred to in the statistical analysis sections 
3.2 and 3.3. 
Analysis using BRFSS 
BRFSS Dataset Overview 
The CDC initiated the BRFSS, a cross-sectional telephone survey conducted monthly by 
state health departments. This dataset was established in 1984 and collects data in all 50 states, the 
District of Columbia and three U.S. territories. In total, over 400,000 adult interviews are 
conducted each year making this dataset the largest continuously conducted health survey system 
in the world. BRFSS contains prevalence data on risk behaviors and preventive health practices 
among adult U.S. residents. The BRFSS questionnaire consists of a standard core (yearly survey 
asked by all states), rotating core (portion of survey asked by all states on every other year basis), 
optional modules (standardized questions on various topics that each state may select) and state-
added questions.  (Centers for Disease Control and Prevention, 2013). BRFSS does not include 
any questions related to immigration status (State Health Access Data Assistance Center, 2009). 
BRFSS Sample Design  
The BRFSS sample consists of landline and cellular telephone users. The landline sample 
is drawn using disproportionate stratified sampling (DDS) where telephone numbers are 
classified into high density (listed) or medium density (not listed) numbers, with high density 
stratum being sampled at a higher rate, a ratio of 1:1.5 (Centers for Disease Control and 
Prevention, 2013). The landline sample consists of household sampling where individual 
respondents are selected randomly from all adults aged 18 years and older living within the 
household. Cellular telephone respondents are weighted as a single adult household although 
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geographic specificity is less reliable for cellular than landline numbers. In addition, persons in 
college housing are considered single households. A household is defined as a housing unit with 
a separate entrance, where residents eat separately and the household is the principal or 
secondary place of residence. Eligible household members include all adults aged 18 years or 
older who consider the household their home. Non-eligible households include: unoccupied 
vacation homes for more than 30 days per year, group homes, institutions and households in an 
outside state (for the landline sample) (Centers for Disease Control and Prevention, 2013).  
 As of 2011, the sample design was updated to reflect the growing number of U.S. 
households relying solely on cellular telephones and the declining response rates. By adding 
cellular telephone-only households, greater representation of individuals with lower incomes, 
lower educational levels and younger age groups was expected. The CDC adopted a 
sophisticated weighting method known as “raking” or iterative proportional fitting. In raking, 
non-response adjustments for each variable are made individually and weights are re-adjusted as 
each variable is included until the sample weights are representative of the whole population 
(Centers for Disease Control and Prevention, 2012).  
The raking methodology is composed of two sections: design weight and raking. The 
design weight is adjusted to take into account the overlapping sample frames (i.e. cellular 
respondents and landline respondents) (Centers for Disease Control and Prevention, 2016). This 
weighting method updated the previous method of “poststratification”.  Before 2011, post-
stratification adjusted survey response data to known proportions of age, race, sex, geographic 
region or other characteristics of the population taken from U.S. Census data.  A limitation to 
this method was access to information on specific regions or areas. As a result, the CDC 
62 
 
transitioned to raking which does not require demographic data for small geographical areas 
(Centers for Disease Control and Prevention, 2012).  
National Sample 
The national sample consisted of 2,810,525 observations when years 2012 to 2017 were 
concatenated. Once Guam, Puerto Rico and the Virgin Islands were dropped, the national U.S. 
sample consisted of 2,764,052 observations. Income was the variable with the most “missing” 
observations, with about 15.58% of respondents reporting “don’t know/not sure” (7.19%), 
“refused” (8.07%) or missing data (0.58%). The observations without an income reported were 
dropped, leading to a national sample of 2,327,106 observations.  Missing incomes were dropped 
instead of imputing since imputation is already being used to identify those with incomes greater 
than $75,000 (refer to page 70 for additional details). Additionally, income is an important 
variable in this analysis since ACA effects are directly tied to income levels, so imputing a 
variable twice could result in greater biases.  
The following missing data was dropped from the national sample before reducing the 
national sample to the analytic sample: age (0.60% missing), sex (0.01% missing), education 
(0.13% missing), body mass index (BMI) (4.4% missing), and self-reported health (0.26% 
missing). In instances where missing variables were recoded, the recoding will be described in 
detail in the sections that follow. The final national sample consisted of 2,207,012 observations. 
The national sample was used for descriptive statistics and to validate the study data to known 
national trends.  
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Analytic Sample 
The analytic sample was restricted to: non-Hispanic whites, non-Hispanic blacks and 
Hispanic adults between the ages of 18-64 living in 28 Medicaid expansion and 19 non-
expansion states, leading to a sample size of 1,283,537 observations. The minority sample is 
restricted to blacks and Hispanics as these are the two largest minority groups in the U.S. and 
have been known to be disproportionately at higher risk of developing diabetes, when compared 
to non-Hispanic whites. Adults over 65 years old were excluded as they are eligible for Medicare 
and thus do not rely solely on Medicaid or insurance subsidies for insurance coverage. All adults, 
regardless of health status were included in order to identify those at high risk of diabetes.  
Given that pre-ACA Medicaid expansion %FPL levels were highly variable among states 
(refer to Appendix U), only Medicaid expansions that did not expand beyond 138% FPL in the 
pre-ACA period and non-expansion states as of 2017 were included in the analytic sample. 
Therefore, Medicaid expansion states: Hawaii, Massachusetts, Vermont, and Washington, DC 
were not included. See Appendix U for Table U-1 of states with their expansion dates, if 
applicable. Sensitivity analysis was conducted by including all states and D.C, with a sample size 
of approximately 1.3 million observations. 
Outcome Variables 
The outcome variables of interest include: (1) having health insurance coverage; and (2) 
having health care access. These outcomes were derived from questions located within the 
section titled “Health Care Access” in the BRFSS Questionnaire.  
  INSURANCE COVERAGE. For access to insurance coverage, BRFSS measures access 
with the question,  
64 
 
“Do you have any kind of health care coverage, including health insurance, prepaid 
plans such as HMOs, government plans such as Medicare, or Indian Health Service?” 
(Appendix I).  
The insurance coverage variable (INS) measures the likelihood of having health 
insurance and was recoded to: (0) no insurance coverage and (1) yes to any kind of health care 
coverage. The responses of “don’t know/not sure” and “refused” were recoded to (0). This is the 
only question in BRFSS that asks about health insurance coverage.  
A limitation to this question is the inability to differentiate between different types of 
health care coverage, especially between government programs (i.e. Medicare, Medicaid, Indian 
Health Service and the VA) and private insurance. Deleting individuals over age 65 removes the 
Medicare population (over 40 million nationally) who should be relatively unaffected by the 
ACA. Still, a few individuals in the study sample may be covered by Medicare due to disability-
related eligibility. They would also have Medicaid coverage for uncovered or unpaid Medicare 
bills. Including them in the study sample creates a very minor bias towards null findings with 
regard to the ACA.  
 HEALTH CARE ACCESS. Health care access is measured via two BRFSS questions. 
The first question asks,  
“Do you have one person that you think of as your personal doctor or health care 
provider? If “No”, is there more than one, or is there no person who you think of as your 
personal doctor or health care provider?” (Appendix I).  
The second question asks,  
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“About how long has it been since you last visited a doctor for a routine checkup? A 
routine checkup is a general physical exam, not an exam for a specific injury, illness or 
condition.” (Appendix I).   
The second question overlaps the first question as it demonstrates that a participant 
visited a care provider, but also received a routine visit. Both questions were used as alternative 
measures for determining health care access in specific aim 2 post ACA implementation (Figure 
7). Health care access was measured two different ways- either by having a health care provider, 
or having a clinic visit with a health care provider- both of which give valuable insight to how 
individuals have access to the health care system. Therefore, for the first question, the likelihood 
of having access to a primary care provider will be labeled PCP where the dichotomous variable 
was coded to (0) for no provider and (1) yes, has provider. The responses of “don’t know/not 
sure” and “refused” were recoded to (0) since the respondent is not aware of their PCP or did not 
answer “yes”, which demonstrates a weak relationship with the health care system. 
A limitation to the PCP variable is that- just because a patient-provider relationship has 
been established, does not necessarily mean that the patient has accessed the health care system 
to see their provider for preventive care. Preventive care typically occurs during the routine 
checkup as the patient is not there for an acute injury or condition, and time is available for 
preventive purposes. 
The second variable was labeled “primary care access” (PCA_1yr) and focuses on the 
last time a patient visited a physician and received a routine checkup. Appendix I has the BRFSS 
question with the 7 options available for the participant. The PCA_1yr variable was recoded to 
(0) routine checkup beyond 1 year and (1) checkup in the last year. The responses of “refused” 
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and “don’t know” were recoded to (0) since the respondent is not aware of their last checkup, 
which demonstrates a weak relationship with the health care system.  
This question has limitations as it specifically states the word “doctor” instead of the 
word “health care provider” and may prompt respondents to under report routine primary care 
visits to providers who are not physicians. Another limitation is that this question does not make 
known if the participant received preventive care related to diabetes prevention. This is why the 
NAMCS dataset is important to add for this study. However, this second question gives valuable 
information that NAMCS does not. This question provides critical information on the proportion 
of individuals living within below 400% FPL who have a primary care provider and have not 
utilized primary care services.      
Predictor Variables. 
The predictor variables included: race, income, being at high risk for diabetes, and state 
Medicaid expansion status (See Appendix H).  
 RACE. In the initial analyses using the full study sample, we are interested in ACA 
effects for all groups regardless of race; but in the analyses that follow, we were interested in 
ACA effects on blacks and Hispanics versus whites in order to determine if racial/ethnic 
disparities decreased in the outcomes of interest. BRFSS captures race/ethnicity in three 
questions. All questions are included in Appendix I. The first question focuses on whether a 
respondent reports being Hispanic or Latino; whereas, the second question allows respondents to 
check all that apply to a set of five race-based categories and an “other” option. If a respondent 
choses more than one race, he/she was asked in the third question to select the group that best 
represents their race. For simplification, the data from the three questions was reduced to two 
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race-based variables labeled: Black and Hispanic. The black and Hispanic variables were 
generated from the BRFSS variables _racegr2 (2012) and _racegr3 (2013-2017). In these 
computed variables, BRFSS recategorized race into mutually exclusive groups of whites, blacks 
and Hispanics (Appendix I). The dichotomous black variable was coded to (0) Non-Hispanic 
white and (1) Non-Hispanic black.  The dichotomous Hispanic variable was coded to: (1) 
Hispanic and (0) Non-Hispanic white. For descriptive purposes a third variable was created 
which included all three racial/ethnic groups: (0) whites, (1) blacks and (2) Hispanics.  
 INCOME. The four income categories (INC_yearly) that were created represent the 
following percent of federal poverty level (FPL) groups: 
1. INCh < 1.00*FPLhsize; 
2. 1.00* FPLhsize ≤  INCh ≤ 1.38* FPLhsize; 
3. 1.39* FPLhsize ≤  INCh ≤ 4.0* FPLhsize; 
4. INCh > 4.0* FPLhsize 
Percent of FPL groups were constructed using respondents’ reported income, household size and 
2012-2017 Department of Health and Human Services (HHS) Poverty Guidelines. The following 
formula was used to calculate percent of federal poverty level (%FPL):  
% FPL= (incomecat/PGHSIZE)*100 
  Incomecat. For the income variable, BRFSS has one question for household income 
from all sources. Refer to Appendix I for the question. Eight income options are provided with 
“1” representing less than $10,000 and “8” representing $75,000 dollars or more.  Since income 
categories do not exactly conform to ACA effects related to Medicaid and the insurance 
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subsidies, household size and federal poverty guidelines (FPLhzize) were used to determine to 
which of the four income categories (i.e. <100% FPL, 100-138% FPL, 139-400% FPL, or 
>400% FPL) the respondent belonged to. Respondents who answered “don’t know/not sure or 
refused” to the income question were dropped, as stated in the beginning of this section.  
First, each income category was converted to a dollar term by taking the median value as 
done in Sommers et al. (2015). For example, the less than $10,000 category was converted to 
$5,000 dollars (and so forth). The dollar term variable for income was given the label 
“incomecat”. These income levels were used to isolate income groups that were hypothesized to 
have benefited the most from the Medicaid coverage expansion (100-138% FPL) or the ACA’s 
subsidy (100-400% FPL).  
To calculate the dollar term for the last category (greater than $75,000), the following 
formula was used:   
Calculation of Mean Income for >$75,000 Group 
(1) HINCg,t  = Σpj,g,t •Yj,g,t    + p>75,g,t •Y>75,g,t   
 
• HINCg,t  = mean income for households in the g-th group (eg., race) in year t (2012-2017) 
• pj,g,t = proportion of households in g-th group in year t in j-th income category <$75,000 
• p>75,g,t = proportion of households in g-th group in year t in income category >$75,000 
• Yj,g,t, Y>75,g,t  = mean income in g-th group in year t with incomes <$75,000 or >$75,000.  
 Solving for the mean income of the top end group: 
(2) Y>75,g,t =  {HINCg,t  -  Σpj,g,t •Yj,g,t } / p>75,g,t  
(3)  
The mean income for the last category was adjusted by year and race/ethnicity. See Appendix V 
for details on the calculation of mean income by race and year for the greater than $75,000 
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income category.  
  PGHSIZE. The 2012-2017 Poverty Guidelines were used to create a variable that 
assigned a poverty guideline dollar term dependent on the household number (PGHSIZE). The 
poverty guidelines are based on household size and are issued on a yearly basis. These guidelines 
are used for determining financial eligibility for federal programs. To note, Alaska and Hawaii 
have their own set of poverty guidelines and were adjusted accordingly (Office of the Assistant 
Secretary for Planning and Evaluation, U.S. Department of Health & Human Services, n.d.). See 
Appendix AD for the 2012-2017 poverty guidelines used in this analysis.  
The BRFSS dataset has two variables that together, give household size, i.e. number of 
adults (numadult) plus number of children (children). Total household was calculated by adding 
the number of adults and number of children reported by the survey respondent. Calculating 
household size is important to calculate the percentages of FPL of study interest. The cutoff for 
household size was 14 as the percentage of the population at 14 in the analytic sample was 
0.0056%. Therefore, the dollar term for households over 14 was given the same dollar term as 
those at 14 (i.e. Household size last category was 14+). In 2010, the average household size was 
2.58 people per household, declining to 2.54 people per household in 2017 (Lofquist, Lugaila, 
O’Connell & Feliz, 2012; Statista, n.d.).  
The study design which consists of landline and cellular calls is a limitation to calculating 
household size because cellular calls are counted as single adult households. In the national 
sample, 38.53% (n=850,461) were cellular calls, compared to 47.28% (n=645,078) in the 
analytic sample. To overcome this, the martial status variable was used to convert single adult 
households to two adult households if the survey respondent reported being “married”. In the 
analytic sample, 51.27% (n=330,701) of cellular respondents (n=645,078) reported being 
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married and were converted to two adult households. Fewer than 0.01% (n=8) of cellular 
respondents had their marital status “missing”.   
 HIGH RISK OF DIABETES. To create the “high risk for diabetes” variable, an 
algorithm was created which consisted of the following BRFSS questions: (1) if the respondent 
was ever told they had diabetes, (2) participant calculated body mass index (BMI) and (3) if the 
respondent participated in any exercise in the past month. The algorithm classified each 
respondent into one of two diabetes risk categories or diabetes: (0) no/low risk for diabetes, (1) 
high risk for developing diabetes, and (2) diabetes. The following paragraphs describe how the 
algorithm was created. Figure 9 provides a detailed flow diagram leading to the creation of the 
high risk for diabetes (HRD_wDIA) variable. Diabetes was included in the algorithm  
The high risk for diabetes algorithm begins with a self-report question on diabetes. The 
actual question from the BRFSS codebook reads,  
“(Ever told) you have diabetes? If “Yes” and respondent is female, ask: “Was this only 
when you were pregnant?” If respondent says pre-diabetes or borderline diabetes, use response 
code 4.  
The available answers to this question include: (1) Yes; (2) Yes, but female told only 
during pregnancy, (3) No; (4) No, pre-diabetes or borderline diabetes, (7) Don’t know/Not sure; 
or (9) Refused. Respondents who answer “yes” were not included in the high-risk variable since 
they have diabetes. Respondents who responded with “told borderline/pre-diabetic” or “only 
during pregnancy” were labeled “1” for high risk; and those who responded “don’t know”; or 
“refused” were moved onto the second step of the algorithm.  
  BMI5cat. Body Mass Index (BMI) is an important variable to determine diabetes risk 
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status. This categorical variable was created using the BRFSS calculated variable for BMI 
(_bmi5). In this calculated variable, BRFSS provides the calculated BMI of respondents from the 
self-reported height and weight questions: 
“About how much do you weight without shoes?” 
“About how tall are you without shoes?” 
Weight was reported in pounds (lbs.) and kilograms (kgs). In order to differentiate between the 
two, metrics were reported with a “9” in column 118 in the dataset. All weights were converted 
to kilograms (kg) using the standard conversion of 1kg= 2.20 lbs. Height was reported in 
feet/inches or meters/centimeters. In order to differentiate between the two, metrics were 
reported with a “9” in column 122 in the dataset. All heights were converted to meters (m) using 
the standard conversion of 1 meter= 39.37 inches. The standard formula for BMI is:  
  BMI Formula = weight (kg) /height (m2)  
Using the BMI calculations, obesity prevalence was calculated using the formula below: 
 
A systematic review assessing reliability and validity of BRFSS 2004-2011 found that 
self-reported physical measures were compromised, especially when reporting measures of 
height and weight (Pierannunzi, Hu & Balluz, 2013). The BRFSS dataset only has self-reported 
data, which research has found adults tend to under-report weight and over-report height, with 
obese adults tending to under-report weight, resulting in artificially lower obesity prevalence 
rates (Elgar & Stewart, 2008; Lin, DeRoo, Jacobs & Sandler, 2012; Gildner, Barrett, Liebert, 
Kowal & Snodgrass, 2015). Although this information is self-reported, it provides an estimated 
Number of people with obesity
Number of people measured 
X 100Prevalence =
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height and weight for each individual since the measured weight and height are not available. If 
an individual in this algorithm reports a high BMI, we can expect this high BMI to be true.  
A BMI dummy variable was created where (0) BMI < 25; (1) 25 ≤ BMI <30; and (2) 
BMI => 30. Individuals who did not report diabetes, borderline diabetes/pre-diabetes or only 
during pregnancy and report a BMI < 25 (normal BMI) were considered no/low risk for diabetes 
and coded “0”. Individuals who did not report diabetes, borderline diabetes/pre-diabetes or only 
during pregnancy and report a BMI > 30 (obese) were considered high-risk for diabetes and 
coded “1”. Individuals who did not report diabetes, pre-diabetes or diabetes during pregnancy 
and had missing data on BMI were coded “0” no/low risk. Individuals who did not report 
diabetes, borderline diabetes/pre-diabetes or only during pregnancy and reported a BMI of 25 to 
30 moved onto the next step of the algorithm.  
The third and last step of the algorithm incorporated the only BRFSS question on 
exercise. Exercise was added to this algorithm because a growing literature indicates that 
exercise alone is the best predictor of self-rated health when compared to the BRFSS variables 
tobacco use or diagnosis of diabetes (Larson & Winn, 2010).  The benefits of regular physical 
activity are well accepted (Brown, Balluz, Heath, Moriarty, Ford, Giles & Mokdad, 2003); 
however, it is important to note that this question focuses only on a month’s timeframe and does 
not mean exercise is practiced habitually. In an attempt to not oversample those “at high risk”, 
exercise will be used to filter through the “overweight” BMI category since being “overweight” 
could misclassify someone with excess muscle mass instead of adipose tissue.  The question 
reads, “During the past month, other than your regular job, did you participate in any physical 
activities or exercises such as running, calisthenics, golf, gardening, or walking for exercise?  
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The available answers to this question included: (1) Yes; (2) No; (7) Don’t know/ Not Sure; and 
(9) Refused. In this last step, a respondent that reports “yes’ to exercise in the last month will be 
categorized as “0”, no/low risk for diabetes. All other respondents will be categorized as “1”, 
high risk for diabetes. This is a crude measure for exercise.  
To summarize, individuals were added to the “1” high risk for diabetes category if they: 
(1) had self-reported pre-diabetes or borderline diabetes; or if they (2) had diabetes only during 
pregnancy or didn’t know if they were pre-diabetic and had a BMI > 30; or had a BMI ≥ 25 with 
report of no exercise in the past month. Since persons with diabetes cannot be categorized as 
“pre-diabetic” or at high risk of developing diabetes, they were identified separately as 
individuals with diabetes.   Although race/ethnicity was an important part of this analysis, 
race/ethnicity was not considered a diabetes risk factor since race/ethnicity is a predictor of 
interest and cannot be evaluated if it is included as part of the high-risk definition. This survey-
based variable for high risk does not mean an individual has “pre-diabetes”. There are 
individuals at high risk who would not be considered pre-diabetic due to a blood glucose level 
within normal range. By creating this “high risk” variable, an approximation of individuals at 
higher risk of developing pre-diabetes or diabetes when compared to those at low/no risk was 
available. This algorithm could potentially underestimate the number of individuals at high risk 
for diabetes due to the reliance on critical self-reported information, such as height, weight and 
exercise routine; but allowed us to identify a population that requires adequate access to diabetes 
preventive care.  
For descriptive statistics purposes, dichotomous variables for diabetes (DIA) and 
prediabetes (preDIA) were also created, where (1) is the report of the respective diagnosis for 
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each variable. Although people with diabetes are not the focus of this study, this information 
provides context for our analysis. 
 MEDICAID EXPANSION STATUS. A dichotomous dummy variable was created to 
determine Medicaid coverage expansion status (EXP) as follows: (0) non-expansion state; and 
(1) Medicaid expansion state. Medicaid expansion will equal “1” for states that went into effect 
after ACA implementation. Expansion status was coded “0” or “1” for the full year, regardless of 
when (which month) the state expanded coverage. Appendix U displays all the states in each 
category and if excluded, why they were dropped.  
Control Variables 
 DEMOGRAPHICS. The demographic control variables included age, sex, and 
education (Appendix K). Age was a continuous variable; whereas, sex was a dichotomous 
variable (FEM) recoded to (0) is male and (1) is female. BRFSS had one question in the 
demographic section related to educational level. The full question is in Appendix I and offers 
six options of increasing levels of educational attainment, from “1”: never attended school to 
“6”: college graduate. Education level was updated to reflect milestones in academic progression 
that are more likely to lead to better health behaviors, when compared to not having completed 
high school (HS). The education variable was recoded to: (0) Less than HS; (1) HS grad; (2) 
Some college; and (3) College grad. The option for “some college” was included since the focus 
was on racial and ethnic minorities who are less likely to be college graduates when compared to 
non-Hispanic whites who have some college (Krogstad & Fry, 2014).  
 LIMITED HEALTH STATUS. Limited Health status (LHS) refers to the report of 
chronic disease and the self-report of health status (Appendix I). Questions about ten health 
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conditions (i.e. myocardial infarction, congestive heart disease, stroke, asthma, skin cancer, 
cancer, COPD/emphysema/chronic bronchitis, arthritis, depression and diabetes) were included 
in the BRFSS (Appendix L). Each question asks if the respondent was ever told they had an MI, 
coronary heart disease, cancer or a stroke, for example. The four responses were (1) yes, (2) no, 
(3) don’t know/not sure and (9) refused. The question on asthma was the only condition that has 
two separate questions for one condition. The first question asks if the respondent was ever told 
they had asthma; whereas the second question asks if they currently have asthma. Only the 
second question will be considered in the creation of the chronic disease variable since we are 
interested in those with chronic conditions. For this study, only the major chronic conditions (i.e. 
cancer, COPD, asthma, heart disease, MI, kidney disease and stroke) were included in this 
analysis and used to create the chronic disease count variable.  
  First, a dichotomous variable was created for each chronic disease, where (0) was no 
disease and (1) was yes, condition present. Asthma and COPD were combined as were heart 
disease and MI. Five chronic disease variables resulted: (1) cardiovascular, (2) respiratory, (3) 
cancer, (4) kidney and (5) stroke. Myocardial infarction and heart disease were recoded to the 
cardiovascular grouping of (0) no disease or (1) yes, disease present. Asthma and COPD were 
recoded to the respiratory grouping of (0) no disease or (1) yes, disease present. Cancer, kidney 
and stoke were recoded to their own grouping of (0) no disease or (1) yes, disease present. Each 
chronic condition grouping was included in a count variable (CDcount) numbered 0 through 5.  
Diabetes was not included as this is the health condition of interest. Reliability of self-reported 
diagnoses of chronic disease was found to be high for BRFSS (Pierannuzi et al., 2013).  
The question on self-reported health asks respondents to rate their general health as (1) 
excellent, (2) very good, (3) good, (4) fair, or (5) poor. Previous studies have shown that a 
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majority of respondents report their health as good to excellent, leading to a skewed distribution; 
however, those who report being fair or poor health actually have some sort of health limitation 
(Van Doorslaer & Jones, 2003). Self-reported health was recoded to a dichotomous variable with 
a healthy/non-healthy distinction, where (0) was healthy and (1) was not healthy. If a respondent 
answered 1-3, they were categorized as healthy; whereas respondents answering 4 or 5 were 
categorized as unhealthy. Respondents answering “don’t know/not sure” or “refused” were 
added to the (1) not healthy category since they were either unaware of their health status or do 
not want to report poor health.   
 PRIMARY CARE PROVIDER SUPPLY. Lastly, the PCP supply variable was 
constructed using data from the 20011 Center for Studying Health System Change which 
measured state variation in primary care physician supply pre-ACA. The states classified as low, 
medium and high PCP based on the ratio of PCPs to the nonelderly U.S. population in 2008. 
Supply was measured using data was from the Health Resources and Services Administration 
(HRSA) where PCP supply was measured by the number of PCPs per 10,000 persons. Low 
supply was less than 11.5 PCPs per 10,000 persons; medium supply was 11.5-15 PCPs per 
10,000 persons and high supply was greater than 15 PCPs per 10,000 persons (Cunningham, 
2011). The dichotomous variable (SUPP) where (0) was adequate supply and (1) was low supply 
was created as a control variable for this study. Medium and high supply states were coded as (0) 
adequate supply, with low supply being coded as (1). The PCP supply dummy variable was not 
introduced into the regression model until specific aim 3 which measures the likelihood of a 
respondent having health care access.  
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Statistical Regression Analysis  
Statistical analyses were conducted by concatenating the 2012 to 2017 cross-sectional 
BRFSS datasets.  The years 2012 to 2017 were selected to conduct a pre/post, difference-in-
difference analysis using STATA 15.0. The intervention year was 2014 with years 2012 to 2013 
were “pre-ACA” and 2014 to 2017 were “post-ACA”. To measure changes over time, a dummy 
variable for ACA effects (ACA) was created where “0” was before ACA implementation and 
“1” after ACA implementation. The time variable “year” captured the year of the data (i.e. year 
1-6 for years 2012-2017). 
To test ACA effects on the main outcomes of interest, multivariate logistic regressions 
were used to determine the likelihood of a given event (e.g., having insurance). The main 
assumption with this type of study design was that trends in outcomes would not differ before 
and after the ACA or between expansion and non-expansion states if the ACA was not present 
(Decker, Brandy & Sommers, 2017). The outcomes of interest are typically dichotomous 
variables where “0” is equal to the probability that event will not occur, and “1” is equal to the 
probability that an event will occur (Angrist & Pischke, 2009).  
Two regression approaches existed for testing ACA effects on race/ethnic groups and 
those with pre-diabetes. A fully-interacted model could be estimated that includes race/ethnic 
group and pre-diabetes indicators in a single equation. This is quite cumbersome, especially 
when we wish to account for state Medicaid expansion status. The alternative is to specify a 
simpler (but not simple) model that does not distinguish between these groups then subset the 
models in certain ways and test for coefficient differences across models. We intend to use a sub-
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sample approach and compare ACA-related race-ethnic and pre-diabetes coefficients post-
stratification.  
Specific Aim #1. To capture the broad effects of the ACA on insurance, Specific Aim1 
provides baseline information by including all adults in the sample, regardless of race or diabetes 
risk status. This aim set the foundation for subsequent analyses focused on health care access and 
preventive care delivery.  We began the modeling process by proposing a two-step model that 
isolates ACA effects on the likelihood of having insurance coverage. This model gave the global 
effects of the ACA on health insurance (INS) in the U.S. and provided a baseline to which 
additional analyses were conducted. If the ACA had differential effects on blacks and Hispanics 
or pre-diabetics, it must do so by (a) increasing insurance coverage, in lower income groups, and 
(b) the race and pre-diabetic groups of interest must be inversely correlated with income levels. 
Once the basic model was estimated, separate models were run by race, resulting in ACA impact 
coefficients comparisons. The same was done for individuals by diabetes risk. It was important 
to show a statistically significant link between ACA and insurance, in order to move onto further 
analyses outlined in aims 2-3.  
Aim 1a. To determine the impact of the ACA’s coverage expansion on the likelihood that 
an adult aged 18 to 64 has health insurance coverage in the U.S. by income category. 
• Hypothesis #1a: When compared to the pre-ACA period, ACA’s subsidy and Medicaid 
expansions will lead to not only to an increase in the percentage of lower income adults 
gaining health insurance coverage, but at a faster rate than for higher income adults post-
ACA implementation. 
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Aim 1b. To determine the differential impact of the ACA’s coverage expansion on the 
likelihood that an adult aged 18 to 64 has health care coverage between Medicaid expansion 
versus non-expansion states by income category.1 
• Hypothesis #1b: When compared to the pre-ACA period, ACA’s subsidy and Medicaid 
expansions will lead not only to an increase in the percentage of lower income adults 
gaining health care coverage, but at a faster rate within Medicaid expansion states than 
non-expansion states post-ACA implementation.   
 (1) Pb[INS]it= 
(Aim 1a., Step 1) 
   α +ΣmϕmXmit + ΣjβjINCjit + μTt + ΣjνjINCjit*Tt     (Line 1) 
(Aim 1b, Step 2)     
   + ρEXPi + ψEXPi*Tt+ εit      (Line 2)  
 
While this model requires estimation of numerous main and interaction coefficients, the 
dataset contained well over 2 million observations (+ 400,000 persons for each of the 5 years). 
The basic model was estimated in two steps. Step 1 estimated ACA effects on the level and trend 
in insurance coverage for the four income groups. Step 2 then differentiated the Step 1 effects 
between expansion and non-expansion states. The variable “T” in the regression model was 
measured two ways (1) pre vs. post ACA and (2) pre vs. each year (i.e. 2014, 2015, 2016 and 
2017). With pre vs. post, we measured aggregate changes, whereas with the year by year 
variable, time trends were measured.  
 
1 For a more detailed discussion of Difference-in-Difference regression methods for program evaluation, 
see J. Cromwell, et al. Pay for Performance in Health Care: Methods and Approaches, Ch. 10, RTI Press, 
March 2011; A. Gelman, J. Hill. Data Analysis: Using Regression and Multilevel/Hierarchical Models, 
Ch.11, Cambridge University Press, 2007. 
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For specific sub aim #1a, step 1 represents the probability of the i-th adult aged 18 to 64 
having health insurance coverage (INS) in year T (pre vs. post ACA). This probability is a 
function of the following variables included in the X-vector: (1) the sum (Σ) of the independent 
variables: income, education, Limited Health Status (LHS), high risk for diabetes (HRD) and the 
covariates: chronic disease, age and gender, (2) the sum (Σ) of j=1-3 low-income levels (INC), 
(3) the annual Tt time counter variable (1-5), and (4) the new ACA coverage expansion policies 
(ACA). For clarification, the subscripts (m) and (j) represent a different independent variable 
within the summation (Σ) sign.  
Step 1, Line 1 (Specific Aim 1a). For the basic model, the alpha (α) intercept and 
represents the probability of having insurance for an adult male age 18 with a household income 
>400% of the FPL, without a high school diploma, and no disabilities or chronic disease in base 
year 2012. Because the annual time trend and ACA variables are included in Step 1, the beta (β) 
coefficients for the three lower-income variables should be less than 1.0 indicating less insurance 
coverage, relative to persons with incomes >400% of the FPL.2 The mu (μ) coefficient represents 
a time trend slope in coverage that is common to all persons in the X-vector during the two-year 
baseline period. The three nu (ν) coefficients quantify the deviation in the mu (μ) baseline trend 
line of μ for each of the three lower income groups- again relative to incomes > 400% FPL. 
While we predict that insurance coverage was less in lower-income groups prior to the ACA, no 
hypotheses are suggested regarding differences in trends in coverage within income groups. 
Given only five years of data, it is quite possible for some or all of the T-interaction coefficients 
 
2 Inspection of base year income coefficients provides a desirable check on the logic of our model. If any 
of the low-income logistic coefficients were >1.0, we likely have a mis-specification of some sort. On the 
other hand, education, health status, age, and sex are held constant. Some of these variables are correlated 
with income, in which case, it is not certain that lower-income persons with each of these interacted cells 
would have less insurance than those in the wealthiest group. 
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to be insignificant, but if they are, then one or more of the ACA shift coefficients must be 
significantly less than 1.0.   
Step 2, Line 2 (Specific Aim 1b). For specific sub aim 1b, multiple indicators for 
expansion state status (EXP) are introduced into the logistic regression model. Line 2 replaces 
the interaction term in Line 1. The EXP interaction term tests for differences in the levels and 
trends between expansion and non-expansion states. The rho (ρ) and psi (ψ), coefficients for 
EXP represent the difference (in any) in the level and trend slope of insurance coverage, on 
average, in expansion vs. non-expansion states for the highest income group prior to ACA 
implementation.  
Specific Aim #2: PCP Provider. A similar regression model was run for aim 2, with the 
outcome variable changing to the likelihood of having a primary care provider or the likelihood 
using primary care services (in order to measure health care access) by race, then by diabetes risk 
status (instead of by income levels in Specific Aim 1). The three income group variables were 
replaced by the insurance (INS) variable in the regression models that follow as income effects 
should be captured by the change in ACA level of insurance. In the following models, income 
has no added effect on having a PCP once insured, controlling for all other variables. The 
predictor variable PCP supply (SUPP) was added to model 2 via the X-vector since the state PCP 
supply impacts the availability and access to primary care providers and services within a given 
geographic location or state.  
Aim 2a. To determine the impact of the ACA’s coverage expansion on the likelihood that 
an adult aged 18 to 64 has health care access (i.e. a primary care provider or visited a physician 
for a routine visit) in the U.S. by race, then by diabetes risk status.  
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• Hypothesis #2a: When compared to the pre-ACA period, ACA’s subsidy and Medicaid 
expansions will lead to an overall increase in health care access among racial/ethnic 
minority adults and adults at high risk of developing diabetes when compared to non-
Hispanic whites and those at low risk respectively, post ACA implementation. 
Aim 2b. To determine the differential impacts of the ACA’s coverage expansion on the 
likelihood that an adult aged 18 to 64 has health care access (i.e. a primary care provider or 
visited a physician for a routine visit) in a Medicaid expansion versus non-expansion states by 
race, then by diabetes risk status. 
• Hypothesis #2b: When compared to the pre-ACA period, ACA’s subsidy and Medicaid 
coverage expansions will lead to an overall increase in the reporting of health care access 
among racial/ethnic minority adults and adults at high risk of developing diabetes when 
compared to non-Hispanic whites and those at low risk respectively within Medicaid 
expansion states than non-expansion states. 
Pb[PCP}it= 
 
(Aim 2a, Step 1) 
   α +ΣmϕmXmit + βINSit + μTt + νINSit*Tt      (Line 1) 
 
(Aim 2b, Step 2)     
   + ρEXPi + ψEXPi*Tt + εit      (Line 2)  
 
Full Model (Steps 1 & 2, Aim 2). For specific aim 2, step 1 represents the probability of 
the i-th adult aged 18 to 64 having a primary care provider (PCP) in year T. This probability is a 
function of the following variables: (1) the sum (Σ) of the independent variables: PCP supply, 
education, LHS and the covariates: chronic disease, age and gender (all represented by the X-
vector), (2) the likelihood of having insurance (INS), and (3) the Tt time variable (1-5, or pre vs. 
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post ACA). The alpha in the global model is the intercept and represents the probability of 
having a primary care provider for an uninsured, adult male age 18, living within a non-
expansion state with an adequate supply of primary care providers in 2012. Runs were run by 
race, then by diabetes risk status.   
It was hypothesized that the beta (β) coefficient on INS will be highly significant in the 
pre-ACA years. The nu (ν) coefficient measures any change in the INS effect over the base 
years. The zeta (ζ) and lambda (λ) coefficients now quantify changes in the level or trend of 
having insurance coverage on primary care access during the ACA period. Neither of these 
coefficients must be significant for the ACA to have a significant effect on gaining a PCP so 
long as beta (β) is significant, and we have shown that the ACA significantly increased INS. If 
being in an expansion state has even different effects of insurance on PCP, at least some of the 
EXP-INS coefficients in lines 3-5 will be statistically significant. 
A more immediate test of ACA effects on PCP was available by simply dropping all INS 
main and interaction effects- and this was done. But it was important to quantify the logical two-
step path of the ACA through insurance to gaining PCP access. As noted earlier, if the ACA had 
no effect on insurance coverage, then how could it affect PCP access? And, if it did increase 
coverage, how important, quantitatively, was broader insurance to gaining access to primary 
care?  
Sub-sample Analysis  
Race/ethnicity and diabetes health risk sub-sample analyses were introduced via specific 
aims 2. To conduct the analysis by race, two separate regressions were run, (using the basic 
regression model shown above). It was anticipated that running separate models for 
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race/ethnicity would lead to cleaner models to estimate and interpret. An F-test was conducted 
on the coefficients to test for differences in the R2 of the regression models between the two 
race/ethnicity samples. The same method will be used for diabetes risk status, where the basic 
model was run for those at high-risk of diabetes.  
Specific Aim #2 Clinic Visit. In specific aim 2, a possibly more meaningful way to 
measure health care access by predicting if a clinic visit with a health care provider for a routine 
checkup (PCA_1yr) occurred was proposed; instead of simply knowing if a respondent had a 
PCP. This outcome variable used the same regression model for the likelihood of a having a PCP 
but allowed for the measurement of health care access in a different manner. With the first 
outcome variable (PCP), an individual may report having a primary care provider, but may not 
actually see their provider for primary care services. Therefore, this alternative health care access 
outcome, labeled Primary Care Access (PCA_1yr) speaks to an actual visit with a physician, 
which would be the first step to receiving recommended prevention interventions, leading to our 
specific aim 3 NAMCS analysis. The regression model used to test for the “use” of primary care 
services was the same as for “having a primary care provider”. The only change was the outcome 
variable in the equation (i.e. Pb [PCP]it to Pb[PCA_1yr]it) 
Regression Weighting 
Sample weighting (via design and raking) was used to adjust for characteristics in the 
population as unweighted sample statistics may be biased. Design weighting takes into account 
the number of phones and number of adults in each household; whereas raking weighting allows 
for the introduction of more demographic variables. To remove bias from the sample, BRFSS 
included the variable _LLCPWT, which is a final weight assigned to each respondent for the 
landline and cellular telephone combined data (Centers for Disease Control and Prevention, 
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2013). To survey weight the data in STATA, the following command was used: svyset _psu 
[pweight = _llcpwt], strata(_ststr) singleunit(scaled).  
Missing Data 
Unless otherwise noted in the text, any variable containing <5% missing data was 
dropped.   
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Analysis using NAMCS 
BRFSS allowed us to quantify the impact of the ACA, first, on the probability of having 
health care coverage, followed by the gain in health care access overall, and for 2 sub-groups in 
the U.S. Since we are interested in studying the delivery of diabetes preventive care, the NAMCS 
dataset allows us to study the ultimate outcome in this multi-stage analysis (Figure 8). The two 
outcomes of interest in this section were: (1) the probability of receiving diabetes screening 
(SCR), and (2) the probability of receiving diabetes prevention education (DPE) during a 
preventive care clinic visit. Logically, the two outcomes of interest are a long way from the 
implementation of ACA and whether the two sub-groups of interest (i.e. high risk and minorities) 
are getting screened or receiving diabetes prevention education. This why the BRFSS analysis 
(Specific Aims 1 & 2) was instrumental to setting up the NAMCS analysis.   
Analysis proposed using the BRFSS addresses the likelihood that the ACA increases 
insurance coverage which, in turn, increased the likelihood of having a PCP. The probability of 
having a clinic visit is dependent on having a PCP and how often a person sees their PCP. This 
ratio does not equal 1.0 for an insured population over a specified time period for example in the 
first ACA year. This produces a “loss” in linkage between the ACA and diabetes preventive care 
through broader insurance coverage. Finally, having a visit does not mean that high-risk persons 
or minorities are actually screened or provided education for diabetes- another loss. Therefore, 
the ACA does not guarantee that newly covered persons will now have a PCP or receive diabetes 
preventive care (even for those that do have a provider).  
  NAMCS Dataset Overview. The National Center for Health Statistics (NCHS) within 
The Centers for Disease Control and Prevention (CDC) has collected ambulatory health care data 
annually since 1989 through the National Ambulatory Medical Care Survey (NAMCS) and the 
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National Hospital Ambulatory Medical Care Survey (NHAMCS) since 1992. NAMCS is a 
national survey (Figures 7 and 8) based on a sample of visits to non-federally employed office-
based physicians; whereas NHAMCS focuses on ambulatory care services in hospital emergency 
and outpatient departments. In 2006, a separate sample of community health centers (CHCs) was 
added to the survey. In the NAMCS dataset, data is collected from the physician via an 
automated laptop-assisted data collection method. Each physician is assigned to a 1-week 
reporting period. Data includes both patient characteristics, as well as physician and practice 
characteristics (Centers for Disease Control and Prevention, 2017).  
There were two data collection forms, the Patient Log and the Patient Record. The Patient 
Log is a sequential list of patients expected to visit throughout the survey week and determines 
which visit should be recorded. The Patient Record is an encounter form which captures 12 items 
of data about the visit. These 12 items include: date and length of visit; patient’s date of birth, 
sex, color, and primary problem; physician’s estimate of the seriousness of the problem, and 
whether the patient has been seen for the problem before, major categorical reasons for visit; 
diagnoses; treatment or services; and disposition. The forms filled out by physicians requires 1-2 
minutes to complete, or about 15 minutes per day. At the end of the survey week, participating 
physicians mail the Patient Records to interviewers who review the forms for completeness, 
before transmitting them for processing. If there is missing information, interviewer contacts 
physician’s office and information is obtained from the patient’s medical record by staff or from 
memory by the physician (National Center for Health Statistics, 1974).  
In 2012, the overall response rate for physician’s induction into the study was 59.7%, 
whereas the response rate for the Patient Record Forms was 37.4% unweighted (38.4% 
weighted) or 3,583 physicians completing the form. In general, rates have been declining from 
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2002 to 2012 for both physician induction interview and the completion of Patient Record 
Forms. As a result, survey weights were adjusted for nonresponse to produce final physician-
level estimates based on (1) induction interview respondents and (2) completion of the Patient 
Record Form. Implementation of a new computerized survey instrument in 2012 may have 
influenced lower than usual physician completion rates than in 2010 and 2011. After adjusting 
for nonresponse among sample visits, no or minimal biases (<2.0 percentage points) were 
observed by MSA status, Census division or targeted state, and physician specialty categories 
(Hhing, Shimizu & Talwalkar, 2012).  
Including the NAMCS dataset in this research was advantageous for the study of diabetes 
preventive care delivery. Since the unit of analysis was a patient visit, a focus was placed on the 
interventions delivered from provider to patient. In addition, there were variables included in this 
dataset that were not available within BRFSS, including: lab data, diagnoses, visit type and the 
type of insurance the patient is enrolled in. The lab data that was useful for this study includes 
tests such as Glycohemoglobin (HbA1c) and fasting blood glucose (FBG). The Patient Record 
Form captures a patient’s diagnoses, including diabetes, which was helpful in identifying the 
high-risk group. The form also captured the visit type which allowed for the selection of 
preventive care visits; but also allowed us to distinguish between established versus new patients. 
Lastly, the form allowed us to differentiate between insurance types, a helpful piece of 
descriptive data that was not available in BRFSS. 
NAMCS Sample Design 
The NAMCS sample consisted of all physician-patient visits in a physician’s office 
throughout the U.S. Only office visits to non-federally employed physicians classified by the 
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AMA or AOA as “office-based, patient care” are included. The visit must have been made 
within the physician’s office, face to face. Since the patient load may vary, physicians were 
assigned to use an “every-patient” or “patient-sampling” procedure. It is expected that sites 
completed approximately 10 patient visits per day. Physicians who anticpated 10 or fewer visits 
daily recorded data on all the visits; whereas physicians expecting 10 visits or more recorded 
data after every second, or third, or fifth visit, maintaining the same predetermined sampling 
interval at all times. The target was to have a sample of 30 visits per provider over a 1-week 
period. The visits that were excluded from the sample included: visits to specialists in 
anesthesiology, clinical pathology, forensic pathology, radiology, diagnostic radiology, pediatric 
radiology, and therapeutic radiology; visits to providers in federal service; and visits to all 
providers not practicing in an office-based practice. The exclusion criterion was focused on a 
provider’s practice characteristics rather than on specific patient characteristics (National Center 
for Health Statistics, 1988; National Center for Health Statistics, 2015).  
 The NAMCS dataset was set up as a multistage probability sampling design involving 
probability samples of primary sampling units (PSUs), physician practices within PSUs, and 
patient visits within practices. The sampling frame consisted of a list of licensed physicians 
classified as office-based and non-federally employed in the master files of the American 
Medical Association (AMA) and the American Osteopathic Association (AOA). These files were 
frequently updated, making them current at the time of the sample selection (National Center for 
Health Statistics, 1988).   
In the first-stage sample, metropolitan statistical areas (SMSA’s) and nonmetropolitan 
counties were sorted and stratified by size, region and demographic characteristics- and then 
each frame was divided into sequential zones of 1 million residents. A random number was 
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drawn to determine which primary sampling unit (PSU) came into the sample from each zone 
(National Center for Health Statistics, 1974). The first stage sample included 112 PSUs. PSUs 
are geographic segments composed of counties, group of counties or towns across the U.S. 
(National Center for Health Statistics, 2015).  
The second stage consisted of a probability sample of practicing physicians selected from 
a list of physicians located in the sample PSU’s, which were ordered by major specialty 
categories. This list came from the master files maintained by the AMA and the AOA. In this 
method, the overall probability for including any individual was the reciprocal of the number of 
physicians in the frame at the time of selection. Within each PSU, all eligible physicians were 
stratified by 15 groups by specialty (National Center for Health Statistics, 1974; National Center 
for Health Statistics, 2015).   
The third stage was the selection of patient visits within the annual practices of sample 
physicians, which involves two steps. First, the total physician sample was divided into 52 
random subsamples of approximately equal size. Then, each subsample was randomly assigned 
to 1 of the 52 weeks in the survey year. The second step involves the physician selecting a 
random sample of visits from the reporting week. The sampling rate varies from a 100 percent 
sample for very small practices, to a 20 percent sample for very large practices in this final step 
(National Center for Health Statistics, 2015).   
NAMCS Analytic Sample 
The NAMCS study sample focused on patient visits. The total sample sizes for each year 
was: 76,330 visits/year (2012), 54,873 visits/year (2013), 45,710 visits/year (2014), and 28,332 
visits/year (2015). The type of visit was restricted to new and established patients who had a 
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preventive care visit in 2012-2015. Like the BRFSS sample, the NAMCS sample was restricted 
to patients who were: Non-Hispanic whites, Non-Hispanic blacks and Hispanic adults aged 18-
64. All adults, regardless of health status were included in order to identify those at high risk of 
diabetes. Only 16 states were identified in 2015 and were included in the sample: Arizona, 
California, Florida, Georgia, Illinois, Indiana, Massachusetts, Michigan, New Jersey, New York, 
North Carolina, Ohio, Pennsylvania, Texas, Virginia and Washington. Following BRFSS 
eligibility requirements, Massachusetts was excluded from the analysis due to expanding 
Medicaid above 138% FPL in the pre-ACA period. The cut off year to be included as a Medicaid 
expansion state was 2015. Refer to Appendix Y for a list of states with their expansion dates, if 
applicable. Once the study sample was limited to preventive visits by white, black, or Hispanic 
adults aged 18-64 in one of the 15 states, the sample size was reduced to 8,974 visits from 2012-
2015.  
Outcome Variables 
As primary care outcome measures for high-risk or pre-diabetes do not exist, adherence 
to clinical guidelines was used as a proxy to determine if appropriate diabetes interventions were 
delivered. The outcome variables of interest focus on health care delivery, specifically the 
delivery of diabetes prevention via (1) diabetes screening (SCR) and (2) diabetes prevention 
education (DPE) during a preventive care visit (Appendix U). The two variables were taken from 
the NAMCS Patient Record found in the section labeled “tests” for screening and “services” for 
counseling (Refer to Appendices N & O).  
   DIABETES SCREENING. To determine if diabetes screening was performed during a 
visit, a dichotomous variable was created where (0) was no screening and (1) was yes, blood 
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glucose or HgA1c performed during visit. The diabetes screening came from 2 fields in the 
Patient Record From: (1) Hemoglobin A1c level and/or (2) glucose drawn during the preventive 
care visit in years 2012-2015. Sensitivity analysis was conducted where 4 fields in the Patient 
Record Form were included for years 2012-2014: (1) Hemoglobin A1c level drawn during visit, 
(2) glucose drawn during visit (3) fasting blood glucose in the past year, or (4) A1c in the past 
year. Year 2015 was dropped due to no entries in HgA1c or fasting blood glucose in the past 
year. The screening variable for the sensitivity analysis will be coded (0) was no screening and 
(1) was yes, blood glucose or HgA1c performed during visit or within the past year. To compare 
the sensitivity analysis to the main analysis, the 2 tests from the main analysis were also run 
using 2012-2014 data only.  
 DIABETES PREVENTION EDUCATION. Similarly, a dichotomous variable was 
created for diabetes prevention education where (0) was no diabetes prevention education and (1) 
was yes, at least one form of diabetes prevention education was provided during the clinic visit 
(i.e., diet/nutrition, exercise, or weight reduction). To note, survey years 2014 and 2015 have the 
option for diabetes education so this type of education was included in the variable for sensitivity 
analysis purposes.   
Predictor Variables 
The predictors (Appendix V) for this analysis included: race/ethnicity, diabetes risk 
status, and state Medicaid expansion status. PCP supply was not used in this analysis as the 
supply of PCPs should have no effect on visit content.  
  RACE/ETHNICITY. NAMCS has five race categories: (1) white, (2) black, (3) Asian, 
(4) Native Hawaiian or another Pacific Islander and (5) American Indian or Alaska Native. 
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Ethnicity has two options: (1) Hispanic or Latino and (2) Not Hispanic or Latino. As with the 
BRFSS analysis, race/ethnicity will be represented by two variables (i.e. black and Hispanic). 
The black variable was generated from the race section on the Patient Record From and was 
coded to (0) Non-Hispanic white and (1) Non-Hispanic black. The Hispanic variable was 
recoded to: (0) Not Hispanic or Latino and (1) Hispanic or Latino.   Refer to Appendix V.  
  HIGH RISK FOR DIABETES. A separate algorithm was developed to determine 
diabetes risk. A variable labeled, “high risk for diabetes” (HRD) was constructed where (0) was 
no/low risk and (1) was high-risk (2) diabetes and (3) unknown risk. Individuals identified at 
higher risk for diabetes were more accurate than in BRFSS since the NAMCS data is not self-
reported; rather the provider enters all the data for each patient.  
Any patient with a diagnosis of diabetes was recoded to a (2) and not considered at risk 
since they already had a diagnosis of diabetes. Diabetes diagnosis was determined by 
information entered by the provider on the front side of the Patient Record Form (Appendix R). 
The NAMCS dataset includes a calculated BMI for each patient. Patients with a BMI > 25 and 
no diabetes diagnosis were placed in the (1) high risk category; whereas patients with no diabetes 
diagnosis and a BMI < 25 were coded (0) no/low risk. Almost half of the BMI values were 
missing in the sample and were coded a (3) unknown risk. Missing BMI values with a diagnosis 
of obesity were recoded to (1) high-risk. Figure P-1 displays the algorithm that determines 
diabetes risk.  
 MEDICAID EXPANSION STATUS. Lastly, a dichotomous variable was created for 
expansion status as follows: (0) non-expansion state; and (1) Medicaid expansion state. Medicaid 
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expansion will equal “1” for states that went into effect after ACA implementation in 2015. 
Refer to Appendix AD for the map of Medicaid expansion states.   
Control Variables 
Covariate controls included age, gender and the presence of chronic disease (Appendix S-
1). The covariates of interest included the continuous variable for age as well as the dichotomous 
variable for gender where gender was recoded to (0) male and (1) female. Chronic disease was 
simplified to one dichotomous variable representing chronic disease, labeled CDV. The chronic 
disease variables from BRFSS were different from those recorded on the NAMCS Patient 
Record Form. The chronic diseases available in the NAMCS Patient Record Form included: 
arthritis, asthma, cancer, cerebrovascular disease (stroke), COPD, chronic renal failure, 
depression, and ischemic heart disease. The chronic disease variable was reduced to 6 
conditions: asthma, stroke, COPD, depression, CAD and CHF. Diabetes is also captured on the 
Patient Record Form but will not be included. The physician reported each of these diagnoses by 
checking off a checkbox on the front side of the NAMCS form (Appendix N). To account for 
chronic disease, a patient must have had at least one of the six chronic diseases checked off 
during their visit. The CDV variable was coded to: (0) no chronic disease and (1) at least one 
chronic disease or more. 
Statistical Regression Analysis: Tabular and multivariate 
Statistical analyses were conducted by concatenating the 2012 to 2015 cross-sectional 
NAMCS datasets. The years 2012 to 2015 were selected as these years cover the timeframe of 
interest. The 2016 data was not available by state. As with the BRFSS, a pre/post, difference in 
difference analysis was conducted. The intervention year was 2014, with 2012 to 2013 being pre-
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ACA and 2014 to 2015 being post-ACA. The time trend (T) was not included in the model due 
to the shorter pre/post time period (2012-2015), when compared to BRFSS (2012-2017). As with 
the BRFSS analysis, Massachusetts was excluded from the analysis due to expanding Medicaid 
before 2014.   
Descriptive Statistics 
Descriptive statistics were calculated using the chi square test to compare results. 
Insurance status was included in the descriptive data. The Patient Record form captures if a 
patient had some form of health insurance coverage for their visit. The options included: (1) 
private insurance, (2) Medicare, (3) Medicaid or CHIP, (4) Worker’s Compensation, (5) Self-
pay, (6) No Charge, (7) Other or (8) Unknown. The options for Medicare and Worker’s 
Compensation were dropped as these options were not applicable to the study. Even though 
insurance status was not relevant for the analysis, this information was valuable to the overall 
study to show how many individuals with a given insurance type visited a provider for 
preventative services.  
Statistical Regression Analysis 
Multivariate logistic difference-in-difference regression models were estimated to 
determine whether the ACA coverage expansion was associated with the odds of receiving 
diabetes prevention intervention. Two regression models were used to determine first, the 
likelihood that an adult received diabetes screening by expansion status and second, the 
likelihood that an adult received diabetes prevention education during a clinic visit by expansion 
status. These two outcomes are the main objectives of Specific Aim 3. After the Aim 3 is 
described, each model will be described in greater detail in the sections that follow.  
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Specific Aim #3:  
Aim 3a. To determine if the ACA’s coverage expansion increased the rate of diabetes screening 
and diabetes prevention education for adults within Medicaid expansion versus non-expansion 
states.  
• Hypothesis #3a.1: When compared to the pre-ACA period, ACA’s subsidies and 
Medicaid expansions led to an increase in the rate of diabetes screening and counseling 
overall, with greater proportions of adults receiving diabetes prevention within Medicaid 
expansion states than in non-expansion states post-ACA implementation.  
Aim 3b. To determine if the ACA’s coverage expansion increased the rate of diabetes screening 
and diabetes prevention education within Medicaid expansion versus non-expansion states by 
race/ethnicity, then by diabetes risk status.  
• Hypothesis #3b.1: When compared to the pre-ACA period, ACA’s subsidies and 
Medicaid expansions will lead to increased rate of diabetes screening and counseling 
overall, with greater proportions of black, Hispanic and high-risk adults receiving 
diabetes prevention within Medicaid expansion states than in non-expansion states post-
ACA implementation. 
    DIABETES SCREENING. The following 2-step model for diabetes screening 
was proposed based on v-visits over the t=2012-2015 period. The probability was a function of 
the following variables: (1) the new ACA coverage expansion policies (ACA), and (2) expansion 
state status (EXP).  
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Model 1.  
Pb[SCR}vt= 
(Aim 4a) 
  α + βACAt + γEXPv + δACA*EXPvt       (Step 1) 
(Aim 4b)  
 + κAGEvt + ψFEMvt + ωRHvt + θRH*ACAvt +πRH*ACA*EXPvt+ εvt  (Step 2) 
Step 1, Aim 4a. The alpha (α) is the average screening rate at the base period in non-
expansion states.  The beta (β) coefficient for ACA is interpreted as the average difference in 
screening rates during the two ACA years (2014-2015) for visits in non-expansion states.  They 
gamma (γ) coefficient tests for any difference in visit screening rates in expansion versus non-
expansion states in the base period. The interactive delta (δ) coefficient tests for larger (smaller) 
ACA effects for expansion versus non-expansion states. If the ACA increased insurance 
coverage, leading to a higher PC office visit rate, then the ACA should also show a higher 
screening rate for diabetes in the ACA period. An even higher screening rate may be observed in 
expansion states after the ACA went into effect. Since the ACA targeted Medicaid and lower-
income groups, we can assume that the ACA disproportionately favored lower-income 
individuals in screening for diabetes.  
 Step 2, Aim 4b by RACE. In Step 1, the model does not adjust for age, sex or 
race/ethnicity. These patient characteristics were included in Step 2 of this model.  Now that age 
(AGE) and being female (FEM) were controlled for, the pre/post-ACA visit samples should be 
fairly “balanced”. Now, the alpha (α) coefficient is interpreted for males for a specific age. If the 
large samples were already well-balanced, then the ACA-related coefficients on line 1 should not 
change significantly.  
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Race/ethnicity (RH) had also been specified with both main and interactive coefficients. 
(The omega (ω) coefficient is interpreted as the average difference in screening rates for blacks 
(or Hispanics) in the base period within age-gender groups in non-expansion states. The theta (θ) 
coefficient tests for the change in screening rates for black (or Hispanics) during the ACA period 
in non-expansion states. Finally, pi (π) coefficient tests for a different rate of change of 
minorities for expansion states once ACA insurance coverage was implemented. Both the theta 
(θ) and pi (π) coefficients test hypotheses that ACA effects were greater for minorities. If both 
are insignificant but either or both beta (β) and delta (δ) coefficients are significant, then we can 
conclude that minorities shared equally with lower-income whites in higher ACA screening 
rates. Conversely, the two ACA coefficients in Step 2 may become insignificant if ACA effects 
were concentrated among minorities.  
Step 2, Aim 4b by Diabetes Risk. Lastly, a separate analysis was conducted using the 2-
Step Model 1 to test whether the ACA disproportionately affected screening for persons 
considered high risk of diabetes. It may be that a patient or clinician was aware of the patient’s 
high-risk status prompting the clinician to recommend clinical screening for diabetes during the 
visit. Assuming the “high-risk” status was determined upon entering the clinic, this “pathway” to 
screening can be tested by replacing the race/ethnicity (RH) variable in the 2-Step Model 1 with 
the high risk for diabetes (HRD) variable. By dropping the race/ethnicity variable, any measure 
associated with being at high risk for diabetes cannot be interpreted separately for minorities.  
When interpreting ACA effect on diabetes screening, it must be remembered that visits 
will represent both new and established patients to the clinic. Established patients with previous 
visits may have been screened for diabetes already and found to be negative or positive. To 
obtain a sharper estimate of ACA screening effects, we suggested dropping visits with a previous 
99 
 
diagnosis of diabetes since we are most interested in whether the ACA enhanced screening rates 
for patients most at risk of incurring diabetes in the future. However a sensitivity analysis of the 
descriptive data will be done to compare differences in measurement for screening. 
  DIABETES PREVENTION EDUCATION. While it would be ideal for clinicians to 
educate patients on diet, exercise and weight reduction on each visit, this does not happen in 
many cases as more pressing health issues take precedence. Diabetes prevention education, 
however, should be triggered more often when the patient is at high risk of developing diabetes, 
as determined by their high BMI or elevated blood glucose levels- two major observable 
characteristics known to be a risk factor. Assuming this leads to screening during the visit, we 
should be able to test whether high risk individuals are not only screened more often during the 
ACA period because their visit rates have increased, they should also be receiving more diabetes 
prevention education in order to raise awareness of their health risk. The analysis involved 
replacing the screening (SCR) outcome in Model 1 with diabetes prevention education (DPE) in 
Model 2.  
The following 2-Step model for diabetes prevention education was proposed based on v-visits 
over the t=2012-2015 period: 
Model 2. 
Pb[EDU}it= 
  α + βACAt + γEXPv + δACA*EXPvt        (Step 1) 
 + κAGEvt + ψFEMvt + ωHRDvt + θHRD*ACAvt +πHRD*ACA*EXPvt+ εvt  (Step 2) 
Step 1, Aim 4a. Refer to pg. 91 for explanation of coefficients. Only difference is the 
outcome of interest changing from screening to diabetes prevention education.  
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Step 2, Aim 4 by Diabetes Risk. In Model 2, the omega (ω) coefficient is interpreted as 
the average difference in diabetes prevention education rates for those at high risk in the base 
period within age-sex groups in non-expansion states. The theta (θ) coefficient tests for the 
change in education rates for those at high risk during the ACA period in non-expansion states. 
Both the theta (θ) and pi (π) coefficients test hypotheses that ACA effects were greater for those 
at high risk of diabetes. If both are insignificant but either or both beta (β) and delta (δ) 
coefficients are significant, then we can conclude that those at high risk of diabetes shared 
equally with those with no/low risk for diabetes in receiving higher diabetes prevention 
education. Conversely, the two ACA coefficients in Model 2 Step 2 may become insignificant if 
ACA effects were concentrated among those at high risk of diabetes.  
Step 2, Aim 4 by RACE. Lastly, a separate analysis will be conducted using the 2-Step 
Model 2 to test whether the ACA disproportionately affected diabetes prevention education for 
black and Hispanic minorities. In Step 2, the HRD variable will be replaced by RH variable 
representing race/ethnicity. Separate versions of Model 2 will be run for blacks (or Hispanics) 
versus whites. Refer to pg. 91 for discussion on regression coefficients. The only difference is 
the outcome of interest changing from screening to diabetes prevention education.  
Regression Weighting 
Sample weighting was used to adjust for national estimates. In order to remove bias from 
the sample, NAMCS included the variable PATWT, which is the patient visit weight used for 
national, regional, and divisional estimates and PATWTST for patient visit weight for state level 
estimates. The visit weight was calculated from the physician and visit-sampling rates, adjusting 
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for non-response (Meigs & Stafford, 2000). The final weight used in STATA for the analytic 
sample was: svyset PHYCODE [pweight=PATWTST], stata(CSTRATUM) singleunit (scaled). 
Missing Data 
Unless otherwise noted in the text, any variable containing <5% missing was dropped.  
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CHAPTER 4  
RESULTS 
Chapter 4 is presented in two sections: Section 1: BRFSS Results and Section 2: NAMCS 
Results. Section 1 is sub-divided into Parts I-VI.  Part I includes descriptive statistics displayed in 
the following format: (1) demographic data, (2) health status data, (3) state-specific data and (4) 
outcomes. Data from the full national BRFSS sample will be discussed in Part I to provide context, 
but the main datasets of interest are the two analytic BRFSS samples (i.e. 50 states and D.C. vs. 47 
states). In Part II, more complex analytic tables are be presented that differentiate between Medicaid 
expansion and non-expansion states. In Part III, pre/post ACA changes in outcomes are presented. 
Parts IV-VI consist of multivariate regression results on insurance coverage, access to primary care 
providers (PCPs) and primary care checkups. All descriptive statistics and analyses are discussed 
using sample-weighted data. Data weights were provided by BRFSS documentation found on the 
BRFSS website; except when accounting for single sampling units within a stratum. Refer to 
Appendix X for additional details on how single sampling units were handled for this analysis.  
BRFSS National and Analytic Sample Descriptive Statistics 
We begin by reporting general results using the entire national BRFSS concatenated 
samples spanning years 2012-2017. This dataset includes all adult respondents 18 years and older 
in all U.S. states (and D.C.) for all race/ethnic groups with one major exclusion. Respondents not 
reporting household income (approximately 16%) were deleted, as described in Chapter 3 Methods 
Section 3.2. This was necessary given the study’s focus on ACA effects across income groups. It 
was necessary to compare national BRFSS estimates to known U.S. population estimates in order 
to validate that any study findings could be generalizable to the U.S. population. 
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From the national BRFSS sample, two key analytic files were created. They differ from 
the national sample in two substantive ways: (a) all persons over age 64 and (2) race/ethnic 
groups besides whites, blacks, and Hispanics were deleted. Comparing ACA effects on the two 
largest minority groups versus whites was a goal of this study. The two analytic files differ from 
each other in the number of states included. The first analytic sample included all 50 states and 
the District of Columbia (DC); compared to the second analytic sample which consisted of 47 
states. In the second analytic sample, three states (Hawaii, Massachusetts and Vermont) and D.C. 
were dropped when studying ACA effects as they materially expanded Medicaid (>138% FPL) 
prior to the ACA’s implementation of 2014.  
National BRFSS Sample 
The total sample sizes for each year in BRFSS are shown below (total sample size, 
n=2,809,505):  
Table 1  
BRFSS Sample Sizes for Years 2012-2017.  
 
Non-reported incomes were dropped as described in Chapter 3 Methods Section 3.2, 
leading to a sample size shown in Table 2. A breakdown of non-reported incomes by race and 
education can be seen in Appendix Y.  
 
 
2012 2013 2014 2015 2016 2017
475,687 491,773 464,644 441,456 486,303 450,642
2012-2017 BRFSS Sample Sizes
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Table 2.  
All BRFSS Respondents Aged 18 and Over with Income Non-reporters Dropped.  
 
 
The unweighted national BRFSS sample size over six years was 2,207,012. This 
produced a mean annual national sample size of 367,835 that resulted in a weighted U.S. 
population of 206,705,174. As of 2010, the number of U.S. adults aged 18 and over was 
234,564,071 million people (Howden & Meyer, 2011). Hence, the national sample (minus non-
income reporters) currently accounts for approximately 88% of the U.S. adult population.   
Analytic BRFSS Samples 
 The analytic samples were restricted to adults aged 18 to 64 who were either white only; 
black only; or Hispanic (all races). This produced an unweighted mean sample size of 227,376 and a 
corresponding U.S. population of 144,603,548 (displayed in Table 3).  As of 2010, the number of 
U.S. adults aged 18 to 64 was 194,296,087 (Howden & Meyer, 2011). The analytic sample accounts 
for approximately 74% (144/194) of the U.S. adult population between the ages of 18-64 after 
deleting income non-responders and other races/ethnicities. A second, smaller sample dropping 
three states and D.C. reduced the analytic sample by a trivial amount.  
 
 
 
 
 
Unweighted Weighted
Sample Size 2,207,012 1,240,231,044
Sample Size, mean per year 367,835 206,705,174
National BRFSS Sample 2012-2017
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Table 3 
Analytic Samples of all BRFSS Respondents Aged 18 to 64 who are White, Black, or Hispanic in 50 
states and D.C. versus 47 states and D.C., excluding 3 pre-ACA States (2012-2017). 
 
 
 
Demographic Variables. Tables 4 and 5 display data on demographic variables within 
the BRFSS national sample and the analytic sample with all states.  
 
 
 
 
 
 
 
 
 
 
 
 
Unweighted Weighted Unweighted Weighted
Sample Size 1,364,254 867,621,289 1,283,537 844,741,467
Sample Size, mean per year 227,376 144,603,548 213,923 140,790,245
BRFSS Analytic Sample 2012-2017
ALL 50 STATES & D.C. 47 STATES
106 
 
Table 4. 
Demographic Variables for National Sample: All BRFSS Respondents Aged 18 and Over, 
Unweighted or Weighted by Sampling Fractions (2012-2017).  
 
Unweighted Weighted
Sample Size 2,207,012 1,240,231,044
Sample Size, mean per year 367,835 206,705,174
Income, mean (95% CI)
$80,160.66 
($80,067.73-
$80,253.59)
$81,003.06 
($80,807.17- 
$81,198.96)
Unweighted, % Weighted, %
FPL
<100% FPL 10.52 14.53
100-138% FPL 7.97 8.25
139-400% FPL 44.61 40.39
>400% FPL 36.91 36.84
Age Group
18 to 24 4.74 11.28
25 to 29 4.67 8.45
30 to 34 5.55 9.67
35 to 39 6.02 8.37
40 to 44 6.51 9.02
45 to 49 7.58 8.14
50 to 54 9.68 10.02
55 to 59 11.02 8.58
60 to 64 11.59 8.21
65 to 69 10.91 6.29
70 to 74 8.41 4.64
75 to 79 5.98 3.52
80+ 7.34 3.82
Sex
Men 44.94 49.84
Women 55.06 50.16
Race/Ethnicity
Non-Hispanic White 78.37 64.14
Black 7.98 11.59
Hispanic 6.37 15.32
Other 7.29 8.96
Education
Less than HS 7.06 13.49
HS Grad 27.55 27.61
Some College 27.67 31.35
College Grad 37.72 27.55
National BRFSS Sample 2012-2017
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Table 5.  
Demographic Variables for Analytic Sample: White, Black and Hispanic BRFSS Respondents 
Aged 18-64 in 50 States and D.C., Unweighted or Weighted by Sampling Fractions (2012-2017).  
 
Unweighted Weighted
Sample Size 1,364,254 867,621,289
Sample Size, mean per year 227,376 144,603,548
Income (year), mean (95% CI)
$86,360.63 
($86,243.79- 
$86,477.47)
$82,663.57 
($82,426.04-
$82,901.10)
Unweighted, % Weighted, %
FPL
<100% FPL 11.78 15.79
100-138% FPL 7.3 8.1
139-400% FPL 38.6 37.4
>400% FPL 42.31 38.71
Age Group
18 to 24 6.74 13.41
25 to 29 6.67 9.93
30 to 34 8.06 11.51
35 to 39 8.8 9.96
40 to 44 9.62 11
45 to 49 11.3 10.13
50 to 54 14.53 12.71
55 to 59 16.67 10.87
60 to 64 17.61 10.48
Sex (Fem)
Men 45.88 51.85
Women 54.12 48.15
Race/Ethnicity
Non-Hispanic White 81.57 68.35
Black 9.59 13.49
Hispanic 8.84 18.16
Education
Less than HS 6.26 12.88
HS Grad 26.11 27.68
Some College 28.47 32.34
College Grad 39.15 27.1
BRFSS Analytic Sample 2012-2017
ALL 50 STATES & D.C.
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 Household Incomes. Mean household income for the analytic sample was $86,306.63 
($86,243.79- $86,577.47, CI) averaged over 2012-2017. In comparison, the national BRFSS 
sample’s mean household income was $81,003.06 ($80,807.17- $81,198.96, CI). According to 
Census data found in Table V-1, the mean household income for all races from 2012-2017 was 
$91,618.17, about $10,00 more than the full national sample. A modest amount of the difference 
is likely due to the way we have imputed a continuous income figure using BRFSS categories. 
The analytic sample’s mean income was about $5,000 dollars higher than the national BRFSS 
sample since it is restricted to working-age adults who generally earn higher incomes than older 
adults (65+). As of 2016, the median annual household income of the 65+ population was 
$39,823 dollars from all sources (Pension Rights Center, n.d.).  
 ACA Federal Poverty Level (FPL) Groups. The ACA coverage expansion provisions 
were expected to benefit the uninsured living between 100-400% FPL, which nationally 
represents 48% of the U.S. population (KFF, 2018). In our national BRFSS sample, 48.64% of 
respondents live between 100-400% FPL, which is very close to national population estimates. 
In the BRFSS national sample, 63% of individuals had incomes below 400% of the FPL. In the 
analytic sample, the percentage of respondents living between 100-400% FPL was only slightly 
smaller (45.5%). This reduction may be because whites and younger adults are a greater 
proportion of the analytic sample.  
 Age Groups. In the BRFSS unweighted survey responses, those under age 54 were 
underrepresented. Survey respondents tend to be older and more likely to participate in telephone 
surveys. By weighting the sample, the fraction of younger adults increased and older adults 
decreased, making the estimates closer to population estimates: 9% for adults 19-25; 12% for 
adults 26-34; 26% for adults 35-54; 13% for 55-64 and 16% for those 65+ as of 2017 (Kaiser 
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Family Foundation, 2018). Table 4 displays BRFSS national sample age estimates that differ 
slightly from population estimates due to different age groupings. In the analytic sample, the 65+ 
category is dropped, leading to greater representation of younger age groups. 
 Gender Groups. Representation of men and women in the BRFSS national sample was 
49.84% and 50.16%, respectively. Using Census data, as of 2017, this ratio was 49% men to 
51% women (KFF, 2018). Before dropping the non-reported incomes, the ratio of men to women 
in the BRFSS dataset was 48.66% to 51.34%, respectively.   
 Race/Ethnic Groups. According to KFF reports compared with BRFSS, the national 
and analytic population distributions by race/ethnicity as of 2017 were:  
Table 6.  
Racial/Ethnic Population Distributions by Data Source.  
 
Greater proportions of minority populations are expected in the analytic sample as 
respondents aged 65+ were dropped- which consisted of a larger proportion of whites. Blacks 
and Hispanics tend to be younger populations. Weighting the analytic sample appears to 
reallocate most of the other race/ethnic groups to whites.  
 Education Groups. According to the U.S. Census Bureau’s 2011 Current Population 
Survey, 12% of adults aged 25 years and older did not complete high school; whereas, 31% 
completed high school, 26% completed some college or an associate degree and 30% completed 
a bachelor’s degree or higher (U.S. Census Bureau, n.d.). In the national BRFSS sample, 13.49% 
Data Source White Black Hispanic Other
KFF 61.0% 12.0% 18.0% 9.0%
BRFSS (national) 64.1% 11.6% 15.3% 9.0%
BRFSS (analytic) 68.3% 13.5% 18.2% n/a
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of adults aged 18 and older did not complete high school; 27.61% completed high school; 
31.31% completed some college; whereas, 27.55% completed a bachelor’s degree or higher. The 
completion of degrees, especially in the bachelor’s degree category (or higher) was slightly 
higher given the BRFSS sample includes years post 2011 and over time, data from the Census 
Bureau has shown that young workers in the U.S. are more likely than ever, to be college 
graduates. In fact, 40% of employed millennials, aged 25 to 29, have a bachelor’s degree or 
higher (Graf, 2017).  
 Health Status Data. Tables 7 and 8 display results on health status variables for the 
national BRFSS and analytic samples.  
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Table 7.  
Health Status Variables for National Sample: All BRFSS Respondents Aged 18 and Over, 
Unweighted or Weighted by Sampling Fractions (2012-2017).  
 
Unweighted Weighted
Sample Size 2,207,012 1,240,231,044
Sample Size, mean per year 367,835 206,705,174
BMI, mean (95% CI) 28.08 (28.07-28.09) 27.92 (27.91-27.94)
Unweighted, % Weighted, %
BMI 
Normal Weight (<25) 33.25 32.86
Overweight (25-29.9) 36.36 34.05
Obesity Class 1 (30-34.9) 18.62 17.18
Obesity Class 2 (35-39.9) 7.16 6.63
Obesity Class 3 (>40) 4.61 9.28
Exercise in last 30 days
No 26.89 27.66
Yes 73.11 72.34
Diabetes Risk
No/Low Risk 54.98 53.68
High Risk 32.13 35.86
Diabetes 12.89 10.47
Gestational Diabetes
No 99.19 99.09
Yes 0.81 0.91
Pre-diabetes Diagnosis
No 98.3 98.39
Yes 1.7 1.61
Diabetes Diagnosis
No 87.11 89.53
Yes 12.89 10.47
Self-Reported Health
Healthy 81.45 82.22
Not Healthy 18.55 17.78
Chronic Disease Count
0 69.48 75.31
1 22.39 18.9
2 6.16 4.44
3 1.62 1.11
4 0.32 0.22
5 0.03 0.02
National BRFSS Sample 2012-2017
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Table 8.  
Health Status Variables for Analytic Sample: All White, Black and Hispanic BRFSS Respondents 
Aged 18-64, Unweighted or Weighted by Sampling Fractions (2012-2017). 
 
 
Unweighted Weighted
Sample Size 1,364,254 867,621,289
Sample Size, mean per year 227,376 144,603,548
BMI, mean (95% CI) 28.33 (28.32-28.34) 28.14 (28.12-28.16)
Unweighted, % Weighted, %
BMI 
Normal Weight (<25) 32.81 33.78
Overweight (25-29.9) 35.25 35.28
Obesity Class 1 (30-34.9) 18.87 18.48
Obesity Class 2 (35-39.9) 7.69 7.4
Obesity Class 3 (>40) 5.38 5.05
Exercise in last 30 days
No 24.4 25.62
Yes 75.6 74.38
Diabetes Risk
No/Low Risk 56.66 57.31
High Risk 34.38 34.95
Diabetes 8.96 7.75
Gestational Diabetes
No 99.00 98.97
Yes 1.00 1.03
Pre-diabetes Diagnosis
No 98.7 98.68
Yes 1.3 1.32
Diabetes Diagnosis
No 91.04 92.25
Yes 8.96 7.75
Self-Reported Health
Healthy 84.15 83.84
Not Healthy 15.85 16.16
Chronic Disease Count
0 77.45 80.08
1 17.99 16.29
2 3.58 2.87
3 0.82 0.63
4 0.16 0.12
5 0.02 0.02
BRFSS Analytic Sample 2012-2017
ALL 50 STATES & D.C.
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 BMI.  Weighted 6-year mean BMI in the national BRFSS sample was 27.92kg/m2. 
According to the National Health and Nutrition Examination Survey (NHANES), the average 
BMI of an adult male in 2010 was 26.6kg/m2, almost identical to that for females (Centers for 
Disease Control and Prevention, n.d.) This estimate was 5% less than the BRFSS national 
estimate which may be due to rising BMIs among the population over the 2010-2017 period. 
Another consideration was that NHAMES BMI was measured by a well-defined protocol; 
whereas BRFSS was self-reported, leading to variation. In the analytic sample, the average BMI 
was 28.14kg/m2. BMI also is presented in 5 categories with the majority of respondents in the 
national BRFSS sample in the 25-29.9 kg/m2 range. One third in the national BRFSS sample and 
30% in the analytic sample were obese with BMIs greater than 30 g/m2.  
 Exercise. In both the national and analytic samples, almost 3/4ths of respondents reported 
exercise in the last 30 days. To note, the 2008 federal physical activity guidelines recommended 
that adults participate in either 150 minutes of moderate-intensity aerobic exercise or 75 minutes 
of vigorous exercise each week. Unfortunately, the BRFSS does not provide this kind of detail 
regarding exercise. A recent study found that only 23% U.S. adults aged 18-64 met the 
guidelines in 2010-2015 (Blackwell & Clarke, 2018). The exercise variable was used in this 
analysis as a second filter besides BMI to identify someone as high risk for diabetes. Almost 
one-quarter of individuals reported no exercise. As exercise tends to be overreported, it is 
possible that our estimate of the high-risk group is not well measured. 
 Diabetes. According to the American Diabetes Association (ADA), in 2015, 84.1 
million Americans aged 18 and older had prediabetes (ADA, 2018). This number, divided by the 
2010 U.S. adult population, gives a rough estimate of 36% of adults aged 18 and older who have 
pre-diabetes. This is a low estimate as there has been growth in the population since 2010. In the 
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national BRFSS sample, the percentage identified at high risk for diabetes was nearly identical 
(35.86%). In the national BRFSS sample, those with diabetes accounted for 10.47% of the 
sample, compared with 9.4% reported by the ADA in 2015 (ADA, 2018). In the analytic sample, 
the high-risk group accounted for 34.95% of the high-risk population, and people with diabetes 
accounted for 7.75% of the population. The high-risk group included individuals who were 
obese, individuals who reported gestational diabetes, individuals who are overweight and did not 
exercise and individuals with self-reported prediabetes.  Of all high-risk subgroups, those with 
prediabetes are of great interest as these adults have blood glucose levels nearing a diabetes 
diagnosis.  
The potential for underreporting prediabetes using a specific BRFSS question is severe. 
In the BRFSS national sample, only 1.61% of individuals reported being told they had 
prediabetes. According to the ADA, this percentage should be about 36% of the adult population 
(based primarily on elevated blood glucose or A1c levels). Yet, the report of an actual diabetes 
diagnosis in the BRFSS national sample is close to national estimates. This discrepancy may be a 
sign that providers are not frequently warning patients of their high-risk status. 
 Self-Reported Health. In the national BRFSS sample, 82.22% of respondents reported 
being healthy (good, very good, or excellent health), compared to 83.84% of respondents in the 
analytic sample. The slightly higher report of being healthy among those in the analytic sample 
was most likely due to the sample being younger and offset to some unknown degree by greater 
minority representation.   
 Chronic Conditions. In the national BRFSS dataset, a majority of respondents (75.3%) 
reported no chronic disease, with the percentage of respondents who reported additional chronic 
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diseases quickly declining after reports of 2 chronic diseases (4.4%). These proportions were less 
than national rates (45%) of all Americans have at least one chronic disease (National 
Association of Chronic Disease Directors, n.d.) since BRFSS reports on a limited number of 
chronic conditions. The analytic sample showed a slightly lower percentage with two-or-more 
chronic conditions than in the national BRFSS sample (2.87% vs. 4.4%), which was expected 
given the exclusion of the over-65 population in the former and limiting the variable to more 
serious conditions that might lead to insurance and a PCP visit. 
 State ACA Expansion Status & PCP Supply. Tables 9 and 10 display the distribution 
of the national BRFSS and analytic samples regarding Medicaid expansion and per capita 
primary care supply (PCP) over 6 years.  
Table 9.  
State-Specific Variables for National Sample: All BRFSS Respondents Aged 18 and Older, 
Unweighted or Weighted by Sampling Fractions (2012-2017).  
 
 
 
 
Unweighted Weighted
Sample Size 2,207,012 1,240,231,044
Sample Size, mean per year 367,835 206,705,174
Unweighted, % Weighted, %
Expansion Status
Non-expansion 39.51 37.76
Medicaid Expansion 60.49 62.24
PCP Supply 2008
Adequate Supply 71.77 70.27
Low Supply 28.23 29.73
National BRFSS Sample 2012-2017
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Table 10.  
State-Specific Variables for Analytic Sample: All White, Black and Hispanic BRFSS Respondents 
Aged 18-64, Unweighted or Weighted by Sampling Fractions (2012-2017).  
 
Expansion states were classified as states that expanded Medicaid by 2017 (Figure 5). 
Refer to Appendix U for a list of Medicaid expansion and non-expansion states included in this 
analysis. Respondents living in Medicaid expansion states accounted for 62.24% of the weighted 
national sample and 60.12% in the analytic sample. Roughly 7-in-10 respondents in both 
samples lived within a state that had an adequate supply of primary care providers. Ten out of 19 
non-expansion states were classified as low supply: Alabama, Georgia, Idaho, Mississippi, North 
Carolina, Oklahoma, South Carolina, Texas, Utah and Wyoming. Seven out of 31 Medicaid 
expansion states and D.C. were classified as low supply: Alaska, Arizona, Arkansas, Indiana, 
Kentucky, Louisiana, and Nevada (Cunningham, 2011). Figure 6 is a U.S. map demonstrating 
PCP supply status.  Table with expansion dates found in Table U-1. Table with PCP supply and 
expansion status data in Table U-1. 
 
 
 
Unweighted Weighted
Sample Size 1,364,254 867,621,289
Sample Size, mean per year 227,376 144,603,548
Unweighted, % Weighted, %
Expansion Status
Non-Expansion 39.88 38.77
Medicaid Expansion 60.12 61.23
PCP Supply 2008
Adequate Supply 71.67 69.17
Low Supply 28.33 30.83
BRFSS Analytic Sample 2012-2017
ALL 50 STATES & D.C.
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Figure 5. BRFSS Map of U.S. 50 states and D.C. included in the Analysis as Medicaid Expansion 
and Non-expansion States.  
 
Figure 6. BRFSS Map of U.S. 50 States and D.C. Demonstrating PCP Supply Status.  
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 Outcomes. Tables 11 and 12 display the distribution of the national BRFSS and analytic 
samples.  
Table 11.  
Outcome Variables for National Sample: All BRFSS Respondents Aged 18 and Older, 
Unweighted or Weighted by Sampling Fractions (2012-2017). 
 
Table 12.  
Outcome Variables for Analytic Sample: All White, Black and Hispanic BRFSS Respondents 
Aged 18-64, Unweighted or Weighted by Sampling Fractions (2012-2017). 
 
Unweighted Weighted
Sample Size 2,207,012 1,240,231,044
Sample Size, mean per year 367,835 206,705,174
Unweighted, % Weighted, %
Insurance
No insurance 8.89 14.27
Yes, has insurance 91.11 85.73
Provider
No provider 15.44 22.45
Yes, has provider 84.56 77.55
Check up 1 year
No checkup in past year 27.01 31.38
Yes, checkup in past year 72.99 68.62
National BRFSS Sample 2012-2017
Unweighted Weighted
Sample Size 1,364,254 867,621,289
Sample Size, mean per year 227,376 144,603,548
BMI, mean (95% CI) 28.33 (28.32-28.34) 28.14 (28.12-28.16)
Unweighted, % Weighted, %
Insurance
No insurance 12.44 16.84
Yes, has insurance 87.56 83.16
Provider
No provider 19.62 25.65
Yes, has provider 80.38 74.35
Check up 1 year
No checkup in past year 32.9 35.38
Yes, checkup in past year 67.1 64.62
BRFSS Analytic Sample 2012-2017
ALL 50 STATES & D.C.
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 Insurance Coverage. The uninsured accounted for 14.27% of the BRFSS national 
sample and 16.84% of the analytic sample.  
 Primary Care Access. The last two outcomes variables, primary care provider and 
checkup in the past year are two variables that are used to measure health care access.  In the 
national sample, 22.45% of respondents reported no health care provider; whereas 25.65% in the 
analytic sample reported no provider. In the national sample, 31.38% of respondents reported no 
checkup in the past year; whereas, 35.38% of respondents reported no checkup in the past year. 
According to CDC data from the 2016 National Health Interview Survey, 84.6% of adults 
reported they had contact with a health care professional in the past year (CDC, 2017), implying 
that 15% did not have contact with a PCP.  
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Descriptive Statistics of Medicaid Expansion vs. Non-expansion States 
 In non-expansion states, the insurance subsidy was available for those living between 100-
400% FPL. In expansion states, not only was the insurance subsidy available to the same income 
groups, but Medicaid was also available to those living between 100-138% FPL.  In this section, 
more complex analytic tables are presented that differentiate among four income groups within 
Medicaid expansion and non-expansion states. The four income groups included: (1) <100% FPL; 
(2) 100-138% FPL; (3) 139-400% FPL; and (4) >400% FPL. These distinct income groups were 
chosen in order to differentiate where the greatest gains in insurance and health care access occurred 
among white, black and Hispanic individuals between the ages of 18-64. Separate tables for 
demographic variables, health status variables, states-specific variables and outcomes are 
presented- first for non-expansion states, then Medicaid expansion states- then by income and 
race/ethnicity within each state group. Pearson chi-squared tests (x2) assess statistical differences 
in the distribution of multi-valued categorical variables and the independent groups of interest 
(i.e. expansion status and/or income groups). In addition, tests were run to test the population 
means between two groups (e.g., sex), as appropriate.  
The weighted proportion of BRFSS respondents residing in the 19 non-expansion states 
as of 2017 was 56,057,274 white, black and Hispanic adults aged 18-64 (39% of the analytic 
sample). The weighted proportion of BRFSS respondents residing in the 32 states3 that opted to 
expand Medicaid by the end of 2017 was 88,546,274 white, black and Hispanic adults aged 18 to 
64 (or 60.79% of the analytic sample) (Table 13). As a geographic reference (Figure 5), 89% of 
adults living in non-expansion states as of 2017 resided in the South; with 7% in the Midwest; 
 
3 The 32 states include states that expanded after 2014 plus the 4 pre-ACA expanders that are dropped in 
subsequent analyses. 
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3% in the West and less than 1% in the Northeast region of the United States (Garfield, Damico 
& Orgera, 2018).   
Table 13.  
Demographic Variables in Analytic Sample by Expansion Status: All White, Black and Hispanic 
BRFSS Respondents Aged 18-64 Living in 19 Non-expansion Versus 32 Medicaid Expansion 
States, Weighted by Sampling Fractions (2012-2017). 
 
Non-expansion 
States
Medicaid Expansion 
States X 2Value P Value
Sample Size (unweighted) 544,122 820,132
Population Size (weighted) 336,343,646 531,277,643
Population Size, mean 56,057,274 88,546,274
FPL Weighted (%) Weighted (%) 4,451.01 <0.001
<100% FPL 16.03 15.63
100-138% FPL 8.67 7.75
139%-400% FPL 40.01 35.81
>400% FPL 35.29 40.81
Age Group 116.15 <0.001
18 to 34 34.92 34.81
35 to 44 21.35 20.70
45 to 54 22.70 22.93
55 to 64 21.02 21.56
Sex 3.1 0.3746
Male 51.76 51.91
Female 48.24 48.09
Race/Ethnicity 0.0001 <0.001
Non-Hispanic White 65.75 69.99
Black 17.21 11.14
Hispanic 17.04 18.86
Education 476.66 <0.001
Less than HS 12.92 12.85
HS Grad 28.11 27.41
Some College 32.90 31.99
College Grad 26.07 27.75
 BRFSS Analytic Sample 2012-2017
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 Demographic Variables by Expansion Status  
 In this section we show expansion and non-expansion states by demographic 
characteristic. It should be remembered that the analytic sample runs across the entire 2012-2017 
period and, therefore, masks to some extent any shifts in demographic variables after the ACA 
insurance policies came into effect.  
 Income groups, Overall. Overall, white, black and Hispanic adults aged 18 to 64 
reported higher household incomes within Medicaid expansion states (40.81% in Medicaid 
expansion states living >400% FPL when compared to 35.29% in non-expansion states living 
>400% FPL) (Table 13). In non-expansion states, the ratio of blacks to Hispanics was almost 
1:1; whereas in Medicaid expansion states, there were about 60% more Hispanics than blacks in 
the expansion group (Table 13).  
 Race/Ethnicity by Income Group. To gain a better understanding of race-income 
differences, separate tables were created by expansion status.   
Theory predicts that most of the effect of the ACA in narrowing the gap between whites, 
blacks and Hispanics will come from the negative correlation between minority status and 
household income. Tables 14-21 present the BRFSS race-ethnic characteristics of expansion and 
non-expansion states within four ACA-related income groups. The row, Proportions by income 
group, %, gives the race percentages within each income group. For example, 31.82% Hispanics 
are of low-income in non-expansion states. The All Races column shows 16% of all non-
expansion respondents were below 100% FPL, 9% were between 100-138% FPL 40% between 
139-400% FPL and 35% of income above 400% FPL (Table 14). A higher proportion of high-
income earners resided within Medicaid expansion states (41%), when compared to residents in 
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non-expansion states (35%) (Table 15). The Proportions by race only, % row give the race 
percentages within an income group. For example, 29.94% of Hispanics in non-expansion states 
were in the low-income group versus only 18.52% in the high-income group. This means that a 
Hispanic person was 62% more likely to be in the low-than in the high-income group.  
 Percentages by income-race-characteristic within each cell beginning with Age Group 
sum to 100% by characteristic, e.g., age and education. For example, 40.81% of all low-income 
whites were aged 18-34, compared with 44.04% of all low-income Hispanics. Multiplying each 
cell percentage by the fraction of the sample in the income-race group converts the cell percents 
to shares in the All Races column. For example, 42.17% of low-income people in non-expansion 
states were aged 18-34 versus 14.79% aged 55-64. This distribution by age is similar in 
expansion states.   
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It is apparent that blacks and Hispanics made up greater proportions of the low-income 
groups. (See Proportions by race only rows in Tables 14 and 15). In the non-expansion group, 
Hispanics reported the lowest incomes, with 30% being of low-income, when compared to 10% 
of whites. These proportions are similar in the Medicaid expansion low-income group. In the 
moderate-income group, there are similar proportions of whites, blacks and Hispanics in the non-
expansion and Medicaid expansion groups. In the high-income groups in both state groups, 
whites make up by far the largest percentage (~80%) when compared to blacks only (~9%) or 
Hispanics only (~9%). 
The non-expansion group had greater proportions of blacks in the low income and 
overlap low income groups (35.35%) than Hispanics (15.50%).4 Whereas, the Medicaid 
expansion group had a greater proportion of Hispanics (46.53%) in the low income and overlap 
income group than blacks (35.17%).5 Whites make up the majority within all income groups in 
both non-expansion and Medicaid expansion states. Slightly more low-income whites were 
found within non-expansion states (17.15%) than Medicaid expansion states (15.26%).6  
To summarize, greater proportions of blacks and Hispanics were found in the low-income 
non-expansion group and Medicaid expansion group. In both groups, higher proportions of 
Hispanics reported lower incomes (<400% FPL), 81% in both the non-expansion and Medicaid 
expansion group. Income distribution differences between Medicaid expansion and non-
expansion states were found to be statistically significant (p<0.001) (Table 13). 
 
4 Svy weighted: 3,411,906/9,649,498= 35.35% blacks in non-expansion states; 4,115,052/26,550,147=15.50% 
Hispanics in non-expansion states.  
5 Svy weighted: 3,469,504/9,864,526= 35.17% blacks in expansion states; 7,772,026/16,703,849= 46.53% Hispanics 
in expansion states. 
6 Svy weighted: 6,320,178/36,856,946= 17.15% whites in non-expansion states; 9,458,776/61,977,898 = 15.26% 
whites in expansion states.  
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 Age group. Across income groups, young adults (18-34) in the non-expansion and 
Medicaid expansion groups made up the greatest proportions within all income groups, about 
35% in each group (Table 13). The share of persons aged 18-34 declined systematically in 
higher income groups. Age distribution differences among the four income groups within non-
expansion and Medicaid expansion states were found to be statistically significant (p<0.001) 
(Tables 14 and 15).  
Between Medicaid expansion and non-expansion states, the number of young adults 
living 100-138% FPL was relatively similar (40% vs. 38%, respectively).  Differences in the 
distribution of age between Medicaid expansion and non-expansion states was statistically 
significant (p<0.001) (Table 13).  
 Sex. Overall, males and females have equal proportions within each expansion group 
(Table 13). However, in the non-expansion states, women made up a greater proportion of the 
low-income groups for each race/ethnic group.  A greater proportion of black women were low 
income when compared with white women and Hispanic women (Table 14). Black women also 
made up a greater proportion of low-income women in Medicaid expansion states, when 
compared to white or Hispanic women (Table 15). Interesting to note, Hispanic men made up 
the majority within the 100-138% FPL group in both non-expansion (53%) and Medicaid 
expansion states (52%). Sex differences between Medicaid expansion and non-expansion states 
were not statistically significant (p=0.3746) (Table 13). Sex distribution differences among the 
four income groups within non-expansion and Medicaid expansion states were found to be 
statistically significant (p<0.001) (Tables 14 and 15). 
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   Education. The percentage of college graduates is nearly equal by expansion status, 
although expansion states have a higher percentage with incomes >400% FPL. Medicaid 
expansion states had slightly more college graduates than non-expansion states (Table 13). 
College graduates made up the largest proportions in the high-income group representing all 
races (47% in both non-expansion and Medicaid expansion states). Hispanics had the lowest 
level of educational attainment within the low-income groups, with 52% of Hispanics having less 
than a HS diploma in non-expansion states (Table 14) and 55% in Medicaid expansion states 
(Table 15). To note, Hispanics in Medicaid expansion states reported lower levels of education 
when compared to those living in non-expansion states- possibly due to a higher number of 
immigrants in the expansion states. The majority of low-income whites and blacks reported at 
least a high school degree or higher in the low-income non-expansion group. This was similar to 
the proportions in the Medicaid expansion group. Differences in the distribution of educational 
levels between expansion and non-expansion groups was statistically significant (p<0.001). 
Differences in education distributions among the four income groups within non-expansion and 
Medicaid expansion states were statistically significant (p<0.001) (Tables 14 and 15). 
 Health Status Variables 
  BMI. Overall, the Medicaid expansion group had a marginally greater proportion of 
adults (35% vs. 32%) who were of normal weight (BMI < 25) (Table 16).  
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Table 16.  
Health Status Variables in Analytic Sample by Expansion Status: All White, Black and Hispanic 
BRFSS Respondents Aged 18-64 Living in Non-expansion versus Medicaid Expansion States, 
Weighted by Sampling Fractions (2012-2017). 
 
Non-expansion 
States
Medicaid Expansion 
States X 2Value P Value
Sample Size (unweighted) 544,122 820,132
Population Size (weighted) 336,343,646 531,277,643
Population Size, mean 56,057,274 88,546,274
BMI 1,244.14 <0.001
Normal Weight (<25) 32.46 34.62
Overweight (25-29.9) 35.06 35.42
Obesity Class 1 (30-34.9) 19.12 18.08
Obesity Class 2 (35-39.9) 7.86 7.11
Obesity Class 3 (>40) 5.50 4.77
Diabetes Risk 1,181.17 <0.001
No/Low Risk 55.58 58.40
High Risk 36.05 34.25
Diabetes 8.37 7.35
Pre-diabetes Diagnosis 22.77 <0.05
No 98.74 98.65
Yes 1.26 1.35
Self-Reported Health 340.17 <0.001
Healthy 83.11 84.31
Not Healthy 16.89 15.69
T Value P Value
No. Chronic Disease -1.01 0.312
0 80.33 79.92
1 15.79 16.60
2 3.04 2.77
3 0.66 0.60
4 0.15 0.10
5 0.05 0.01
 BRFSS Analytic Sample 2012-2017
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Across all races/ethnicities, there were low proportions of individuals at a normal weight. 
The prevalence of obesity in non-expansion states is 32.5 per 100 respondents for all races, 
compared to 30 per 100 respondents for all races in Medicaid expansion states (Table 16). 
Prevalence was calculated using the formula below: 
 
Among racial/ethnic subgroups in the expansion groups, blacks and Hispanics had greater 
proportions of overweight or obese respondents in the low- and moderate-income groups in non-
expansion and Medicaid expansion states (Tables 17 and 18). Even though there were lower 
proportions of respondents within the Obesity Class 2 or greater (BMI≥ 35) groups than the other 
BMI categories, a higher proportion of blacks were found to have greater prevalence of obesity 
when compared to whites or Hispanics. However, as income increased, a reduction in the 
proportion of respondents with obesity declined. Differences in BMI among the four income 
groups within non-expansion and Medicaid expansion states were found to be statistically 
significant (p<0.001) (Tables 17 and 18). 
Interesting to note, as income increased for blacks, the proportion of respondents that 
reported being obese (BMI 30 or greater) was consistently high for this demographic, when 
compared to whites and Hispanics. Generally speaking, as income levels increased, obesity 
levels decreased for all racial/ethnic groups. BMI differences between Medicaid expansion and 
non-expansion states were statistically significant (p<0.001) (Table 16).  
 
 
Number of people with obesity
Number of people measured 
X 100Prevalence =
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Diabetes Risk. The prevalence of diabetes in non-expansion states was 8.37 per 100 
respondents for all races, compared to 7.35 per 100 respondents in Medicaid expansion states 
(Table 16). Prevalence was calculated using the formula below:  
 
In non-expansion states, the income group with the highest report of diabetes was those living 
below 100% FPL (12.08%). The proportion of individuals reporting diabetes in the same group 
in expansion states was 10% less, but still was the income group with the highest report of 
diabetes (10.88%). Blacks had the greatest proportion of respondents with diabetes in all income 
groups in non-expansion and Medicaid expansion states when compared to whites and Hispanics 
(Tables 17 and 18).  
 Similarly, among all races, the income group with the highest proportion of respondents 
at high risk for developing diabetes in non-expansion states was individuals living below 100% 
FPL (42.73%). The same group of individuals in the Medicaid expansion group had a proportion 
4% less than that of the non-expansion group, but remained the largest proportion of individuals 
at high risk across all income groups (41.22%) (Table 18). Respondents living in the overlap low 
income group (100-138% FPL) in non-expansion and Medicaid expansion states had slightly 
lower proportions of high-risk respondents than those living below 100% FPL.  
 In both non-expansion and Medicaid expansion states, blacks had the highest proportion 
of individuals at high risk. Across all income groups in both state groups, whites had the lowest 
proportions of those at high risk of diabetes. Differences in the distribution of diabetes risk 
between Medicaid expansion and non-expansion states was statistically significant (p<0.001) 
Number of people with diabetes
Number of people measured 
X 100Prevalence =
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(Table 16). Differences in distribution of diabetes risk among the four income groups within 
non-expansion and Medicaid expansion states was also statistically significant (p<0.001) (Tables 
17 and 18). 
  Pre-diabetes. The prevalence of pre-diabetes in non-expansion states was 1.26 per 100 
for all races, compared to 1.35 per 100 for all races in Medicaid expansion states (Table 16). In 
non-expansion states, respondents living <100% FPL reported greater proportions of prediabetes 
(1.77%), than those at higher incomes (e.g. 0.88% for >400% FPL). Their low-income 
counterparts in Medicaid expansion states reported 15% more prediabetes (2.03%). The greater 
report of prediabetes in Medicaid expansion states may be associated with expanded insurance 
options. Differences in in the report of prediabetes existed between all races. However, Hispanics 
within expansion states, across all income groups, had the highest report of prediabetes.  
Within non-expansion states, whites in the two low income groups had the highest 
reporting of prediabetes, which was then surpassed by blacks in the moderate- and high-income 
groups. Differences in the distribution of prediabetes between states was statistically significant 
(x2=22.88, p<0.05). Differences in the distribution of prediabetes among the four income groups 
within the two state groups was statistically significant (p<0.001) (Tables 17 and 18). 
  Self-reported Health. In non-expansion states, 17% of respondents reported being 
unhealthy, which was only a 1% difference compared to respondents in expansion states (16%) 
(Table 16). Low income whites living within non-expansion states had the highest report of 
being unhealthy (35%) (Table 17). Meanwhile, Hispanics in all income groups within Medicaid 
expansion states had the highest reports of being unhealthy, when compared to whites and 
blacks. The report of being unhealthy in non-expansion states is inconsistent with the report of 
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pre-diabetes, where Medicaid expansion states had higher reports of pre-diabetes than non-
expansion states (Table 16).  Differences in the distribution of self-reported health was 
statistically significant between state groups (p<0.001). Differences in the distribution of self-
reported health among the four income groups within state groups was statistically significant 
(p<0.001) (Tables 17 and 18), with high income earners reporting being healthier than lower 
income groups in both expansion groups.  
 Chronic Disease Count. Like the national BRFSS sample, the number of chronic 
diseases began to taper off after the report of two in both non-expansion and Medicaid expansion 
states. In both non-expansion and Medicaid expansion states, 80% of respondents reported no 
major chronic disease (Table 16). The greatest disparity in the report of chronic disease was 
among Hispanics across all income groups in non-expansion and Medicaid expansion states. 
Hispanics had greater proportions of respondents reporting no chronic disease than blacks or 
whites. For example, Hispanics living below 100% FPL in non-expansion states had a report of 
no chronic disease at 85%, whereas blacks reported no chronic disease 71% and whites 63% 
(Table 17). In Medicaid expansion states, 83% of Hispanics living below 100% FPL reported no 
chronic disease (Table 18). Yet, low income racial/ethnic minorities tend to be at greater risk for 
many chronic conditions over whites. Overall, there was no difference in the report of chronic 
conditions between non-expansion and Medicaid expansion groups (t= -1.01, p= 0.312) (Table 
16). Differences in the report of chronic disease among the four income groups within non-
expansion and Medicaid expansion states was statistically significant (p<0.001), with more high-
income earners reporting no chronic disease than earners in the lower income groups (Tables 17 
and 18). 
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   Primary Care Provider (PCP) Supply. A dummy variable for PCP Supply was created 
that classified states based on the supply of non-federal primary care physicians relative to the 
size of the non-elderly population pre-ACA; therefore, PCP supply states are based on the 
distribution of the U.S. population. Low supply was less than 11.5 PCPs per 10,000 persons and 
adequate supply was greater than 11.5 PCPs per 10,00 persons (Cunningham, 2011). 
Respondents living within Medicaid expansion states were found to live in a state with a greater 
proportion of primary care providers (85%), when compared to respondents living in non-
expansion states (44%) (Table 19).  
Table 19.  
State-Level Variables in Analytic Sample by Expansion Status: All White, Black and Hispanic 
BRFSS Respondents Aged 18-64 Living in Non-expansion versus Medicaid Expansion States, 
Weighted by Sampling Fractions (2012-2017). 
 
The disparities in PCP supply between non-expansion and Medicaid expansion states became 
even more stark when comparing income-race differences (Tables 20 and 21). Even within non-
expansion states, the low-income Hispanic population had higher proportions of respondents 
living in an area with a low PCP supply (71%), than whites (53%) or blacks (65%) in the same 
income group (Table 20). In the low-income Medicaid expansion group, whites and blacks had a 
greater proportion of respondents residing in an area with a low PCP supply (21%), when 
Non-expansion 
States
Medicaid Expansion 
States X 2Value P Value
Sample Size (unweighted) 544,122 820,132
Population Size (weighted) 336,343,646 531,277,643
Population Size, mean 56,057,274 88,546,274
PCP Supply 0.00003 <0.001
Adequate Supply 43.91 85.17
Low Supply 56.09 14.83
 BRFSS Analytic Sample 2012-2017
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compared to Hispanics (10%) (Table 21) although at far lower rates than in non-expansion 
states. The differences in the supply of PCPs by race may be attributed to more blacks living in 
non-expansion states, and more Hispanics living in Medicaid expansion states. The distribution 
of PCP state supply between non-expansion and Medicaid expansion states was statistically 
significant (p=<0.001) (Table 19). Differences in the distribution of state level PCP supply for 
the four incomes within both expansion groups was statistically significant (p<0.001), with the 
low-income group living in areas with the lowest supply of PCPs, when compared to higher 
income groups (Tables 20 and 21). 
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 Outcome Variables 
  Insurance. A greater proportion of respondents in expansion states reported having 
insurance (86% vs. 79%) (Table 22). Had non-expansion states had the 86% expansion rate, 4.8 
million more persons would be insured annually. It was expected that respondents living within 
Medicaid expansion states would have lower uninsured proportions as this group had more 
coverage options (i.e. Medicaid and subsidy options). Since the respondents living within 100-
400% FPL were expected to benefit the most from the ACA’s coverage expansion provisions, 
focus was placed on the overlap low income group and moderate-income groups within non-
expansion and Medicaid expansion states.  
Table 22.  
Outcome Variables in Analytic Sample by Expansion Status: All White, Black and Hispanic 
BRFSS Respondents Aged 18-64 Living in Non-expansion versus Medicaid Expansion States, 
Weighted by Sampling Fractions (2012-2017).  
 
In non-expansion states, stark differences in the proportions of the uninsured can be seen 
between low- and high-income groups, which points to the need for subsidized insurance 
Non-expansion 
States
Medicaid Expansion 
States X 2Value P Value
Sample Size (unweighted) 544,122 820,132
Population Size (weighted) 336,343,646 531,277,643
Population Size, mean 56,057,274 88,546,274
Insurance 9,488.32 <0.001
Uninsured 20.76 14.36
Insured 79.24 85.64
Primary Care Provider 5,305.06 <0.001
No Provider 29.07 23.48
Yes, Provider 70.93 76.52
Checkup in Last Year 2.4675 0.435
No Checkup 35.30 35.43
Yes, Checkup 64.70 64.57
 BRFSS Analytic Sample 2012-2017
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(Tables 23 and 24). A greater proportion of low-income individuals were uninsured (46% in the 
<100% FPL group and 36% in the 100-138% FPL group) than in the moderate-income group 
(21%). Even the difference between the moderate-income group and high-income group is 
dramatic, with only 5% of high-income earners reporting being uninsured. Under the ACA, the 
lack of Medicaid expansion means that federal the insurance subsidies were instrumental in 
closing the insurance gap between high- and low-income groups. This will be examined in the 
next section when comparing pre-ACA and post-ACA statistics. 
Although Medicaid expansion states had lower proportions of uninsured, stark 
differences in the proportion of uninsured still existed between high- and low-income groups 
(4% vs. 30%, respectively) (Table 24). As the literature has stated, many Hispanics, pre and post 
ACA remained uninsured. In both state groups, Hispanics had the largest proportions of 
uninsured; while whites had the lowest proportions of uninsured across all four income groups. 
Overall, differences in the distribution of insurance status were statistically significant (p<0.001) 
between non-expansion and Medicaid expansion states. Differences in insurance status among 
the four incomes within non-expansion and Medicaid expansion states were statistically 
significant (p<0.001), with high income earners far less likely to be uninsured (Tables 23 and 
24). 
  Primary Care Provider. A greater proportion of BRFSS respondents within Medicaid 
expansion states reported having a primary care provider (77% vs. 71%) (Table 22). It is 
expected that respondents living within Medicaid expansion states would have lower proportions 
of respondents reporting no PCP as this group had more coverage options (i.e. Medicaid and 
subsidy options), leading to the selection of a provider. In addition, as shown in Table 19, 
Medicaid expansion states had a greater proportion of respondents living in an area with an 
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adequate supply of PCPs when compared to respondents living in non-expansion states. Having 
an adequate supply of PCPs within a state increases the probability that an individual will have a 
provider (as shown later using multivariate regression).  
In non-expansion states, 43% of respondents living below 100% FPL reported not having 
a provider, compared to only 35% of respondents in the Medicaid expansion low-income group 
(Table 23). As income increased, the overall proportion in the report of no provider decreased 
across all races. However, Hispanics had the highest proportions in the report of no provider 
across all income groups in non-expansion states and Medicaid expansion states. Although the 
proportion of Hispanics without a PCP was high in Medicaid expansion states, it was 
consistently lower than in non-expansion states. For example, 53% of Hispanics in the overlap 
low income group in non-expansion states reported no PCP versus 43% of Hispanics in the 
Medicaid expansion group. Distribution differences in the report of a PCP between the two state 
groups was statistically significant (p<0.001) (Table 22). Differences in the report of a PCP 
among the four incomes within both state groups was statistically significant (p<0.001), with 
high income earners having a greater proportion report having a PCP than the lower income 
group respondents (Tables 23 and 24).  
  Checkup in Last Year. The proportion of white, black and Hispanic adults aged 18 to 
64 who had a preventive visit with a provider in the last year was similar between non-expansion 
and Medicaid expansion states, 65% (Table 22). In non-expansion states, the two lower income 
groups had the largest proportions of respondents who reported no provider, 43% vs. 41%, with 
the report of no provider decreasing as income increased (Table 23). As income increased in 
Medicaid expansion state, the report of no provider also decreased (Table 24). Interestingly, 
blacks within both expansion groups had the lowest proportions in the report of no checkup in 
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the past year compared to whites and Hispanics. This may be related to more whites living in 
rural areas where geographic barriers to health care access exist. Overall differences in the report 
of a checkup in the past year between Medicaid expansion and non-expansion states were not 
statistically significant (p=0.58) (Table 22). However, differences in the report of no checkup 
among the four incomes groups within state groups was statistically significant (p<0.001), with 
low income earners reporting no checkup in the past year at greater proportions than high income 
earners (Tables 23 and 24).  
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Pre/Post ACA Differences in Insurance Coverage and PCP Access 
 The focus for using BRFSS was to assess changes in insurance and health care access 
after the implementation of the ACA among racial/ethnic minorities and for individuals at high 
risk for diabetes living within non-expansion and Medicaid expansion states. In this section, 
pre/post descriptive statistics comparing changes in insurance status and health care access (i.e. 
PCP or a checkup in past year) by income, race, and diabetes health risk before and after ACA 
implementation were explored. Pearson Chi-square statistics were used to assess for differences 
in the sampling distributions between variables and outcomes of interest.   
 Until this point, expansion groups have been dichotomized into two groups: (1) non-
expansion and (2) Medicaid expansion states based on whether the state expanded Medicaid by 
2017. However, there are four different expansion types. Within our sample, we have identified: 
• Pre-ACA Expanders (i.e. Massachusetts, Vermont, Hawaii and D.C.) which are 
states/districts that expanded Medicaid beyond the 138% FPL limit before 2014. The pre-
ACA expanders will be known as the first expansion group and are highlighted green in 
the expansion map in Figure 5. The second state group is the  
• 2014 Expanders. These are the 23 states that expanded Medicaid up to 138% FPL during 
2014. This group is highlighted light blue in the Medicaid expansion map in Figure 5. 
The third group is the  
• Late Expanders, that includes 5 states that expanded Medicaid up to 138% FPL after 
2014: Montana, Indiana, Pennsylvania, Louisiana and Alaska, highlighted dark blue in 
Figure 5. The last group  
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• Never Expanders, included 19 states that did not expand Medicaid by 2017. To note, 
there are a few states in this last group that have considered or expanded Medicaid post- 
2017 and have been identified in Table U-1. 
This section shows any trends in the BRFSS analytic sample over the pre/post-ACA period. 
The next section will focus on positive gains in insurance and health care access and is organized 
around Specific Aims 1 and 2. The last section mathematically links trends in PCP access to 
ACA-related changes in insurance coverage using the descriptive results.  
Pre-and Post-ACA Trends in Sample Population Characteristics 
In the descriptive tables in this section, the focus was on changes on outcomes where 
control variables have not been introduced. In the beginning of Chapter 4, basic descriptive 
statistics were described but did not look at changes over time or pre/post ACA. To ensure major 
changes over time did not occur in the 47-state analytic sample, Table 25 was included to show 
mean changes over time for the independent and control variables. The analytic sample did not 
show differences in the pre and post ACA periods for the time-invariable variables race and sex. 
In the time variant variables, income, education, age, health status and state level supply 
differences were found since our weighted sample is very large and small changes will be 
detected between groups. But, in review of the numbers, the relative changes between the pre 
and post ACA groups are small and consistent with what is occurring nationally.  
For example, average household incomes have been increasing over time, which is 
consistent with the data shown in Table 25. Household incomes have been rising as noted by a  
decrease in the <100% FPL income group from 18.36% in 2012 to 13.65% by 2017. 
Over time, education completion rates for high school and college have also increased. This was 
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noted by a post-ACA decrease in the less than HS group of 7% and a gain in the college graduate 
group by 3%. Increases in age over time are expected. The 55 to 64 group increased by 4% and 
is the age group to have the greatest increase. Across the country there has been an increase in 
obesity rates, which had led to a growth in the high-risk group of about 4% in the post-ACA 
period. There was no difference in the pre and post ACA period in the reporting of chronic 
disease. This was probably due to the short time period under study in combination with the 
length of time it takes to have a condition classified as chronic. This was consistent with the 
finding that report of diabetes was not different in the pre and post ACA periods. Reports of 
being unhealthy decreased by 1.8%. PCP supply decreased by almost 2% in the post-ACA 
period. It may be a larger decrease considering this variable was created only using data from the 
pre-ACA period and was not adjusted to include changes over time. Changes in this table have 
not been controlled for.  
The results from Table 25 were consistent with the descriptive statistics for the 
independent and control variables stratified by expansion states in Appendix AB. Medicaid 
expansion states saw the greatest decline in the less than <100% FPL and the greatest increases 
in the completion of a college degree than in non-expansion states (3.88% vs. 2.73%, 
respectively). Non-expansion states saw the greatest increase in the high-risk group (4.54%, 
p<0.001), compared to 4.17% in expansion groups. Expansion states saw a decline in PCP 
supply in the post ACA period by 2%. Non-expansion states had no difference in PCP supply 
between the pre and post ACA periods. Refer to Tables AA-1 and AA-2 in Appendix AA to 
review non-expansion and expansion states descriptive data by time.  
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Table 25.  
Mean Changes Over Time for Predictor and Control Variables in 47-state Analytic Sample. 
 
 
 
 
 
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
Variables n=225,471 n=233,074 n=212,865 n=191,162 n=214,746 n=206,219 n=458,545 n=824,992 (Post/Pre ACA) X
2
Demographics
Income 
>400% FPL 37.92 39.11 35.59 37.92 38.91 40.22 38.51 38.17 -0.88% p<0.05
139-400% FPL 34.97 34.51 39.61 39.13 39.23 38.43 34.74 39.10 12.55% p<0.001
100-138% FPL 8.75 8.51 8.18 8.09 7.74 7.70 8.63 7.93 -8.11% p<0.001
<100% FPL 18.36 17.88 16.62 14.85 14.12 13.65 18.12 14.80 -18.32% p<0.001
Race
Whites 68.23 68.23 68.92 68.09 67.35 67.42 68.23 67.94 -0.43% 0.1215
Blacks 13.75 13.45 13.56 13.65 13.55 13.72 13.60 13.62 0.15% 0.8722
Hispanics 18.03 18.32 17.52 18.26 19.10 18.86 18.17 18.44 1.49% 0.1212
Education
<HS 13.45 13.82 13.11 12.60 12.74 12.20 13.63 12.66 -7.12% -
HS Grad 28.02 27.68 27.97 27.72 27.64 27.64 27.85 27.74 -0.39% -
Some College 32.27 32.40 32.49 32.57 32.43 32.66 32.34 32.54 0.62% -
College Grad 26.25 26.10 26.43 27.11 27.20 27.51 26.17 27.06 3.40% p<0.001
Age
18 to 34 34.55 34.48 34.60 34.95 35.59 34.99 34.51 35.03 1.51% -
35 to 44 21.36 20.67 20.96 20.93 20.82 21.13 21.02 20.96 -0.29% -
45 to 54 23.75 23.74 23.13 22.61 21.96 21.79 23.74 22.36 -5.81% -
55 to 64 20.34 21.12 21.32 21.52 21.64 22.09 20.73 21.65 4.44% p<0.001
Sex
Male 51.79 51.63 51.73 52.00 52.18 51.82 51.71 51.93 0.43% -
Female 48.21 48.37 48.27 48.00 47.82 48.18 48.29 48.07 -0.46% 0.2182
Health 
Diabetes Status
No/Low Risk 59.74 56.58 58.27 55.63 57.67 54.65 58.16 56.56 -2.75% p<0.001
High Risk 32.48 35.77 33.85 36.64 34.54 37.41 34.12 35.61 4.37% p<0.001
Diabetes  7.79 7.65 7.88 7.72 7.79 7.94 7.72 7.83 1.42% 0.229
Chronic Disease
0 80.33 79.82 79.85 80.54 80.11 79.94 80.08 80.10 0.02% -
1 15.99 16.66 16.45 15.93 16.25 16.27 16.32 16.23 -0.55% -
2 2.87 2.81 2.94 2.80 2.85 3.01 2.84 2.90 2.11% -
3 0.67 0.60 0.65 0.61 0.66 0.60 0.63 0.63 0.00% -
4 0.12 0.10 0.11 0.11 0.11 0.16 0.11 0.12 9.09% -
5 0.03 0.02 0.01 0.01 0.01 0.01 0.02 0.01 -50.00% 0.1459
Self Reported Health
Healthy 83.52 83.49 83.74 84.22 84.02 83.29 83.51 83.81 0.36%
Unhealthy 16.48 16.51 16.26 15.78 15.98 16.71 16.49 16.19 -1.82% p<0.05
State Level 
PCP Supply
Adequate 68.7 68.79 68.17 68.43 68.14 68.14 68.74 68.13 -0.89% -
Low 31.30 31.21 31.83 31.57 31.86 31.86 31.26 31.87 1.95% p<0.001
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Gains in Insurance Coverage & Access 
Specific Aim 1- Insurance (INS) 
     Overall INS Trends by Expansion Status. In the first aim, focus was placed on 
determining the likelihood of an 18-64-year-old white, black or Hispanic individual gaining 
health insurance in the post ACA period. In Table 26, it is apparent that the Pre-ACA Expanders 
had the highest levels of insured persons (92.13%) when compared to the other state groups prior 
to 2014. Their growth in insurance was a modest 2.28% (p<0.001), which was expected given 
their very high levels of insurance in the pre-ACA period. Any gains in insurance for this group 
are attributed to uninsured Medicaid-eligible residents signing up for insurance in the post-ACA 
period or previously uninsured individuals living between the state’s upper Medicaid threshold 
(i.e. 200% FPL for Massachusetts) and 400% FPL who gained access to affordable health care 
coverage through the insurance subsidies on the health insurance exchange.  
Table 26.  
Pre/Post Differences in the Report of Being Insured Among Expansion Groups in Full Analytic 
Sample.  
 
 
2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
Mean (INS) No. States BRFSS Sample Weighted % Weighted % Weighted % Weighted % Weighted % Weighted % Weighted % Weighted % (Post/Pre ACA) X
2
Expansion Status
Pre-ACA Expanders 4 18,478 92.31 91.97 94.06 93.80 94.11 94.94 92.13 94.23 2.28% <0.001
2014 Expanders 23 109,003 79.40 80.94 86.01 88.15 88.89 88.79 80.17 87.97 9.73% <0.001
Late Expanders 5 26,519 80.86 81.66 84.20 87.34 88.80 89.96 81.26 87.58 7.78% 0.6203
Never Expanders 19 89,949 74.56 75.73 79.57 81.73 82.44 81.40 75.14 81.28 8.17% <0.001
Analytic Sample
All 50 States/DC 51 243,949 78.03 79.34 83.56 85.67 86.50 86.16 84.14 89.49 6.36% <0.001
Notes:
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, black or Hispanic living in the U.S. who reported being insured, propprtions weighted by sampling fractions
2. Proportions are rounded and may not add up to 100
3. P value clumn: Pearson Chi-square tests performed to assess differences in sample distribution between expansion status and insurance by year (pre vs. post ACA)
2012
Mean Insurance by Expansion Status and Time
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 During 2014, 23 states expanded Medicaid up to 138% FPL with 5 additional states 
expanding between 2015 and 2017. The 2014 Expanders and Late Expanders are similar with 
their pre-ACA percent insured being about 80%. The 2014 Expanders had a 9.73% insurance 
growth while the insurance growth of 7.78% (p=0.6203) in the Late Expanders group was nearly 
as high but statistically insignificant. This is related to their small sample size, already high 
coverage rates, and fewer years to sign up. 
 Lastly, the Never Expanders group had the lowest levels of percent insured in the pre-
ACA period (75.14%, p<0.001). As a reminder, many of these states operated conservative 
programs with strict Medicaid eligibility levels that left many low-income adults without any 
affordable insurance options. The 8.17% insurance growth seen in this group in the post-ACA 
period is due to insurance subsidies available via the federal health insurance marketplace 
(p<0.001). Opportunities for increasing insurance levels exist by opting into Medicaid expansion 
for the Never Expanders. Had the Never Expanders expanded Medicaid, post ACA insurance 
levels could have reached 88% insured like in the 2014 Expanders and Late Expanders groups, 
instead of only 81% insured post-ACA.  
 Relationship between Pre and Post-ACA Insurance Rates. When the 50 states and 
D.C. are grouped into the 4 expansion groups, it was a challenge to identify which states made 
the greatest coverage gains post-ACA expansion. To derive an estimate of post-ACA insurance 
values for each state, a curvilinear function was estimated by plotting the change in insurance 
over time for each of the 50 states and D.C. Each dot in the Figures 7-10 is a state with its 
average pre-ACA insurance values are on the x-axis and post-ACA insurance values are on the 
y-axis. A 45° line is included to indicate post-ACA values that exceed or fall short of pre-ACA 
insurance rates. The range of the graph is 60-100 as no state had a pre-ACA rate less than 65. A 
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curvilinear quadratic line has been estimated to fit the observations. (A linear line produces the 
same R2). Taking the derivative,  
dy/dx = 0.9419- 2*(0.0021x)= 0.9419-0.0042x  
For every 10-percentage point increase in a state’s pre-ACA coverage rate, the marginal increase 
fell by 0.042 points. At over 90%, the post-ACA gain becomes quite small as the ceiling rate 
approaches 100%. For example, setting x=92 gives a predicted post-ACA rate of 94.5%. At a 
pre-ACA value, the predicted post-ACA rate is 77.4% Surprisingly, the line doesn’t become flat 
with no gain until a pre-ACA rate=224, clearly an impossible figure.7   
It is important to remember that the estimated line was only capturing the rate of 
insurance growth beginning in the pre-ACA period, but the line begins many years before when 
insurance rates were much lower. The line without a doubt was more curvilinear over longer 
periods, but the short 2012-2017 period covers a time when the trend line is much flatter.  
 
7 The 224 figure is derived by setting the derivative equal to zero and solving for x.  
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Figure 7. Changes in INS over time (Pre to Post-ACA) using all 50 states and D.C.  
 Since all points were above the 45˚ line in Figure 7, it was clear that no state experienced 
a decline in insurance coverage between the pre-ACA and post-ACA periods. (Figure 5 shows 
several interesting outlier states, which are discussed later in the text). States that have low initial 
levels of insurance pre-ACA have a large pool of uninsured to enroll, but once pre-ACA levels 
reach 85% or more, the pool of uninsured has narrowed considerably and includes many who are 
not interested in (or eligible for) ACA subsidies or enrolling in Medicaid.   
Figure 7 demonstrates how difficult it would be for the ACA to increase insurance in 
expansion states that already had a high percentage of individuals insured before the ACA (i.e. 
Massachusetts). Starting at a lower percentage would give states the opportunity for greater 
coverage gains. Medicaid expansion states with lower levels of insurance in the pre-period 
should show the greatest benefit as both the Medicaid expansion and the insurance subsidy 
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policies would in effect. Similarly, we would expect to see a higher insured rate in the non-
expansion states had they expanded like expansion states.  
Figures 8 and 9 estimated the pre/post relationship, separately, for non-expansion vs. 
expansion states. When non-expansion states are separated from expansion states, it becomes 
clear that the negative (slight) curve that is seen in Figure 7, is due to the non-expansion states. 
The intercept implies that the post-ACA insurance coverage rate is not positive until the pre rate 
exceeds 21.1- at least for the censored rage 2012-2017. The non-expansion line shows a slope 
equal to 1.91-0.0146x with an extremely high R2. 
 
Figure 8. Changes in INS over time (Pre to Post-ACA) using 19 Non-expansion States.  
In Figure 9, the curve for expansion states was positive, not negative, with greater growth 
in insurance being shown in Figure 10 when the 4 states that expanded Medicaid pre-ACA were 
dropped out. The expansion line had a positive, not negative, squared coefficient and a large 
positive intercept term. This was due to Arkansas and Nevada, expansion states who had actual 
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post-ACA rates show extraordinary increases in coverage even for their low initial levels (see 
Table 26). Other expansion states were not able to reproduce these gains; hence, the negative 
2.78 term associated with x in Figure 9.  
 
Figure 9. Changes in INS over time (Pre to Post-ACA) using all 32 Expansion States as of 2017. 
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Figure 10. Changes in INS over time (Pre to Post-ACA) using 28 Expansion States as of 2017.  
  Curvilinear Function Goodness of Fit. Figure 7 shows several low and high 
outlier states at very low pre-ACA coverage rates. The five states with the lowest pre-ACA 
percent insured are displayed below in Table 27.  
Table 27. 
The Five States with Lowest Pre-ACA Percent Insured (2012-2013). 
 
LOWEST 5 
STATES (%) STATE
ACTUAL PRE-
ACA INS 
RATE (%)
ACTUAL 
POST-ACA 
INS RATE (%)
PREDICTED 
RATE (%)
EXPANSION 
STATUS
1 TEXAS 66.53 73.75 78.40 Non-expansion
2 ARKANSAS 70.99 86.06 81.32 Expansion
3 NEVADA 71.14 90.04 82.81 Expansion
4 FLORIDA 72.63 79.82 82.36 Non-expansion
5 MISSISSIPPI 72.72 78.88 82.41 Non-expansion
Notes:
1. Predicted INS Rate based on eq: 25.03+0.9419xPre-ACA- 0.0021x(pre-ACA)^2
2. Source: BRFSS Analtyic File, including all states, 2012/13 vs. 2014/17
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It became apparent that non-expansion states did not reach their predicted post-ACA insurance 
values. For example, Texas, a non-expansion stated achieved 73.75% insured in the post-ACA 
period, an increase of about 7 points. Had the state expanded Medicaid, it could have achieved 
78% insured had it performed like other states. This also was true for both Florida and 
Mississippi (non-expansion states) where their post-ACA values were several points under their 
predicted values. By comparison, Arkansas, a state that had 70.99% insured in the pre-ACA 
period, expanded Medicaid and had 86.06% insured post-ACA. The predicted value post-ACA 
using the curvilinear function was only 81%. Nevada, also an expansion state, performed better 
than predicted with 90.04% insured in the post-ACA period compared to 82% predicted. Full 
calculations for predicted insurance values for the states in Table 27 can be found in Appendix 
Z. These calculations are helpful in showing the impact Medicaid expansion has in increasing 
insurance coverage, even in states with very low levels of insurance and within a short period of 
time.   
  Changes in INS by Income and Expansion Status. The ACA’s coverage expansion 
provisions worked through income (eligibility by %FPL) to provide access to insurance. For 
Specific Aim 1, the interest was on determining what changes in insurance levels occurred by 
income group. It was hypothesized that lower income groups would benefit the most from 
coverage expansion. Overall changes in insurance levels by income for the full analytic sample 
(50 state and DC), the 47-state analytic sample, non-expansion sample and expansion sample are 
provided in Tables 27-30. Considering that only 4 states (i.e. pre-ACA expansion states) were 
removed in the later analytic sample, the percentage changes are not too different over time 
between both analytic samples, which include over 1 million observations unweighted.  
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Overall, without adjusting for other variables and including the 4 pre-ACA early 
expanders, the income group to benefit the most from the ACA’s coverage expansion provisions 
was the less than 100% FPL income group (23.19% increase, p<0.001), which was mainly 
driven by increases in Medicaid enrollment. The next income group with the greatest insurance 
growth was the 100-138% FPL group, with a growth of 19.96%, but this increase was not 
statistically significant (p=0.4793). The 139-400% FPL income group had a 9.19% (p<0.001) 
growth in insurance that was mainly driven by federally subsidized insurance (Table 28). 
Percentages for the 50-and 47-state samples were similar over time. Refer to Appendix AB for 
50-state tables.   
Table 28.  
Percent Insured by Income Group and Time (47-state Analytic Sample). 
 
In the pre-ACA period for Medicaid expansion states, the insurance rate was only 
59.30% for the <100% FPL group (Table 30). This was surprising considering Medicaid was 
available in many states up to 100% FPL for specific adult populations. The 27.17% (p<0.001) 
increases in coverage for the lowest income group in Medicaid expansion states led to an overall 
insurance growth of 24% for the 47-state analytic sample (Table 28). Even with limited 
availability of Medicaid in non-expansion states, the 100-138% FPL group and the 139-400% 
FPL group mean INS increased in the post-ACA period (17.62% and 18.94%, respectively) 
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
Mean (INS) BRFSS Sample Weighted % (Post/Pre ACA) X
2
U.S. Income  Groups
>400% FPL 96,601 94.45 94.82 95.89 95.90 95.97 95.58 94.64 95.83 1.26% p<0.001
139-400% FPL 81,414 76.43 76.73 82.51 84.16 85.00 83.34 76.58 83.75 9.36% p<0.001
100-138% FPL 17,460 60.05 62.87 71.28 74.97 73.08 75.52 61.43 73.69 19.96% 0.4114
<100% FPL 29,996 53.58 56.39 63.89 67.87 70.59 70.65 54.96 68.05 23.82% p<0.001
Analtyic Sub Sample
47 States 224,441 77.63 78.99 83.26 85.45 86.31 85.93 78.31 85.24 8.85% p<0.001
Mean INS by Income and Time (47 States)
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(Table 29). However, the 100-138% FPL groups in both expansion states did not show increases 
that were statistically significant. The insurance increases seen within the 139-400% FPL income 
group within non-expansion states shows the value the federal marketplace had on increasing 
coverage for many low-income adults without access to Medicaid. Had Medicaid expanded in 
non-expansion states, greater gains could have been actualized for many low-income adults.   
Table 29. 
Percent Insured by Income Group and Time for the Non-expansion Group.  
 
Table 30.  
Percent Insured by Income Group and Time for Medicaid Expansion Group.  
 
Specific Aim 2-Primary Care Provider (PCP) and Checkup  
In the second aim, focus was placed on determining the likelihood of an 18 to 64-year-old 
white, black or Hispanic individual having health care access in the post-ACA period, as 
measured by having a PCP or receiving a checkup in the past year. It was notable that large gains 
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
Mean (INS) BRFSS Sample Weighted % (Post/Pre ACA) X
2
U.S. Income  Groups
>400% FPL 35,847 93.82 94.13 95.37 95.45 95.11 94.32 93.98 95.04 1.13% p<0.001
139-400% FPL 34,090 74.56 74.77 80.14 81.71 82.81 79.81 74.66 81.11 8.64% p<0.001
100-138% FPL 7,526 56.36 58.06 66.27 69.37 64.94 68.58 57.20 67.28 17.62% 0.6981
<100% FPL 12,486 47.07 49.38 53.85 57.87 58.85 59.42 48.20 57.33 18.94% p<0.001
Non-Expansion States
19 States 89,949 74.56 75.73 79.56 81.73 82.44 81.40 75.14 81.28 8.17% p<0.001
Mean INS by Income and Time (19 Non-expansion States)
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
Mean (INS) BRFSS Sample Weighted % (Post/Pre ACA) X
2
U.S. Income  Groups
>400% FPL 60,754 94.80 95.21 96.20 96.17 96.48 96.31 95.01 96.30 1.36% p<0.001
139-400% FPL 47,324 77.75 78.09 84.23 86.06 86.63 86.01 77.92 85.72 10.01% p<0.001
100-138% FPL 9,934 62.67 66.28 75.04 79.23 79.10 80.59 64.44 78.45 21.74% 0.1877
<100% FPL 17,510 57.81 60.81 70.74 75.21 78.13 78.38 59.30 75.41 27.17% p<0.001
Expansion States
28 States 135,522 79.61 81.05 85.74 88.03 88.88 88.96 80.33 87.91 9.44% p<0.001
Mean INS by Income and Time (28 Expansion States)
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in insurance did not yield gains in having a PCP for any of the four expansion groups (Table 31). 
Very small percentage increases occurred even within states that expanded Medicaid: Pre-ACA 
Expanders (0.22%); 2014 Expanders (1.89%) with both being statistically significant (p<0.001). 
A trivial decline of 0.07% (p<0.001) was seen even within the Never Expanders group.  
Table 31.  
Pre/Post Differences in the Report of having a PCP Overall, and Among Expansion Groups in 
Full Analytic Sample.  
 
 Within the same aim, the likelihood of an 18 to 64-year old white, black or Hispanic 
individual reporting a checkup in the past year was used as another measure of primary care 
health care access which focuses more on the primary care utilization. Overall, there were greater 
increases seen in the report of having a checkup than in the report of having a PCP across all 
expansion groups (Table 32). Yet, the gains in insurance did not yield similar proportions in the 
report of a checkup in the past year in the post-ACA period. The 2014 Expanders had the 
greatest gains in having a checkup in the past year (4.41%, p<0.001) which was expected as this 
group had the greatest gains in insurance coverage.  
 
 
2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
Mean (PCP) No. States BRFSS Sample Weighted % Weighted % Weighted % Weighted % Weighted % Weighted % Weighted % Weighted % (Post/Pre ACA) X
2
Expansion Status
Pre-ACA Expanders 4 18,478 85.83 85.29 86.23 85.92 86.90 83.99 85.56 85.75 0.22% <0.001
2014 Expanders 23 109,003 75.57 73.78 75.50 76.82 76.15 75.93 74.68 76.09 1.89% <0.001
Late Expanders 5 26,519 79.94 78.07 78.14 80.19 79.15 79.09 79.00 79.12 0.15% 0.5661
Never Expanders 19 89,949 71.60 70.32 70.93 71.56 71.27 69.91 70.96 70.91 -0.07% <0.001
Analytic Sample
All 50 States/DC 51 243,949 74.70 73.16 74.23 75.24 74.77 74.06 73.93 74.57 0.87% <0.001
Notes:
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, black or Hispanic living in the U.S. who reported having a PCP, propprtions weighted by sampling fractions
2. Proportions are rounded and may not add up to 100
3. P value clumn: Pearson Chi-square tests performed to assess differences in sample distribution between expansion status and report of PCP by year (pre vs. post ACA)
2012
Mean PCP by Expansion Status and Time
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Table 32.  
Pre/Post Differences in the Report of having a Checkup in the Past year, Overall and Among 
Expansion Groups in the Full Analytic Sample.  
 
 Changes in Health Care Access by Race and Expansion Status. In Specific Aim 2, 
one of the objectives was to assess for changes in health care access by race and expansion 
status. In the analytic sample, there was only a 1% growth in having a PCP. The greatest PCP 
growth occurred among Hispanics (4.24%, p<0.001). One would expect with access to a PCP 
and regular preventive care, a yearly checkup would be reported at a similar rate as the PCP rate. 
However, whites had a greater number of respondents with a PCP pre-ACA (78.18%) than 
blacks (72.12%) or Hispanics (57.54%). The PCP percentage for whites was much greater than 
the percentage for having a checkup (62.51%).  Post-ACA, blacks and Hispanics had relatively 
similar PCP and checkup rates; however, a greater proportion of whites reported having a PCP 
(78%) than having a checkup (64%) post-ACA (Table 33). The percentages for PCP and 
checkup found in the 50-state analytic sample were similar to those found in Table 33. The 50-
state analytic sample can be found in Appendix AB. 
 
 
2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
Mean (PCA_1YR) No. States BRFSS Sample Weighted % Weighted % Weighted % Weighted % Weighted % Weighted % Weighted % Weighted % (Post/Pre ACA) X
2
Expansion Status
Pre-ACA Expanders 4 18,478 72.22 71.30 72.25 72.43 72.71 71.32 71.76 72.17 0.57% <0.001
2014 Expanders 23 109,003 61.84 62.90 64.89 64.69 65.82 65.05 62.37 65.12 4.41% <0.001
Late Expanders 5 26,519 63.08 64.36 65.28 64.38 65.30 65.47 63.72 65.12 2.20% 0.958
Never Expanders 19 89,949 63.00 64.31 65.26 65.22 66.00 64.44 63.65 65.23 2.48% <0.001
Analytic Sample 
All 50 States/DC 51 243,949 62.67 63.78 65.27 65.08 66.02 65.00 63.23 65.34 3.34% <0.001
Notes:
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, black or Hispanic living in the U.S. who reported having a checkup, propprtions weighted by sampling fractions
2. Proportions are rounded and may not add up to 100
3. P value clumn: Pearson Chi-square tests performed to assess differences in sample distribution between expansion status and report of a checkup by year (pre vs. post ACA)
2012
Mean Checkup by Expansion Status and Time
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Table 33.  
Mean PCP or Checkup in Past Year by Race and Time (47-state Analytic Sample).  
 
Overall, whites in expansion states had the highest percentage of having a PCP in the pre-
ACA period (79.62%), with Hispanics in non-expansion states having the lowest (55.91%). In 
non-expansion states, there was a decrease of -0.07% in the report of a PCP after the ACA 
(Table 34), but an increase of 1.66% in expansions states (Table 35). Only blacks (5.75%, 
p<0.001) and Hispanics (5.85%, 0<0.001) saw increases in the proportions reporting having a 
PCP in the post-ACA period, compared to the pre-ACA period. In non-expansion states, 
Hispanics were the only racial/ethnic group to benefit from the ACA in obtaining a provider, a 
growth of 1.85% (p<0.05). Whites reported a decline in having a PCP in non-expansion states, a 
decline of 0.82%, p<0.05; whereas blacks did not have any statistically significant changes.  
 
 
 
 
2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
BRFSS Sample Weighted % (Post/Pre ACA) X2
U.S. Race/Ethnic Groups
Whites 184,347 78.99 77.37 77.78 78.69 78.29 77.28 78.18 78.00 -0.23% p<0.001
Blacks 23,178 72.54 71.69 74.44 74.91 75.51 75.13 72.12 75.00 3.99% p<0.05
Hispanics 17,946 58.39 56.69 58.17 61.04 60.25 60.39 57.54 59.98 4.24% p<0.001
Analtyic Sub Sample
47 States 225,471 74.39 72.82 73.90 74.95 74.47 73.80 73.61 74.27 0.90% p<0.001
U.S. Race/Ethnic Groups
Whites 184,347 62.02 62.99 64.32 64.22 65.14 63.85 62.51 64.38 2.99% p<0.05
Blacks 23,178 73.06 73.85 75.96 75.37 76.47 76.55 73.45 76.10 3.61% 0.7788
Hispanics 17,946 55.74 58.18 59.62 59.50 60.80 59.87 56.97 59.96 5.25% p<0.05
Analtyic Sub Sample
47 States 225,471 62.40 63.57 65.07 64.88 65.85 64.84 62.99 65.16 3.44% p<0.001
Mean Health Care Access by Race and Time (47 States)
2012
Mean (PCP)
Mean (Checkup)
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Table 34.  
Mean PCP or Checkup in the Past Year by Race and Time for Non-expansion States.  
 
Table 35. 
Mean PCP or Checkup in the Past Year by Race and Time for Expansion States.  
 
 Changes in Health Care Access by Diabetes Risk and Expansion Status. The second 
objective for Specific Aim 2 was to assess for changes in health care access by diabetes risk. In 
the full analytic sample, there was an overall increase in the report of a PCP among low risk 
(0.22%, p<0.001), high risk (1.26%, p<0.001) and individuals with diabetes (p<0.01), with 
2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
BRFSS Sample Weighted % (Post/Pre ACA) X
2
U.S. Race/Ethnic Groups
Whites 73,146 76.69 74.88 75.38 75.77 75.58 74.00 75.80 75.18 -0.82% p<0.05
Blacks 11,347 69.72 70.07 71.49 70.89 72.71 70.99 69.89 71.51 2.32% 0.4464
Hispanics 5,456 53.15 52.94 52.44 56.22 53.83 53.58 53.04 54.02 1.85% p<0.05
Non-Expansion States
19 States 89,949 71.60 70.32 70.93 71.56 71.27 69.91 70.96 70.91 -0.07% p<0.001
U.S. Race/Ethnic Groups
Whites 73,146 62.52 63.67 64.58 64.44 65.08 63.15 63.09 64.31 1.93% 0.1165
Blacks 11,347 72.96 73.58 75.38 74.37 75.51 75.66 73.26 75.23 2.69% 0.5276
Hispanics 5,456 54.45 57.35 57.51 58.95 60.29 58.19 55.91 58.75 5.08% p<0.05
Non-Expansion States
19 States 89,949 63.01 64.31 65.26 65.22 66.00 64.44 63.65 65.23 2.48% p<0.001
Mean Health Care Access by Race and Time (19 States)
2012
Mean (PCP)
Mean (Checkup)
2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
BRFSS Sample Weighted % (Post/Pre ACA) X2
U.S. Race/Ethnic Groups
Whites 111,201 80.40 78.85 79.30 80.59 80.01 79.36 79.62 79.80 0.23% p<0.001
Blacks 11,831 75.32 73.29 77.49 79.29 78.29 79.31 74.32 78.59 5.75% p<0.01
Hispanics 12,490 61.32 58.78 61.67 64.07 63.96 64.43 60.05 63.56 5.85% p<0.001
Expansion States
28 States 135,522 76.19 74.39 75.89 77.31 76.59 76.40 75.29 76.54 1.66% p<0.001
U.S. Race/Ethnic Groups
Whites 111,201 61.72 62.59 64.15 64.08 65.18 64.29 62.16 64.42 3.64% 0.0755
Blacks 11,831 73.15 74.12 76.56 76.45 77.42 77.45 73.63 76.98 4.55% 0.6403
Hispanics 12,490 56.46 58.65 60.91 59.84 61.10 60.86 57.56 60.70 5.46% 0.1161
Expansion States
28 states 135,522 62.02 63.11 64.94 64.64 65.74 65.11 62.56 65.12 4.09% p<0.001
Mean Health Care Access by Race and Time (28 States)
Mean (PCP)
Mean (Checkup)
2012
164 
 
individuals with diabetes having the highest PCP rate at 90.79% post-ACA (Table 36). (Refer to 
Appendix AB for 50-state analytic sample).  
Table 36.  
Mean PCP or Checkup in the Past Year by Diabetes Risk and Time (47-state Sample).  
 
Across all diabetes risk groups, the report of a PCP was higher than the report of a checkup, with 
the low risk group having the lowest report of a checkup (62.85%) in the post-ACA period. 
Interesting to note, changes in the report of a checkup from pre-to-post-ACA among the diabetes 
group was not statistically significant. The group that would benefit the most from preventive 
care is the high-risk group, yet their PCP and checkup means pre and post-ACA were similar to 
those of the low risk groups.  
Within non-expansion states, there was a 0.07% decline in having a PCP, which is 
attributed to those at low risk (-0.71%, p<0.001). Any PCP increases in the non-expansion states 
are mainly due to the diabetes group (2.12%, p=0.05). The high-risk group living within non-
expansion states had mean PCPs 6 percentage-points lower than those living in expansion states. 
For both state groups, the mean PCP levels for each diabetes risk group was higher than the 
mean Checkups. Although the diabetes group had the highest means for checkups in both state 
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
BRFSS Sample Weighted % (Post/Pre ACA) X2
U.S. Diabetes Risk 
No/Low Risk 132,297 72.63 71.04 71.66 72.95 72.09 71.49 71.86 72.04 0.25% p<0.001
High Risk 72,771 74.17 72.36 74.04 74.53 74.74 73.57 73.22 74.21 1.35% p<0.001
Diabetes 20,403 88.86 88.10 89.79 91.35 90.89 90.75 88.49 90.69 2.49% p<0.05
Analtyic Sub Sample
47 States 225,471 74.39 72.82 73.90 74.95 74.47 73.80 73.61 74.27 0.90% p<0.001
U.S. Diabetes Risk 
No/Low Risk 132,297 60.06 61.34 62.55 62.54 63.28 62.13 60.68 62.63 3.21% p<0.001
High Risk 72,771 62.44 63.16 65.07 64.32 65.91 64.79 62.81 65.01 3.50% p<0.001
Diabetes 20,403 80.28 81.98 83.71 84.39 84.60 83.78 81.12 84.11 3.69% 0.1945
Analtyic Sub Sample
47 States 225,471 62.40 63.57 65.07 64.88 65.85 64.84 62.99 65.16 3.44% p<0.001
Mean Health Care Access by Diabetes Risk and Time (47 States)
Mean (PCP)
Mean (Checkup)
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groups, these were not statistically significant. The mean Checkups for both the low and high-
risk groups were similar in the post-ACA period in expansion and non-expansion states.  
Table 37.  
Mean PCP or Checkup in the Past Year by Diabetes Risk and Time for Non-expansion States.  
 
Table 38.  
Mean PCP or Checkup in the Past Year by Diabetes Risk and Time for Medicaid Expansion 
States.  
 
 
 
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
BRFSS Sample Weighted % (Post/Pre ACA) X
2
U.S. Diabetes Risk 
No/Low Risk 51,529 69.38 68.28 68.53 69.20 68.79 66.96 68.86 68.37 -0.71% p<0.001
High Risk 29,924 71.47 69.68 70.77 70.92 70.79 69.79 70.53 70.55 0.03% p<0.001
Diabetes 8,496 87.88 86.57 87.93 89.72 89.86 88.85 87.23 89.08 2.12% 0.0502
Non-Expansion States
19 States 89,949 71.60 70.32 70.93 71.56 71.27 69.91 70.96 70.91 -0.07% p<0.001
U.S. Diabetes Risk 
No/Low Risk 51,529 60.73 62.18 62.73 63.03 63.59 61.78 61.42 62.78 2.21% p<0.001
High Risk 29,924 62.76 63.43 65.08 64.11 65.47 63.96 63.11 64.63 2.41% p<0.001
Diabetes 8,496 80.21 82.25 83.33 84.45 84.36 83.07 81.23 83.79 3.15% 0.253
Non-Expansion States
19 States 89,949 63.00 64.31 65.26 65.22 66.00 64.44 63.65 65.23 2.48% p<0.001
Mean (Checkup)
Mean (PCP)
Mean Health Care Access by Diabetes Risk and Time (19 States)
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
BRFSS Sample Weighted % (Post/Pre ACA) X
2
U.S. Diabetes Risk 
No/Low Risk 80,768 74.66 72.68 73.71 75.41 74.16 74.38 73.69 74.40 0.96% p<0.001
High Risk 42,847 75.96 74.14 76.28 77.20 77.52 76.22 75.01 76.79 2.37% p<0.001
Diabetes 11,907 87.88 86.57 87.93 89.72 89.86 88.85 89.39 91.91 2.82% 0.1812
Expansion States
28 States 135,522 76.19 74.39 75.89 77.31 76.59 76.40 75.29 76.54 1.66% p<0.001
U.S. Diabetes Risk 
No/Low Risk 80,768 59.64 60.85 62.44 62.23 63.08 62.35 60.23 62.53 3.82% p<0.001
High Risk 42,847 62.22 62.98 65.06 64.48 66.21 65.36 62.62 65.28 4.25% p<0.001
Diabetes 11,907 80.33 81.78 84.00 84.34 84.79 84.31 81.04 84.36 4.10% 0.5491
Expansion States
28 States 135,522 62.02 63.11 64.94 64.64 65.74 65.11 62.56 65.12 4.09% p<0.001
Mean Health Care Access by Diabetes Risk and Time (28 States)
Mean (PCP)
Mean (Checkup)
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Relationship between Specific Aims 1 & 2 
 In the previous sections, it became apparent that gains in insurance across the expansion 
groups led to minor effects on having a PCP or checkup. In this section, the relationship between 
PCP and INS will be explored via a PCP to INS ratio which effectively controls for growth in 
coverage. PCP is used instead of Checkup because Checkup was a secondary measure for 
primary care health care access. This INS to PCP link is important as conceptually we 
hypothesized that the ACA worked primarily through higher INS rates to increase the number of 
individuals with a PCP. The PCP/INS ratio is stratified by variables of interest that identify 
where disparities in having a PCP or INS exist among subgroups.  
It is anticipated that the ratio of PCP to INS for most demographic variables will be less 
than 1.0. However, a PCP to INS ratio greater than 1.0 is possible if some uninsured persons 
actually report having a PCP. The ratio can be thought of as a simple count of sample numbers 
reporting having a PCP and/or having insurance. It is actually constructed as a ratio of two 
percentages with identical total (or sub-sample) denominators. As the ratio of two percentages, 
changes are expected to be inelastic, or less than 1.0 when access to a PCP does not change 
commensurate with increases in insurance.  
Stratification of PCP/INS Ratio 
When focusing on race, whites had the highest levels of insurance in the pre-ACA period 
yet the lowest PCP/INS ratio (0.9266) when compared to blacks (0.9767) or Hispanics (0.9771) 
(Table 39). In the post-ACA period, as insurance coverage increased for all racial/ethnic groups, 
increases in having a PCP did not occur at the same rate. In fact, for whites, the percent reporting 
a PCP remained relatively unchanged in the post-ACA period (from 78.18% pre-ACA to 78% 
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post-ACA). Blacks had the highest PCP to INS ratio in the post-ACA period (0.9025) and is 
primarily attributed to the almost 3% gain in having a PCP from the pre-to post-ACA period. 
Nonetheless, their PCP/INS ratio fell over 7 percentage points. Hispanics actually had a 
PCP/INS ratio of 1.03 in the pre-ACA period within non-expansion states. Some uninsured 
Hispanics in both must be reporting having a PCP. But as insurance levels increased in the post-
ACA period for Hispanics in both expansion and non-expansion states, they saw the greatest 
decline in the PCP/INS ratio of 11 percentage points. This suggests many newly insured 
Hispanics are not accessing a PCP for some reason.  
 Individuals living below 100% FPL and between 100-138% FPL had the lowest levels of 
insurance in the pre-ACA period and even lower PCP rates reported. This led to PCP/INS ratios 
above 1.0 for these two low income groups. This must be due to low-income earners who are 
uninsured being eligible for care at no cost. Even in the post-ACA period, the two lower income 
groups had the highest PCP/INS ratios, and the 100-138% FPL group experienced the largest 
decline (13 percentage points). Even though the ACA did not directly target the high-income 
group, small increases in insurance coverage did not lead to equal increases in obtaining a PCP.  
The highest income group (>400% FPL) had the lowest PCP/INS ratio in the pre-ACA 
period (0.897) but only a slight decline relative to the lower-income groups. In part this must be 
due to less access to free PCP care and voluntarily deciding not to have a regular PCP.  
 As with income, lower levels of education resulted in lower levels of being insured, 
which resulted in a PCP/INS ratio above 1.0 in the pre-ACA period for those with less than a 
high school diploma. As the mean INS increased in the post-ACA period, levels of PCP did not 
steadily increase at the same rate. Individuals with less than a high school education saw the 
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greatest decrease in the PCP/INS ratio, a decrease of 12 percentage points. This is due to a 10-
point increase in coverage with only a 2-point increase in PCP.  Individuals with less than a high 
school diploma in non-expansion states had the lowest levels of insurance (47.15%). For 
individuals with college degrees, as with the >400% FPL group, there were insured adults who 
did not subsequently obtain a PCP, leading to a PCP/INS ratio below the average of 0.8713. 
Although the ratio is low, this income group would not expect to have large gains in having a 
PCP since pre-ACA insurance levels were the highest (94.64%).   
Table 39.  
PCP/INS Ratio Stratified by ACA, Expansion Status and Key Demographic/Health Status 
Variables.  
 
In the pre-ACA period, the PCP/INS ratio for females was 0.9986 compared to 0.8823 
for males, a difference of about 12 percentage points. This difference remained unchanged from 
the pre to the post ACA period. 
RACE SAMPLE NEXP EXP TOTAL NEXP EXP TOTAL NEXP EXP TOTAL NEXP EXP TOTAL NEXP EXP TOTAL NEXP EXP TOTAL
WHITES 1,048,152 0.8230 0.8562 0.8437 0.7580 0.7962 0.7818 0.9210 0.9299 0.9266 0.8701 0.9194 0.9002 0.7518 0.7980 0.7800 0.8640 0.8680 0.8665
BLACKS 121,844 0.7074 0.7688 0.7384 0.6989 0.7432 0.7212 0.9880 0.9667 0.9767 0.7906 0.8725 0.8310 0.7151 0.7859 0.7500 0.9045 0.9007 0.9025
HISPANICS 113,541 0.5148 0.6302 0.5889 0.5304 0.6005 0.5754 1.0303 0.9529 0.9771 0.6160 0.7378 0.6921 0.5402 0.6356 0.5998 0.8769 0.8615 0.8666
TOTAL 1,283,537 0.7514 0.8033 0.7831 0.7096 0.7529 0.7361 0.9444 0.9373 0.9400 0.8128 0.8791 0.8524 0.7091 0.7654 0.7427 0.8724 0.8707 0.8713
INCOME
<100%FPL 152,358 0.4820 0.5930 0.5496 0.5587 0.6093 0.5895 1.1591 1.0275 1.0726 0.5733 0.7541 0.6805 0.5823 0.6734 0.6363 1.0157 0.8930 0.9350
100-138%FPL 94,446 0.5720 0.6444 0.6143 0.6190 0.6482 0.6351 1.0822 1.0059 1.0339 0.6728 0.7845 0.7369 0.6275 0.6956 0.6666 0.9327 0.8867 0.9046
138-400%FPL 500,262 0.7466 0.7792 0.7658 0.6883 0.7292 0.7123 0.9219 0.9358 0.9301 0.8111 0.8572 0.8375 0.6922 0.7386 0.7187 0.8534 0.8616 0.8581
>400%FPL 536,451 0.9398 0.9501 0.9464 0.8319 0.8585 0.8489 0.8852 0.9036 0.8970 0.9504 0.9630 0.9583 0.8028 0.8370 0.8243 0.8447 0.8692 0.8602
TOTAL 1,283,517 0.7514 0.8033 0.7831 0.7096 0.7529 0.7361 0.9444 0.9373 0.9400 0.8128 0.8791 0.8524 0.7091 0.7654 0.7427 0.8724 0.8707 0.8713
EDUCATION
<HS 81,864 0.4715 0.5795 0.5377 0.5310 0.5917 0.5683 1.1262 1.0211 1.0569 0.5602 0.6924 0.6393 0.5486 0.6373 0.6017 0.9793 0.9204 0.9412
HS GRAD 338,187 0.7017 0.7677 0.7416 0.6803 0.7325 0.7119 0.9695 0.9541 0.9600 0.7646 0.8523 0.8166 0.6704 0.7429 0.7134 0.8768 0.8716 0.8736
SOME COLLEGE 369,710 0.7865 0.8253 0.8101 0.7358 0.7712 0.7573 0.9355 0.9344 0.9348 0.8480 0.9063 0.8824 0.7342 0.7814 0.7621 0.8658 0.8622 0.8637
COLLEGE GRAD 493,776 0.9099 0.9289 0.9216 0.8033 0.8350 0.8229 0.8828 0.8989 0.8929 0.9410 0.9601 0.9526 0.7957 0.8280 0.8154 0.8456 0.8624 0.8560
TOTAL 1,283,517 0.7514 0.8033 0.7831 0.7096 0.7529 0.7361 0.9444 0.9373 0.9400 0.8128 0.8791 0.8524 0.7091 0.7654 0.7427 0.8724 0.8707 0.8713
SEX
MALE 558,505 0.7360 0.7809 0.7635 0.6455 0.6913 0.6736 0.8770 0.8853 0.8823 0.7984 0.8604 0.8355 0.6470 0.7059 0.6822 0.8104 0.8204 0.8165
FEMALE 695,032 0.7677 0.8273 0.8041 0.7779 0.8191 0.8030 1.0133 0.9901 0.9986 0.8283 0.8993 0.8706 0.7760 0.8298 0.8081 0.9369 0.9227 0.9282
TOTAL 1,283,517 0.7514 0.8033 0.7831 0.7096 0.7529 0.7361 0.9444 0.9373 0.9400 0.8128 0.8791 0.8524 0.7091 0.7654 0.7427 0.8724 0.8707 0.8713
AGE
18 to 34 276,428 0.6827 0.7427 0.7194 0.5617 0.6254 0.6007 0.8228 0.8421 0.8350 0.7639 0.8427 0.8108 0.5662 0.6437 0.6123 0.7412 0.7639 0.7552
35 to 44 336,476 0.7462 0.7982 0.7776 0.7122 0.7513 0.7358 0.9544 0.9412 0.9462 0.7985 0.8648 0.8377 0.7030 0.7550 0.7337 0.8804 0.8730 0.8759
45 to 54 330,682 0.7831 0.8375 0.8164 0.7897 0.8245 0.8110 1.0084 0.9845 0.9934 0.8380 0.9001 0.8753 0.7968 0.8393 0.8222 0.9508 0.9325 0.9393
55 to 64 439,951 0.8357 0.8695 0.8566 0.8634 0.8838 0.8760 1.0331 1.0164 1.0226 0.8815 0.9291 0.9102 0.8597 0.8937 0.8802 0.9753 0.9619 0.9670
TOTAL 1,283,517 0.7514 0.8033 0.7831 0.7096 0.7529 0.7361 0.9444 0.9373 0.9400 0.8128 0.8791 0.8524 0.7091 0.7654 0.7427 0.8724 0.8707 0.8713
DIABETES RISK
LOW RISK 721,552 0.7657 0.8103 0.7934 0.6886 0.7369 0.7186 0.8993 0.9094 0.9057 0.8226 0.8827 0.8363 0.6837 0.7440 0.7204 0.8311 0.8429 0.8614
HIGH RISK 445,547 0.7226 0.7834 0.7591 0.7053 0.7501 0.7322 0.9761 0.9575 0.9646 0.7918 0.8673 0.8106 0.7055 0.7679 0.7421 0.8910 0.8854 0.9155
DIABETES  116,438 0.7749 0.8378 0.8117 0.8723 0.8939 0.8849 1.1257 1.0670 1.0902 0.8402 0.9069 0.8556 0.8908 0.9191 0.9069 1.0602 1.0135 1.0600
TOTAL 1,283,537 0.7514 0.8033 0.7831 0.7096 0.7529 0.7361 0.9444 0.9373 0.9400 0.8128 0.8791 0.8524 0.7091 0.7654 0.7427 0.8724 0.8707 0.8713
PRE-ACA POST-ACA
INS PCP PCP/INS INS PCP PCP/INS
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 Young adults (18-34) in the pre-ACA period had the lowest levels of insurance and 
having a PCP leading to the lowest PCP/INS ratio by age category of 0.8350. Yet, this age 
demographic had the greatest gains in insurance (9 percentage points) in the post-ACA period, 
but only a 1 percentage point increase in reporting a PCP (Table 39). The 55 to 64-year-old 
group were more likely to have a PCP in the pre-ACA period than insurance, leading to a 
PCP/INS ratio of 1.02. Like other age groups, gains in INS during the ACA period did not 
translate to rapid gains in having a PCP, which led to declines in their PCP/INS ratios.  
 For diabetes risk in the pre-ACA period, individuals with a diagnosis of diabetes had a 
PCP/INS ratio of 1.0902, which is expected given their increased demand for health care services 
when compared to individuals at high or low risk of diabetes. In the post-ACA period, there was 
a 1% increase in having a PCP for the diabetes group. Individuals at high risk also saw a 1% 
increase in having a PCP in the post-ACA period, but an overall decline in the INS/PCP ratio by 
5 percentage points. Generally speaking, increases in insurance did not translate to equal 
increases in having a PCP across various subgroups.  
Elasticity of PCP 
Before any stratification, the overall average PCP to INS ratio was 0.94 in the pre-ACA 
period and 0.87 in the post-ACA period, a decline of 7 percentage points.  An elasticity was 
calculated by dividing the percent change in PCP between the pre and post-ACA periods by the 
percent change in INS. To calculate the overall average elasticity of PCP with regards to INS 
using data from Table 39: 
  Elasticity (PCP wrt INS)= %ΔPCP/%ΔINS  
((0.7427/0.7361)-1)/((0.8524/0.7831)-1) = 0.102.  
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For every 10% increase in the INS rate (that increased 8.85% post-ACA), a 1% increase in 
having a PCP resulted. This PCP-INS link assumes that changes were a result of the ACA. This 
assumption will be strengthened when other variables are controlled for within the multivariate 
regression work in Part IV. Refer to Appendix AB for additional descriptive analyses on the 
uninsured.  
 Table 40 consolidates Table 39 and displays changes in INS and PCPs for each 
demographic variable of interest. In addition, the PCP/INS elasticities are displayed in the last 
column. Using race as an example, whites were the only racial/ethnic group to see a decline in 
their PCP rate, however insignificant. Other groups that experienced a decrease in PCP for every 
10% increase in INS included: >400% FPL (-2.28%), college graduates (-0.27%), and the 35 to 
44 age group (-0.03%). No group was found to have PCP changes elastic to changes in INS.  
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Table 40.  
Levels and Change in INS and PCP Rate, including Elasticity of PCP, Pre/Post-ACA.  
 
 
 
 
 
 
Variables INS-Pre INS-Post INS-Change PCP-Pre PCP-Post PCP-Change
PCP/INS-
Elasticity
RACE
WHITES 0.8437 0.9002 0.0670 0.7818 0.7800 -0.0023 -0.0343808
BLACKS 0.7384 0.8310 0.1254 0.7212 0.7500 0.0399 0.3184326
HISPANICS 0.5889 0.6921 0.1752 0.5754 0.5998 0.0424 0.2419813
TOTAL 0.7831 0.8524 0.0885 0.7361 0.7427 0.0090 0.101319
INCOME
<100%FPL 0.5496 0.6805 0.2382 0.5895 0.6363 0.0794 0.3333259
100-138%FPL 0.6143 0.7369 0.1996 0.6351 0.6666 0.0496 0.2485184
138-400%FPL 0.7658 0.8375 0.0936 0.7123 0.7187 0.0090 0.0959651
>400%FPL 0.9464 0.9583 0.0126 0.8489 0.8243 -0.0290 -2.3046572
TOTAL 0.7831 0.8524 0.0885 0.7361 0.7427 0.0090 0.101319
EDUCATION
<HS 0.5377 0.6393 0.1890 0.5683 0.6017 0.0588 0.3110392
HS GRAD 0.7416 0.8166 0.1011 0.7119 0.7134 0.0021 0.0208344
SOME COLLEGE 0.8101 0.8824 0.0892 0.7573 0.7621 0.0063 0.0710188
COLLEGE GRAD 0.9216 0.9526 0.0336 0.8229 0.8154 -0.0091 -0.2709536
TOTAL 0.7831 0.8524 0.0885 0.7361 0.7427 0.0090 0.101319
SEX
MALE 0.7635 0.8355 0.0943 0.6736 0.6822 0.0128 0.1353857
FEMALE 0.8041 0.8706 0.0827 0.8030 0.8081 0.0064 0.0767968
TOTAL 0.7831 0.8524 0.0885 0.7361 0.7427 0.0090 0.101319
AGE
18 to 34 0.7194 0.8108 0.1271 0.6007 0.6123 0.0193 0.1519934
35 to 44 0.7776 0.8377 0.0773 0.7358 0.7337 -0.0029 -0.0369268
45 to 54 0.8164 0.8753 0.0721 0.8110 0.8222 0.0138 0.1914189
55 to 64 0.8566 0.9102 0.0626 0.8760 0.8802 0.0048 0.0766229
TOTAL 0.7831 0.8524 0.0885 0.7361 0.7427 0.0090 0.101319
DIABETES RISK
LOW RISK 0.7934 0.8363 0.0541 0.7186 0.7204 0.0025 0.0463255
HIGH RISK 0.7591 0.8106 0.0678 0.7322 0.7421 0.0135 0.1992954
DIABETES  0.8117 0.8556 0.0541 0.8849 0.9069 0.0249 0.4596841
TOTAL 0.7831 0.8524 0.0885 0.7361 0.7427 0.0090 0.101319
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Multiple Logistic Regression Analyses of Health Care Coverage and Access 
 In Part IV, logistic regression results are presented and discussed in two sections by aim: 
• Specific Aim 1 the impact of the ACA on the likelihood of having insurance by income 
group and expansion status; 
• Specific Aim 2: the impact of the ACA on the likelihood of having a PCP, (or an annual 
checkup) by race and, by diabetes risk status. 
Each aim consisted of two parts (a and b). For each aim, the policy effect of ACA was measured 
two ways: 1) an ACA indicator for pre/post changes or, 2) time dummy variables (2014-2017) to 
assess trends by year in the post-ACA period. The analyses using time dummy variables are 
referenced once within the text, with subsequent analyses provided in the Appendix. A 
difference-in-difference approach was used to quantify ACA effects between expansion and 
income groups. ACA interaction terms form the crucial difference-in-difference estimators.  
Up to this point, two analytic datasets have been referenced: 1) the full 50 state and D.C. 
analytic sample; and 2) the 47-state analytic sample which excludes the 4 pre-ACA Medicaid 
expansion states. To isolate ACA effects alone, the 47-state sample will be used exclusively in 
Part IV. Regression methods were used to determine the statistical significance and size of the 
causal paths from the ACA to insurance coverage, and then to health care access. Sensitivity 
analysis was done using the full analytic sample which produced the same regression coefficients 
as in the 47-state sample.   
Prior to running the multivariate logistic regressions, the correlations among the 
dependent and independent variables were reviewed to describe the association between random 
variables. Although the correlation matrix does not control for confounders, it is helpful in 
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identifying the presence of causal relationships, which will be confirmed by regression results 
found later within this section.  
When interpreting the correlation coefficients in Table 41, the coefficients include 6 
years of data and reflect mean differences between the values of 0 or 1 as most variables are 
dichotomous or are represented by groups. All variables except income, education, diabetes risk, 
and chronic disease count are dichotomous variables; whereas chronic disease count was ordinal, 
with the rest of the variables being represented by groups. For variables that are not time-
sensitive, (Table 40), a single correlation is repeated 6 times, helping the power. For time-
sensitive variables (such as ACA), the correlation coefficient gives an indication of how the 
variable means differ by time (pre vs. post ACA). Generally, the correlations with ACA will be 
quite low because the sample is weighted and the BRFSS mix changes are gradual.  
Table 41. 
Correlation Matrix for All Independent and Outcome Variables (47-state Analytic Sample).
 
Matrix results in Table 41 weighted with [aweight=_llcpwt]. Statistically significant correlations 
at 0.05 marked with an (*).  
Income Whites Blacks Hispanics Education Age Female D Risk  CDcount SRH Supply Expansion ACA INS PCP Checkup
Income 1.0000
Whites 0.3105* 1.0000
Blacks -0.1296* -0.5792* 1.0000
Hispanics -0.2598* -0.6917* -0.1882* 1.0000
Education 0.4420* 0.2454* -0.0358* -0.2640* 1.0000
Age 0.1101* 0.1109* -0.0203* -0.1156* -0.0022* 1.0000
Female -0.0879* -0.0125* 0.0353* -0.0162* 0.0654* 0.0158* 1.0000
D Risk -0.1391* -0.1070* 0.0854* 0.0533* -0.1565* 0.2164* -0.0117* 1.0000
CDcount -0.1313* 0.0271* 0.0276* -0.0571* -0.0910* 0.1738* 0.0735* 0.1862* 1.0000
SRH -0.2730* -0.1066* 0.0384* 0.0944* -0.2406* 0.1304* 0.0211* 0.2720* 0.3161* 1.0000
Supply -0.0547* -0.0547* 0.0806* -0.0055* -0.0404* -0.0205* 0.0004 0.0391* 0.0064* 0.0294* 1.0000
Expansion 0.0287* 0.0399* -0.0854* 0.0275* 0.0072* 0.0072* -0.0016 -0.0268* -0.0017 -0.0131* -0.4271* 1.0000
ACA 0.0316* -0.0029* 0.0003 0.0032* 0.0140* -0.0044* -0.0021* 0.0128* 0.0004 -0.0039* 0.0063* -0.0134* 1.0000
INS 0.3099* 0.2019* -0.0309* -0.2158* 0.2652* 0.1039* 0.0489* -0.0092* 0.0267* -0.0881* -0.0824* 0.0787* 0.0872* 1.0000
PCP 0.1765* 0.1338* -0.0002 -0.1610* 0.1545* 0.2172* 0.1448* 0.0867* 0.1020* 0.0142* 0.0626* 0.0578* 0.0072* 0.3554* 1.0000
Checkup 0.0770* -0.0208* 0.0893* -0.0541* 0.0604* 0.1417* 0.1054* 0.0939* 0.0818* 0.0274* -0.0162* -0.0048* 0.0215* 0.2383* 0.3599* 1.0000
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 Given the tremendous power in our analysis, standard biostatistics correlation guidelines 
are used with caution. For example, the variable pairs with moderate correlation coefficients 
(0.30-0.70) include: (1) education and income (0.4420*); (2) insurance and income (0.3099*); 
(3) expansion status and PCP supply (-0.4271*); (4) checkup and PCP (0.3599*); and (5) INS 
and PCP (0.3554*) (Table 41). There were no variable pairs in the matrix that were highly 
correlated (correlation coefficient > 0.70) using standard guidelines. But, given the large sample 
size, the variable pairs with “moderate” correlation coefficients are highly correlated in the 
positive direction. The negative correlation with expansion status and PCP supply is due to the 
coding of PCP supply as “1” for low supply, meaning expansion states are associated with an 
adequate supply of PCP, or a variable coding of “0”. Generally, non-expansion states have been 
known to have less health care resources. Self-reported health or SRH is another variable that is 
coded with “1” being unhealthy.    
 The variables of great interest in the matrix include ACA, INS and PCP, as these 
variables cover our main research interest. The correlation between ACA and INS is a positive 
relationship of 0.0872 (p<0.05), meaning insurance coverage increases in the post-ACA period. 
The correlation between ACA and PCP is also positive (0.0072, p<0.05), with a coefficient that 
is much lower than ACA and INS. This suggests little ACA effect on PCP, which is consistent 
with descriptive statistic results. Yet, the correlation coefficient for ACA and PCP is still 
statistically significant which demonstrates the power available to detect very low effects.  
In the next section, focus will be placed on the multivariate regression work conducted, 
where outside factors were adjusted to determine if changes in health care coverage and health 
care access post ACA carried policy significance. Additionally, by controlling for variables, 
disparities for the subgroups of interest (race or diabetes risk status) in the post-ACA period can 
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be assessed.  Typically, multicollinearity is an issue in regression analysis and the correlation 
matrix is helpful in identifying which variables are highly correlated to one another. 
Multicollinearity occurs when two highly correlated variables are placed within the same 
regression model, causing some variables to be statistically insignificant, when they are indeed 
significant. This phenomenon occurs because one variable can be predicted from another 
variable with a substantial degree of accuracy, leading to increased standard errors since partial 
regression coefficients cannot be estimated accurately. Given the large sample size in this 
analysis (>1.2 million observations) and weighting over six years, the standard errors are not 
affected due to the amount of power available to detect statistical significance.  
 Specific Aim 1- Odds of Insurance (INS) 
In Specific Aim 1a, the purpose is to assess the impact of the ACA on enhanced access to 
U.S. health insurance coverage, overall and then stratified by ACA-related income groups. In 
Specific Aim 1b, the purpose is to determine if differences in insurance gains during the ACA 
existed among ACA-related income groups, adjusting for expansion status. Multiple logit and 
logistic regressions were run with findings displayed in Tables 42-48. Table 42-45 address 
Specific Aim 1a and represent simple pre/post-ACA effects. Tables 46-48 address Specific Aim 
2b and stratify the odds of having insurance by income levels to test for pre/post ACA effects 
among ACA-related income groups, adjusting for expansion status. Appendix AD contains 
additional Specific Aim 1 regression models not included in the text.  
 Specific Aim 1a. Pre/Post-ACA Insurance Coverage Odds with ACA-Income 
Interactions. Model 1 only includes the predictor variable ACA, to give the overall gross 
correlation of the ACA period indicator with INS. The odds of having insurance in the post-ACA 
176 
 
period (2014-2017) was 60% greater (p<0.001, 1.57-1.63 95% CI) than the odds of having 
insurance in the pre-ACA reference period (2012-2013). The constant term of 3.61 is the overall 
odds of being insured for a U.S. adult aged 18-64 in the pre-ACA period (Table 42). The overall 
average ACA-related INS gain in odds (60%) represents the rising INS probability from 78.31% 
(pre-ACA) to 85.27% (post-ACA).  
Model 2 includes the addition of the ACA-related income groups. The ACA regression 
coefficient was relatively unchanged, with an odds ratio of 1.61 (p<0.001, 1.57-1.64 95% CI). 
This demonstrates the broad, strong effect of the ACA on INS. The constant term increased to an 
odds of 15.63 because the reference group narrowed to include only U.S. adults aged 18-64 
living above 400% FPL in the pre-ACA period. The reference group, due to their high income, 
had a much higher odds of having insurance, than the groups living below 400% FPL. At this 
point in the regression process, the coefficients for each income level are percentage adjustments 
applied equally to both the pre-and post-ACA periods. Adjusting for the ACA, the <100% FPL 
group was the least likely to be insured (OR 0.08, p<0.001, 0.08-0.08 95% CI), when compared 
with the >400% FPL group. The 100-138% FPL group was 89% less likely to be insured than 
the >400% FPL group; whereas the 139-400% FPL group was 79% less likely to be insured than 
the >400% FPL group. 
In Model 3, the ACA coefficient increased by 3.75% to an odds ratio of 1.66 (p<0.001, 
1.62-1.70 95% CI) when demographic and health status variables were stepped in and adjusted 
for. This demonstrates that the ACA had a greater effect on INS when adjusting for race, 
education, age, sex, diabetes risk status, and chronic disease. As all coefficients are jointly 
estimated, the marginal increase in insurance to 15-28% odds for the 3 lower income groups 
shows that differences between the demographic and health status variables exist. Since lower 
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income groups tend to have poorer health, less education and belong to a minority group, for 
example, by adjusting for these variables, the insurance gap closes (if even slightly) between the 
low-income groups and the high-income group. The constant in Model 3 reduced to an odds of 
4.92 as the reference group became more specific. The constant represents U.S. white adult 
males aged 18-44 living above the 400% FPL with less than a high school education and were 
healthy and at low risk for diabetes with no chronic disease in the pre-ACA period.  
Although the other coefficients were not the central focus for Specific Aim 1, it is 
interesting to note the following disparities in insurance coverage existed when adjusting for 
other factors: 
• Blacks and Hispanics were 21-48% less likely to have insurance when compared to 
whites; 
• Large gains for college graduates (3.66 times more likely than those with less than HS);  
• Individuals aged 45 to 64 had increased odds (1.43) of having insurance when compared 
to those aged 18 to 44;  
• Females had increased odds (1.42) of having insurance when compared to males;  
• High Risk individuals were 8% more likely to have insurance than no/low risk 
individuals; 
• Individuals with Diabetes were 60% more likely to have insurance than no/low risk 
individuals  
• As the number of reported chronic diseases increased, the odds increased by 1.26, yet the 
individuals who reported being “unhealthy” were 14% less likely to have insurance than 
those who reported being “healthy”.  
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The odds ratios for the demographic and health status variables listed above are percentage 
adjustments applied equally for the 6 years under study.  
To differentiate between the pre-and post-ACA periods, an interaction term of 
ACA*Income was introduced in Model 4. Without an interaction term, the <100% FPL income 
group in Model 3 was 85% less likely (odds= 0.15) to have insurance in the pre-ACA period 
than those living above 400% FPL, when adjusting for other factors. With the addition of an 
ACA*Income<100% FPL interaction term in Model 4, a distinction between the pre-and post-
ACA periods can be quantified. Once the main odds coefficient is “split”, between pre-and post-
ACA periods, the less than 100% FPL group had a slightly lower percent insured in Model 4 
(odds= 0.13), compared with Model 3’s odds of 0.15 because Model 3’s coefficient is averaged 
over 6 years. The odds ratio of 0.13 (relative to the >400% FPL) now represents solely the pre-
ACA period. The post-ACA coefficient (1.34) is now limited to the >400% FPL income group, 
whites and other reference groups. It is not directly comparable to the 1.60 overall ACA effect.  
With the addition of interaction terms, the marginal ACA effect on the 3 lower income 
groups was between 21-40% greater than for the >400% group of 34%. The lower income 
groups (<139% FPL) benefited more from the ACA considering Medicaid expansion was 
available. Since there were no changes in the odds for other demographic and health status 
variables, this implies that there was no change pre/post ACA.  
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Table 42. 
Logistic Regression Models for the Odds of INS using Pre/Post ACA Indicator (47-state Sample).  
 
Probability of Insurance  
(n=1,283,537)
Model 1                         
Odds Ratio
Model 2                         
Odds Ratio
Model 3                         
Odds Ratio
Model 4                         
Odds Ratio
Time
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.60** 1.61** 1.66** 1.34**
Income
>400% FPL Ref Ref Ref
139-400% FPL 0.21** 0.28** 0.25**
100-138% FPL 0.11** 0.17** 0.14**
<100% FPL 0.08** 0.15** 0.13**
ACA*Income
ACA* >400% FPL Ref
ACA* 139-400% FPL 1.21**
ACA* 100-138% FPL 1.40**
ACA* <100% FPL 1.35**
Other Variables
Race
Whites Ref Ref
Blacks 0.79** 0.79**
Hispanics 0.52** 0.52**
Education
Less than HS Ref Ref
HS Grad 1.61** 1.61**
Some College 2.13** 2.13**
College Grad 3.66** 3.67**
Age
18 to 44 Ref Ref
45 to 64 1.43** 1.43**
Sex
Male Ref Ref
Female 1.42** 1.42**
Health Variables
Diabetes Status
No/Low Risk Ref Ref
High Risk 1.08** 1.08**
Diabetes 1.60** 1.60**
Chronic Disease
Count 0-5 1.26** 1.26**
Self Reported Health
Healthy Ref Ref
Unhealthy 0.88** 0.88**
Constant 3.61** 15.63** 4.92** 5.57**
F Statistic 2149** 5574** 2301** 1948**
Notes: 
1. Contains odds ratio for 47-state analtyic sample 
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Refer to Appendix AD, Table AD-1 for 95% CI’s for Table 42.  
To gain a better understanding of key ACA regression coefficients in Specific Aim 1a, 
Table 43 provides a summary and was created from regression coefficients in Table 42. 
Columns 1, 2 and 3 were directly taken from Table 42. The values for Post-ACA Income Odds 
(column 4) and the ACA Effect (column 5) were calculated and discussed below.   
Table 43. 
Summary of ACA Effects by Income Group. 
 
 
Calculations: 
To derive a gross (total) estimate of the ACA effect (column 5 in Table 43) on the odds 
of having insurance coverage for the <100% FPL group, both ACA terms in Model 4 were used 
to produce a combined ACA effect:   
ACA Effect <100% FPL: Exp {ln(1.34) + ln(1.35)= 0.293+0.297}= exp [0.590] = 
1.809, or an 80% gain in insurance coverage relative odds versus the >400% FPL group over the 
pre-ACA period. The estimated total ACA effects on the odds of having insurance coverage for 
all four income groups when compared to the <400% FPL income group were:  
COLUMN 1 2 3 4 5
<100% FPL 0.13 1.34 1.35 0.24 1.81
100-138% FPL 0.14 1.34 1.40 0.25 1.88
139-400% FPL 0.25 1.34 1.21 0.45 1.62
>400% FPL 1.00 - - - -
Notes:
1. Pre-ACA Odds: Table 46, Specfic Aim 1a
2. Post-ACA Odds (Coefficient): Table 46, Specific Aim 1a
3. ACA*Income Odds (Interaction): Table 46, Specific Aim 1a
4. Post-ACA Income Odds: Calculation (Exp{ln(preACA) + ln(postACA) + ln(ACA*Income)})
5. ACA Low vs. High Income Effect: Calculation (Exp{ln(postACA)+ ln(ACA*Income)})
ACA LOW vs HIGH 
INCOME EFFECTINCOME GROUP
PRE-ACA 
ODDS
POST-ACA 
ODDS
ACA*INCOME 
ODDS
POST-ACA 
INCOME ODDS
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• <100% FPL: 1.809 
• 100-138% FPL: 1.876= Exp{ln(1.34)+ ln(1.4)= 0.293+ 0.336= 0.629}  
• 138-400% FPL: 1.621= Exp{ln(1.34)+ ln(1.21)= 0.293+ 0.191= 0.484} 
• >400% FPL: 1.34 (reference group).    
To derive the regression-based post-ACA odds for the <100% FPL group (column 3 in Table 
47), the group’s own logit coefficient, ln(0.13) was added to the ACA effect:  
 <100% FPL Post-ACA Odds: Exp {ln(0.13) + ln(1.34) + ln(1.35)= -2.04 
+0.297+0.293} = exp[-1.47] = 0.235,  
which also produced the same 80 percentage point difference from the baseline of 0.13 for the 
<100% FPL group in the pre-ACA period. The regression-based post ACA odds for all income 
groups were: 
• <100% FPL: 0.235 
• 100-138% FPL: 0.263 =Exp{ln(0.14) + ln(1.34) + ln(1.40) = -1.97 + 0.297 +0.336}= 
exp[-1.337]  
• 138-400% FPL: 0.405 =Exp{ln(0.25) + ln(1.34) + ln(1.21)= -1.386 + 0.297+0.191}= 
exp[-0.902] 
• >400% FPL: 7.46 (constant plus ACA) 
Comparing Descriptive Results to Regression Results. For ease of interpretation, 
descriptive and regression results are summarized in Table 44. The pre/post INS percentages 
were taken from Table 28, with the change in the percentages being calculated under column 4 
heading “change”. The percent change for the less than 100% FPL group was 23.82% in the 
post-ACA without controlling for other variables. The greatest percentage change in having 
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insurance after the ACA was seen among the <100% FPL group, followed by the 100-138% FPL 
group at 19.96%. Interestingly, using percentage changes only, the <100% FPL saw the greatest 
gains despite the legislation not directly targeting this income group. 
Table 44. 
Comparison of BRFSS Descriptive and Regression Results (47-state Sample).  
 
Insurance percentages from the descriptive statistics were converted to odds ratios to 
compare them to the regression odds. The following calculations were used to convert the pre 
and post insurance percentages to pre/post insurance odds ratios: 
Pre INS Odds:  [Pre INS %/(1-Pre INS %)] 
• Example (Pre INS Odds for <100% FPL): (0.5496/1-0.5496) = 1.2202 
Post INS odds:  [Post INS %/(1-Post INS %)] 
• Example (Post INS Odds for <100% FPL): [0.6805/(1-0.6805)] =2.1299 
When comparing the descriptive percentages and descriptive odds ratios, it’s clear that the odds 
ratios are much larger than the percentage changes.  This is because the percentages (or 
probabilities) are bound by 0 and 1, whereas odds are dependent upon the size of the 
denominator as it is a ratio of the probability of an event occurring divided by the probability of 
INCOME GROUP
PRE-INS 
%
POST-INS 
%
PERCENT 
CHANGE
PRE-INS 
ODDS
POST-INS 
ODDS
CHANGE 
IN ODDS
PRE-
ODDS 
>400%
PRE-
ODDS
POST-
ODDS
CHANGE 
IN ODDS
<100% FPL 0.55 0.68 23.82% 1.22 2.13 1.75 0.07 0.13 0.24 1.81
100-138% FPL 0.61 0.74 19.96% 1.59 2.80 1.76 0.09 0.14 0.26 1.88
139-400% FPL 0.77 0.84 9.36% 3.27 5.15 1.58 0.19 0.25 0.41 1.62
>400% FPL 0.95 0.96 1.31% 17.66 23.33 1.32 1.00 - - -
Notes:
Descriptive Results Source: Table 28, Percentages of INS by inccome group and time, 47 states
Regression Results Source: Table 46, Logistic Regression Models for Specific Aim 1a
DESCRIPTIVE STATISTICS REGRESSION RESULTS
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the event not occurring. Unless the event is a rare event, typically the odds ratio will be much 
higher than the probability for the same event. 
The converted percentages to unadjusted odds ratios show the 100-138% FPL group having 
the greatest increase in the odds, of 76%. The unadjusted changes in the odds for the additional 
income groups are: 30% for the >400% FPL group, 58% for the 139-400% FPL group and 75% 
for <100% FPL group. The change in the odds for the descriptive statistics is less than in the 
regression model since the trends are unadjusted. Once adjusted for race and education, the pre-
INS odds are greater in the regression results since more minorities and uneducated individuals 
are more likely to be uninsured. When compared to the >400% FPL income group, the very low-
income groups were about 80% more likely to have insurance in the post-ACA period, when 
adjusting for demographic and health status variables. The reference group (>400% FPL) was 
34% more likely to have insurance over the pre-ACA period.  
 Specific Aim 1a. Annual ACA Insurance Coverage Odds Ratios with ACA-Income 
Interactions. In the previous regression models, the ACA regression coefficient was averaged 
over 4 years, 2014-2017. When the post-ACA period was broken out by year, insurance 
coverage was rising from 2014-2016 (odds of 38%-75%), with a small decline by 2017 (odds of 
69%) when compared to the pre-ACA period (Table 45, Model 1). When income, and other 
variables were adjusted for, the ACA effect increased (odds of 45-83%) as it did in the pre/post 
ACA models. However, by using dummy variables for the post ACA years (2014-2017), changes 
over time by income group were better understood. All pre/post ACA regressions were run using 
time series dummy variables, and after this section will be referenced in Appendix AD. 
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Table 45.  
 
Logistic Regression Models for the Odds of Insurance using 2014-2017-Time Dummies; 47-state 
sample.  
 
Refer to Appendix AD, Table AD-2 for 95% CI’s for Table 45.  
Probability of Insurance 
(n=1,283,537) 
Model 1                      
Odds Ratio
Model 2                      
Odds Ratio
Model 3                      
Odds Ratio
Model 4                      
Odds Ratio
Time
Year
2012 Ref Ref Ref Ref
2013 Ref Ref Ref Ref
2014 1.38** 1.44** 1.45** 1.34**
2015 1.63** 1.64** 1.70** 1.36**
2016 1.75** 1.73** 1.83** 1.40**
2017 1.69** 1.64** 1.71** 1.27**
Income
>400% FPL Ref Ref Ref
139-400% FPL 0.21** 0.28** 0.25**
100-138% FPL 0.11** 0.17** 0.14**
<100% FPL 0.08** 0.15** 0.13**
Year*Income
2014* >400% FPL Ref
2014 * 139-400% FPL 1.08
2014* 100-138% FPL 1.21*
2014* <100% FPL 1.08
2015* >400% FPL Ref
2015 * 139-400% FPL 1.22**
2015* 100-138% FPL 1.47**
2015* <100% FPL 1.32**
2016* >400% FPL Ref
2016 * 139-400% FPL 1.30**
2016* 100-138% FPL 1.35**
2016* <100% FPL 1.49**
2017* >400% FPL Ref
2017 * 139-400% FPL 1.26**
2017* 100-138% FPL 1.65**
2017* <100% FPL 1.62**
Other Variables
Race
Whites Ref Ref
Blacks 0.79** 0.79**
Hispanics 0.52** 0.52**
Education
Less than HS Ref Ref
HS Grad 1.61** 1.61**
Some College 2.13** 2.14**
College Grad 3.66** 3.67**
Age
18 to 44 Ref Ref
45 to 64 1.43** 1.43**
Sex
Male Ref Ref
Female 1.42** 1.42**
Diabetes Status
No/Low Risk Ref Ref
High Risk 1.08** 1.08**
Diabetes 1.60** 1.60**
Chronic Disease
Count 0-5 1.26** 1.26**
Self Reported Health
Healthy Ref Ref
Unhealthy 0.88** 0.88**
Constant 3.61** 15.60** 4.91** 5.57**
F Statistic 574** 3192** 1918** 1175**
Notes: 
1. Contains odds ratio for 47-state analtyic sample 
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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In 2014, the 100-138% FPL income group was the only income group to see increases in 
insurance coverage (21%, p<0.05), when compared to the >400% FPL income group post-ACA. 
Since 2014 was the 1st year post ACA implementation, it seems logical that the group that was 
impacted the most was the 100-138% FPL group as this group benefited from both Medicaid 
expansion and the insurance subsidies. By 2015, all lower income groups saw increases in the 
odds of having insurance (30-47%) in the post-ACA period, when compared to the >400% FPL 
group and controlling for other factors. During this time, the 100-138% FPL had the greatest 
likelihood of having insurance (47%, p<0.001). By 2016, interestingly, the <100% FPL was 49% 
(p<0.001) more likely to have insurance than the >400% FPL, when adjusting for other factors. 
The lowest income group now had the greatest likelihood of having insurance.  The decline in 
the likelihood of having insurance by 2017, was due to the decline in the odds of having 
insurance in the post-ACA period by the >400% FPL group. Small increases (34-40%) were seen 
from 2014-2016 in the odds of insurance in the post-ACA period for the >400% FPL income 
group; however, a decline for this group took place by 2017.  
The decline in the likelihood of having insurance in the post-ACA period for the >400% 
FPL group, lead to greater odds of insurance (62-65%) for the <100% FPL and 100-138% FPL 
income groups. The 139-400% FPL income group seemed to experience a marginal decline in 
the likelihood of having insurance (from 30% in 2016 to 26% in 2017), like the >400% FPL 
income group. The declines seen in the >139% FPL groups could be attributed to the rising costs 
of health insurance premiums, causing individuals to opt out of health insurance coverage post-
ACA. According to a recent survey conducted by The Commonwealth Fund, individuals who 
receive insurance subsidies via the marketplace were significantly more likely than those with 
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employer coverage or Medicaid to report health care as unaffordable (Collins, Gunja, Doty & 
Bhupal, 2018).  
 Specific Aim 1b. Pre/Post-ACA (and Annual) Insurance Coverage Odds Ratios 
Controlling for Expansion Status In Specific Aim 1b, the focus is to understand how 
expansion status influenced the odds of having insurance. Tables AD-3 and AD-4, the 
dichotomous expansion status variable (0=non-expansion and 1=expansion) was added to 
Specific Aim 1a’s full model in order to assess pre/post-ACA changes in the odds of having 
insurance. Table AD-3 shows logistic regression models using the pre/post ACA indicator; 
whereas Table AD-4, shows logistic regression models using the (2014-2017) time dummy 
variables. A brief write-up is presented along the models in Appendix AD. A limitation to 
running the full models, controlled by expansion status is that changes in the odds of insurance 
are relative to the >400% FPL income group. Alternatively, full models were run controlling for 
expansion status, by income group in order to compare changes across all groups. These models 
were helpful in understanding changes in regression coefficients for not only the low income 
groups, but for all income groups.   
 Specific Aim 1b. Pre/Post-ACA Insurance Coverage Odds Ratios Controlling for 
Expansion Status by Income Group. In Table 50, full regression models are presented, 
stratified by income, with the addition of an ACA*Expansion (EXP) interaction term to 
differentiate between pre/post differences in expansion groups. The constant represents the odds 
ratio for the combined set of reference groups in the regression. For example, the reference group 
within the <100% FPL group represents U.S. white male adults aged 18-44 with less than a high 
school education, reporting good health, who are at low risk for diabetes with no chronic disease 
in the pre-ACA period. This reference group is represented by the constant of 0.59 in the <100% 
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FPL group. When comparing the constant terms across income groups, the odds of having 
insurance for the baseline group was the lowest for the less than 100% FPL income group.  This 
is consistent with the base percentages insured in the descriptive Table 28 showing the <100% 
FPL income group having the lowest levels of insurance. 
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Table 46.  
Logistic Regression Models for the Odds of Insurance by Income and Expansion Status Using 
Pre/Post-ACA Indicator (47-state Analytic Sample).  
 
Appendix AD includes regressions without interaction term and 95% CI’s (Table AD-3).  
Probability of Insurance 
by Income Group
Income 
<100% FPL                      
Odds Ratio 
(n=152,358)
Income 100-
138% FPL                      
Odds Ratio 
(n=94,466)
Income 139-
400% FPL                     
Odds Ratio 
(n=500,262)
Income 
>400% FPL                      
Odds Ratio 
(n=576,687)
ACA
Pre ACA Ref Ref Ref Ref
Post ACA 1.48** 1.62** 1.49** 1.27**
Expansion Status
Non-expansion Ref Ref Ref Ref
Expansion  1.82** 1.50** 1.21** 1.21**
Interaction Term
ACA*EXP 1.47** 1.31** 1.20** 1.12
Other Variables
Race
Whites Ref Ref Ref Ref
Blacks 0.94* 0.99 0.78** 0.64**
Hispanics 0.46** 0.56** 0.52** 0.49**
Sex
Male Ref Ref Ref Ref
Female 1.40** 1.35** 1.39** 1.58**
Age
18 to 44 Ref Ref Ref Ref
45 to 64 1.17** 1.33** 1.50** 1.79**
Education
Less than HS Ref Ref Ref Ref
HS Grad 1.34** 1.54** 2.05** 2.25**
Some College 1.66** 1.95** 2.75** 3.44**
College Grad 1.87** 2.35** 4.49** 7.75**
Diabetes Status
No/Low Risk Ref Ref Ref Ref
High Risk 1.04 1.12** 1.11** 1.08*
Diabetes 1.66** 1.61** 1.67** 1.53**
Chronic Disease
Count 0-5 1.36** 1.35** 1.18** 1.09*
Self Reported Health
Healthy Ref Ref Ref Ref
Unhealthy 0.99 0.96 0.80** 0.77**
Constant 0.59** 0.63** 1.01 2.89**
F Statistic 286** 133** 499** 214**
Notes: 
1. Contains odds ratio for 47-state analtyic sample 
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
4. Separate model run per income level 
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The variables of interest in Table 46 are the ACA, expansion (EXP) and ACA*EXP 
interaction terms. These terms provide critical information on how insurance levels changed by 
income and expansion groups over the ACA period. Even though the 100-138% FPL group saw 
the greatest gains in insurance coverage in the post-ACA period (ACA OR 1.62), the less than 
100% FPL group in expansion states had greater odds of being insured in the post-ACA period 
(47%). The <100% FPL group was 3.96 times more likely to be insured post-ACA in expansion 
states, than in non-expansion states, when adjusting for other factors. (This was calculated by 
adding the logits of ACA, EXP and ACA*EXP). The overall odds of being insured for someone 
living in an expansion state and in the 100-138% FPL income group was 3.18; whereas the odds 
of someone in the 138-400% FPL was 2.16 and for those living at >400% FPL in expansion 
states the odds of being insured were 1.79, when adjusting for other factors.  To note, the odds 
ratio of 1.12 for the ACA*EXP interaction term in the >400% FPL group had a p value of 0.068, 
which is very close to the cutoff point for statistical significance and is worth including in our 
analysis of ACA effects. 
The post-ACA odds ratios for each income group are not representative of their own 
post-ACA values because covariates are introduced in the model causing the constant term to 
underestimate the pre-ACA insurance rate and odds ratio. When an odds ratio is adjusted for, as 
was done in the logistic regression analysis, there is no longer a shared baseline risk as the 
covariates take on different baseline values (Grant, 2014). However, since baseline insurance 
rates per income level are known from Part III, Tables 29 and 30, and the (estimated) change in 
the percent insured due to the ACA is known (per the regression odds ratios), these values were 
used as to calculate average odds ratios for persons living in expansion and non-expansion states 
by income group (Table 51). “Average” (odds) refers to the pre-ACA descriptive odds ratios that 
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exist before any adjustments are made for race, income, etc. Then, marginal odds ratios are 
calculated for the post-ACA period. “Marginal” (odds) refers to creating post-ACA odds ratios 
based on regression-adjusted coefficients and then comparing them with the pre-ACA odds. In 
an ideal setting, mean pre-values for expansion and non-expansion states would be used. 
First, the pre-ACA percentages by income and expansion status were converted to odds 
ratios using the following formula: 
(1) OR= Percent insured/(1-percent insured) 
• Example: OR= 0.931= 0.482/1-0.482.   
The OR’s in Rows 1 and 2 in Table 47 below become the base upon which logistic marginal 
effects are constructed. Rows 2 and 4 are reproduced in Rows 5 and 8 for comparison purposes 
in non-expansion and expansion states separately. Post-ACA ORs, or ACA effects, by expansion 
status (Rows 6 and 9) were calculated using the following formulas:  
 (2) OR[NEXP]= exp(LN(ACA OR) + LN(NEXP-pre)) 
• Example: 1.377= Exp{ln(1.48) + ln(0.931)}= Exp{0.392 -0.071=0.321}= 
1.377 
 (3) OR[EXP] = exp((LN(ACA OR) + LN(ACA*EXP OR) + LN(EXP-pre)) 
• Example: 3.170= Exp{ln(1.48) + ln(1.47) + ln(1.457)}= Exp{1.153}=3.167.  
The EXP coefficient is not included in calculating OR(EXP) because it is already included in the 
pre-ACA baseline insurance rate.  
  Then Rows 5 and 8 show the post-ACA insurance gains over the pre-ACA period.   
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Table 47.  
Conversion of Marginal Odds Ratios for Insurance to Average Odds Ratio for Insurance in Non-
expansion and Expansion States. 
 
The greatest relative gains in insurance in expansion states were within the <100% FPL 
with a pre/post odds ratio of 2.176. The 100-138% FPL income group had the next largest 
pre/post-odds ratio of 2.122. The >400% FPL income group, although not directly targeted by 
the ACA, did see increases in insurance coverage odds in the post-ACA period, but not at similar 
rates as the lower income level groups. The increase seen in the <100% FPL was above the gains 
seen with the descriptive data seen in Table 30.  
For non-expansion states in the post-ACA period, individuals living 100-138% FPL had 
the greatest gains in insurance with an odds ratio of 1.62. This was 13-percentage points greater 
than the next largest gain in the 138-400% FPL group. Greater gains in the 100-400% FPL group 
would be expected for non-expansion states as insurance subsides were available to this group; 
Row Odds INC<100
INC100-
138
INC138-
400
INC>400
1
NEXP-pre 0.931 1.336 2.953 15.667
2
EXP-pre 1.457 1.809 3.525 19.000
3 Pre-ACA 0.931 1.336 2.953 15.667
4 Post-ACA 1.377 2.165 4.399 19.897
5 Post/Pre 1.480 1.620 1.490 1.270
6 Pre-ACA 1.457 1.809 3.525 19.000
7 Post-ACA 3.170 3.839 6.302 27.026
8 Post/Pre 2.176 2.122 1.788 1.422
EXPANSION ODDS RATIOS W/ PRE-ACA %INS ODDS
NEXP
EXP
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whereas, residents who had incomes less than 100% FPL did not qualify for Medicaid and were 
not eligible for the premium tax credit. The Kaiser Family Foundation estimated that 2.2 million 
Americans in non-expansion states fell into this coverage gap (Kaiser Family Foundation, 2018). 
The 62% increase seen in the 100-138% FPL was above the gains seen with the descriptive data 
seen in Table 29 (summarized in Table 48 below). By calculating the change in the odds in the 
expansion group over the overall ACA effect for each income group, it is clear that the odds of 
having insurance in the post ACA period was 6-20% greater than the overall ACA effect, within 
expansions states. The lowest income groups benefited the most, at 20% gains over ACA effect.  
Table 48.  
Summary Table Comparing Changes in Odds Ratios from 3 Sources: Table 23 Descriptive 
Statistics, Table 46 for Overall Changes from Logistic Regressions, and Table 50 for Logistic 
Regression by Income Group.  
 
 Generally, from this analysis expansion states benefited the most given the higher levels 
of insurance in the pre-ACA period, and potentially a political environment that was conducive 
of enrolling individuals for health insurance, which was not controlled for in this analysis. Non-
expansion states did make coverage gains as highlighted in Table 48, but not enough to reap the 
INCOME TABLE 28
TABLE 47: 
OVERALL
TABLE 53: 
EXP
TABLE 53: 
NEXP
RATIO: 
T53/T46 
(EXP)
RATIO: 
T53/T46 
(NEXP)
<100% FPL 1.750 1.810 2.180 1.480 1.204 0.818
100-138% FPL 1.760 1.880 2.120 1.620 1.128 0.862
139-400% FPL 1.580 1.620 1.790 1.490 1.105 0.920
>400% FPL 1.320 1.340 1.420 1.270 1.060 0.948
Notes:
1. Under Table 28 heading: Percent insured converted to Odds Ratios
2. Under Table 47 heading: Overall ACA Effect
3. Under Table 53 headings: Computed odds ratio from baseline percentages by EXP status
4. Under Ratio: Expansion status odds divided by overall ACA effect odds
PRE/POST-ACA ODDS RATIOS
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full benefit of the ACA effect. The greatest opportunities to improve insurance enrollment within 
non-expansion states was among individuals living below 100% FPL, who were 28% less likely 
to benefit from the ACA (Table 48). The 100-138% FPL was close behind, with an odds ratio of 
0.862. This highlights the integral role Medicaid expansion played in ensuring access to 
insurance for low-income adults during the ACA period.  
For a summary of logistic regression results and discussion on additional regression 
coefficients found in this section, refer to Appendix AD.  
 Specific Aim 2- Health Care Access  
In Specific Aim 2a, the purpose was to assess the impact of the ACA on increasing health 
care access (as measured by PCP or Checkup in the past year) in the U.S. by race, then by 
diabetes risk status. In Specific Aim 2b, the purpose was to determine if differences in health 
care access existed between non-expansion and Medicaid expansions states, stratified by race, 
then by diabetes risk status. Multivariate logit and logistic regressions were run with findings 
displayed in Tables 49-68. For each aim, the odds of having a PCP will be discussed first, 
followed by the odds of having a checkup in the past year. The odds of having a checkup in the 
past year was a secondary measure for health care access, with most of the analyses found in the 
appropriate Appendix. Important to note, explanatory variables included in this model are the 
same as the variables in Specific Aim 1, except insurance replaced income, and PCP supply was 
added as a control variable in the full model. As previously mentioned, the ACA is working via 
expanded insurance coverage, in part, to provide access to a PCP (or a checkup in the past year). 
As hypothesized, if insurance coverage is controlled for, the ACA effect on access to primary 
care should be less and possibly zero. Appendix AE contains additional Specific Aim 2 
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regressions models for PCP, including the time series models, not included in the text. Appendix 
AF contains additional Specific Aim 2 regression models for Checkup.  
From the previously presented correlation matrix in Table 41, the INS and PCP variables 
for the analytic sample are highly correlated with a correlation coefficient of ρ= 0.3554 (p<0.05). 
The INS and Checkup variables are also highly correlated: ρ= 0.2383, (p<0.05), but less so then 
INS and PCP. Models 1 and 2, respectively, in Table 49 convert the correlation coefficients into 
the odds of having health care access with versus without insurance. Models 1 and 2 only include 
the INS variable in each Model.  
Table 49.  
Logistic Regression Odds of Having a PCP or Checkup in the Past Year for White, Black or 
Hispanic Insured Adults Aged 18-64.  
 
Averaged over 6 years, insured whites, blacks and Hispanics aged 18-64 living in one of 
the sample’s 47-states were 6.5-times more likely to have a PCP (p<0.001) than the uninsured, 
and 3.53-times more likely to have a checkup in the past year (p<0.001). Table 33 suggests a 
PCP fraction of 0.74 for the insured averaged 40-60% over the pre-and post-ACA periods 
Probability of Health Care 
Access (n=1,283,537) 
Model 1                      
Odds Ratio 
(PCP)
95% CI
Model 2                      
Odds Ratio 
(Checkup)
95% CI
Insurance
Uninsured Ref Ref
Insured 6.51** (6.38, 6.65) 3.53** (3.46, 3.61)
Constant 0.66** (0.65, 0.67) 0.65** (0.64, 0.66)
F Statistic 32268** 14704**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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converts into an odds ratio of 0.351. The logistic-based odds ratio for insured is 
exp{ln(0.66)+ln(6.51)}=(0.429)/(1+0.429)= 0.812, which is quite similar to 0.74 from Table 33. 
The constant term of 0.66 for Model 1 or 0.65 for Model 2 is the odds of being uninsured for a 
U.S adult aged 18-64 across the six years under study. The odds for PCP and checkup show that 
insurance plays an important role in ensuring health care access, especially in having a PCP. 
Insurance appears to play a lesser role in ensuring access to a checkup as many safety net 
systems are in place across the country that provide preventive medicine to the uninsured without 
a one-to-one assignment of a PCP.  
 Once the average odds for the insured were known over the 6-year period, regression 
models were run to determine the impact of the ACA on PCP access with and without insurance 
coverage. When ACA was stepped in Model 1 alone, respondents were only 3% more likely 
(p<0.001, 1.02-1.05 95% CI) to have a PCP in the post-ACA period, compared with the pre-
ACA period. The constant of 2.79 is the overall odds of having a PCP for a U.S. adult aged 18-
64 in the pre-ACA period (Table 50). The overall ACA average PCP gains in odds (3%) derives 
the rising PCP probability from 73.61% to 74.27% (Table 33).8  
 The likelihood of having a checkup was 10% greater (p<0.001, 1.08-1.12 95% CI) post-
ACA, when compared to the pre-ACA period. The constant term of 1.70 was the overall odds of 
having a checkup in the past year for a U.S. adult aged 18-64 in the pre-ACA period (Table 51). 
The overall average gains in odds (10%) of having a checkup in the past year represents the 
rising checkup probability from 63.23% to 65.34% (Table 33).  
 
 
8 OR= 1.03= (0.7427)/(1-0.7427)/(0.7361)/(1-0.7361)= 2.887/2.789 
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Table 50.  
Logistic Regression Models for the Odds of Having a PCP by INS Status using Pre/Post ACA 
Indicator for 47-state Analytic Sample.  
 
Appendix AE includes 95% CI’s (Table AE-1) for regression models found in Table 50. 
Probability of Having a 
PCP (n=1,283,537) 
Model 1                      
Odds Ratio
Model 2                      
Odds Ratio
Model 3                      
Odds Ratio
Model 4                      
Odds Ratio
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.03** 1.04** 0.90** 1.01
Insurance
Uninsured Ref Ref
Insured 5.33** 5.88**
ACA*INS
ACA*INS 0.85**
Other Variables
Race
Whites Ref Ref Ref
Blacks 0.86** 0.95* 0.95*
Hispanics 0.56** 0.69** 0.69**
Education
Less than HS Ref Ref Ref
HS Grad 1.62** 1.31** 1.31**
Some College 2.04** 1.49** 1.49**
College Grad 2.83** 1.78** 1.78**
Age
18 to 44 Ref Ref Ref
45 to 64 2.50** 2.39** 2.39**
Sex
Male Ref Ref Ref
Female 1.94** 1.96** 1.96**
Diabetes Status
No/Low Risk Ref Ref Ref
High Risk 1.18** 1.18** 1.18**
Diabetes 2.98** 2.88** 2.88**
Chronic Disease
Count 0-5 1.39** 1.36** 1.36**
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 0.93** 1.03* 1.03*
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.74** 0.81** 0.81**
Constant 2.79** 0.85** 0.30** 0.28**
F Statistic 16** 2285** 3070** 2877**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table 51.  
Logistic Regression Models for the Odds of having a Checkup in the past year using pre/post 
ACA indicator; 47-state Analytic Sample. 
 
Appendix AF includes 95% CI’s (Table AF-1). 
Probability of Checkup 
(n=1,283,537) 
Model 1                      
Odds Ratio
Model 2                      
Odds Ratio
Model 3                      
Odds Ratio
Model 4                      
Odds Ratio
Time
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.10** 1.10** 1.01 1.11**
Insurance
Uninsured Ref Ref
Insured 3.49** 3.75**
ACA*INS
ACA*INS 0.89**
Other Variables
Race
Whites Ref Ref Ref
Blacks 1.81** 2.02** 2.02**
Hispanics 1.00 1.21** 1.21**
Education
Less than HS Ref Ref Ref
HS Grad 1.35** 1.13** 1.13**
Some College 1.42** 1.10** 1.11**
College Grad 1.67** 1.19** 1.19**
Age
18 to 44 Ref Ref Ref
45 to 64 1.66** 1.57** 1.57**
Sex
Male Ref Ref Ref
Female 1.51** 1.49** 1.49**
Diabetes Status
No/Low Risk Ref Ref Ref
High Risk 1.08** 1.08** 1.08**
Diabetes 2.52** 2.43** 2.43**
Chronic Disease
Count 0-5 1.23** 1.20** 1.20**
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 0.92** 0.98 0.98
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.91** 0.98* 0.98*
Constant 1.70** 0.69** 0.32** 0.30**
F Statistic 158** 1229** 1827** 1706**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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In Model 2, respondent demographic and health status variables, along with state supply 
of PCP were added to the model, still excluding insurance. Post-ACA odds changed by only 
0.001 for PCP and was unchanged for checkup. This shows that the other predictor variables had 
no meaningful effect on the likelihood of having a PCP during the ACA period. The constant 
terms were reduced to 0.85 for PCP and 0.69 for checkup since the baseline group now includes 
only U.S. adults aged 18-64 living above 400% FPL in the pre-ACA period. 
 The next two models are key to the analysis but difficult to interpret as they require 
keeping in mind differences in insurance effects pre-versus post-ACA, as well as correlations of 
insurance with other included variables. Based on these results, two questions can be answered: 
1. What effect does controlling for insurance coverage have on the effect of the ACA on 
PCP access?   
2. What effect does controlling for the ACA time period plus other variables have on the 
insurance effect on PCP access? 
Once INS is in Model 3, the post-ACA effect on PCP declined from 1.03 to 0.90. 
Individuals in the post-ACA period were 10% less likely to have a PCP. The gains in the one-
year odds for having a checkup now was only 1% in the post-ACA period. This is consistent 
with the descriptive data that showed much slower gains in PCP than gains in having insurance. 
Such anomalous results, however, are largely due to controlling for the primary way the ACA 
could have affected PCP access. This become evident when an ACA*INS interaction term is 
added to Model 4. The post-ACA odds coefficient has increased to 1.01 and is not statistically 
different from 1.0. The 1% gain is consistent with the 0.9% gain in the PCP/INS ratio. The 
interaction coefficient, however, is 0.85, implying a 15% decline in the effectiveness of 
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insurance in affording access to a regular PCP during the post-ACA period. The overall INS 
effect on PCP in Model 4 is determined as: 
• Exp{ln(5.88)+ln(0.85)= 1.772- 0.163= 1.609}= 5.00, 
which is about 6% less than the 5.33 estimate in Model 2. Comparing the INS effect of 5.00 to 
the uncontrolled effect of 6.51, the decline has been 23.2%.  
 We also note that in PCP Model 3, Table 50, that the insurance effect on having a PCP 
has declined from 6.51 to 5.33, an 18% reduction. This must be due to controlling for the ACA 
period and other variables in the model. Comparing Model 3 with Model 2, we see that the odds 
for minority status, self-reported health, and PCP supply have all increased. All three are 
negatively correlated with INS (see Table 41). Their effects on PCP access were less in Model 2 
because they included their lower average level of insurance coverage. By contrast, minority 
status, college, and age saw their odds fall once INS was controlled for. This because some of the 
Model 2 coefficients reflected higher average levels of insurance (resulting from positive INS 
correlations; see Table 41).  
 Deriving ACA-INS Effect on PCP 
 In order to derive an ACA-INS to PCP effect, logit regression coefficients were produced 
in Table 52. The key ACA to INS pathway is measured by the logit coefficient 0.01, which is 
positive. When multiplied by the positive logit coefficient, 1.77, connecting INS to PCP, the 
product gives the contribution of the ACA through INS to having a PCP. The logit coefficients 
0.01 and 1.77 are partial effects, adjusting for other covariates in the model. Hypothetically, a 
direct pathway (not going through INS) from ACA to PCP is included, but is hypothesized to 
approach zero when controlling for INS.  
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Table 52.  
Logit Regression Models for the Likelihood of having a PCP using Pre/Post ACA Indicator; 47-
state Analytic Sample. 
 
Probability of Having a 
PCP (n=1,283,537) 
Model 1                          
Logit
Model 2                         
Logit
Model 3                             
Logit
Model 4                        
Logit 
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 0.03** 0.03** -0.11** 0.01
Insurance
Uninsured Ref Ref
Insured 1.67** 1.77**
ACA*INS
ACA*INS -0.16**
Other Variables
Race
Whites Ref Ref Ref
Blacks -0.15** -0.05* -0.05*
Hispanics -0.59** -0.37** -0.37**
Education
Less than HS Ref Ref Ref
HS Grad 0.48** 0.27** 0.27**
Some College 0.71** 0.40** 0.40**
College Grad 1.04** 0.58* 0.58**
Age
18 to 44 Ref Ref Ref
45 to 64 0.92** 0.87** 0.87**
Sex
Male Ref Ref Ref
Female 0.66** 0.67** 0.67**
Diabetes Status
No/Low Risk Ref Ref Ref
High Risk 0.16** 0.16** 0.16**
Diabetes 1.09** 1.06** 1.06**
Chronic Disease
Count 0-5 0.33** 0.31** 0.31**
Self Reported Health
Healthy Ref Ref Ref
Unhealthy -0.07** 0.03* 0.03*
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply -0.30** -0.21** -0.21**
Constant 1.03** -0.16** -1.19** -1.26**
F Statistic 16** 2285** 3070** 2877**
Notes:
1. Contains logit coefficients for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logit regression models
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 The full effect of the ACA on PCP involves taking the total derivative of the semi-log 
logit function with respect to ACA (Keisler, 2012), i.e., 
(1)  δlnPCPodds/δACA = 0.01*( δACA/δACA =1) + 1.772*δINS/δACA    
 - 0.163*δ(ACA*INS)/δACA.  
The derivative (δ) of a natural log is the percent change in the PCP log odds. The derivative, 
δ(ACA*INS)/δACA, has two terms: 
o INS* δACA/ δ/ACA= INSbase x 1, plus 
o ACAbase* δINS/ δACA.  
The first term captures what would have happened to ln(PCP) if greater coverage boosted access 
at historical coverage rates. The second term reflects what happened to the 35% pre-ACA sample 
in terms of PCP access during the post-ACA period. Both are multiplied by a -0.163 [logit 
coefficient for ACA*INS] reflecting the weakening effect of insurance in gaining access to a 
PCP in the post-ACA period.  
 According to Table 28, the actual percent insured increased 8.85% post-ACA (from 
78.3% to 85.2%) in the 47-state sample. Equation 1 was modified by inserting the 8.85% into the 
equation, as well as the base period average rate (0.7831) and percent of the sample in the pre-
ACA period (0.35),  
(2)     δlnPCPodds/δACA = 0.01 + 1.772*.0885 - .163*(.7831 + 0.35*0.0885) 
                      = 0.01 +   0.157 – 0.128 – 0.005 = 0.01 + 0.024 = 0.034. 
This estimate is almost identical to the 0.345 found using the single ACA term to explain PCP 
gains from the ACA. It assumes that the ACA was responsible for the entire observed growth in 
coverage; an assumption that is modified later.  
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The ACA effect is in four parts. Two are negative, and they offset the very large positive 
effect (0.157) that the ACA had on PCP by increasing insurance coverage at base period 
insurance rates.  
 From Equation 2, the ACA effect is in four parts, where two are negative and offset the 
very large positive effect (0.157) that the ACA had on PCP. The ACA increased insurance 
coverage at base period insurance rates. This could have been the increase in PCP access had 
coverage remained as effective in the post-ACA period as earlier. Once the potentially large 
ACA insurance effect is accounted for, the largest offset (-0.128= -0.163*0.7831) represents a 
downward shift in the advantage of having insurance coverage in the ACA versus the base 
period. From sample-weighted tables of trends in insurance and PCP, the ratio of PCP/INS fell 
from 0.939 in the ACA period to 0.873 in the base ACA period, a 7.6 reduction. Although many 
more individuals were gaining insurance coverage, these gains were not being transformed into 
gains in PCP at the former rate. This diminished gain was compounded by a 0.5% (-0.005 in 
equation 2) additional “loss” from being either insured or uninsured in the ACA period. 
Accounting for the two deficits, the net PCP gain from increased coverage was only 2.4 
percentage points (0.024 in equation 2). Other ACA-related factors not controlled for in the 
model must have added almost another percentage point.  
 A Regression-based Measure of ACA’s Effect on PCP via INS 
 Considering that all the gains in insurance coverage post-ACA was not due entirely to the 
ACA program, a regression-based measure is calculated to derive ACA’s effect on PCP via INS. 
Controlling for the same variables as before, the ACA odds ratio for INS was 1.66, a ratio that is 
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consistent with a predicted post-ACA insurance rate of 0.857 using 0.7831 as the pre-ACA rate.9 
This is very close to the 0.852 in the descriptive tables (Table 28). Therefore, the ACA-related 
percentage point change in coverage is 0.074 (0.857-0.7831). Inserting this new value into 
equation 2 gives: 
(3)    δlnPCPodds/δACA = 0.01 + 1.772*.074 - .163*(.7831 + 0.35*0.074) 
                      = 0.01 +   0.131 – 0.128 – 0.004 = 0.01 -0.001 = 0.009. 
In this calculation, the ACA-related increase on PCP of 7.4 percentage points is completely 
offset by the weakening effect of insurance in leading to a PCP. This suggests that the entire 
expected growth in PCP access from greater coverage was hindered by a combination of newly 
insured individuals failing to access a PCP, and/or previously insured losing their access in the 
post-ACA period, despite retaining coverage. Additional considerations and discussion will 
follow in Chapter 5.  
 
 
 
 
 
 
 
9 Predicted post-ACA insurance rate:  
(1) Convert 0.7831 to odds = [0.7831/0.2169];  
(2) Add pre-ACA odds to post-ACA change in odds (1.66)= exp((ln(5.9926)+ln(1.66))= 0.857.  
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 Specific Aim 2a: Health Care Access by Race 
 Specific Aim 2a. Pre/Post-ACA Health Care Access Odds with ACA-Race 
Interactions. The previous two tables split the ACA effects between the insured and uninsured 
using pre/post ACA*INS interaction term. Single main effects coefficients were used for the 
three race/ethnic groups (with whites in the intercept). This implicitly assumes no differential 
effect of the ACA on race/ethnicity. In this section, this assumption is tested by introducing an 
ACA*Race interaction term in place of the INS interaction. Hypothesis 2a is that the ACA 
policies should increase access to primary health care and narrow disparities for the two minority 
groups, blacks and Hispanics. Insurance coverage is included in the model as the main effect; 
thus, any race-related effects of the ACA would be interpreted as “over-and-above” insurance 
effects. Sensitivity analyses with ACA*INS*Race, ACA*Race and ACA*INS interaction terms 
were included and discussed in Appendix AF. 
Table 53 shows logistic results for models explaining variation in PCP and Checkup 
using main race and ACA interaction variables, along with the post-ACA indicator among other 
variables. When the ACA*Race interaction terms are included, it is apparent that both minority 
groups made gains in having a PCP relative to whites.  
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Table 53.  
Logistic Regression Models for Health Care Access by Race/Ethnicity, using Pre/Post ACA 
Indicator for 47-state Analytic Sample. 
 
Refer to Appendix AE (Table AE-3) for 95% CI’s. 
Probability of Having 
Health Care Access 
(n=1,283,537) 
PCP            
Odds Ratio
95% CI
Checkup                      
Odds Ratio
95% CI
ACA
Pre-ACA Ref Ref
Post-ACA 0.87** (0.85, 0.89) 1.01 (1.00, 1.03)
Race
Whites Ref Ref
Blacks 0.89** (0.85, 0.93) 2.03** (1.94, 2.12)
Hispanics 0.66** (0.63, 0.69) 1.22** (1.17, 1.27)
ACA*Race
ACA*whites Ref Ref
ACA*blacks 1.11** (1.05, 1.18) 0.99 (0.94, 1.05)
ACA*hispanics 1.08* (1.02, 1.14) 0.99 (0.94, 1.04)
Other Variables
Insurance
Uninsured Ref Ref
Insured 5.33** (5.21, 5.46) 3.49** (3.41, 3.57)
Education
Less than HS Ref Ref
HS Grad 1.31** (1.27, 1.36) 1.13** (1.10, 1.17)
Some College 1.49** (1.43, 1.54) 1.10** (1.07, 1.14)
College Grad 1.78** (1.72, 1.85) 1.19** (1.15, 1.22)
Age
18 to 44 Ref Ref
45 to 64 2.39** (2.34, 2.43) 1.57** (1.55, 1.60)
Sex
Male Ref Ref
Female 1.96** (1.92, 1.99) 1.49** (1.47, 1.51)
Diabetes Status
No/Low Risk Ref Ref
High Risk 1.18** (1.17, 1.20) 1.08** (1.06, 1.09)
Diabetes 2.88** (2.74, 3.02) 2.43** (2.34, 2.51)
Chronic Disease
Count 0-5 1.36** (1.33, 1.39) 1.20** (1.18, 1.22)
Self Reported Health
Healthy Ref Ref
Unhealthy 1.03* (1.00, 1.06) 0.98 (0.96, 1.003)
PCP Supply
Adequate Supply Ref Ref
Low Supply 0.81** (0.80, 0.83) 0.98* (0.96, 0.99)
Constant 0.31** (0.30, 0.32) 0.32** (0.30, 0.33)
F Statistic 2686** 1600**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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To gain a better understanding of the key ACA regression effects of having a PCP or 
checkup by race, Table 54 provides a summary of key ACA-related coefficients. Columns 1, 3, 
and 4 were taken directly from Table 53; whereas columns 2 and 5 are calculated as shown 
below.   
Table 54.  
Summary of Pre/Post-ACA Effects on PCP and Checkup by Race/Ethnicity; 47-state Sample.  
 
Two types of ACA effects can be calculated from Table 52:  
1. Post-ACA odds for whites and minorities compared with the pre-ACA period 
2. ACA effects on minorities when compared to whites.  
Post-ACA RACE Odds: 
• Whites: 0.87 
• Blacks: 0.86= EXP((LN(0.89)+LN(0.87)+LN(1.11))),  
• Hispanics: 0.62= EXP((LN(0.66)+LN(0.87)+LN(1.08))) 
COLUMN 1 2 3 4 5
PCP
WHITES 1.00 0.87 - 0.87 0.87
BLACKS 0.89 0.87 1.11 0.86 0.97
HISPANICS 0.66 0.87 1.08 0.62 0.94
CHECKUP
WHITES 1.00 1.01 - 1.01 1.01
BLACKS 2.03 1.01 0.99 2.02 1.00
HISPANICS 1.22 1.01 0.99 1.22 1.00
Notes:
1. Pre-ACA Odds: Table 53, Specfic Aim 2a
2. Post-ACA Coefficient: Table 53, Specific Aim 2a
3. ACA*Race Interaction: Table 53, Specific Aim 2a
4. Post-ACA RACE Odds: Calculation (Exp{ln(preACA) + ln(postACA) + ln(ACA*Race)})
5. ACA MINORITY vs. WHITE EFFECT: Calculation (Exp{ln(postACA)+ ln(ACA*Race)})
ACA MINORITY vs 
WHITE EFFECTRACE GROUPS
PRE-ACA 
ODDS
POST-ACA 
ODDS
ACA*RACE 
ODDS
POST-ACA 
RACE ODDS
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Controlling for insurance and other variables, all three race/ethnic groups experience a 
decline in the likelihood of having a PCP. Such large declines are the result of a decline in the 
efficacy of insurance in increasing PCP access during the four post-ACA years.  
 To drive a net ACA effect (column 6) on the odds of having a PCP or a checkup in the 
past year for the racial groups, the Post-ACA and ACA*RACE coefficients were used: 
ACA MINORITY-WHITE EFFECT:  
• Whites: 0.87 (Reference Group) 
• Blacks: 0.97= EXP((LN(0.87)+LN(1.11))) 
• Hispanics: 0.94= EXP((LN(0.87)+LN(1.08))) 
The ACA*Race interaction terms add 10% to PCP access for blacks relative to whites and 
7% for Hispanics. Of course, the two minority groups were starting at lower pre-ACA PCP rates, 
but closed the gap relative to whites.  
Similar calculations were made for Checkup as an alternative measure of primary care 
access. A statistically insignificant finding for the interaction terms means that there were not 
differences between whites and minorities in receiving a checkup in the past year in the post-
ACA period.   
 Comparing Descriptive Results to Regression Results. For ease of interpretation, in 
Table 55, logistic regression results are compared with earlier descriptive results found in Table 
33. Pre/post PCP and Checkup percentage changes are shown in the data column 3 heading 
“change”. It is clear that blacks and Hispanics saw slight gains (4%, respectively) in having a 
PCP over the ACA period; gains not enjoyed by whites. Any gains, however, may have been due 
to the relative gain insurance coverage for minorities which is not controlled for in the 
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descriptive statistics. Still- Hispanics continued to have low levels of insurance in the post-ACA 
period (59.98%).  
Table 55.  
Comparison of BRFSS Descriptive Results with Regression Results, 47-state Sample.  
 
 Descriptive PCP and Checkup percentages were converted to odds ratios to compare their 
changes to those based on the regression odds.  
Pre-Odds (PCP or Checkup): [Pre (%)/(1-Pre INS %)] 
• Example: Pre-Odds (PCP) for whites = [(0.7818)/(1-0.7818)]= 3.5830 
Post-Odds (PCP or Checkup):  [Post (%)/(1-Post (%)] 
• Example: Post Odds (PCP) for whites= [(0.7800)/(1-0.7800)]= 3.5455.  
The unadjusted, descriptive, odds ratios show that blacks had the largest increase in the 
odds of having a PCP post-ACA; an odds that was 5-percentage points higher than that of 
Hispanics and 17-percentage points higher than whites. Even though whites experienced a slight 
decline in having a PCP, the unadjusted odds of having a Checkup in the past year increased 8%. 
RACE GROUP PRE (%) POST (%) CHANGE
PRE 
(ODDS)
POST 
(ODDS) CHANGE
PRE-REL 
ODDS 
WHITES
PRE-REL 
ODDS
POST-REL 
ODDS CHANGE
COLUMN 1 2 3 4 5 6 7 8 9 10
PCP
WHITES 78.18 78.00 0.9977 3.5830 3.5455 0.9895 1.0000 - - -
BLACKS 72.12 75.00 1.0399 2.5868 3.0000 1.1597 0.7220 0.8900 0.8600 0.9663
HISPANICS 57.54 59.98 1.0424 1.3552 1.4988 1.1060 0.3782 0.6600 0.6200 0.9394
CHECKUP 
WHITES 62.51 64.38 1.0299 1.6674 1.8074 1.0840 1.0000 - - -
BLACKS 73.45 76.10 1.0361 2.7665 3.1841 1.1510 1.6592 2.0300 2.0500 1.0099
HISPANICS 56.97 59.96 1.0525 1.3240 1.4975 1.1311 0.7940 1.2200 1.2300 1.0082
Notes:
1. Descriptive Results Source: Table 33, Percentages of PCP or Checkup by race/ethnic group and time, 47 states
2. Regression Results Source: Table 53 (PCP) and (Checkup), Logistic Regression Models for Specific Aim 2a
DESCRIPTIVE STATISTICS REGRESSION RESULTS
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This gain, however, was 7-percentage points lower than for blacks and 5-percentage points lower 
than for Hispanics.  
Column 7 (Pre-ACA relative odds whites), is the ratio of the odds of a minority group 
having a PCP or a Checkup in the pre-ACA period (Pre-Odds) to that of whites, again, using 
descriptive data. Blacks were 28% less likely to have a PCP when compared with whites pre-
ACA; whereas Hispanics were 62% less likely to have a PCP when compared with whites pre-
ACA. For a checkup, blacks were 34% less likely and Hispanics 62% less likely to have a 
Checkup than whites pre-ACA.  
The descriptive pre-ACA relative odds differ from the pre-ACA relative odds based on 
logistic regression models since they are not adjusted for other factors. Once adjusting for 
demographic, health and state-level factors in the regression models, the gap between minorities 
and whites in having a PCP narrows considerably. Hence, lower minority levels of education, 
insurance coverage, and other factors contribute to lower PCP rates. Still, variables controlled for 
in the regression models do not completely eliminate (or explain) all of the differences. 
Narrowing of the disparity between whites and minorities using regression methods is also 
demonstrated. In fact, whites become even less likely to have a Checkup when compared to 
blacks or Hispanics- and adjusting for other factors in the pre-ACA period.  
 When comparing changes in regression odds, column 10, with changes in descriptive 
odds for PCP, column 6, the positive minority gains from unadjusted data disappear. The only 
variable in the regression model with a strong time trend is insurance coverage, given the way 
the BRFSS sample is drawn and weighted. Thus, while the descriptive data suggest that 
minorities have better access during the ACA period, the regression results indicate that they 
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should have fared even better given large relative gains in insurance coverage. Possibly, many 
newly insured did not have an immediate need for primary care or were not incentive enough in 
the legislation to seek a provider.  
 When adjusting for other factors, the 13-15% increases in the minority odds of having a 
Checkup based on descriptive data disappear. Across all race/ethnicities, the regression-based 
increase in having a Checkup post-ACA is only 1% from the pre-ACA period.   
 From Table 50, the ACA*INS interaction term is statistically significant and from Table 
53, the ACA*Race interaction terms are also statistically significant. A sensitivity analysis was 
conducted by using a more complex logistic regression model that combines the ACA*INS, 
ACA*Race and ACA*INS*Race interaction terms. The three-way interactions indicate that 
blacks and Hispanics show different ACA effects from whites depending on their insurance 
coverage. Blacks were 26-27% more likely to have a PCP over whites in the post-ACA period; 
and Hispanics were 16-22% more likely to have a PCP over whites. Admittedly, the differences 
by insurance status are not great, but the odds ratios are statistically significant by themselves, 
and are therefore included and discussed in more detail in Appendix AF.  
Specific Aim 2a. Annual ACA PCP Odds Ratios with ACA-Race Interactions. In the 
previous regression models, the ACA regression coefficient was averaged over 4 years (2014-
2017). Table 56 highlights post-ACA changes by year and race, which is the focus of this 
section. See Appendix AE for complete regression models. 
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Table 56.  
Summary Table of Logistic Regression Results using Time Dummy Variables (2014-2017) for the 
Likelihood of having a PCP Post-ACA.  
 
In the pre-ACA period, blacks and Hispanics were 11% and 34%, respectively, less likely 
to have a PCP when compared with whites. In 2014, there was a decided downward shift in 
having a PCP (11% for whites). By 2017, the decline had reached 19%. It must be remembered, 
however, that the multivariate model is holding insurance coverage trends constant. Such 
declines indicate a fall in the PCP/INS ratio. Over the 2014 to 2017 period, blacks made gains in 
having a PCP from 10-15%- over that of whites. The gains in PCP between Hispanics and whites 
were fluctuated year by year, but as of 2017, Hispanics were 11% more likely to have a PCP 
over whites. Nevertheless, due to the general decline in the PCP/INS ratio, minority odds of 
having a PCP fell 7% for blacks and 10% for whites.10 The overall pre/post-ACA differences 
have been tested in Table 52.  
 
10 Blacks post-ACA change in own odds by 2017= Pre*(0.81*1.15)= 0.93. Hispanics post-ACA change in own odds by 
2017= Pre*(0.81*1.11)= 0.90.  
2014 2015 2016 2017
POST-ACA YEAR 
(WHITES) 0.89** 0.90** 0.87** 0.81**
RACE GROUP
PRE-ACA 
(2012/13) 2014*RACE 2015*RACE 2016*RACE 2017*RACE
WHITES REF REF REF REF REF
BLACKS 0.89** 1.10* 1.07 1.12* 1.15*
HISPANICS 0.66** 1.03 1.11* 1.07 1.11*
Notes:
1. Regression Coefficients taken from Appendix AE, 47-state sample
2. P value <0.001 (**), P value <0.05 (*)
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  Specific Aim 2a. Annual ACA Checkup Odds Ratios with ACA-Race Interactions. 
Table 57 highlights post-ACA changes for having a checkup by year and race. See Appendix AF 
for complete regression models.   
Table 57.  
Summary Table of Logistic Regression Results using Time Dummy Variables (2014-2017) for 
Likelihood of having a Checkup in the Past Year (Post-ACA).  
 
When compared to the pre-ACA period, whites saw gains of 3-4% in having a checkup, 
with variation in 2015 and 2017, post-ACA. The years 2015 and 2017 were not statistically 
significant, or different, pre-ACA period. In the pre-ACA period, blacks and Hispanics both had 
higher odds of having a checkup in the past year than the white reference group. However, post-
ACA, there was no difference in the odds of having a checkup in the past year between whites 
and blacks, nor whites and Hispanics. 
 Specific Aim 2b: Health Care Access by Race and Expansion Status  
  Specific Aim 2b. Pre/Post-ACA Odds Ratios for PCP Controlling for Expansion 
Status by Race Group. Full regression models were estimated, stratified by race, with the 
addition of the expansion variable (EXP) and an ACA*Expansion interaction term to 
2014 2015 2016 2017
POST-ACA YEAR 
(WHITES) 1.03* 1.00 1.04* 0.98
RACE GROUP
PRE-ACA 
(2012/13) 2014*RACE 2015*RACE 2016*RACE 2017*RACE
WHITES REF REF REF REF REF
BLACKS 2.03** 1.00 0.97 0.98 1.03
HISPANICS 1.22** 1.01 0.99 0.99 0.98
Notes:
1. Regression Coefficients taken from Appendix AF, 47-state sample
2. P value <0.001 (**), P value <0.05 (*)
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differentiate between pre/post differences in expansion groups. Each race/ethnic group model 
was estimated separately rather than using EXP*Race interaction terms. Consequently, 
respondents in each subgroup model are being compared only with others of the same race/ethnic 
background on insurance coverage, education, age, and the like- and not directly with other races 
and ethnicities (although regression coefficients are compared later in this section). See 
Appendix AE for complete models.   
 Table 58 summarizes the key ACA, expansion (EXP) and ACA*EXP interaction terms. 
These terms provide critical information on how PCP levels changed by race and expansion 
groups over the ACA period. Sample sizes differ by 8.6% between blacks and whites and 9.2% 
between Hispanic and whites. Statistical power for minorities, therefore, is only about one-third 
that of whites, as power increases by a square root factor with size.  
Table 58.  
Summary of Pre/Post-ACA Effects of the Likelihood of having a PCP by Race and Expansion 
Status. (Odds Ratios Adjusted for Other Variables).  
 
WHITES BLACKS HISPANICS
VARIABLE
Post-ACA 0.87** 0.90* 0.87*
Expansion 1.15** 1.08 1.09
ACA*EXP 1.01 1.13* 1.11
Constant 0.31** 0.24** 0.19**
F-stat 2159** 417** 505**
N 1048152 121844 113541
Notes:
1. Data abstracted from Table AE-5, (odds of PCP by Race)
2. P value <0.001 (**), P value <0.05 (*)
3. Models adjusted for other variables 
RACE/ETHNICITY
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 The constant term represents the odds ratio for the combined set of reference groups in 
each model. For example, the reference group for whites represents white uninsured adult males 
in good health, aged 18 to 64, with less than a HS education, living within non-expansion states 
with an adequate supply of PCPs in the pre-ACA period. This reference group is represented by 
the constant of 0.31 and shows that this group was not very likely to have a PCP in the pre-ACA 
period. Reference groups for blacks (0.24) or Hispanics (0.19) in the pre-ACA period were even 
lower than for whites.  
 In the post-ACA period, whites and Hispanics were 13% less likely to have a PCP than in 
the pre-ACA period- while blacks were 10% less likely. Whites living in expansion states before 
the ACA legislation was passed were 15% more likely to have a PCP than whites living in non-
expansion states. There was no statistically significant difference for blacks (p=0.135) or 
Hispanics (0.082) in the likelihood of having a PCP in the pre-ACA period by state expansion 
status (although the p values are quite low).  
It’s important to remember that the constant term to underestimates the pre-ACA PCP 
rates and odds ratios for the three races. When an odds ratio is adjusted for using logistic 
regression, there is no longer a shared baseline risk in the constant term as the race/ethnicity 
covariates take on different baseline values (Grant, 2014). However, since pre-ACA PCP rates 
by race/ethnicity are known from Part III, Tables 34 and 35, they can be used to calculate 
average odds ratios for persons living in expansion and non-expansion states by race group 
(Table 59). “Average” (odds) refers to the pre-ACA descriptive odds ratios that exist before any 
adjustments are made for race, income, etc. Then, marginal odds ratios are calculated for the 
post-ACA period. “Marginal” (odds) refers to creating post-ACA odds ratios based on 
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regression-adjusted coefficients and then comparing them with the pre-ACA odds. In an ideal 
setting, mean pre-values for expansion and non-expansion states would be used. 
Pre-ACA. First, the pre-ACA percentages by PCP and expansion status were converted 
to odds ratios using the following formula and rates from Tables 34 and 35:11 
(1) OR-pre= Percent insured/(1-percent insured) 
• Example: OR [Non-expansion, whites, pre-ACA] = 0.7580/(1-0.7518)= 3.132.  
The OR’s in Rows 1 and 2 in Table 59 become the base upon which logistic marginal ACA 
effects are constructed. Rows 1 and 2 are reproduced in Rows 3 and 6 for comparison purposes 
in non-expansion and expansion states separately. 
Post-ACA. Post-ACA ORs, or ACA effects, by expansion status (Rows 4 and 7) were 
calculated using the following formulas:  
 (2) OR[NEXP]-post= exp{(ln(ACA OR) + ln(NEXP-pre)} 
• Example OR [Non-expansion, whites, post-ACA] = exp{ln(0.87) + 
ln(3.132)}= 2.725 
 (3) OR[EXP]-post = exp((ln(ACA OR) + ln(ACA*EXP OR) + ln(EXP-pre)) 
• Example OR [Expansion, whites, post-ACA] =exp{ln(0.87) + ln(3.907) + 
ln(1.01)=3.432. 
 
 
11 An alternative is to multiply mean values for each variable by race, times its corresponding logit coefficient, add 
the logit constant term, and exponentiate the sum.   
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Table 59.  
Conversion of Marginal Odds Ratios for PCP to Average Odds Ratio for PCP in Non-expansion 
and Medicaid Expansion States by Race.  
 
The EXP coefficient is not included in calculating the post-ACA odds ratio, e.g, OR[EXP], 
because its effect is already included in the pre-ACA baseline insurance rate, EXP-pre. Then, 
Rows 5 and 8 show the post-ACA PCP gains over the pre-ACA period.   
 Using known descriptive pre-ACA odds, a decline in the likelihood of having a PCP in 
the post-ACA period occurred in both expansion and non-expansion states, except for blacks 
living within expansion states. Blacks living within expansion states saw about a 2% gain in 
having a PCP post-ACA, even holding insurance and other variables constant. This increase is 
quite modest when compared to the unadjusted probability-to-odds ratios based on percentages 
in Tables 34 and 35 that showed blacks experienced a 27% increase (3.67/2.894; Table 35) in 
the likelihood odds of having a PCP in the post-ACA period. Still, blacks living in expansion 
Row Odds Whites Blacks Hispanics
1 NEXP-pre 3.132 2.321 1.129
2 EXP-pre 3.907 2.894 1.503
3 Pre-ACA 3.132 2.321 1.129
4 Post-ACA 2.725 2.089 0.983
5 Post/Pre 0.870 0.900 0.870
6 Pre-ACA 3.907 2.894 1.503
7 Post-ACA 3.433 2.943 1.452
8 Post/Pre 0.8787 1.017 0.9657
EXPANSION ODDS RATIOS W/ PRE-ACA %PCP ODDS
NEXP
EXP
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states had a regression-adjusted 13% increase (1.017/0.90) in the likelihood of having a PCP, 
over those in non-expansion states. Hispanics experienced an unadjusted 4% increase 
(1.175/1.124; Table 34) in the likelihood of having a PCP in the post-ACA expansion states, but 
once adjusting for other factors, their PCP gain was 11% (0.966/0.87) over non-expansion states.  
Specific Aim 2b. Pre/Post-ACA Odds Ratios for Checkup Controlling for Expansion 
Status by Race Group. Table 60 provides a summary of impacts of the three key ACA and 
expansion variables on having a checkup within one year by race/ethnic group. Refer to 
Appendix AF, Table AF-5 for full regression models.  
Table 60.  
Logistic Regression Odds of having a Checkup in the Past Year by Race and Expansion Status.  
 
 In the post-ACA period, the Checkup odds ratios for Post-ACA and ACA*EXP were 
statistically insignificant among whites, blacks and Hispanics living in expansion and non-
expansion states, when controlling for other variables in the full model (Table 60). Null findings 
for Post-ACA (Table 60) without an ACA*INS interaction term is consistent with the general 
WHITES BLACKS HISPANICS
VARIABLE
Post-ACA 0.99 0.98 1.02
EXPANSION 0.90** 0.91* 0.89*
ACA*EXP 1.03 1.05 1.00
Constant 0.31** 0.75** 0.47**
F-stat 1457** 217** 265**
N 1048152 121844 113541
Notes:
1. Data abstracted from Table AF-5, (odds of Checkup by Race)
2. P value <0.001 (**), P value <0.05 (*)
3. Modesl adjusted for other variables 
RACE/ETHNICITY
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findings that ACA effects worked primarily through expanded coverage. Once coverage is held 
constant, the ACA effect disappears and the Checkup/INS ratio declines.  
As a comparison, the full regression model (Appendix AF, Table AF-3), the Post-ACA 
odds was 1.10 and significant prior to including insurance coverage but did not differ from 1.0 
when controlling for insurance. Post-ACA odds then became significant again (odds=1.11) when 
including an ACA*INS interaction term (odds=0.89). Adjusting for other variables, including 
insurance, whites were still 10% less likely to have a checkup within expansion states, compared 
with whites in non-expansion states. Hispanics were 11% less likely to have a Checkup in 
expansion states than in non-expansion states. Blacks were 9% less likely to have a Checkup in 
expansion states than in non-expansion states.  
Refer to Appendix AF for additional results related to the odds of having a Checkup, 
which was the secondary measure of health care access. For a summary of logistic regression 
results and discussion on additional regression coefficients found in this section, refer to 
Appendix AE.  
 Specific Aim 2: Health Care Access by Diabetes Risk Status   
  Specific Aim 2a. Pre/Post-ACA PCP Odds with ACA-Diabetes Risk Interactions.  In 
this section, an ACA*Diabetes Risk interaction term is used in place of the ACA*Race 
interaction term to determine the differential effect of the ACA on diabetes risk. Hypothesis 2a is 
that the ACA policies should increase access to primary health care, leading to greater gains in 
PCP/Checkup for the high risk for diabetes group. Changes in the high risk for diabetes group is 
the main focus in this section. Again, insurance coverage is included in the model as the main 
effect; thus, any diabetes risk-related effects of the ACA would be interpreted as “over-and-
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above” insurance effects. Sensitivity analyses with ACA*INS*Diabetes Risk, ACA*Diabetes 
Risk and ACA*INS interaction terms were included and discussed in Appendix AG. 
 Table 61 shows logistic results for models explaining variation in PCP and Checkup 
using main diabetes risk and ACA interaction variables, along with the post-ACA indicator 
among other variables. When the ACA*Diabetes Risk interaction terms are included, it is 
apparent that the high-risk group did not experience any statistically significant gains in health 
care access (PCP or Checkup) during the ACA period. 
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Table 61.  
Logistic Regression Models for Health Care Access by Diabetes risk, using Pre/post-ACA 
Indicator; 47-state Analytic Sample. 
 
Refer to Appendices AG (Table AG-1) and AH (Table AH-1) for full regressions and 95% CI’s.  
Probability of Having a 
Health Care Access 
(n=1,283,537) 
PCP       
ODDS RATIO
CHECKUP    
ODDS RATIO
ACA
Pre-ACA Ref Ref
Post-ACA 0.88** 1.01
Diabetes Status
No/Low Risk Ref Ref
High Risk 1.16** 1.08**
Diabetes 2.56** 2.28**
ACA*Diabetes Risk
ACA*no/low risk Ref Ref
ACA*high risk 1.02 1.00
ACA*diabetes 1.20** 1.10*
Insurance
Uninsured Ref Ref
Insured 5.33** 3.49**
Other Variables
Race
Whites Ref Ref
Blacks 0.95* 2.02**
Hispanics 0.69** 1.21**
Education
Less than HS Ref Ref
HS Grad 1.31** 1.13**
Some College 1.49** 1.10**
College Grad 1.78** 1.19**
Age
18 to 44 Ref Ref
45 to 64 2.39** 1.57**
Sex
Male Ref Ref
Female 1.96** 1.49**
Chronic Disease
Count 0-5 1.36** 1.20**
Self Reported Health
Healthy Ref Ref
Unhealthy 1.03* 0.98
PCP Supply
Adequate Supply Ref Ref
Low Supply 0.81** 0.98*
Constant 0.31** 0.32**
F Statistic 2687** 1598**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models
4. Values indicate odds ratios
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 Table 62 is a summary of key ACA regression coefficients. Columns 1, 3 and 4 were 
taken directly from Table 61; whereas columns 2 and 5 are calculated as shown below:  
Table 62.  
Specific Aim 2a Summary Table of ACA Effects on PCP and Checkup by Diabetes Risk Status for 
the 47-state Sample.  
 
Two types of ACA effects can be calculated from Table 62:  
1. Post-ACA odds by diabetes risk compared with the pre-ACA period 
2. ACA effects on individuals at high risk or with diabetes when compared to those at no or 
low risk for diabetes. 
  Post-ACA Diabetes Risk Odds: 
• No/Low Risk: 0.88 
• High Risk: 1.04= EXP((LN(1.16)+LN(0.88)+LN(1.02))),  
• Diabetes: 2.70= EXP((LN(2.56)+LN(0.88)+LN(1.20))) 
COLUMN 1 2 3 4 5
PCP
NO/LOW RISK 1.00 0.88 - 0.88 0.88
HIGH RISK 1.16 0.88 1.02 1.04 0.90
DIABETES  2.56 0.88 1.20 2.70 1.06
CHECKUP
NO/LOW RISK 1.00 1.01 - 1.01 1.01
HIGH RISK 1.08 1.01 1.00 1.09 1.10
DIABETES 2.28 1.01 1.10 2.53 2.56
Notes:
1. Pre-ACA Odds: Table 61, Specfic Aim 2a
2. Post-ACA Coefficient: Table 61, Specific Aim 2a
3. ACA*Diabetes Risk Interaction: Table 61, Specific Aim 2a
4. Post-ACA Diabetes Risk Odds: Calculation (Exp{ln(preACA) + ln(postACA) + ln(ACA*Diabetes Risk)})
5. ACA RISK vs. NO RISK EFFECT: Calculation (Exp{ln(postACA)+ ln(ACA*Diabetes Risk)})
ACA RISK vs NO 
RISK EFFECTRACE GROUPS
PRE-ACA 
ODDS
POST-ACA 
ODDS
ACA*RISK 
ODDS
POST-ACA RISK 
ODDS
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Controlling for insurance and other variables, differences in the uptake of a PCP in the post-
ACA period are apparent. The no/low risk had a decline in the odds of having a PCP in the post-
ACA period; however, saw a 1% increase in checkups.  High-risk individuals experienced a 4% 
increase in the odds of having a PCP post-ACA. Individuals who reported diabetes saw the 
greatest gains in having a PCP and/or Checkup in the post-ACA period. 
To derive a net ACA effect (column 6) on the odds of having a PCP or a Checkup in the past 
year for the diabetes risk groups, the Post-ACA and ACA*Diabetes Risk coefficients were used:   
ACA RISK-NO RISK EFFECT: 
• No/Low Risk: 0.88 (Reference Group) 
• High-Risk: 0.90= EXP((LN(0.88)+LN(1.04))) 
• Diabetes: 1.06= EXP((LN(0.88)+LN(2.70))) 
The ACA*Diabetes Risk interaction terms add 2% to PCP access for the high-risk group 
relative to the no/low risk group and 18% for individuals with reported diabetes.  
Similar calculations were made for Checkup as an alternative measure of primary care 
access. A statistically insignificant finding for the high-risk interaction terms means that there 
were not differences between those at high-risk and no risk in receiving a checkup in the past 
year post-ACA.  
 Comparing Descriptive Results to Regression Results. Earlier descriptive results found 
in Table 38 are compared with logistic regression results for PCP and Checkup in Table 63. 
Pre/post PCP and Checkup percentage changes are shown in column 3.   
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Table 63.  
Comparison of BRFSS Descriptive Results with Regression Results, 47-state Sample.  
 
 Descriptive PCP and Checkup percentages were converted to odds ratios to compare their 
changes to those based on the regression odds.  
 Pre-Odds (PCP or Checkup): [Pre (%)/(1-Pre (%)] 
• Example: Pre-Odds (PCP) for no/low risk= [(0.7186)/(1-0.7186)]=2.5537  
Post-Odds (PCP or Checkup): [Post (%)/(1-Post (%)] 
• Example: Post-Odds (PCP) for no/low risk= [(0.7204)/(1-0.7204)]=2.5765 
The unadjusted, descriptive, odds ratios show that individuals who reported diabetes had the 
largest increase in the odds of having a PCP or Checkup post-ACA. The odds of having a PCP 
for the diabetes group was 22- percentage points higher than those at high risk for diabetes, and 
26-percentage points higher than those at no/low risk for diabetes. The odds of having a checkup 
in the past year for the diabetes group was 13-percentage points higher than for those at high 
risk, and 14-percentage points higher for those at no/low risk.  
DIABETES RISK PRE (%) POST (%) CHANGE
PRE 
(ODDS)
POST 
(ODDS) CHANGE
PRE-REL 
ODDS LOW 
RISK
PRE-REL 
ODDS
POST-REL 
ODDS CHANGE
COLUMN 1 2 3 4 5 6 7 8 9 10
PCP
NO/LOW RISK 71.86 72.04 1.0025 2.5537 2.5765 1.0090 1.0000 - - -
HIGH RISK 73.22 74.21 1.0135 2.7341 2.8775 1.0524 1.0707 1.1600 1.0412 0.8976
DIABETES  88.49 90.69 1.0249 7.6881 9.7411 1.2670 3.0106 2.5600 2.7034 1.0560
CHECKUP 
NO/LOW RISK 60.68 62.63 1.0321 1.5432 1.6759 1.0860 1.0000 - - -
HIGH RISK 62.81 65.01 1.0350 1.6889 1.8580 1.1001 1.0944 1.0800 1.0908 1.0100
DIABETES 81.12 84.11 1.0369 4.2966 5.2933 1.2320 2.7842 2.2800 2.5331 1.1110
Notes:
1. Descriptive Results Source: Table 36, Percentages of PCP or Checkup by diabetes risk and time, 47 states
2. Regression Results Source: Table 61, Logistic Regression Models for Specific Aim 2a
DESCRIPTIVE STATISTICS REGRESSION RESULTS
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Column 7 (Pre-ACA relative odds risk), is the ratio of the odds of a high risk or individual 
with diabetes having a PCP or a Checkup in the pre-ACA period (Pre-Odds) to that of the no/low 
risk group, using descriptive data. The high-risk group was 7% more likely to have a PCP than 
the no/low risk group; whereas the diabetes group was 3.01-times more likely to have a PCP than 
the no/low risk group. For checkup, the high-risk group was 9% more likely and the diabetes 
group was 2.78-times more likely to have a checkup in the past year than the no/low risk for 
diabetes group.  
As discussed in the previous section based on race, the descriptive pre-ACA relative odds 
differ from the regression pre-ACA relative odds since they are unadjusted for other factors. 
Once adjusted, the gap in having a PCP between the high-risk and no/low risk widens, but 
narrows considerably between the diabetes group and the no/low risk group.  
When comparing changes in regression odds, column 10, with changes in descriptive odds 
for PCP, column 6, the positive gains experienced by the high-risk group (in the unadjusted data) 
for having a PCP or checkup disappear. The diabetes group did experience gains in PCP and 
Checkup, but at a lesser degree. For example, the unadjusted data showed a 27% increase in 
having a PCP in the post-ACA period, whereas the regression results showed a 6% increase, 
when adjusting for other factors. The high-risk group experienced an adjusted 10% decline in 
having a PCP in the post-ACA period.  
From Table 50, the ACA*INS interaction term is statistically significant and from Table 61, 
the ACA*high risk interaction term is not statistically significant. A sensitivity analysis was 
conducted by using a more complex logistic regression model that combines the ACA*INS, 
ACA*Risk and ACA*INS*Risk interaction terms. The three-way interactions indicate that high 
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risk individuals had different ACA effects from the no/low risk group that were statistically 
significant, unlike in Model 4, Table 50. The high-risk group was found to be 10-11% more 
likely (p<0.05) to have a PCP in the post-ACA period when compared to the no/low risk group. 
A detailed discussion of the complex regression analysis can be found in Appendix AG. 
  Specific Aim 2a. Annual ACA PCP Odds Ratios with ACA-Diabetes Risk 
Interactions. In the previous regression models, the ACA regression coefficient was averaged 
over 4 years (2014-2017). Table 64 highlights post-ACA changes by year and diabetes risk, 
which is the focus of this section. See Appendix AG for complete regression models.  
Table 64.  
Summary Table of Logistic Regression Results using Time Dummy Variables (2014-2017) for 
Likelihood of having a PCP in the Past Year (Post-ACA).  
 
 In the pre-ACA period, both the high risk and diabetes groups were more likely to have a 
PCP when compared with the no/low risk group; however, had a much higher odds (2.56) than 
the high-risk group (1.16). In 2014, there was a downward shift in having a PCP (10% for the 
no/low risk group). By 2017, the decline reached 16%. Over the 2014 to 2017 period, the high-
risk group made gains in having a PCP from 2-5% over that of the no/low risk group, but it was 
not statistically significant. The diabetes group made PCP gains from 10 to 29% over that of the 
2014 2015 2016 2017
POST-ACA YEAR 
(NO/LOW RISK) 0.90** 0.92** 0.87** 0.84**
DIABETES RISK
PRE-ACA 
(2012/13) 2014*RISK 2015*RISK 2016*RISK 2017*RISK
NO/LOW RISK REF REF REF REF REF
HIGH RISK 1.16** 1.02 1.00 1.05 1.02
DIABETES 2.56** 1.10 1.21* 1.22* 1.29*
Note(s):
1. P value <0.001 (**), P value <0.05 (*)
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no/low risk group. By 2017, the likelihood of having a PCP for the high-risk group was 18% 
over the no/low risk group, and 3.30-times for the diabetes group12. 
  Specific Aim 2a. Annual ACA Checkup Odds Ratios with ACA-Diabetes Risk 
Interactions. Table 65 highlights post-ACA changes for having a checkup by year and diabetes 
risk status. See Appendix AG for complete regression models.  
Table 65.  
Summary Table of Logistic Regression Results using Time Dummy Variables (2014-2017) for the 
Likelihood of having a Checkup Post-ACA.  
 
 When compared to the pre-ACA period, the no/low risk group saw a decline of 6% in 
having a checkup in the past year, from 2014 to 2017. The years 2015 and 2016 were not 
statistically significant, or different, from the pre-ACA period. Pre-ACA, individuals at high risk 
or with reported diabetes had higher odds of having a checkup than the reference group, with 
individuals with diabetes being 2.28-times more likely to have a checkup. However, post-ACA, 
there was no difference in the odds of having a checkup in the past year between those at no/low 
 
12 The high-risk post-ACA change in own odds by 2017= Pre*(1.16*1.02)= 1.18. Diabetes post-ACA change in own 
odds by 2017= Pre*(2.56*1.29)= 3.30. 
2014 2015 2016 2017
POST-ACA YEAR 
(NO/LOW RISK) 1.03* 1.00 1.02 0.97*
DIABETES RISK
PRE-ACA 
(2012/13) 2014*RISK 2015*RISK 2016*RISK 2017*RISK
NO/LOW RISK REF REF REF REF REF
HIGH RISK 1.08** 0.99 0.98 1.01 1.02
DIABETES 2.28** 1.06 1.11* 1.12* 1.10
Note(s):
1. P value <0.001 (**), P value <0.05 (*)
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risk and those at high risk for diabetes. Post-ACA, individuals with reported diabetes were 11-
12% more likely to have a checkup from 2015-2016, when compared to those at no/low risk. 
 Specific Aim 2b. Health Care Access by Diabetes Risk and Expansion Status  
  Specific Aim 2b. Pre/Post-ACA Odds Ratios for PCP Controlling for Expansion 
Status and Diabetes Risk Group.  Full regression models were estimated, stratified by diabetes 
risk, with the addition of the expansion variable (EXP) and an ACA*Expansion interaction term 
to differentiate between pre/post differences in expansion groups. Each diabetes risk group 
model was estimated separately rather than using EXP*Diabetes Risk interaction terms. As a 
result, respondents in each subgroup model are compared only with others of the same diabetes 
risk group and not directly with other diabetes risk conditions (although regression coefficients 
are compared later in this section). See Appendix AG for complete models.  
 Table 66 summarizes key ACA, expansion (EXP) and ACA*EXP interaction terms. 
These terms provide critical information on how PCP levels changed by diabetes risk status and 
expansion groups over the ACA period. Sample sizes differ by 34.71% between the high risk and 
no/low risk groups, and 9.07% between the diabetes and no/low risk groups. The main group of 
interest in this analysis is the high-risk group which is about two-thirds the size of the no/low 
risk group. The diabetes group is included to provide context, but are not the main focus.  
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Table 66.  
Summary of Pre/Post-ACA Effects of having a PCP by Diabetes Risk and Expansion Status.  
 
Refer to Appendix AG for full models.  
 The constant term represents the odds ratio for the combined set of reference groups in 
each model. For example, the reference group for the no/low risk represents uninsured white 
adult males in good health, aged 18 to 64, with less than a HS education, living within non-
expansion states with an adequate supply of PCPs in the pre-ACA period. This reference group is 
represented by the constant of 0.27 and shows that his group was not very likely to have a PCP in 
the pre-ACA period. Reference groups for the high risk (0.31) and diabetes (1.05) were higher 
than the no/low risk group.  
 In the post-ACA period, the no/low and high-risk groups had the same likelihood of 
having a PCP, when compared to the pre-ACA period. The no/low risk group in expansion states 
was 14% more likely to have a PCP than the same group in non-expansion states. The high-risk 
group in expansion states was 12% more likely to have a PCP than the same group in non-
expansion states. However, the ACA*EXP interaction term was not statistically significant 
NO/LOW HIGH DIABETES
VARIABLE
Post-ACA 0.87** 0.87** 0.99
Expansion 1.14** 1.12** 1.06
ACA*EXP 1.03 1.06 1.11
Constant 0.27** 0.31** 1.05
F-stat 1707** 1128** 163**
N 721552 445547 116438
Notes:
1. Data abstracted from Table AG-3, (odds of PCP by Diabetes Risk)
2. All models adjusted for other variables
3. P value <0.001 (**), P value <0.05 (*)
DIABETES RISK
229 
 
(using standard p<0.05) for any of diabetes risk groups, meaning there was no difference in the 
likelihood of having a PCP between expansion post-ACA for the diabetes risk subgroups. The 
no/low risk p value=0.184; the high-risk p value=0.071; and the diabetes p value=0.286. 
Considering that the p value for the high-risk is quite low and close to the standard cutoff of 
p<0.05, for policy implications, this finding is considered significant.  
 The constant term in these models underestimates the pre-ACA PCP rates and odds ratios 
for the three diabetes risk groups. Since the pre-ACA rates by diabetes risk are known from Part 
III, Tables 39 and 40, they can be used to calculate average odds ratios for persons living in 
expansion and non-expansion states by diabetes risk group (Table 67). “Average” (odds) refers 
to the pre-ACA descriptive odds ratios that exist before any adjustments are made for race, 
income, etc. Then, marginal odds ratios are calculated for the post-ACA period. “Marginal” 
(odds) refers to creating post-ACA odds ratios based on regression-adjusted coefficients and then 
comparing them with the pre-ACA odds. In an ideal setting, mean pre-values for expansion and 
non-expansion states would be used. 
Pre-ACA. First, the pre-ACA percentages by diabetes risk and expansion status were 
converted to PCP odds ratios using the following formula and rates from Tables 39 and 40:13 
(1) OR-pre= Percent insured/(1-percent insured) 
• Example: OR [Non-expansion, no/low risk, pre-ACA] = 0.6886/(1-0.6886)= 
2.211.  
 
13 An alternative is to multiply mean values for each variable by race, times its corresponding logit coefficient, add 
the logit constant term, and exponentiate the sum.   
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The OR’s in Rows 1 and 2 in Table 67 become the base upon which logistic marginal ACA 
effects are constructed. Rows 1 and 2 are reproduced in Rows 3 and 6 for comparison purposes 
in non-expansion and expansion states separately. 
Post-ACA. Post-ACA ORs, or ACA effects, by expansion status (Rows 4 and 7) were 
calculated using the following formulas:  
 (2) OR[NEXP]-post= exp{(ln(ACA OR) + ln(NEXP-pre)} 
• Example OR [Non-expansion, no/low risk, post-ACA] = exp{ln(2.211) + 
ln(0.87)}= 1.924 
 (3) OR[EXP]-post = exp((ln(ACA OR) + ln(ACA*EXP OR) + ln(EXP-pre)) 
• Example OR [Expansion, no/low risk, post-ACA] =exp{ln(2.801) + ln(0.87) + 
ln(1.14)=2.778. 
The EXP coefficient is not included in calculating the post-ACA odds ratio, e.g, OR[EXP], 
because its effect is already included in the pre-ACA baseline insurance rate, EXP-pre. Then, 
Rows 5 and 8 show the post-ACA PCP gains over the pre-ACA period.    
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Table 67.  
Conversion of Marginal Odds Ratios for PCP to Average Odds Ratio for PCP in Non-expansion 
and Expansion States by Diabetes Risk.  
 
 Using known descriptive pre-ACA odds, a decline in the likelihood of having a PCP in 
the post-ACA period occurred in both expansion and non-expansion states, except for 
individuals with diabetes living within expansion states. Individuals with diabetes saw about a 
5% gain in having a PCP post-ACA, holding insurance and other variables constant.  
The high-risk for diabetes group, which is the subgroup of interest, had an unadjusted 
10% increase (3.31/3.00, Table 36) in the likelihood of having a PCP within expansion states 
and no change in the pre/post-ACA period in non-expansion states. The regression-adjusted 
increase in the likelihood of having a PCP was 12% (0.9744/0.870, Table 67) over those living 
in non-expansion states. Interestingly, the no/low risk group saw a regression-adjusted increase 
Row Odds Low Risk High Risk Diabets
1 NEXP-pre 2.211 1.711 4.328
2 EXP-pre 2.801 3.002 8.425
3 Pre-ACA 2.211 1.711 4.328
4 Post-ACA 1.924 1.488 4.284
5 Post/Pre 0.870 0.870 0.990
6 Pre-ACA 2.801 3.002 8.425
7 Post-ACA 2.778 2.925 8.841
8 Post/Pre 0.9918 0.9744 1.0494
EXP ODDS RATIOS W/ PRE-ACA %PCP ODDS
Non-EXP
EXP
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in the likelihood of having a PCP (14%), over those living in non-expansion states and was 
higher than the percentage for the high-risk group. 
  Specific Aim 2b. Pre/Post-ACA Odds Ratios for Checkup Controlling for 
Expansion Status by Diabetes Risk Group. Table 68 providers a summary of three key ACA 
and expansion variables on having a checkup within the past year by diabetes risk group.  
Table 68.  
Logistic Regression of the Odds of having a Checkup in the Past Year by Diabetes Risk and 
Expansion Status.  
 
 In the post-ACA period, the Checkup odds ratios for Post-ACA and ACA*EXP were 
statistically insignificant among the no/low risk, high-risk and diabetes groups living in 
expansion and non-expansion states, when controlling for other variables in the full model. The 
null findings for post-ACA are consistent with the general findings that ACA effects worked 
primarily through expanded coverage. Once coverage is held constant, the ACA effect 
disappears and the Checkup/INS ratio declines.  
NO/LOW HIGH DIABETES
VARIABLE
Post-ACA 0.99 0.99 1.07
Expansion 0.89** 0.91** 0.89
ACA*EXP 1.02 1.02 1.04
Constant 0.33** 0.36** 1.25*
F-stat 899** 662** 1.01**
N 721552 445547 116438
Notes:
1. Data abstracted from Table AH-3, (odds of Checkup by Diabetes Risk)
2. All models adjusted for other variables
3. P value <0.001 (**), P value <0.05 (*)
DIABETES RISK
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 After adjusting for other variables, including insurance, the no/low risk were 11% less 
likely to have a checkup in expansion states, with the high-risk being 9% less likely to have a 
checkup in expansion states, when compared to non-expansion states- mainly due to the rising 
insurance rates.  
Refer to Appendix AH for additional results related to the odds of having a Checkup, 
which was the secondary measure of health care access.  
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NAMCS Results 
 This section consists of four parts. Part I includes annual pre/post-ACA changes for 
independent and outcome variables. Part II includes concatenated data for independent and 
outcome variables to distinguish between non-expansion and Medicaid expansion states. Part III 
includes stratified outcome variables by race, then by diabetes risk status for the full sample, and 
by expansion status. Part IV consists of multivariate logistic regression results on the likelihood 
of having diabetes screening and diabetes prevention education. Sensitivity analysis using only 
2014 data in the post-ACA period was done to compare changes in diabetes screening rates 
(Appendix AI). All results used sample-weighted data. Data weights were provided by NAMCS: 
PHYCODE [pweight=PATWTST], stata(CSTRATUM) singleunit(scaled). Single sampling 
units were handled the same way as with the BRFSS analysis (Appendix X).  
NAMCS Analytic Sample Pre/Post ACA Descriptive Statistics  
Analytic NAMCS Sample 
The sampling unit in NAMCS is the physician-patient visit, which includes only visits to 
non-federally employed physicians classified by the AMA and AOA. Although, non-physician 
clinicians (i.e. physician assistants and advanced practice nurses) who work within Community 
Health Centers (CHCs) were eligible to participate in NAMCS data collection (Centers for 
Disease Control and Prevention, 2015). Office visit settings include: private practice, group 
practice, health maintenance organizations (HMOs), freestanding clinics, urgicenters, non-
federal government clinics, CHCs, family planning clinics and faculty practice plans (Lau, 
McCaig, Hing, 2016). The total sample sizes for NAMCS years 2012 to 2015 are shown in 
Table 69 below. 
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Table 69  
Change in NAMCS Full and Analytic Unweighted Sample Sizes (2012-2015).  
 
There was a steady decline in the sample size from 2012 to 2015 as the number of state-
based estimates decreased each year in accordance with funding availability. In fact, preventive 
care visits fell by 22% pre to post-ACA (Table 69). In 2012, 34 of the most populous states were 
included; 22 by 2013; 18 by 2014; and 16 by 2015 (Centers for Disease Control and Prevention, 
2019). To maintain consistent sample sizes over time, only 15 states (Massachusetts excluded) 
were included in the analytic file. The unweighted pre-ACA analytic sample is 4% of the full 
NAMCS dataset; whereas the post-ACA sample is 5% of the full dataset when only keeping 
visits coded as preventive care for individuals aged 18-64 who were white, black or Hispanic 
living in one of 15 states.   
As of 2008, 51.3% of the 956 million office visits were to primary care physicians, 
resulting in 490,428,000 primary care visits in the U.S (Agency for Healthcare Research and 
Quality, 2011.). In Table 70, the weighted sample from 2012 represents 61,547,461 preventive 
care visits in 15 states, representing about 12.5% of the national estimated sample.  
Demographic Variables 
Refer to Table 70 for data on key demographic variables in this NAMCS analysis.  
2012 2013 2014 2015 Pre-ACA Post-ACA
Full 76,330 54,873 45,710 28,332 131,203 74,042
Analytic 2,634 2,415 2,191 1,734 5,049 3,925
Note. NAMCS reduced the number of states surveyed over time. The 
analytic sample contains only white, black or Hispanics aged 18-64 
who visited a provider for a preventive care visit from 2012-2015. Pre-
ACA is 2012-2013; Post-ACA is 2014-2015.  
236 
 
Table 70.  
Change in Demographic Characteristics of Individuals Receiving Preventive Care within 15-
State Sample (2012-2015).   
 
 
  Race/Ethnicity. A greater proportion of white adults received a preventive care visit 
over time, despite a decline of 6.37% by the post-ACA period. Blacks and Hispanics both saw 
gains in their share of preventive clinic visits, with Hispanics experiencing a 17% increase by the 
post-ACA period. Differences in the number of preventive care visits pre vs. post-ACA by race 
were not statistically significant (p=0.5274).  
  Age. The 18 to 34 age group had the greatest proportion of individuals who received a 
preventive care visit (40%, pre-ACA). The rate for individuals aged 35 to 64 was between 18 to 
21% in the pre-ACA period. Declines in preventive clinic visits in the post-ACA period were 
seen in the 18 to 34 age group (-7.89%) and the 45 to 54 (-1.92%). The pre-Medicare group saw 
the greatest increases in preventive care visits in the post-ACA period (11.19%).  Differences in 
preventive care visits pre vs. post-ACA by age group were not statistically significant 
(p=0.5530).  
Change (%) Chi Square
Sample Size (unweighted) 2,634 2,415 2,191 1,734 5,049 3,925
Preventive Visits (weighted) 61,547,461 60,245,157 51,194,211 66,143,533 121,792,619 117,337,744
Preventive Visits, mean - - - - 60,896,310 58,668,872
2012 2013 2014 2015 Pre-ACA Post-ACA (Post/Pre) P value
Race/Ethnicity 0.5274
Whites 67.43 70.11 70.09 59.95 68.75 64.37 -6.37%
Blacks 10.58 13.99 11.66 14.68 12.27 13.37 8.96%
Hispanics 21.99 15.90 18.25 25.37 18.98 22.26 17.28%
Age 0.5530
18 to 34 38.55 41.81 34.44 38.96 40.16 36.99 -7.89%
35 to 44 19.24 15.92 18.97 18.73 17.60 18.84 7.05%
45 to 54 22.02 20.63 21.57 20.43 21.33 20.92 -1.92%
55 to 64 20.20 21.63 25.03 21.87 20.91 23.25 11.19%
Gender 0.8104
Male 28.79 26.60 32.79 25.01 27.71 28.41 2.53%
Female 71.21 73.40 67.21 74.99 72.29 71.59 -0.97%
*p<0.05. **p<0.01. ***p<0.001
ANNUAL Pre/Post ACA
Note. Sample includes all white, black and Hispanic adults aged 18-64 who received a preventive care visit in 15 states. Chi-square calculated for 
pre-vs. post-ACA differences for each variable. Pre-ACA includes 2012-2013; Post-ACA includes 2014-2015. Survey weighted data. 
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  Gender. There was greater representation of women receiving a preventive care clinic 
visit during the 2012-2015 period (67-75%) than men (25-33%). There was a slight increase in 
the number of men receiving a preventive care visit post-ACA (2.5%) and about a 1% decrease 
in the number of women receiving a preventive are visit post-ACA. Differences in preventive 
care visits pre vs. post-ACA by sex were not statistically significant (p=0.8104).  
  Health Status Data. Table 71 displays results on health status variables for the NAMCS 
analytic sample.  
Table 71 
Change in Health Status Characteristics of Individuals Receiving Preventive Care in 15-State 
Sample (2012-2015).  
 
  Diabetes Risk Status. Most of the individuals seen for preventive care services had an 
unknown diabetes risk status since their BMI’s were missing or incalculable (32-41%) from 
2012-2015. To gain a better understanding of the demographics of those in the “unknown” 
category, additional descriptive statistics were run (Appendix AI). By the post-ACA period, the 
Change (%) Chi Square
Sample Size (unweighted) 2,634 2,415 2,191 1,734 5,049 3,925
Preventive Visits (weighted) 61,547,461 60,245,157 51,194,211 66,143,533 121,792,619 117,337,744
Preventive Visits, mean - - - - 60,896,310 58,668,872
2012 2013 2014 2015 Pre-ACA Post-ACA (Post/Pre) P value
Diabetes Risk Status
a
0.0896
No/low risk 16.23 16.82 18.09 16.52 16.52 17.21 4.18%
High Risk 36.03 35.95 41.87 40.77 35.99 41.25 14.62%
Diabetes   6.40 6.07 7.71 7.56 6.24 7.63 22.28%
Unknown 41.33 41.16 32.33 35.14 41.25 33.91 -17.79%
Chronic Disease
b
0.2137
No chronic disease 86.57 85.87 82.67 82.67 86.22 83.56 -3.09%
At least 1 chronic disease 13.43 14.13 17.33 17.33 13.78 16.44 19.30%
*p<0.05. **p<0.01. ***p<0.001
ANNUAL Pre/Post ACA
Note. Sample includes all white, black and Hispanic adults aged 18-64 who received a preventive care visit in 15 states. Chi-square calculated for 
pre-vs. post-ACA differences for each variable. Pre-ACA includes 2012-2013; Post-ACA includes 2014-2015. Survey weighted data.
a
Diabetes Risk Status defined as: No/low-risk (BMI< 25 and no diagnosis of obesity or diabetes); High-risk (BMI=> 25 and <30 and no diagnosis 
of diabetes, or a obesity diagnosis); Diabetes (diabetes diagnosis); Unknown (BMI not available and no diagnosis of obesity or diabetes). 
b
Chronic disease included a diagnosis at least 1 of the following conditions: asthma, stroke, COPD, depression, CAD or CHF. 
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“unknown” group had disproportionately more Hispanic visits than the other diabetes risk groups 
(30%), with non-expansion states having the most visits by Hispanic patients who were 
categorized as “unknown” risk (40%). The 18 to 34 age group made up 60% of the preventive 
care visits that were categorized as “unknown” risk, with the proportion rising to 66% for this 
age group in non-expansion states. Women made up 83% of the unknown risk group with about 
27% being Medicaid recipients overall, with 35% being Medicaid recipients within non-
expansion states.  
Overall, there was a decline of almost 18% in the unknown risk group post-ACA, with 
increases seen for the low risk for diabetes group (4%), high risk for diabetes (15%) and diabetes 
(22%) groups in having a preventive care clinic visit. For preventive care visits with reported 
diabetes risk, 62.42% were high-risk, 26.04% were no/low risk and 11.54% had diabetes in the 
post-ACA period. By the post-ACA period, the high-risk group made up the largest proportion of 
preventive care visits, even when those with unknown diabetes risk (41% of visits) were 
included. Differences in the number of preventive care visits pre vs. post-ACA by diabetes risk 
status was not statistically significant (p=0.0896).  
  Chronic Disease Count.  A majority of patient’s seen did not have a chronic disease 
(83-87%), but preventive care visits by patients with chronic disease increased by 19.3% post-
ACA. In the post-ACA period, there was a small decline (3%) in preventive visits for individuals 
with no chronic disease. Differences in preventive care visits pre vs. post-ACA by chronic 
disease status were not statistically significant. 
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  State ACA Expansion Status & Insurance Coverage. Refer to Table 72 for the 
number of preventive care visits within non-expansion and Medicaid expansion states and the 
type of payment received for the visit over time.  
Table 72 
Change in Expansion Status and Payment Method for Preventive Care Visits in 15-State Sample 
(2012-2015). 
 
  Expansion Status. Expansion states were classified as states that expanded Medicaid by 
2015 (Figure 11). Refer to Appendix U for a list of Medicaid expansion and non-expansion 
dates of expansion.   Most (61-63%) of the preventive care visits occurred within Medicaid 
expansion states. An increase of almost 2% in preventive care visits occurred post-ACA. 
Differences in preventive care visits pre vs. post-ACA by expansion status were not statistically 
significant (p=0.8403). It is important to note that non-expansion and expansion groups grossly 
underestimate the total number of states within each group as shown in the state map in Figure 
11 and does not cover many of the states that are known to be rural or have high proportions of 
low-income adults.  
Change (%) Chi Square
Sample Size (unweighted) 2,634 2,415 2,191 1,734 5,049 3,925
Preventive Visits (weighted) 61,547,461 60,245,157 51,194,211 66,143,533 121,792,619 117,337,744
Preventive Visits, mean - - - - 60,896,310 58,668,872
2012 2013 2014 2015 Pre-ACA Post-ACA (Post/Pre) P value
Medicaid Expansion Status
a
0.8403
Non-expansion 38.59 39.12 37.24 38.42 38.85 37.91 -2.42%
Expansion 61.41 60.88 62.76 61.58 61.15 62.09 1.54%
Insurance Status 0.7571
Private 69.87 68.89 70.93 59.56 69.39 64.52 -7.02%
Medicaid  12.99 14.23 11.49 20.15 13.60 16.37 20.37%
Medicare 3.76 4.02 3.87 4.79 3.89 4.39 12.85%
Self Pay 4.04 4.55 6.31 2.93 4.30 4.41 2.56%
Other 9.34 8.31 7.40 12.57 8.83 10.31 16.76%
*p<0.05. **p<0.01. ***p<0.001
ANNUAL Pre/Post ACA
Note. Sample includes all white, black and Hispanic adults aged 18-64 who received a preventive care visit in 15 states. Chi-square calculated for 
pre-vs. post-ACA differences for each variable. Pre-ACA includes 2012-2013; Post-ACA includes 2014-2015. Survey weighted data.
a
Non-expansion includes 5 states and Medicaid expansion includes 10 states that expanded as of 2015.
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Figure 11. Map of Non-expansion vs. Medicaid Expansion States as of 2015. Purple states 
include Medicaid expansion states as of 2015.  
In Figure 11, Yellow states are non-expansion states that never expanded Medicaid. 
Massachusetts was originally in the sample but was removed due to expanding Medicaid above 
138% FPL in the pre-ACA period. 
  Insurance Status. In the pre-ACA period, private insurance accounted for almost 3/4th 
of the payment type for preventive care visits. This payment method decreased by 7% in the 
post-ACA period. Interestingly, Medicaid saw a 20% (p=0.5047) increase in the payment type 
for clinic visits in the post-ACA period, followed by Medicare (13%). The “other” insurance 
type included workers compensation, no charge, other and unknown payment types.  
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 Outcome Variables  
  Diabetes Screening. Diabetes screening was measured as a blood glucose or HgA1c 
performed during the preventive care clinic visit. Diabetes screening increased in the post-ACA 
period by 1.53%, although not statistically significant (Table 73).  
  Diabetes Prevention Education.  Diabetes prevention education (DPE) included 
receiving at one form of teaching within the clinical setting on diet/nutrition, exercise or weight 
reduction. DPE increased by 48.86% (p<0.05) in the post-ACA period (Table 73).  
Table 73 
Change in Diabetes Screening and Prevention Education for Preventive Care Visits in 15-state 
sample (2012-2015).  
  
 
 
 
 
 
 
 
 
 
Change (%) Chi Square
Sample Size (unweighted) 2,634 2,415 2,191 1,734 5,049 3,925
Preventive Visits (weighted) 61,547,461 60,245,157 51,194,211 66,143,533 121,792,619 117,337,744
Preventive Visits, mean - - - - 60,896,310 58,668,872
2012 2013 2014 2015 Pre-ACA Post-ACA (Post/Pre) P value
Diabetes Screening
a
12.16 11.39 9.82 13.86 11.78 11.96 1.53% 0.9465
Diabetes Prevention Education
b
13.12 14.90 17.77 23.21 14.00 20.84 48.86% 0.0289*
*p<0.05. **p<0.01. ***p<0.001
ANNUAL Pre/Post ACA
Note . Sample includes all white, black and Hispanic adults aged 18-64 who received a preventive care visit in 15 states. Chi-square calculated for 
pre-vs. post-ACA differences for each variable. Pre-ACA includes 2012-2013; Post-ACA includes 2014-2015. Survey weighted data.  
a
Diabetes Screening includes a glucose or HgbA1c test performed during clinic visit. 
b
Diabetes Prevention Education includes at least 1 form of education (i.e. weight reduction, diet/nutrition or exercise) performed during visit. 
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NAMCS Descriptive Statistics by Expansion Status 
 In Part II, tables include the average number of preventive care visits by white, black and 
Hispanic individuals aged 18-64 overall, then by expansion status. The years 2012-2015 were 
concatenated in order to draw comparison between the two state groups, non-expansion and 
Medicaid expansion states. Chi square was the statistical method used to distinguish between the 
two state groups. Non-expansion states (n=3,089) included 5 states: Florida, Georgia, North 
Carolina, Texas and Virginia. The Medicaid expansion state group was almost twice as large as 
the non-expansion group (n=5,885) and included 10 states that expanded Medicaid to 138% FPL 
by 2015: Arizona, California, Illinois, Indiana, Michigan, New Jersey, New York, Ohio, 
Pennsylvania and Washington (Table 74).  
Table 74 
NAMCS Analytic Sample Size by Expansion Status for Years 2012-2015 
 
Demographic Variables  
 Table 75 displays weighted percentages of key demographic variables: race/ethnicity, 
age and gender.  
  Race/Ethnicity.  Differences in the distribution of race/ethnicity within the 2012-2015 
time period by expansion status existed, with a greater number of minorities receiving a 
n Unweighted (%) Weighted (%)
Medicaid Expansion Status
a
Non-expansion 3,089 34.42 38.39
Expansion 5,885 65.58 61.61
Note. Sample includes all white, black and Hispanic adults aged 18-64 who 
received a preventive care visit in 15 states from 2012-2015. 
a
Non-expansion includes 5 states and Medicaid expansion includes 10 states 
that expanded as of 2015.
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preventive care visit within non-expansion states (43.51%), than in Medicaid expansion states 
(27.01%, p<0.001).  
  Age. There was no difference in the sampling distribution of age from 2012-2015 by 
expansion status (p=0.8239) within the NAMCS analytic sample.  
  Gender. There was no difference in the sampling distribution of gender from 2012-2015 
by expansion status (p=0.2484) within the NAMCS analytic sample.  
Table 75.  
Differences in Demographic Characteristics by Expansion Status for Years 2012-2015 
 
 Health Status Variables  
 Table 76 displays weighted percentages of key health status variables by expansion 
status: diabetes risk and chronic disease. 
Sample Size (unweighted) 3,089 5,885
Preventive Visits (weighted) 91,799,023 147,331,340
Preventive Visits, mean 22,949,756 36,832,835
n Weighted (%) Weighted (%) Weighted (%) X
2
 p value
Race/Ethnicity p<0.001***
Whites 6,615 66.60 56.49 72.91
Blacks 1,041 12.81 17.87 9.65
Hispanics 1,318 20.59 25.64 17.45
Age p=0.8239
18 to 34 3,542 38.60 39.74 37.90
35 to 44 1,592 18.21 18.42 18.07
45 to 54 1,791 21.13 20.55 21.49
55 to 64 2,049 22.06 21.29 22.54
Gender p=0.2484
Male 2,375 28.05 25.95 29.36
Female 6,599 71.95 74.05 70.64
*p<0.05. **p<0.01. ***p<0.001
Note. Sample includes all white, black and Hispanic adults aged 18-64 who received a preventive care visit in 2012-
2015. Chi-square calculated for variable differences by expansion group. Survey weighted data. 
a
Non-expansion states includes 5 states. 
b
Medicaid Expansion states includes 10 states.
Overall Non-expansion
a
Expansion
b
8,974
239,130,363
59,782,591
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  Diabetes Risk Status. Most of the preventive care visits within non-expansion states 
were of unknown diabetes risk due to no documentation of BMI or obesity diagnosis (39%). The 
Medicaid expansion group also had a high rate of unknown diabetes risk (37%). When the 
unknown risk group was dropped, non-expansion and Medicaid expansion groups had similar 
proportions of high-risk individuals (62% for both groups), with slightly more individuals with 
diabetes (13%) who had a preventive care visit in non-expansion states than Medicaid expansion 
states (10%). The proportion of visits who were of no/low risk in non-expansion states was 25% 
and 28% in Medicaid expansion states. There was no difference in the sampling distribution of 
diabetes risk by expansion status in the sample that includes all four diabetes risk groups 
(p=0.5620) or when the unknown risk group was dropped (p=0.1037). 
  Chronic Disease. Chronic disease was a dichotomous variable with “0” being no 
chronic disease and “1” being at least one chronic disease or more. The diseases included in this 
variable were: asthma, stroke, chronic obstructive pulmonary disease, depression, coronary 
artery disease, and congestive heart failure. The rate of chronic disease between both state groups 
was very close (16% vs. 15%). There was no difference in the sampling distribution of chronic 
disease by expansion status in the NAMCS analytic sample (p=0.7533).  
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Table 76.  
Differences in Health Status Characteristics by Expansion Status for Years 2012-2015 
 
  Health Insurance Coverage. Private insurance was the largest source of payment within 
both non-expansion (64%) and Medicaid expansion states (69%), with Medicaid being the 
second largest payer (15% in non-expansion states, 15% in Medicaid expansion states). There 
was no difference in the sampling distribution of insurance status by expansion group in the 
2012-2015 NAMCS analytic sample (p=0.6171) (Table 77).  
 
 
 
 
Sample Size (unweighted) 3,089 5,885
Preventive Visits (weighted) 91,799,023 147,331,340
Preventive Visits, mean 22,949,756 36,832,835
n Weighted (%) Weighted (%) Weighted (%) X
2
 p value
Diabetes Risk Status
c
p=0.4189
No/low risk 1,489 16.86 15.25 17.86
High Risk 3,146 38.57 37.69 39.12
Diabetes   607 6.92 7.92 6.29
Unknown 3,732 37.65 39.13 36.72
Chronic Disease
d
p=0.7533
No chronic disease 7,751 84.91 84.45 85.20
At least 1 chronic disease 1,223 15.09 15.55 14.80
*p<0.05. **p<0.01. ***p<0.001
Note. Sample includes all white, black and Hispanic adults aged 18-64 who received a preventive care visit in 2012-
2015. Chi-square calculated for variable differences by expansion group. Survey weighted data. 
a
Non-expansion states includes 5 states. 
b
Medicaid Expansion states includes 10 states.
c
Diabetes Risk Status defined as: No/low-risk (BMI< 25 and no diagnosis of obesity or diabetes); High-risk 
(BMI=> 25 and <30 and no diagnosis of diabetes, or a obesity diagnosis); Diabetes (diabetes diagnosis); Unknown 
(BMI not available and no diagnosis of obesity or diabetes). 
d
Chronic disease included a diagnosis at least 1 of the following conditions: asthma, stroke, COPD, depression, 
CAD or CHF. 
59,782,591
Overall Non-expansion
a
Expansion
b
8,974
239,130,363
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Table 77 
Differences in Preventive Care Visit Payment Type by Expansion Status for Years 2012-2015 
 
 Outcome Variables  
 Table 78 displays weighted percentages of preventive care visits where diabetes 
screening or diabetes prevention education occurred within non-expansion and Medicaid 
expansion states.  
  Diabetes Screening. Of all visits, 11% of high-risk individuals in non-expansion states 
were screened for diabetes at their preventive care visit, compared to 12% of high-risk 
individuals in Medicaid expansion states. There was no difference in the sampling distribution of 
diabetes screening by expansion status for the NAMCS analytic sample (p=0.8710).  
When the unknown group was dropped, 19% of high-risk individuals were screened in non-
expansion and Medicaid expansion states. Yet, from Table 76, 38-39% of individuals in the 
sample were at high risk for diabetes, demonstrating the low rate of diabetes screening occurring 
during preventive care visits, not including those who were of unknown diabetes risk.     
Sample Size (unweighted) 3,089 5,885
Preventive Visits (weighted) 91,799,023 147,331,340
Preventive Visits, mean 22,949,756 36,832,835
n Weighted (%) Weighted (%) Weighted (%) X
2
 p value
Insurance Status p=0.6286
Private 6,193 67.00 63.87 68.95
Medicaid  1,220 14.96 15.30 14.75
Medicare 364 4.13 4.73 3.76
Self Pay 419 4.35 4.28 4.39
Other 778 9.56 11.81 8.15
*p<0.05. **p<0.01. ***p<0.001
Note. Sample includes all white, black and Hispanic adults aged 18-64 who received a preventive care visit in 2012-
2015. Chi-square calculated for variable differences by expansion group. Survey weighted data. 
a
Non-expansion states includes 5 states. 
b
Medicaid Expansion states includes 10 states.
Overall Non-expansion
a
Expansion
b
8,974
239,130,363
59,782,591
247 
 
  Diabetes Prevention Education. Slightly more individuals within non-expansions states 
(19%) received diabetes prevention education (DPE) compared to those living in Medicaid 
expansion states (16%). However, there was no difference in the sampling distribution of 
diabetes prevention education by expansion status in this sample (p=0.4560). When the unknown 
for diabetes group was dropped, 16% of high-risk individuals in non-expansion states received 
DPE, compared to 13% in expansion states. Again, despite the high levels of individuals at high-
risk for diabetes attending a preventive care visit, low levels of diabetes prevention education 
were recorded in the medical record.  
Table 78 
Differences in Diabetes Screening and Prevention Education by Expansion Status for Years 
2012-2015.  
 
 
 
 
  
 
Sample Size (unweighted) 3,089 5,885
Preventive Visits (weighted) 91,799,023 147,331,340
Preventive Visits, mean 22,949,756 36,832,835
n Weighted (%) Weighted (%) Weighted (%) X
2
 p value
Diabetes Screening
c 
820 11.87 11.44 12.14 p=0.8330
Diabetes Prevention Education
d
1,306 17.36 18.99 16.34 p=0.4883
*p<0.05. **p<0.01. ***p<0.001
239,130,363
59,782,591
8,974
Non-expansion
a
Expansion
b
Overall
Note. Sample includes all white, black and Hispanic adults aged 18-64 who received a preventive care visit in 2012-
2015. Chi-square calculated for variable differences by expansion group. Survey weighted data. 
a
Non-expansion states includes 5 states. 
b
Medicaid Expansion states includes 10 states.
c
Diabetes Screening includes a glucose or HgbA1c test performed during clinic visit. 
d
Diabetes Prevention Education includes at least 1 form of education (i.e. weight reduction, diet/nutrition or exercise) 
performed during visit. 
248 
 
NAMCS Descriptive Statistics Stratified by Race and Diabetes Risk 
 In Part III, unadjusted changes in diabetes screening and diabetes prevention education 
over the ACA period are stratified by race, then by diabetes risk status in order to differentiate if 
changes occurred overall- and then between non-expansion and Medicaid expansion states. 
Criteria for testing for diabetes or prediabetes in asymptomatic adults includes testing for 
overweight or obese (BMI >= 25kg/m2 or 23kg/m2 in Asian Americans) adults who have one or 
more risk factors, with minority status (black or Hispanic) being one of the risk factors 
(American Diabetes Association, 2018). Although the criteria above are specific to testing of 
diabetes or prediabetes, no criteria exist for individuals at high-risk for diabetes; although a 
recent meta-analysis showed that obesity alone was significantly associated with an increased 
risk of Type II diabetes (Riaz, Khan, Siddiqi, 2018). As a result, BMI and race/ethnicity are of 
focus. Pearson Chi-square statistics were used to assess for differences in the sampling 
distributions between variables and outcomes of interest using survey (svy) weighted data. 
Sensitivity analysis using only 2012-2014 data is also included in this section and is discussed in 
the following paragraph. 
In NAMCS from years 2012-2015, there are six lab tests that capture blood sugar levels: 
CMP, BMP, GLUCOSE, HGBA, FBG, A1C (with the last two tests being performed in the last 
year). The main text includes only the two lab tests that were drawn during the preventive care 
visit: Glucose or HgbA1c. In this sensitivity analysis, fasting blood glucose and HgbA1c that 
were drawn in the past 12 months were also included. To include labs drawn in the past 12 
months, the year 2015 was dropped since no data on FBG or A1C in the past 12 months was 
available. The tables that follow display diabetes screening in two ways using only 2014 data in 
the post-ACA period. The first screening values included glucose and HgbA1c drawn during the 
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visit from 2012-2014, whereas the second screening values included glucose and HgbA1c drawn 
during the visit or in the past 12 months from 2012-2014. CMP and BMP were not included as 
these two lab values were only collected in 2014 and 2015. 
In NAMCS from years 2012-2015, there were four topics related to diabetes prevention 
education: Diabetes Education, Weight Reduction, Exercise and Diet/Nutrition. In the text, the 
main outcome (DPE) did not include diabetes education because data was not available for years 
2012 and 2013. For the sensitivity analysis, diabetes education was included in the outcome 
variable, which only affected the post-ACA period. Per the NAMCS Micro-Data File 
Documentation, diabetes education includes helping patients manage their insulin, blood sugar, 
diet and fitness routine. An insulin pump is given as an example of managing insulin. This 
definition may be more consistent with education provided to those with diagnosed diabetes; 
however, the sensitivity analysis was still conducted since this included other areas relevant to 
individuals at high-risk for diabetes. 
 Pre-vs. Post-ACA Changes in Outcomes by Race 
  Overall Change in Diabetes Screening and Education by Race. The sample size for 
whites was almost 6-times the size of blacks or Hispanics. By the post-ACA period, diabetes 
screening rates ranged from 10-17% across all racial/ethnic groups (Table 79). Whites 
experienced a 17% decrease in diabetes screening in the post-ACA period, with blacks and 
Hispanics both experiencing 14-17% increases. All changes in diabetes screening by 
race/ethnicity over the ACA period were found to be statistically insignificant.  
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Table 79 
Overall Change in Diabetes Screening and Prevention Education Pre-vs. Post-ACA by 
Race/Ethnicity (2012-2015) 
 
  Change in Diabetes Screening and Education by Race and Expansion Status. Blacks 
within non-expansion states had the lowest levels of diabetes screening in the pre-ACA period 
(6.91%); whereas Hispanics in Medicaid expansion states had the lowest levels of diabetes 
screening pre-ACA (10.43%). Post-ACA the largest gains in diabetes screening was among 
blacks living in non-expansion states (135%), with a post-ACA screening rate of 16%. The gains 
in screening for whites was very different. In non-expansion states, whites experienced a gain in 
screening of 30%, but a loss in screening of 11% in Medicaid expansion states. Hispanics 
experienced greater gains in diabetes screening within non-expansions states (70%). Although 
there were gains or losses in diabetes screening for all races, all changes were found to be 
statistically insignificant (Tables 80 and 81).    
 Diabetes prevention education during preventive care visits increased post-ACA for all 
racial/ethnic groups. The greatest gains in the administration of diabetes prevention education 
occurred within non-expansion states. Blacks (247%, p<0.001) and Hispanics (333%, p<0.05) 
experienced major gains in receiving diabetes prevention education post-ACA (Table 80). The 
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=3,696 n=2,919 n=599 n=442 n=754 n=564
Diabetes Screening
a
12.26 10.20 -16.80% 11.70 16.90 44.44% 10.08 14.08 39.68%
DPE
b
16.05 19.19 19.56% 9.68 25.59** 164.36% 9.35 22.74 143.21%
Change  
(%)
Change  
(%)
Change  
(%)
a
Diabetes Screening includes a glucose or HgbA1c test performed during clinic visit. 
b
Diabetes Prevention Education includes at least 1 form of education (i.e. weight reduction, diet/nutrition or exercise) 
performed during visit. 
Whites Blacks Hispanics
Note. Chi square calculated for pre-(2012-2013) vs. post-ACA (2014-2015) differences in outcomes by race/ethnicity. 
15-state group sample, survey weighted.
*p<0.05. **p<0.01. ***p<0.001
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gains in diabetes prevention education for all race/ethnicities within Medicaid expansion states, 
however, were statistically insignificant (Tables 80 and 81).  
Table 80 
Change in Diabetes Screening and Prevention Education in Non-expansion States, Pre-vs. Post-
ACA by Race/Ethnicity (2012-2015) 
 
Table 81 
Change in Diabetes Screening and Prevention Education in Medicaid Expansion States, Pre-vs. 
Post-ACA by Race/Ethnicity (2012-2015) 
 
 Pre-vs. Post-ACA Changes in Outcomes by Diabetes Risk  
  Overall Change in Diabetes Screening and Education by Diabetes Risk. The high-
risk for diabetes group had the highest rate of diabetes screening in the pre-ACA period (15%) 
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA p
n=1,156 n=836 n=280 n=240 n=352 n=225
Diabetes Screening
a
12.13 8.53 -29.68% 6.91 16.25 135.17% 9.73 16.55 70.09% 0.5203
DPE
b
14.60 20.45 40.07% 8.51 29.51*** 246.77% 8.21 35.61* 333.74% 0.0485
Note. Chi square calculated for pre-(2012-2013) vs. post-ACA (2014-2015) differences in outcomes by race/ethnicity. Non-
expansion (5-state) group sample, survey weighted.
Whites Blacks Hispanics
*p<0.05. **p<0.01. ***p<0.001
Change  
(%)
Change  
(%)
Change  
(%)
a
Diabetes Screening includes a glucose or HgbA1c test performed during clinic visit. 
b
Diabetes Prevention Education includes at least 1 form of education (i.e. weight reduction, diet/nutrition or exercise) performed 
during visit. 
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=2,540 n=2,083 n=319 n=202 n=402 n=339
Diabetes Screening
a
12.33 10.97 -11.03% 16.78 17.7 5.48% 10.43 11.96 14.67%
DPE
b
16.79 18.62 10.89% 10.93 20.67 89.11% 10.48 11.64 11.07%
b
Diabetes Prevention Education includes at least 1 form of education (i.e. weight reduction, diet/nutrition or exercise) 
performed during visit. 
*p<0.05. **p<0.01. ***p<0.001
Note .Chi square calculated for pre-(2012-2013) vs. post-ACA (2014-2015) differences in outcomes by race/ethnicity. 
Medicaid expansion (10-state) group sample, survey weighted.
Change  
(%)
Change  
(%)
Change  
(%)
a
Diabetes Screening includes a glucose or HgbA1c test performed during clinic visit. 
Whites Blacks Hispanics
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when compared to other non-diabetes groups.  Post-ACA, the high-risk group saw a 7% increase 
in diabetes screening, which was well above the percent change of the low-risk and unknown 
risk groups. Although screening rates increased for the high-risk group, the change was found to 
be statistically insignificant. The decline in screening among the unknown group was the only 
change in diabetes screening during the ACA period to be statistically significant (-44.54%, 
p<0.05).  
The high-risk for diabetes group saw an increase of 30% in the rate of prevention 
education provided in the post-ACA period. In fact, all groups experienced increases except the 
no/low risk group which saw a minor decrease of 0.34%. However, any differences in the 
delivery of diabetes prevention education during a preventive care visit in the post-ACA period 
for each risk group was found to be statistically insignificant.  
Table 82.  
Overall Change in Diabetes Screening and Prevention Education, Pre-vs. Post-ACA by Diabetes 
Risk (2012-2015) 
 
  Change in Diabetes Screening and Education by Diabetes Risk and Expansion 
Status. Diabetes screening increased for all groups in non-expansion states, with the high-risk 
group experiencing the greatest gains of all the risk groups (48%) (Table 83). Surprisingly, the 
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non-expansion high-risk group experienced greater gains in diabetes screening than the Medicaid 
expansion state group. There was a 9% decrease in diabetes screening among the high-risk group 
in Medicaid expansion states, despite the low-risk and unknown risk groups experiencing gains 
in screening (Table 84). Changes in diabetes screening for all risk groups were statistically 
insignificant in both non-expansion and Medicaid expansion states. 
 The rate of delivering diabetes prevention education was greater than the rate of 
providing diabetes screening for the high-risk groups in both non-expansion and Medicaid 
expansion states. The high-risk group in non-expansion states experienced a 75% increase in 
prevention education leading to a post-ACA teaching rate of 32% (p<0.01). This rate surpassed 
the education rate in expansion states by almost 10%. The increase in teaching for the high-risk 
group in expansion states was only 5%. Most of the diabetes prevention education provided in 
non-expansion states was targeted to the high-risk group, whereas most of the education 
provided in the expansion states targeted the group with already diagnosed diabetes.  
Table 83 
Change in Diabetes Screening and Prevention Education in Non-expansion States, Pre-vs. Post-
ACA by Diabetes Risk (2012-2015) 
 
 
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=276 n=195 n=630 n=460 n=150 n=102 n=732 n=544
Screening
a
9.88 13.83 39.98% 11.28 16.68 47.87% 21.48 29.11 35.52% 8.51 2.72* 68.04%
DPE
b
20.33 13.64 32.91% 18.20 31.83** 74.89% 13.23 22.54 70.37% 3.87 26.66** 588.89%
a
Diabetes Screening includes a glucose or HgbA1c test performed during clinic visit. 
b
Diabetes Prevention Education includes at least 1 form of education (i.e. weight reduction, diet/nutrition or exercise) performed during visit. 
Note. Chi square calculated for pre-(2012-2013) vs. post-ACA (2014-2015) differences in outcomes by diabetes risk. Non-expansion (5-state) 
group sample, survey weighted.
Change  
(%)
No/Low Risk High-Risk Diabetes Unknown
Change  
(%)
*p<0.05. **p<0.01. ***p<0.001
Change  
(%)
Change  
(%)
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Table 84 
Change in Diabetes Screening and Prevention Education in Medicaid Expansion States, Pre-vs. 
Post-ACA by Diabetes Risk (2012-2015) 
 
 Sensitivity Analysis for Changes in Diabetes Screening by Race 
In Table 85, Diabetes Screeninga included a glucose or HgbA1c test performed during 
the clinic visit which was consistent with the definition of diabetes screening in the main text. 
When 2015 was removed from the post-ACA period, the diabetes screening rates decreased even 
more so then when the post-ACA period included 2014 and 2015.  For example, whites 
experienced a 17% decrease in screening in the post-ACA period using 2014-2015; while whites 
experienced a 24% decrease in screening using only 2014 data in the post-ACA period. This 
decline in screening was also seen for blacks and Hispanics. By including 2015 data, the post-
ACA screening rates at the time of the visit were higher than only including 2014 data.  
Dropping 2015 data for Diabetes Screeninga was necessary to make a direct comparison 
between using 2 lab values vs. 4 lab values (Diabetes Screeningb) in Table 85, since the fasting 
glucose and HgbA1c in the past 12 months did not have 2015 data. Notably, the pre-ACA 
screening rates using 4 lab values at least doubled for all racial/ethnic groups. It would make 
sense that the screening rate would be low 10-12% among all groups during their clinic visit 
because the provider saw a previous lab value within the past year. However, the problem with 
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=599 n=419 n=1,108 n=948 n=185 n=170 n=1,369 n=1,087
Screening
a
11.03 7.95 27.92% 17.22 15.63 -9.23% 30.27 29.93 -1.12% 6.53 4.96 24.04%
DPE
b
16.37 19.84 21.20% 20.44 21.51 5.23% 22.38 36.51 63.14% 9.13 6.71 26.51%
a
Diabetes Screening includes a glucose or HgbA1c test performed during clinic visit. 
b
Diabetes Prevention Education includes at least 1 form of education (i.e. weight reduction, diet/nutrition or exercise) performed during visit. 
Unknown
Change  
(%)
Note .Chi square calculated for pre-(2012-2013) vs. post-ACA (2014-2015) differences in outcomes by diabetes risk. Medicaid expansion (10-
state) group sample, survey weighted.
*p<0.05. **p<0.01. ***p<0.001
No/Low Risk High-Risk Diabetes
Change  
(%)
Change  
(%)
Change  
(%)
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using glucose or HgbA1c drawn in the past year is that the additional values in 2014, may not 
have been drawn in 2014; rather those values may have been in 2013. Luckily, NAMCS does 
have 2 separate variables that capture the difference in days from when the glucose or A1c was 
drawn to the clinic visit data. Unfortunately, 83.30% of the values are missing for fasting glucose 
in the past 12 months and 92.80% of values are missing for HgbA1c in the past 12 months, 
making this outcome an undesirable measure to study, given the focus of this study on ACA 
effects as of 2014.  
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Table 85 
Sensitivity Analysis: Change in Diabetes Screening, Pre-vs. Post-ACA by Expansion Status and 
Race (2012-2014) 
 
 Sensitivity Analysis for Changes in Diabetes Prevention by Race  
In Table 86, adding diabetes education did not increase post-ACA rates for diabetes 
prevention teaching by much. Whites and blacks experienced an increase in diabetes prevention 
education in the post-ACA period, even though the increase of adding diabetes education in the 
post-ACA period was minor (<1-percentage-point overall for whites and a little over 1-
percentage point increase overall for blacks). The post-ACA rates of diabetes prevention 
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=3,696 n=1,647 n=599 n=257 n=754 n=287
Overall
Diabetes Screening
a
12.26 9.34 -23.82% 11.70 11.56 -1.20% 10.08 10.53 4.64%
Diabetes Screening
b
24.92 34.30** 37.64% 24.98 30.32 21.38% 25.31 33.23 31.29%
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=1,156 n=529 n=280 n=137 n=352 n=122
Non-expansion
Diabetes Screening
a
12.13 5.85* -51.77% 6.91 7.58 9.70% 9.72 8.03 -17.39%
Diabetes Screening
b
25.86 27.48 6.26% 20.49 28.89 41.00% 28.53 44.05 54.40%
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=2,540 n=1,118 n=319 n=120 n=402 n=165
Expansion
Diabetes Screening
a
12.33 11.11 -9.90% 16.78 14.89 -11.26% 10.43 12.66 21.38%
Diabetes Screening
b
24.43 37.75** 54.52% 29.73 31.52 6.02% 22.17 24.03 8.39%
Note. Chi square calculated for pre-vs. post-ACA differences in outcomes by race/ethnicity. Overall includes 15-state group 
sample; Non-expansion includes 5-state group; Expansion includes 10-state group; survey weighted.
a
Diabetes Screening includes a glucose or HgbA1c test performed during clinic visit using 2012-2014 data. 
b
Diabetes Screening includes: glucose or HgbA1c test performed during clinic visit or either test within the past 12 months 
using 2012-2014 data. 
*p<0.05. **p<0.01. ***p<0.001
Whites Blacks Hispanics
Change  
(%)
Change  
(%)
Change  
(%)
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education in the post-ACA period for Hispanics were unchanged overall, and within both non-
expansion and Medicaid expansion states.  
Table 86  
Sensitivity Analysis: Change in Diabetes Prevention Education, Pre-vs. Post-ACA by Expansion 
Status and Race (2012-2014) 
 
 Sensitivity Analysis for Diabetes Screening by Diabetes Risk Status  
 When 2015 data was removed, the high-risk, diabetes and unknown risks groups 
experienced declines in diabetes screening (measuring only glucose or A1c), which is 
inconsistent with the descriptive data shown in the main text using 2014 and 2015 data. As 
previously mentioned, diabetes screening is underestimated in the post-ACA period when the 
year 2015 is dropped. When glucose and A1c in the past 12 months were added, the baseline 
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=3,696 n=2,919 n=599 n=442 n=754 n=564
Overall
DPE
a
16.05 19.80 23.36% 9.68 25.68** 165.29% 9.35 22.74 143.21%
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=1,156 n=836 n=280 n=240 n=352 n=225
Non-expansion
DPE
a
14.60 21.80 49.32% 8.51 29.68*** 248.77% 8.21 35.61* 333.74%
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=2,540 n=2,083 n=319 n=202 n=402 n=339
Expansion
DPE
a
16.79 18.88 12.45% 10.93 20.67 89.11% 10.48 11.64 11.07%
Note. Chi square calculated for pre-vs. post-ACA differences in diabetes prevention education (DPE) by 
race/ethnicity. Overall includes 15-state group sample; Non-expansion includes 5-state group; Expansion includes 
10-state group; survey weighted.
*p<0.05. **p<0.01. ***p<0.001
a
Diabetes Prevention Education includes at least 1 form of education (i.e. weight reduction, diet/nutrition, exercise 
or diabetes education) performed during visit, using 2012-2015 data. 
Whites Blacks Hispanics
Change  
(%)
Change  
(%)
Change  
(%)
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screening rate in the pre-ACA more than doubled for the low-risk, high-risk and unknown risk 
groups. Since the date the screening was taken in the past 12 months was unknown for a majority 
of the patients, the overall increases in the post-ACA period for all risk groups is of concern.  
Table 87  
Sensitivity Analysis: Change in Diabetes Screening, Pre-vs. Post-ACA by Expansion Status and 
Diabetes Risk (2012-2015) 
 
 Sensitivity Analysis for Changes in Diabetes Prevention by Diabetes Risk 
 This sensitivity analysis reveals that individuals who only received diabetes education 
during the clinic visit were individuals who mainly had diagnosed diabetes, although there was a 
small 0.22-percentage increase in diabetes prevention education provided to the high-risk group 
overall in the post-ACA period. The post-ACA teaching rate for the diabetes group was 33%; 
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=875 n=374 n=1,738 n=860 n=335 n=159 n=2,101 n=798
Overall
Diabetes Screening
a
10.63 12.27 15.43% 14.96 11.89 -20.52% 25.97 15.34 -40.93% 7.32 4.44 -39.34%
Diabetes Screening
b
22.54 35.07* 55.59% 32.00 41.02* 28.19% 42.03 54.42 29.48% 17.30 18.32 5.90%
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=276 n=129 n=630 n=310 n=150 n=67 n=732 n=282
Non-expansion
Diabetes Screening
a
9.88 8.22 -16.80% 11.28 5.41* -52.04% 21.48 17.24 -19.74% 8.51 4.37 -48.65%
Diabetes Screening
b
22.15 28.13 27.00% 29.50 35.48 20.27% 35.10 41.83 19.17% 21.87 24.38 11.48%
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=599 n=245 n=1,108 n=550 n=185 n=92 n=1,369 n=516
Expansion
Diabetes Screening
a
11.03 14.48 106.26% 17.22 16.09 -6.56% 30.27 14.02 -53.68% 6.53 4.48 -31.39%
Diabetes Screening
b
22.75 38.85* 70.77% 33.54 44.60* 32.98% 48.69 63.23 29.86% 14.27 15.09 5.75%
Unknown Risk
Change  
(%)
Note. Chi square calculated for pre-vs. post-ACA differences in diabetes screening by diabetes risk. Overall includes 15-state group sample; Non-
expansion includes 5-state group; Expansion includes 10-state group; survey weighted.
b
Diabetes Screening includes: glucose or HgbA1c test performed during clinic visit or either test within the past 12 months using 2012-2014 data. 
a
Diabetes Screening includes a glucose or HgbA1c test performed during clinic visit using 2012-2014 data. 
*p<0.05. **p<0.01. ***p<0.001
No/Low Risk High-Risk Diabetes
Change  
(%)
Change  
(%)
Change  
(%)
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whereas in the main text the rate was 31%. Most of the gains in teaching was due to education 
being provided to the diabetes group in Medicaid expansion states (Table 88). This group 
experienced a 2.5-percentage point increase in the post-ACA period, over the rate seen when 
only three teaching methods were used (i.e. exercise, weight reduction, or diet/nutrition). For the 
high-group, the gains in diabetes prevention screening in the post-ACA period were within the 
non-expansion states, although gains were very small.  
Table 88  
Sensitivity Analysis: Change in Diabetes Prevention Education, Pre-vs. Post-ACA by Expansion 
Status and Diabetes Risk Status (2012-2015) 
 
 
 
 
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=875 n=614 n=1,738 n=1,408 n=335 n=272 n=2,101 n=1,631
Overall
DPE
a
17.73 17.67 -0.34% 19.59 25.56 30.47% 17.90 32.97 84.19% 7.04 15.15 115.20%
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=276 n=195 n=630 n=460 n=150 n=102 n=732 n=544
Non-expansion
DPE
a
20.33 13.64 -32.91% 18.20 32.42** 78.13% 13.23 23.80 79.90% 3.87 27.81** 619.61%
Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA Pre-ACA Post-ACA
n=599 n=419 n=1,108 n=948 n=185 n=170 n=1,369 n=1,087
Expansion
DPE
a
16.37 19.84 21.20% 20.44 21.51 5.23% 22.38 39.01 74.31% 9.13 6.71 -25.51%
a
Diabetes Prevention Education includes at least 1 form of education (i.e. weight reduction, diet/nutrition, exercise 
or diabetes education) performed during visit, using 2012-2015 data. 
*p<0.05. **p<0.01. ***p<0.001
Unknown Risk
Change  
(%)
No/Low Risk High-Risk Diabetes
Change  
(%)
Change  
(%)
Change  
(%)
Note. Chi square calculated for pre-vs. post-ACA differences in diabetes prevention education (DPE) by diabetes risk. Overall includes 15-state 
group sample; Non-expansion includes 5-state group; Expansion includes 10-state group; survey weighted.
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Multiple Logistic Regression Analyses of Diabetes Screening and Diabetes Prevention 
Education (DPE) 
In this section, logistic regression results are presented and discussed by sub aim: 
• Specific Aim 3a the impact of the ACA on the likelihood of receiving diabetes screening 
or diabetes prevention education overall, and by expansion status; 
• Specific Aim 3b: the impact of the ACA on the likelihood of receiving diabetes 
screening or diabetes prevention education by race and then by diabetes risk status by 
expansion status. 
For each aim, the ACA policy effect was measured with a pre/post ACA indicator, with 2014-
2015 marking the post-ACA period. A difference-in-difference approach was used to quantify 
ACA effects between expansion and race or expansion and diabetes risk groups. ACA interaction 
terms formed the crucial difference-in-difference estimators. Logistic regression methods were 
used to determine the statistical significance and size of the causal paths from the ACA to the 
delivery of diabetes prevention screening and education. Given the previous BRFSS analysis, the 
ACA to PCP link showed a very small effect of the ACA on PCP gains, which in return should 
yield even smaller gains, if any, in diabetes prevention screening and/or education post-ACA.  
Prior to running the multivariate logistic regressions, the correlations among the 
dependent and independent variables were reviewed to describe the association between the 
random variables. Although the correlation matrix does not control for confounders, it was 
helpful in identifying the presence of causal relationships, which were confirmed by regression 
results later in this section.  
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When interpreting the correlation coefficients in Table 89, the coefficients included 4 
years of data and reflected mean differences between the values of 0 or 1, as most variables were 
dichotomous. All variables were dichotomous except for age which was a 4-category variable-
with age increasing as the categories were coded from 0 to 4. For variables that were not time-
sensitive, a single correlation was repeated 4 times, helping the power. For time-sensitive 
variables (such as ACA), the correlation coefficient gave an indication of how the variable 
means differed by time (pre vs. post ACA).  
Table 89. 
Pairwise Correlation Matrix for All Independent and Outcome Variables in 15-State Sample  
 
The variables of interest in the matrix included ACA, Expansion Status (EXP), Diabetes 
Screening (SCR) and Diabetes Prevention Education (DPE). There was no correlation between 
diabetes screening and the ACA or screening and expansion status. The correlation between 
ACA and DPE was a very weak positive relationship (0.0578, p<0.05). This suggests very little 
to no ACA effect on receiving DPE in the post-ACA period. There was no correlation between 
DPE and expansion status. Important to note, there was no correlations between race and 
White Black Hispanic AgeCat Gender Low Risk High Risk Diabetes Unknown C Disease Expansion ACA Screening
a
DPE
b
White 1.0000
Black -0.6066* 1.0000
Hispanic -0.6948* -0.1503* 1.0000
AgeCat 0.1502* -0.0479* -0.1435* 1.0000
Gender -0.0794* 0.0430* 0.0598* -0.2764* 1.0000
Low Risk 0.0908* -0.0652* -0.0539* 0.0154 0.0347* 1.0000
High Risk 0.0164 0.0540* -0.0693* 0.2015* -0.1670* -0.3277* 1.0000
Diabetes -0.0236* 0.0368* -0.0039 0.1780* -0.1140* -0.1201* -0.1979* 1.0000
Unknown -0.0724* -0.0218* 0.1098* -0.2974* 0.1936* -0.3763* -0.6199* -0.2273* 1.0000
C Disease 0.0343* 0.0052 -0.0474* 0.0943* -0.0076 0.0071 0.0839* 0.0676* -0.1210* 1.0000
Expansion 0.1518* -0.1184* -0.0817* -0.0233* -0.0189 0.0262* -0.0035 -0.0402* 0.0041 -0.0110 1.0000
ACA 0.0131 -0.0093 -0.0079 -0.0023 0.0218* -0.0225* 0.0151 0.0058 -0.006 -0.0052 0.0237* 1.0000
Screening
a
-0.0065 0.0143 -0.0048 0.0611* -0.0622* -0.0084 0.0523* 0.1194* -0.1052* 0.0194 0.0181 -0.0192 1.0000
DPE
b
0.0117 0.0025 -0.0168 0.0431* -0.0132 0.0300* 0.1398* 0.0449* -0.1809* 0.0258* -0.0063 0.0578* 0.1148* 1.0000
Note. Correlation matrix using 2012-2015 data. Each variable is a dichotomous variable except for age.
*p<0.05.
a
Diabetes Screening includes a glucose or HgbA1c test performed during clinic visit. 
b
Diabetes Prevention Education includes at least 1 form of education (i.e. weight reduction, diet/nutrition or exercise) performed during visit. 
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diabetes screening; but weak relationships existed between screening and risk status: high risk 
(0.0523, p<0.05), diabetes (0.1194, p<0.05) or unknown risk status (-0.1052, p<0.05). Diabetes 
education had no association with race and a weak correlation with the diabetes risk status: low 
risk (0.0300, p<0.05), high-risk (0.1398, p<0.05), diabetes (0.0258, p<0.05), and unknown (-
0.1809, p<0.05) risk groups. 
In the next section, focus was placed on multivariate regression work where outside 
factors were adjusted to determine if the ACA impacted the delivery of diabetes prevention. 
Additionally, by controlling for variables, disparities for the subgroups of interest (race or 
diabetes risk status) in the post-ACA period could be assessed. Given the initial descriptive 
analysis, diabetes screening for the regression analysis was measured by a fasting glucose or A1c 
level drawn during a clinic visit from 2012-2015. This was further justified by a recent study 
using 2012-2015 NAMCS data that defined fasting glucose or A1C provided during visits as “a 
provision of screening for diabetes” (Shealy, Wu, Waits, Taylor & Sarbacker, 2019). Diabetes 
prevention education was measured by at least 1 form of diabetes prevention education (i.e. 
diet/nutrition, exercise, or weight reduction) provided during a preventive care visit. Shealy, et 
al. (2019) also used only these three forms of education to measure health education/counseling 
provided during a clinic visit.  
 Specific Aim 3a- Odds of Diabetes Prevention Delivery by Expansion Status  
 The focus of this section was to assess for differences in the delivery of diabetes 
screening and diabetes prevention education during preventive care visits for adults within non-
expansion and Medicaid expansion states during the ACA period. Each set of regression models 
for the probability of receiving diabetes screening and the probability of receiving diabetes 
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prevention education are presented separately, with a focus on differentiating differences in 
outcomes by expansion status. 
  Diabetes Screening and Expansion Status. The overall ACA effect (Model 1) on the 
probability of receiving diabetes screening in the post-ACA was an odds ratio of 1.02. However, 
the odds ratio was not statistically significant. When expansion status was added (Model 2), there 
was no difference in the odds of receiving diabetes screening between non-expansion and 
Medicaid expansion states. The interaction term of ACA*EXP (Model 3) also shows no 
difference in the pre vs. post-ACA period by expansion status. When adjusting for other 
demographic and health status factors, such as race, age, gender, diabetes risk and chronic 
disease, there was no significant ACA effect on diabetes screening or differences in the 
probability of being screened between non-expansion and Medicaid expansion states (Model 4). 
Notably, across the 4 years under study, the high-risk for diabetes group was 45% more likely to 
receiving diabetes screening than the low-risk group. Also, the group with unknown risk were 
44% less likely to be screened when compared to the low-risk population. Individuals with 
diabetes were 2.84-times more likely to be screened than the no/low risk group. (Table 90). 
Refer to Appendix AJ, Table AJ-1 for full regression modes with 95% CI’s.  
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Table 90.  
Logistic Regression Models for the Probability of Receiving Diabetes Screening by Expansion 
Status (2012-2015) 
 
Probability of being 
Screened
a
 (n=8,974)
Model 1 
(Odds 
Ratio)
Model 2 
(Odds 
Ratio)
Model 3 
(Odds 
Ratio)
Model 4 
(Odds 
Ratio)
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.02 1.02 0.91 1.10
Expansion Status
Non-expansion Ref Ref Ref
Medicaid Expansion 1.07 1.13 1.31
Interaction Term
ACA*nonEXP Ref
ACA*EXP 0.74
Race
Whites Ref Ref
Blacks 0.98 1.33
Hispanics 1.44 1.44
Age
18 to 34 Ref Ref
35 to 44 0.98 0.98
45 to 54 1.15 1.16
55 to 64 1.65** 1.67**
Gender
Male Ref Ref
Female 0.85 0.85
Diabetes Risk
No/low Risk Ref Ref
High Risk 1.45* 1.45*
Diabetes 2.82*** 2.84**
Unknown 0.56* 0.56*
Chronic Disease
No Disease Ref Ref
At least 1 or more 1.17 1.17
Constant 0.13** 0.13** 0.10*** 0.09**
F Statistic 0.95*** 0.94 9.71*** 8.91***
*p<0.05. **p<0.01. ***p<0.001
Note.  Logistic regressions for the Pb(SCR) by expansion status and 
race in 15-states (2012-2015); survey weighted data. Values indicate 
odds ratios. 
a
Diabetes Screening includes a glucose or HgbA1c test performed 
during a clinic visit using 2012-2015 data. 
b 
Three-way interaction term includes interactions between race, ACA 
and expansion status. Referernce group: whies living in non-expansion 
states, pre-ACA.  
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  Diabetes Prevention Education and Expansion Status. The odds of receiving diabetes 
prevention education (DPE) in the post-ACA period was 1.62 (p<0.05), meaning individuals 
were 62% more likely to receive DPE in the post-ACA period, than in the pre-ACA period 
during a preventive care visit (Model 1). Expansion status did not affect the odds of receiving 
DPE, overall (Model 2) or over time (Model 3). When adjusting for changes between expansion 
groups over time, the ACA coefficient increased to 2.61 (p<0.05). When adjusting for 
demographic and health status variables, the ACA effect decreased to 2.54 (p<0.05) (Model 4). 
Notably, across all years, the high-risk group was 44% more likely to receiving diabetes 
prevention education than the no/low risk group, but the unknown risk group was 49% less likely 
to receive diabetes prevention education than the no/low risk group (Table 91). Refer to 
Appendix AJ, Table AJ-3 for full regression modes with 95% CI’s. 
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Table 91.  
Logistic Regression Models for the Probability of Receiving Diabetes Prevention Education by 
Expansion Status (2012-2015) 
 
Probability of 
Receiving Diabetes 
Prevention Education
a 
(n=8,974)
Model 1 
(Odds 
Ratio)
Model 2 
(Odds 
Ratio)
Model 3 
(Odds 
Ratio)
Model 4 
(Odds 
Ratio)
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.62* 1.62* 1.55 2.54*
Expansion Status
Non-expansion Ref Ref Ref
Medicaid Expansion 0.83 0.81 1.29
Interaction Term
ACA*nonEXP Ref
ACA*EXP 0.44
Race
Whites Ref Ref
Blacks 0.89 0.87
Hispanics 0.93 0.94
Age
18 to 34 Ref Ref
35 to 44 0.83 0.83
45 to 54 0.73 0.74
55 to 64 0.76 0.78
Gender
Male Ref Ref
Female 1.11 1.11
Diabetes Risk
No/low Risk Ref Ref
High Risk 1.44* 1.44*
Diabetes 1.69 1.72
Unknown 0.51* 0.51*
Chronic Disease
No Disease Ref Ref
At least 1 or more 0.89 0.88
Constant 0.16*** 0.18*** 0.22*** 0.16***
F Statistic 4.73* 2.72 6.74*** 7.65***
*p<0.05. **p<0.01. ***p<0.001
Note. Logistic regressions for the Pb(DPE) by expansion status and 
race in 15-states (2012-2015); survey weighted data. Values indicate 
odds ratios. 
a
Diabetes Prevention Education (DPE): at least 1 form of teaching 
(i.e. exercise, diet/nutrition or weight reduction) provided during visit 
using 2012-2015 data. 
b 
Three-way interaction term includes interactions between race, 
ACA and expansion status. Reference group: whites living in non-
expansion states in the pre-ACA period.
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 Specific Aim 3b- Odds of Receiving Diabetes Prevention by Expansion and Race, then by 
Expansion and Diabetes Risk  
In this section, the focus was to determine if the ACA’s coverage expansion increased the 
rate of diabetes screening and diabetes prevention education within Medicaid expansion versus 
non-expansion states by race/ethnicity, then by diabetes risk status. First the odds of receiving 
diabetes screening and prevention education by expansion status and race is discussed; followed 
by the same outcomes by expansion and diabetes risk. To note, Model 4 from Tables 90 and 91 
serve as the baseline regression model before the addition of ACA*Race (or ACA*Risk) 
interaction terms in Model 5 and ACA*Race*EXP (or ACA*Risk*EXP) interaction terms in 
Model 6. Full regression Models 1-6 for each outcome, including 95% CI’s, can be found in 
Appendix AJ.  
  Diabetes Screening by Expansion and Race. In Table 92, Model 5 introduces the 
ACA*Race interaction term. In this model, the odds of receiving diabetes screening for minority 
groups increased (to 81-88% more likely than whites) in the post-ACA period, but remained 
statistically insignificant (Model 5). A three-way interaction term (Race*ACA*Expansion) was 
introduced to assess for differences in expansion states in the post-ACA period by race. Model 6 
shows that diabetes screening rates for minorities in expansion states, pre-ACA were 14% to 2-
times less more likely than the rate for whites in non-expansion states in the pre-ACA period. By 
the post-ACA period, the screening rates decreased to 22-66% less likely to be screened than 
whites in non-expansion states in the pre-ACA period. However, all odds ratios associated with 
the three-way interaction term were statistically insignificant. Notably, over the 4 years, the 55 to 
64 age cohort were 69% more likely to receive diabetes screening than the 18 to 34 age group. 
Refer to Appendix AJ, Table AJ-2 for 95% CI’s.  
268 
 
Table 92 
Logistic Regression Models for the Probability of Receiving Diabetes Screening by Expansion 
Status and Race (2012-2015) 
 
Probability of being 
Screened
a
 (n=8,974)
Model 1 
(Odds 
Ratio)
Model 2 
(Odds 
Ratio)
Model 3 
(Odds 
Ratio)
Model 4 
(Odds 
Ratio)
Model 
5 (Odds 
Ratio)
Model 6 
(Odds 
Ratio)
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref
Post-ACA 1.02 1.02 0.91 1.10 0.83 0.64
Expansion Status
Non-expansion Ref Ref Ref Ref Ref
Medicaid Expansion 1.07 1.13 1.31 1.25 1.12
Interaction Term
ACA*nonEXP Ref Ref Ref
ACA*EXP 0.74 0.81 1.17
Race
Whites Ref Ref Ref Ref
Blacks 0.98 1.33 0.99 0.64
Hispanics 1.44 1.44 1.04 0.95
Interaction Term
ACA*whites Ref Ref
ACA*blacks 1.81 3.15*
ACA*Hispanics 1.88 3.29
3-Way Interaction Term
b
whites*preACA*nonEXP Ref
B*Pre-ACA*EXP 2.00
B*Post-ACA*EXP 0.88
H*Pre-ACA*EXP 1.14
H*Post-ACA*EXP 0.44
Age
18 to 34 Ref Ref Ref Ref
35 to 44 0.98 0.98 0.98 0.99
45 to 54 1.15 1.16 1.16 1.16
55 to 64 1.65** 1.67** 1.68** 1.69**
Gender
Male Ref Ref Ref Ref
Female 0.85 0.85 0.84 0.84
Diabetes Risk
No/low Risk Ref Ref Ref Ref
High Risk 1.45* 1.45* 1.46* 1.46*
Diabetes 2.82*** 2.84** 2.82*** 2.82***
Unknown 0.56* 0.56* 0.56* 0.56*
Chronic Disease
No Disease Ref Ref Ref Ref
At least 1 or more 1.17 1.17 1.19 1.17
Constant 0.13** 0.13** 0.10*** 0.09** 0.10** 0.11***
F Statistic 0.95*** 0.94 9.71*** 8.91*** 7.82*** 6.59***
*p<0.05. **p<0.01. ***p<0.001
Note.  Logistic regressions for the Pb(SCR) by expansion status and race in 15-states (2012-
2015); survey weighted data. Values indicate odds ratios. 
a
Diabetes Screening includes a glucose or HgbA1c test performed during a clinic visit using 
2012-2015 data. 
b 
Three-way interaction term includes interactions between race, ACA and expansion 
status. Referernce group: whies living in non-expansion states, pre-ACA.  
269 
 
 Diabetes Prevention Education by Expansion and Race. In Table 93, with the 
addition of the ACA*Race interaction term in Model 5, blacks were found to be 46% less likely 
to receive DPE than whites in the pre-ACA period. Post-ACA, however, blacks were 2.20-times 
more likely to receive DPE than whites, when adjusting for other factors. There was no 
statistically significant difference between whites and Hispanics in receiving DPE in the post-
ACA period. The three-way interaction (Race*ACA*Expansion) showed no difference between 
expansion groups by race in the post-ACA period. After adjusting for differences in the 
expansion groups over time by race, the ACA*Black coefficient in Model 5 increased from 2.20 
to 2.92 (p<0.05) in Model 6. This shows that despite no differences in the post-ACA period by 
expansion groups and race, blacks in the post-ACA period overall experienced gains in DPE, 
over whites. Refer to Appendix AJ, Table AJ-3 for 95% CI’s.  
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Table 93  
Logistic Regression Models for the Probability of Receiving Diabetes Prevention Education by 
Expansion Status and Race (2012-2015) 
 
Probability of 
Receiving Diabetes 
Prevention Education
a 
(n=8,974)
Model 1 
(Odds 
Ratio)
Model 
2 (Odds 
Ratio)
Model 3 
(Odds 
Ratio)
Model 4 
(Odds 
Ratio)
Model 5 
(Odds 
Ratio)
Model 6 
(Odds 
Ratio)
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref
Post-ACA 1.62* 1.62* 1.55 2.54* 1.89 1.42
Expansion Status
Non-expansion Ref Ref Ref Ref Ref
Medicaid Expansion 0.83 0.81 1.29 1.22 1.19
Interaction Term
ACA*nonEXP Ref Ref Ref
ACA*EXP 0.44 0.49 0.77
Race
Whites Ref Ref Ref Ref
Blacks 0.89 0.87 0.54** 0.54
Hispanics 0.93 0.94 0.60 0.88
Interaction Term
ACA*whites Ref Ref
ACA*blacks 2.20* 2.92*
ACA*Hispanics 2.05 4.63
3-Way Interaction Term
b
whites*preACA*nonEXP Ref
B*Pre-ACA*EXP 1.01
B*Post-ACA*EXP 0.65
H*Pre-ACA*EXP 1.19
H*Post-ACA*EXP 0.23
Age
18 to 34 Ref Ref Ref Ref
35 to 44 0.83 0.83 0.82 0.84
45 to 54 0.73 0.74 0.74 0.73
55 to 64 0.76 0.78 0.78 0.79
Gender
Male Ref Ref Ref Ref
Female 1.11 1.11 1.10 1.10
Diabetes Risk
No/low Risk Ref Ref Ref Ref
High Risk 1.44* 1.44* 1.45* 1.44*
Diabetes 1.69 1.72 1.70 1.71
Unknown 0.51* 0.51* 0.51* 0.50*
Chronic Disease
No Disease Ref Ref Ref Ref
At least 1 or more 0.89 0.88 0.89 0.87
Constant 0.16*** 0.18*** 0.22*** 0.16*** 0.19*** 0.20***
F Statistic 4.73* 2.72 6.74*** 7.65*** 7.66*** 7.12***
*p<0.05. **p<0.01. ***p<0.001
Note. Logistic regressions for the Pb(DPE) by expansion status and race in 15-states 
(2012-2015); survey weighted data. Values indicate odds ratios. 
a
Diabetes Prevention Education (DPE): at least 1 form of teaching (i.e. exercise, 
diet/nutrition or weight reduction) provided during visit using 2012-2015 data. 
b 
Three-way interaction term includes interactions between race, ACA and expansion 
status. Reference group: whites living in non-expansion states in the pre-ACA period.
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  Diabetes Screening by Expansion and Risk Status. In Table 94, Model 5, the 
ACA*Risk interaction term was introduced which showed the high-risk and diabetes group to 
have 10-18% greater likelihood of being screened over the no/low risk; whereas the unknown 
risk group was 45% less likely to be screened in the post-ACA period. The odds ratios associated 
with the interaction terms were all statistically insignificant. With the addition of the three-way 
interaction term (Risk*ACA*Expansion), there was no statistically significant differences 
between expansion states in the pre vs. post-ACA period by diabetes risk (Model 6). Notably, the 
other covariates that were statistically significant were the 55 to 64 age cohort (1.65, p<0.01) and 
the diabetes group (2.14, p<0.01), which are averaged over 4 years of data. The interaction term 
that was statistically significant was ACA*unknown, which showed that the unknown diabetes 
risk group was 81% less likely to receive diabetes screening in the post-ACA period, when 
compared to the no/low risk group in the pre-ACA period. 
 
 
 
 
 
 
 
 
 
272 
 
Table 94  
Logistic Regression Models for the Probability of Receiving Diabetes Screening by Expansion 
Status and Diabetes Risk (2012-2015) 
 
Probability of being 
Screened
a
 (n=8,974)
Model 1 
(Odds 
Ratio)
Model 
2 (Odds 
Ratio)
Model 3 
(Odds 
Ratio)
Model 4 
(Odds 
Ratio)
Model 5 
(Odds 
Ratio)
Model 6 
(Odds 
Ratio)
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref
Post-ACA 1.02 1.02 0.91 1.10 1.15 1.55
Expansion Status
Non-expansion Ref Ref Ref Ref Ref
Medicaid Expansion 1.07 1.13 1.31 1.30 1.22
Interaction Term
ACA*nonEXP Ref Ref Ref
ACA*EXP 0.74 0.74 0.44
Diabetes Risk
No/low Risk Ref Ref Ref Ref
High Risk 1.45* 1.45* 1.38 1.08
Diabetes 2.82*** 2.84** 2.58** 2.14*
Unknown 0.56* 0.56* 0.70 0.90
Interaction Term
ACA*no/low risk Ref Ref
ACA*high risk 1.10 1.00
ACA*diabetes 1.18 1.00
ACA*unknown 0.55 0.19*
3-Way Interaction Term
b
NoRisk*preACA*nonEXP Ref
HR*Pre-ACA*EXP 1.43
HR*Post-ACA*EXP 1.78
Dia*Pre-ACA*EXP 1.39
Dia*Post-ACA*EXP 1.83
UnK*Pre-ACA*EXP 0.64
Unk*Post-ACA*EXP 3.65
Race
Whites Ref Ref Ref Ref
Blacks 0.98 1.33 1.33 1.32
Hispanics 1.44 1.44 1.44 1.46
Age
18 to 34 Ref Ref Ref Ref
35 to 44 0.98 0.98 0.98 0.98
45 to 54 1.15 1.16 1.16 1.15
55 to 64 1.65** 1.67** 1.65** 1.65**
Gender
Male Ref Ref Ref Ref
Female 0.85 0.85 0.84 0.84
Chronic Disease
No Disease Ref Ref Ref Ref
At least 1 or more 1.17 1.17 1.16 1.16
Constant 0.13** 0.13** 0.10*** 0.09** 0.09** 0.09***
F Statistic 0.95*** 0.94 9.71*** 8.91*** 7.19*** 5.70***
*p<0.05. **p<0.01. ***p<0.001
Note. Logistic regressions for the Pb(SCR) by expansion status and diabetes risk in 15-
states (2012-2015); survey weighted data. Values indicate odds ratios. 
a
Diabetes Screening: Glucose or HgbA1c test during visit (2012-2015).
b 
Three-way interaction term: Diabetes risk, ACA and expansion status. Reference 
group:no/low risk for diabetes individuals living in non-expansion states in the pre-ACA 
period.
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 Diabetes Prevention Education by Expansion and Risk Status. With the addition of 
the ACA*Risk interaction term in Model 5, the high-risk group that was more likely to receive 
diabetes screening in Model 4, reduced to an odds ratio of 1.40 and was statistically insignificant. 
In fact, all odds ratios associated with the interaction term were statistically insignificant. Also, 
the ACA term went from 2.54, p<0.05 in Model 4 to 1.63 in Model 5 and was statistically 
insignificant. In Model 6, the three-way interaction term showed that individuals with unknown 
risk living within expansion groups experienced the greatest gains in receiving DPE (12.69, 
p<0.05). All other interactions in the post-ACA period within the three-way were found to be 
statistically insignificant when compared to the reference group: no/low risk for diabetes 
individuals living in non-expansion states in the pre-ACA period. Refer to Appendix AJ, Table 
AJ-4 for 95% CI’s.  
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Table 95  
Logistic Regression Models for the Probability of Receiving Diabetes Prevention Education by 
Expansion Status and Diabetes Risk (2012-2015) 
 
Probability of 
Receiving Diabetes 
Prevention Education
a 
(n=8,974)
Model 
1 (Odds 
Ratio)
Model 2 
(Odds 
Ratio)
Model 3 
(Odds 
Ratio)
Model 4 
(Odds 
Ratio)
Model 5 
(Odds 
Ratio)
Model 6 
(Odds 
Ratio)
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref
Post-ACA 1.62* 1.62* 1.55 2.54* 1.63 0.61
Expansion Status
Non-expansion Ref Ref Ref Ref Ref
Medicaid Expansion 0.83 0.81 1.29 1.28 0.75
Interaction Term
ACA*nonEXP Ref Ref Ref
ACA*EXP 0.44 0.45 2.08
Diabetes Risk
No/low Risk Ref Ref Ref Ref
High Risk 1.44* 1.44* 1.21 0.92
Diabetes 1.69 1.72 1.16 0.67
Unknown 0.51* 0.51* 0.33*** 0.15***
Interaction Term
ACA*no/low risk Ref Ref
ACA*highrisk 1.40 3.46*
ACA*diabetes 2.01 3.14
ACA*unknown 2.21 14.91**
3-Way Interaction Term
no/low*preACA*nonEXP Ref
HR*Pre-ACA*EXP 1.51
HR*Post-ACA*EXP 0.37
DIA*Pre-ACA*EXP 2.45
DIA*Post-ACA*EXP 1.28
Unkn*Pre-ACA*EXP 3.32*
Unkn*Post-ACA*EXP 12.69*
Race
Whites Ref Ref Ref Ref
Blacks 0.89 0.87 0.87 0.86
Hispanics 0.93 0.94 0.93 0.90
Age
18 to 34 Ref Ref Ref Ref
35 to 44 0.83 0.83 0.83 0.86
45 to 54 0.73 0.74 0.73 0.74
55 to 64 0.76 0.78 0.78 0.76
Gender
Male Ref Ref Ref Ref
Female 1.11 1.11 1.10 1.11
Chronic Disease
No Disease Ref Ref Ref Ref
At least 1 or more 0.89 0.88 0.87 0.88
Constant 0.16*** 0.18*** 0.22*** 0.16*** 0.21*** 0.29***
F Statistic 4.73* 2.72 6.74*** 7.65*** 6.53*** 5.75***
*p<0.05. **p<0.01. ***p<0.001
Note.  Logistic regressions for the Pb(DPE) by expansion status and diabetes risk in 15-
states (2012-2015); survey weighted data. Values indicate odds ratios. 
a
Diabetes Prevention Education (DPE) includes at least 1 form of teaching (i.e. exercise, 
diet/nutrition or weight reduction) provided during a clinic visit using 2012-2015 data. 
b 
Three-way interaction term includes interactions between race, ACA and expansion status. 
Reference group:no/low risk for diabetes individuals living in non-expansion states in the pre-
ACA period.
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 Sensitivity Analysis for the Pb (SCR) and Pb (DPE) Stratified by Diabetes Risk Status  
 To gain a better understanding of each diabetes risk group (excluding the unknown risk 
group), logistic regression analyses were conducted where the full regression model was 
stratified by diabetes risk. Two interaction terms were used: ACA*Expansion and ACA*Race to 
differentiate between differences in the outcome variables (i.e. diabetes screening or prevention 
education) by expansion group and by race. The key interest in this sensitivity sub-analysis is to 
discern if outcomes for individuals in the high-risk group differed by a state’s expansion status or 
by an individual’s race. Following clinical practice guidelines alone, being a minority who is 
overweight is enough to warrant diabetes screening, which hypothetically should mean more 
minorities are screened than whites just using these two broad criteria. The interaction terms in 
the regression models in the main text did not capture this information as diabetes risk was not 
interacted with race. Refer to Appendix AJ for full regression models including 95% CI’s.  
 In Table 96, high-risk individuals who were 45+ years were more likely to be screened 
for diabetes, than high-risk individuals aged 18 to 34. The 55 to 54 age group had the greatest 
odds of being screened, 2.56 (p<0.001). Hispanics in the post-ACA period were 4.49-times 
(p<0.05) more likely to be screened compared to whites, when adjusting for other factors. Blacks 
were also 2.17-times more likely to be screened than whites, but this difference was not 
statistically significant. There was no difference in the overall likelihood of being screened by 
expansion group. The high-risk for diabetes regression model was the only model to have a 
statistically significant F Statistic (3.57, p<0.001), which means the other two models for low 
risk and diabetes were not different than the intercept-only model. Refer to Appendix AJ, Table 
AJ-5 for 95% CI’s.  
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Table 96 
Logistic Regression Models for the Probability of Receiving Diabetes Screening, Stratified by 
Known Diabetes Risk  
 
Probability of being 
Screened
a 
Low Risk 
(n=1,489)
95% CI
High-Risk 
(n=3,146)
95% CI
Diabetes 
(n=607)
95% CI
ACA
Pre-ACA Ref Ref Ref
Post-ACA 1.17 (0.42, 3.26) 0.92 (0.36, 2.38) 1.39 (0.33, 5.93)
Expansion Status
Non-expansion Ref Ref Ref
Medicaid Expansion 1.15 (0.46, 2.83) 1.66 (0.95, 2.91) 1.68 (0.71, 3.93)
Age
18 to 34 Ref Ref Ref
35 to 44 0.91 (0.33, 2.52) 0.98 (0.42, 2.25) 1.40 (0.40, 4.86)
45 to 54 0.72 (0.22, 2.33) 1.65* (1.11, 2.45) 1.33 (0.46, 3.88)
55 to 64 1.47 (0.67, 3.25) 2.56*** (1.61, 4.08) 1.00 (0.34, 2.92)
Gender
Male Ref Ref Ref
Female 0.61 (0.26, 1.44) 0.74 (0.47, 1.17) 1.16 (0.68, 1.99)
Race
White Ref Ref Ref
Black 0.62 (0.18, 2.08) 1.15 (0.64, 2.05) 0.39 (0.12, 1.28)
Hispanic 1.10 (0.51, 2.39) 0.81 (0.42, 1.53) 1.18 (0.44, 3.20)
Chronic Disease
No Disease Ref Ref Ref
At least 1 or more 0.89 (0.46, 1.72) 1.08 (0.60, 1.94) 1.94 (0.93, 4.03)
Interaction Term
ACA*Non-expansion Ref Ref Ref
ACA*Expansion 0.44 (0.11, 1.82) 0.64 (0.18, 2.28) 0.72 (0.14, 3.65)
ACA*White Ref Ref Ref
ACA*Black 1.03 (0.08, 13.39) 2.17 (0.82, 5.75) 2.46 (0.30, 20.20)
ACA*Hispanic 2.56 (0.61, 10.73) 4.49* (1.12, 17.97) 0.36 (0.08, 1.67)
Constant 0.16*** (0.06, 0.38) 0.10*** (0.05, 0.18) 0.20* (0.05, 0.83)
F Statistic 1.67 3.57*** 1.04
*p<0.05. **p<0.01. ***p<0.001
Note.  Logistic regressions for the Pb(SCR) by expansion status and race in 15-states (2012-2015); 
survey weighted data. Values indicate odds ratios. 
a
Diabetes Screening: Glucose or HgbA1c test performed during a clinic visit from 2012-2015. 
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 In Table 97, the focus is on the likelihood of receiving diabetes prevention education in 
the post-ACA period. The delivery of diabetes education increased by 96% for the high-risk for 
diabetes group post-ACA. However, blacks were 2.17-times more likely (p=0.056) to receive 
diabetes prevention education, compared to their white counterparts in the post-ACA period. 
Hispanics were 39% less likely to receive diabetes prevention education than their white 
counterparts post-ACA, although not statistically significant. There was no overall difference in 
diabetes prevention education provided between expansion groups. Interesting to note, blacks 
who were no/low risk were almost 11-times more likely to receive diabetes prevention education 
in the post-ACA period, when compared to their white no/low risk counterparts.  Refer to 
Appendix AJ, Table AJ-6 for 95% CI’s.  
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Table 97 
Logistic Regression Models for the Probability of Receiving Diabetes Prevention Education, 
Stratified by Known Diabetes Risk  
 
Probability of Receiving 
DPE
a 
Low Risk 
(n=1,489)
95% CI
High-Risk 
(n=3,146)
95% CI
Diabetes 
(n=607)
95% CI
ACA
Pre-ACA Ref Ref Ref
Post-ACA 0.47 (0.17, 1.34) 1.96* (1.11, 3.45) 2.05 (0.48, 8.74)
Expansion Status
Non-expansion Ref Ref Ref
Medicaid Expansion 0.73 (0.33, 1.53) 1.07 (0.66, 1.76) 1.77 (0.56, 5.59)
Age
18 to 34 Ref Ref Ref
35 to 44 0.67 (0.34, 1.29) 0.88 (0.60, 1.29) 0.38 (0.12, 1.24)
45 to 54 1.09 (0.63, 1.89) 0.73 (0.50, 1.08) 0.38* (0.15, 0.96)
55 to 64 1.07 (0.61, 1.88) 0.78 (0.51, 1.18) 0.42 (0.15, 1.16)
Gender
Male Ref Ref Ref
Female 1.31 (0.70, 2.45) 0.90 (0.65, 1.23) 1.17 (0.62, 2.22)
Race
White Ref Ref Ref
Black 0.27* (0.08, 0.86) 0.55* (0.32, 0.93) 0.54 (0.16, 1.81)
Hispanic 0.78 (0.31, 1.99) 0.65 (0.34, 1.24) 1.17 (0.35, 3.84)
Chronic Disease
No Disease Ref Ref Ref
At least 1 or more 0.73 (0.39, 1.35) 0.79 (0.45, 1.39) 1.17 (0.55, 2.50)
Interaction Term
ACA*Non-expansion Ref Ref Ref
ACA*Expansion 2.34 (0.71, 7.74) 0.54 (0.27, 1.09) 1.13 (0.19, 6.85)
ACA*White Ref Ref Ref
ACA*Black 10.97* (1.68, 71.49) 2.17 (0.98, 4.81) 1.04 (0.18, 6.01)
ACA*Hispanic 1.13 (0.25, 5.09) 0.61 (0.21, 1.77) 0.60 (0.10, 3.68)
Constant 0.25** (0.11, 0.57) 0.35*** (0.22, 0.57) 0.31 (0.08, 1.24)
F Statistic 1.02 2.21** 1.05
*p<0.05. **p<0.01. ***p<0.001
a
Diabetes Prevention Education (DPE) includes at least 1 form of teaching (i.e. exercise, diet/nutrition 
or weight reduction) provided during a clinic visit using 2012-2015 data. 
Note.  Logistic regressions for the Pb(SCR) by expansion status and race in 15-states (2012-2015); 
survey weighted data. Values indicate odds ratios. 
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CHAPTER 5 
RESEARCH FINDINGS, POLICY IMPLICATIONS & LIMITATIONS 
 Historically, changes to national U.S. health policy have been incremental, and highly 
debated. The incremental policy approach to improving our health care system up to 2010, had 
left 49.9 million Americans uninsured with limited access to health care services (Kaiser Health 
News, 2012). In this section, we discuss the findings of our research and compare the findings 
with previous scholarly work on the ACA and access to care, specifically focusing on 
racial/ethnic health disparities and diabetes preventive care. Methodological challenges are 
discussed, including opportunities for future research. This discussion is centered around 
developing evidenced-based policy recommendations to address the existing gaps in health 
insurance coverage and primary care access for low-income, minority adult populations and 
individuals at high-risk for diabetes within our fragmented health care system.  
 The overall purpose of this research was to assess the impact of the ACA on reducing 
health disparities in the delivery of diabetes prevention for those at high-risk of developing 
diabetes in the U.S. The literature reviewed included 7 studies that met the following four 
criteria: (1) Medicaid expansion or the insurance marketplace as the policy intervention, (2) a 
variable for race/ethnicity, (3) a variable for diabetes and (3) analysis of data post 2013. 
However, to conduct this research, a connection had to be made first from the ACA to health 
care coverage, and then from coverage to health care access and the delivery of diabetes 
preventive care.   
Conceptually, the Modified Quality Health Outcomes Model linked the ACA’s Medicaid 
expansion and insurance subsidies to increased coverage options for low-income adults, with 
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greater gains seen for those living between 100-400% FPL in Medicaid expansion states, than in 
non-expansion states. The increased levels of insurance had a positive 1% spillover effect (gain) 
in the percent of individuals who had access to the primary health care system, as measured by 
the percent of individuals who reported having a primary care provider in the post-ACA period. 
There was also a narrowing of racial/ethnic disparities, but Hispanics continued to have the 
lowest levels of reported PCP in the post-ACA period. The small increases in PCP did not lead to 
differences between the no/low risk and high risk for diabetes groups in having diabetes 
screening or diabetes prevention education in the post-ACA period. However, Hispanics at high-
risk for diabetes were 4 times more likely to be screened than high-risk whites. There were no 
differences by race in receiving at least one form of diabetes prevention in the post-ACA period; 
although the high-risk for diabetes group was 96% more likely to receive diabetes prevention 
than the no/low risk group. To note, blacks at no/low risk were 11 times more likely to receive 
diabetes prevention education in the post-ACA period, than low-risk whites. Supplemental 
studies were included in this discussion section to compare our overall results to other study 
findings that address the specific aim/sub aim.  
Specific Aim 1 Study Findings for ACA Effect on Insurance, Overall and by Expansion 
Status 
The ACA’s Medicaid expansion and insurance subsides worked primarily through 
income (i.e. eligibility by % FPL) to provide access to insurance coverage. From our research it 
was apparent that of the almost 9% gains in insurance coverage nationwide, most of the gains 
occurred in the two lower income groups (<138% FPL). Surprisingly, the <100% FPL 
experienced the largest gains in insurance by the post-ACA period. Despite these gains, the low-
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income groups still had many individuals who remained uninsured, especially within states that 
did not expand Medicaid.   
To compare our findings, we discuss one study that met the inclusion criteria (Sommers 
et al, 2015) and three supplemental articles that included post-ACA data (Decker e al., 2017, 
Griffith et al., 2017, and McKenna et al., 2018). All of these studies used national federal 
datasets (i.e. BRFSS and NHIS) except Sommers et al. (2015) who used the Gallup-Healthways 
Well-Being Index. McKenna et al. (2018) was the only study that included data up to 2016. Our 
study included post-ACA years up to 2017.  
Overall, these four studies confirmed our results that insurance coverage rates improved 
post-ACA, with the largest gains in insurance occurring within Medicaid expansion states. In our 
study we used percent of FPL to assess where the changes in insurance levels occurred since 
BRFSS did not provide the type of insurance coverage available (i.e private vs. Medicaid.). 
Sommers et al. (2015) also converted household income from the Gallup survey to %FPL, but 
only had three groups: (1) 0-138; (2) 139-400; and (3) >400 to which overall changes and 
changes by expansion status were assessed. Griffith et al. (2017) who also used BRFSS (2013 to 
2015) did not convert household income to a % of FPL as was done in our study. Instead a 
binary dummy variable for household poverty was created to identify households most likely to 
live below the 2014 FPL line, which was a household income less than $25,000 per year. Income 
was also used as a continuous variable as provided by BRFSS in the main models (Griffith et al., 
2017). Decker et al., (2017) limited their study sample to individuals living below 138% FPL, 
which did not allow for the study of the insurance subsidies. McKenna et al. (2018) did a similar 
approach to ours and converted household income to %FPL. The categories included: (1) 0-
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124%; (2) 125% to 199%; (3) 200 to 299%; (4) 300 to 399%; and (5) > or = to 400% (McKenna 
et al., 2018).   
A benefit to the way we isolated ACA effects by income was that our income (or %FPL 
variable) was created to easily discern which income levels were affected by Medicaid, and 
which by the insurance subsidies. By not taking into account household income, this may 
contribute to a misrepresentation of individuals in poverty as some higher household incomes 
with a large household size would be excluded from the low-income sample. In the Griffith 
(2017) study the pre-ACA insurance estimate was 90% for households with incomes more than 
$75,000 and 60% insured for households with incomes below $25,000 per year. In our study we 
were able to see that the <100% FPL had even lower insurance rates in the pre-ACA period, a 
rate of 54.96%, which decreased to 48.20% in non-expansion states. As insurance levels 
increased past 100% FPL, it becomes a challenge to interpret changes by income if it is not 
directly aligned with the %FPL associated with Medicaid or the insurance subsidies.  
Medicaid expansion states were different within all studies. We excluded 4 states that 
expanded Medicaid up to 200% FPL in the pre-ACA period. McKenna et al. (2018) did not 
control for Medicaid expansion and all assessed overall ACA effects. Sommers et al. (2015) used 
all 50 states in their analyses, 28 Medicaid expansion states plus D.C. Decker et al (2015) also 
used all 50 states to make the expansion groups. Griffith et al. (2017) excluded several states and 
D.C. from the Medicaid expansion group: Arizona, Delaware, Hawaii, New York, Vermont, 
Massachusetts, Maryland. When we performed a sensitivity analysis keeping the 4 states in our 
analyses, there was not much difference between the 50-state and 47-state sample; but it was 
easier to interpret ACA effects when the 4 states were dropped.  
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All studies used a difference-in-difference approach which is a version of fixed effects 
estimation using data in aggregate instead of repeated observations on individuals (Angrist & 
Pischke, 2009). Sommers et al., (2015) used an interrupted time-series linear regression models 
using quarterly indicators for ACA (time); whereas the other studies used linear probability 
regression models with a pre/post-ACA indicator.  Generally, linear models were used instead of 
logistic models to improve to interpretability (McKenna et al., 2018). In the Griffith et al. (2017), 
the largest regression-adjusted percentage-point change in insurance (15 percentage points) was 
seen among the $0-<$35,000 household income groups, living within Medicaid expansion states, 
which is consistent with our results that the lowest income group experienced the greatest gains 
in insurance. McKenna et al. (2018) also found the greatest insurance gains for incomes <199% 
FPL and also ran sensitivity analyses using logistic regression which found no observable 
changes in the significance or direction of main effects. Sommers et al. (2017) saw a 7.9 
percentage point decrease in the overall rate of uninsured.  
Griffith et al. (2017) measured the narrowing of socioeconomic disparities as the absolute 
gap difference in insurance coverage between the two income groups in expansion and non-
expansion states. A greater reduction in socioeconomic disparities was seen in Medicaid 
expansion states (Griffith et al. 2017). McKenna et al. (2018) measured the narrowing of 
socioeconomic disparities as the relative difference from the >400% FPL reference group. We 
measured differences in disparities as absolute differences.  
From recent research on the ACA, it was clear that being an expansion state amplified the 
overall ACA effect, increasing the likelihood of having insurance for the low-income groups. 
From our analysis, there was no statistically significant expansion effect on the >400% FPL 
group, although the p value for the ACA*EXP interaction term was 0.068. The increase in the 
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likelihood of having insurance among the >400% FPL group could be attributed to the 
“welcome-matt effect” as more individuals were aware of insurance recruitment efforts and 
subsequently enrolled for coverage, or possibly because the individual mandate that was effect 
early in the post-ACA period (Medicaid and CHIP Payment and Access Commission, 2019).   
Generally, from our analysis and previous research, expansion states benefited the most 
given the higher levels of insurance in the pre-ACA period, more coverage options for the 100-
138% FPL group and potentially a political environment that was conducive of enrolling 
individuals for health insurance, which was not controlled for in this analysis (and discussed in 
the future research section). Non-expansion states did make coverage gains, but not enough to 
reap the full benefit of the ACA effect. From our analysis, the greatest opportunities to improve 
insurance enrollment within non-expansion states was among individuals living below 138% 
FPL. This highlights the integral role Medicaid expansion played in ensuring access to insurance 
for low-income adults during the ACA period  
Specific Aim 2 on ACA Effect on Health Care Access, Overall and by Expansion Status 
The ACA worked through expanded insurance coverage to provide health care access to 
low-income adults. Health care access was defined as the report of having a primary care 
provider (PCP) or a checkup in the past year; although having a PCP was considered the primary 
measure of health care access for our analysis. Griffith et al. (2015) used the same BRFSS PCP 
measure as we did, but found that Medicaid expansion reduced the percentage of individuals 
without a PCP by 3.6 percentage points (Griffith et al., 2015). Sommers et al.(2015) also saw a 
decline of 3.4 percentage points in the number of individuals without a PCP.  In our study, we 
hypothesized that the ACA’s subsidy and Medicaid expansion provisions would lead to an 
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overall increase in health care access for adults aged 18-64, with racial and ethnic minorities and 
those at high-risk for diabetes experiencing greater gains in having a PCP within Medicaid 
expansion states, than non-expansion states. Unexpectedly, large gains in insurance coverage did 
not yield similar gains in having a PCP or checkup in the past year, even within Medicaid 
expansion states.  
Overall, our descriptive study statistics showed only a 1% gain in having a PCP and a 3% 
gain in having a checkup in the past year. Most of the gains in health care access occurred within 
Medicaid expansion states (2% gains in PCP, 4% gains in Checkup), with a slight decline in 
having a PCP in non-expansion states (-0.07% loss in PCP). The low levels of PCP uptake could 
be attributed to three areas: (1) a low supply of PCPs within a state, which this data is not 
adjusted for; (2) an increase in the utilization of another type of health care provider, such as an 
Nurse Practitioner or Physician Assistant, which the BRFSS does not fully capture; or (3) the 
lack of an incentive in the ACA to encourage the selection of a PCP. It is important to note that 
when an individual enrolls for private insurance, only a Health Maintenance Organization 
(HMO) requires an enrollee to select a PCP, while a Preferred Provider Organization (PPO) 
insurance plan does not. Most Medicaid programs use HMOs to manage care delivery (Centers 
for Medicare and Medicaid Services, n.d.). However, given the different payment structure for 
Medicaid, many primary care physicians could choose not to accept Medicaid payments (or 
patients) even after the ACA temporarily included increases to physician payments in some 
states (Decker, 2012) potentially limiting the availability of PCP’s for Medicaid patients.  
The overall increased rate in having a checkup (despite an overall lower percentage of 
individuals reporting a PCP) could be attributed to respondents seeking preventive services in 
non-traditional settings (i.e. convenient care clinics) or with non-traditional primary care 
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providers living in states that have expanded provider scope of practice laws for Nurse 
Practitioners and Physician Assistants. The increase in checkups may also be related to the ACA 
provision that was added to insurance coverage, which ensures preventive care services are 
covered at no additional cost to the consumer. Coverage of Essential Health Benefits began in 
September 2010, but was effective much more broadly as of January 1, 2014- the same time as 
coverage expansion (National Conference of State Legislatures, 2019). Therefore, even if 
someone did not have a provider assigned to them, preventive care services would still be 
covered for a visit. Although it is great that increases in a checkup in the past year did occur, 
lower increases in PCP is of concern as having a PCP is an integral component of ensuring 
timely, consistent and coordinated preventive care.  
It was a challenge to compare our regression analysis to Sommers et al. (2016), McKenna 
et al. (2018) and Griffith et al. (2017) because our analysis was the only one to replace income 
levels with insurance. The other regression models kept income as a predictor variable which 
may have led to PCP gains instead of a decline in the odds of having a PCP or checkup in our 
analysis in the post-ACA period. Since we did not focus our analysis on ACA effects of PCP by 
income, we did not see changes by income group in having a PCP. McKenna et al. (2018) found 
that the 0% to 124% and the 125% to 199% FPL groups experienced increases in having a PCP 
in the post-ACA period, relative to the >400% FPL group.  
However, in our study once INS and other covariates were controlled, we were able to 
see the ACA effect on PCP, was over and above the main insurance effect. With insurance alone, 
individuals were 6.5-times more likely to have a PCP than the uninsured and 3.5-times more 
likely to have a checkup in the past year than the uninsured over the unadjusted 6-year time 
period. This shows that insurance plays a lesser role in ensuring access to a checkup as many 
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safety net systems are in place across the country that provide preventive medicine to the 
uninsured without a one-to-one assignment of a PCP. Additionally, otherwise healthy adults, 
especially younger adults tend to utilize primary care services less frequently, with yearly annual 
exams being emphasized for adults (>45) at higher risk for certain chronic conditions. 
PCP supply was added as a covariate for our regression analysis to adjust for differences 
in the supply of primary care providers across states. Sommers et al. (2015) did include a 
measure for residence, urban vs. rural. However, Sommers et al. (2016), adjust for a variable 
labeled as “lives in county designated a primary care health profession shortage area”. In this 
study the researchers found a 12.1 percentage point increase in having a PCP in Medicaid 
expansion states. Large increases here are attributed to the sample only comparing Arkansas and 
Kentucky (Medicaid expansion states) with Texas (non-expansion states).  
 Quantifying the INS to PCP Link 
 We were the only study to quantify the link between the ACA to INS to PCP. When 
adjusting for other variables, the calculated ACA-related increase on PCP of 7.4 percentage 
points was completely offset by the weakening effect of insurance in leading to a PCP. The ACA 
effect on PCP via insurance was only 1%, which was much lower than expected. This suggests 
that the entire expected growth in PCP access from greater coverage was hindered by a 
combination of newly insured individuals failing to access a PCP, and/or previously insured 
losing their access in the post-ACA period, despite retaining coverage. It may be possible that 
the post-ACA period under study may be too short of a time to see dramatic increases in PCP, 
considering healthy adults aged 18 to 64 may not seek out preventive care if they feel otherwise 
healthy. To gain a better understanding of which additional factors may have contributed to the 
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low levels of PCP update in the post-ACA period, sub-analyses by race and diabetes risk status 
were also considered.    
Descriptive Sub-Analysis for Overall ACA Effect on Health Care Access by Race  
In this sub-analysis, the hypothesis was that the ACA would increase access to primary 
health care and narrow disparities for blacks and Hispanics when compared to whites. Since 
insurance coverage was included in the regression model as a main effect, any race-related 
effects were interpreted as “over-and-above” insurance effects. Unadjusted data showed that 
blacks and Hispanics had 10-15% increased likelihood of having a PCP. But, once controlling 
for insurance and other variables, the regression results indicated that blacks and Hispanics 
should have fared better given their large relative gains in insurance coverage. In the post-ACA 
period, blacks were 14% and Hispanics 38% less likely to have a PCP than whites in the pre-
ACA period. This may be due to newly insured not seeking a PCP right away, or not enough 
incentive in the legislation to seek a provider.   
Griffith et al. (2017) did not include race as a predictor variable. Sommers et al. (2015) 
included only whites and Latinos in the study which showed no statistically significant 
differences between whites and Latinos in having a personal physician in the post-ACA period. 
Sommers et al. (2016) showed that blacks and Hispanics experienced significant increases in 
office visits and checkups, although the sample size was limited to 3 states. McKenna et al. 
(2018) included blacks and Hispanics in their study, and US citizenship and language of 
interview as covariates, but did not explore disparities by race.  
Previous research has linked low-income and educational attainment of Hispanics as 
barriers to health care; and for some Hispanic sub-populations, acculturation, language and 
289 
 
immigration status are additional obstacles that prohibit health care access- which we could not 
control for in our analysis (Escarce & Kaur, 2006).  In addition, a lack of awareness has been 
cited as a reason that Hispanics have not enrolled for health insurance which would then affect 
their ability to obtain a PCP. Two years after ACA’s open enrollment, a recent survey of 
Hispanic adults showed that 1 in 4 heard “nothing at all about the health insurance marketplaces 
or exchanges, with another 28 percent indicating they heard “not that much”. In addition, of the 
individuals who were insured, only 68% were insured for the full year. More than one in ten 
Hispanics sited they did not enroll in health care because it was either “too expensive” or they 
would rather pay the fine (Sanchez, Pedraza & Vargas, 2015).  
Even if Hispanics did manage to enroll for insurance, low levels of health insurance 
literacy contributed to the disconnect between insurance enrollment and health care access to 
health care providers. Only 1/3rd of Hispanic adults were somewhat or very confident in their 
understanding of the terms “provider network, covered services, annual limits on services, and 
excluded services”, while 2/3rds of non-Hispanic whites reported understanding these terms 
(Blavin, Zuckerman, Karpman & Clemans-Cope, 2014). Misunderstanding of these terms among 
the Hispanic community highlights the disconnect many may have in linking improved coverage 
to increased access to a PCP. 
The minor growth in the uptake of a PCP led to a decline in the PCP/INS ratio for all 
racial/ethnic groups. Interesting to note, black and whites had relatively similar post-ACA PCP 
rates (75% and 78%, respectively), yet, the PCP/INS ratio was greater for blacks than whites, 
which was also confirmed by the regression analysis showing blacks had a 13% increased 
likelihood of having a PCP in the post-ACA period in expansion states. Although changes in 
insurance was not explored by race, it is hypothesized that whites made major coverage gains, 
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surpassing that of blacks, leading to a small PCP/INS ratio for whites. In addition, considering 
that blacks may have better access to a PCP due to primarily living in urban areas (that tend to 
have more PCPs) when compared to whites, may also be contributing to the increased PCP/INS 
ratio for blacks. Additionally, cities tend to have more safety net primary care systems that will 
see patients without insurance, as the PCP numerator can include access to a PCP even for the 
uninsured. However, it is interesting that Hispanics also tend to live in urban areas but have not 
experienced similar increases in having a PCP as blacks have. Exploring differences in insurance 
by race is a potential area for future research that is discussed in the future research section.  
 Sub-Analysis for Overall ACA Effect on Health Care Access by Diabetes Risk Status  
 For this sub-analysis, it was hypothesized that the high-risk for diabetes group would 
experience PCP gains over that of the low-risk group, with most of the gains occurring within 
expansion states. From our review of literature, it was apparent that research using a high-risk for 
diabetes variable was missing in the literature. Therefore, this section will focus on a discussion 
of our results. Of most concern is the 10% decline in having a PCP among the high-risk for 
diabetes group in the post-ACA period. Considering that individuals who were aware of their 
diabetes status experienced an increase in the PCP rate. A strong first step to increasing the PCP 
rate among the high-risk group would be to increase awareness of this health condition to those 
who have it. Awareness from a health care provider would serve as an incentive for individuals 
to seek a PCP, as demonstrated by the gains in PCP experienced by the diabetes group. In our 
analysis, there was an extremely low rate of self-reported pre-diabetes within the high-risk for 
diabetes group. In fact, less than 2% of respondents reported pre-diabetes, meanwhile the 
estimated population percentage with diabetes is 33%.  Using BRFSS data, the vast majority of 
individuals were unaware of their pre-diabetes status which could be contributing to the low PCP 
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gains for the high-risk group. Of the individuals who were aware and reported pre-diabetes, 81% 
reported having a PCP. This is why assessing the delivery of diabetes prevention to the high-risk 
group was integral to this analysis and is explored further with the NAMCS dataset in the next 
section. 
Specific Aim 3 for the Delivery of Diabetes Prevention Screening and Education 
 It was initially hypothesized that more individuals would receive diabetes screening and 
diabetes prevention education overall, with greater proportions receiving diabetes prevention 
within Medicaid expansion states due to the increased number of individuals gaining health 
insurance coverage. There were no studies in the literature that focused on the high-risk for 
diabetes group and the ACA effects on diabetes prevention outcomes. However, two recent 
studies will be discussed that focus on prediabetes using the NAMCS database. The time period 
under study was 2013-2015 NAMCS for the Wu, Ward & Zhiqiang (2018) study and only 2012 
NAMCS data was used in the Mainous, Tanner and Baker (2016) study. Our sub-study is timely 
considering a new commentary was published July 2019 in The Journal of American Board of 
Family Medicine states that it’s time to prioritize diabetes prevention in practice (Mainous & 
Schatz, 2019).  
 Mainous et al. (2016) focused on assessing if individuals with prediabetes were likely to 
be diagnosed correctly or receive treatment. The study found that the most common primary 
diagnosis for visits with individuals with pre-diabetes was hypertensive disease and that 3/4ths 
were not provided a treatment plan (i.e. education or medication). Prediabetes was defined as 
mainly as an individual aged 45 or older with a HbA1c between 5.7 to 6.4% since the diagnosis 
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code for prediabetes was too small to allow reliable estimates to be produced (Mainous et al., 
2016). 
 Wu et al. (2018) also focused on individuals with prediabetes and defined the population 
as visits where patients with a recent A1C (5.7-6.4%), fasting blood glucose (100-125 mg/dL) 
for years 2013-2014 since lab data was removed from 2015 due to low response rate. As a result, 
2015 was only coded as prediabetes if an ICD-9 code was available for impaired fasting glucose, 
impaired glucose tolerance, or other abnormal glucose levels. The main outcome was to assess if 
lifestyle management (i.e. education) was provided. The sample size was limited to visits with 
individuals who were identified to have prediabetes (Wu et al., 2018).  Wu et al. (2018) found 
that 22.8% of visits with patients who had prediabetes received lifestyle management and that 
individuals who were younger than 65, obese, black living in the south or had hyperlipidemia 
were more likely to receive education.  
The structural study differences between these two studies and our study is that high risk 
for diabetes was used instead of prediabetes only, and the sample was limited only to preventive 
care visits within states that NAMCS provided state level estimates in order to compare non-
expansion to expansion states. Unlike Mainous et al. (2016), we included everyone aged 18 to 
64. We did not use lab data to determine if a patient had prediabetes since one of our primary 
outcomes of interest was diabetes screening. The other main outcome was the delivery of at least 
1 form of diabetes education in the post-ACA period.  
One of the major challenges that the two previous studies did not mention (since they did 
not use BMI to determine prediabetes status), was the lack of documentation for height and 
weight. By 2015, there were many missing values which NAMCS has made researchers aware 
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of. Overall, there was a 22% decline in preventive care visits by the post-ACA period, with this 
decline being mainly among whites (-6.37%). The decline in preventive care visits by whites is 
consistent with the smaller white PCP/INS ratio, compared to the black and Hispanic PCP/INS 
ratios. However, this could also be related to the fact that there is a high number of missing data 
in 2015, leading to a decline in the size of the unweighted group.  When focusing on diabetes 
risk groups, the unknown risk group was the only group to experience a decline in the post-ACA 
period. This is most likely related to better documentation in the post-ACA period, which 
allowed us to categorize the individual within the appropriate diabetes risk group of low, high or 
diabetes. For preventive care visits with reported diabetes risk, 62.42% were high-risk, 26.04% 
were no/low risk and 11.54% had diabetes in the post-ACA period.  
 ACA Effect on the Delivery of Diabetes Prevention Overall, and by Expansion Status  
Per the American Diabetes Association’s (ADA’s) Standards of Medical Care in Diabetes 
(2018), criteria for testing of diabetes or prediabetes in asymptomatic adults includes testing for 
overweight/obese adults with one or more of the following risk factors: 
• A1c>5.7% 
• Impaired fasting glucose on previous testing 
• First degree relative with diabetes 
• High-risk race/ethnicity (i.e. black and Hispanics) 
• Women diagnosed with gestational diabetes or polycystic ovary disease 
• History of cardiovascular disease  
• Hypertension (>= 140/90 mmHg or on medication for HTN) 
• HDL cholesterol level ,35mg/dl and/or triglyceride level >250mg/dL 
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• Physical inactivity  
• Other clinical conditions associated with insulin resistance (i.e. severe obesity or 
acanthosis nigricans.  
In the full 15-state sample of preventive care visits, there was only a 1.5% increase in diabetes 
screening. Of the 62% of visits with individuals identified at high-risk, only 17% were screened 
for diabetes post-ACA, which was a 48% increase from the pre to post-ACA period. A decline of 
9% screening for the visits with high-risk individuals was noted in Medicaid expansion states, 
which could be related to the greater proportion of whites living in these states (as whites were 
the only racial/ethnic group to experience declines in diabetes screening).  
 When ACA was unadjusted, the regression model showed a 2% increase in diabetes 
screening in the post-ACA period; however, this was statistically insignificant, but similar to 
what was found in the descriptive statistics. Expansion status did not play a statistically 
significant role in increasing diabetes screening during the ACA period, which may be related to 
the low number of states included in this analysis. Across all 4 years in the full model, 
individuals aged 55 to 64 (1.67 OR, p<0.01), individuals at high-risk (1.45 OR, p<0.05) and 
individuals with diabetes (2.84 OR, p<0.01) were more likely to receive diabetes screening in the 
post-ACA period. The unknown risk group were 44% less likely to receive diabetes screening 
which could be attributed to a greater proportion of this group being of younger age (18 to 34).    
 Interestingly, the rate of diabetes prevention education was higher than the overall 
screening rate. There was a 49% increase (p<0.05) in diabetes prevention education provided in 
the post-ACA period. One would think that if a patient received diabetes prevention education 
during a clinic visit, then they should have been screened for diabetes also, which was not the 
case. The high-risk for diabetes group was about 1.5-times more likely to receive diabetes 
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prevention education than the no/low risk group, with non-expansion states providing more 
education than Medicaid expansion states.  
 The regression model with only ACA showed an overall 62% increase in diabetes 
prevention education in the post-ACA period. However, once adjusted for other factors, the rate 
of DPE provided increased to 2.54-time greater than the likelihood of receiving DPE in the pre-
ACA period. The high-risk for diabetes alone, experienced a 44% increased likelihood of 
receiving DPE in the post-ACA period over the no/low risk group. However, there was no 
statistically significant difference between expansion groups in receiving DPE in the post-ACA 
period.  
 ACA Effect on Diabetes Prevention Stratified by Diabetes Risk and Race 
The main focus in this sub-analysis was to assess if racial/ethnic disparities in screening 
existed by race, primarily among the high-risk for diabetes group. High-risk individuals who 
were 45+ years were more likely to be screened for diabetes, than high-risk individuals aged 18 
to 34. This practice follows the 2018 ADA Guidelines diabetes screening criteria, as diabetes 
screening was recommended yearly for high-risk individuals aged 45 or older. For individuals 
under 45, if results were normal, testing should be repeated at least every 3 years. Interesting to 
note that within the no/low risk group, there was no statistically significant difference in 
screening rates among the no/low risk group by age, even though the ADA recommends 
screening for all adults at age 45. There is an opportunity to improve the screening rates for 
no/low risk adults 45 and older. High-risk Hispanics had 4.49-times increased odds of being 
screened than their high-risk white counterparts in the post-ACA period. However, Hispanics 
also started at lower screening levels than whites in the pre-ACA period. In fact, 50% of the 
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preventive care visits made by Hispanics had an unknown diabetes risk based on no BMI 
documentation. For blacks and whites, the percent of visits with unknown diabetes status was 
about 34%, based on no BMI documentation.  
The high-risk for diabetes group did experience an overall 95% increased likelihood of 
receiving diabetes prevention education in the post-ACA period. The no/low risk and diabetes 
groups did not. This is interesting considering there was an overall decline of 8% in the 
likelihood of being screened in the post-ACA period for the high-risk group (although not 
statistically significant). Based on the descriptive statistics, this decline was primarily driven by 
whites who saw a reduction in diabetes screening in the post-ACA period.  
When it came to providing DPE by race, minorities had lower rates of education provided 
in the pre-ACA period. However, blacks experienced a two-fold increased likelihood of having 
DPE in the post-ACA period compared to whites, although not statistically significant. The low 
levels of diabetes prevention provided to Hispanics relative to whites could be due to language or 
literacy issues that this study did not control for. Interesting to note that no/low risk blacks saw 
an almost 11-times increased likelihood of being screened in the post-ACA period when 
compared to their white counterparts. Further research into this no/low risk black group would be 
needed to see how no/low risk whites differ from blacks. For example, do more normal weight 
blacks have insulin resistance than whites?  A 2006 study found that normal weight black 
women were at greater risk of insulin resistance than white or Hispanic women (Harvard Health 
Publishing, 2006). A closer look at diabetes screening for the no/low risk black population by 
sex and documented glucose/A1c levels would be needed to determine population differences.  
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Policy Implications 
This research has shed light on four priority areas: (1) elevating insurance levels for low-
income adults; (2) increasing access to primary care providers, (3) improving quality within 
primary care practices and (4) and a comprehensive plan by health professions to diversify the 
nursing (health care) workforce.  
 Elevating National Insurance Levels for Low-income Adults  
Previous research has estimated that nearly 20 million people gained coverage in the 
post-ACA period (Kaiser Family Foundation, 2018). According to our research, approximately 
12 million adults aged 18-64 gained health insurance in the post-ACA period (2014-2017). Had 
insurance levels for all income groups reached the levels of the >400% FPL group, an additional 
21 million adults aged 18 to 64 would have gained insurance coverage in the post-ACA period, 
but instead remained uninsured (Appendix AJ). As a result, approximately 73% of the targeted 
population (individuals living below <400% FPL) gained insurance from the ACA’s Medicaid 
expansion or insurance subsidies in the 2014-2017 period. But is this enough??  
According to a May 2019 national opinion poll on U.S. registered voters, Americans 
across the country ranked health care as the top policy issue facing the country today-but there 
was not consensus over which health care issue was the priority. Democrats focused on ensuring 
access for all; whereas Republicans prioritized lowering costs. Overall, costs outweighed 
accessibility (RealClear Opinion Research, 2019). Current Democratic policy proposals focus 
heavily on increasing coverage options, not only for the uninsured, but for individuals who also 
feel the burden of increased health care costs (Goldstein, 2019). The hot topic and highly debated 
“Medicare for All” is the policy platform that many Democratic Candidates have been proposing 
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during the current campaign season, but it’s not the only one. To date, the Kaiser Family 
Foundation (2019) has an ongoing list of current proposals to expand the role of public programs 
for health care. Democrats have introduced 10 public plan proposals in the 116th Congress and fit 
into 5 categories: (1) A national single-payer health insurance program, commonly known as 
Medicare for All; a new public plan with an opt out option, Medicare for America; (3) a public 
plan option; (4) Medicare Buy-in for Older Adults (under 65); and (5) Medicaid Buy-In (Kaiser 
Family Foundation, 2019).  
On the other hand, Republican policy proposals have focused mainly on repealing and 
replacing the ACA, with some of the key highlights including: (1) repealing the ACA’s 
individual mandate (which was successful); (2) Modifying the ACA premium tax credits; (3) 
Converting federal Medicaid funding to a per capita allowance; (4) Adding the option for states 
to add a work requirement for eligibility of Medicaid coverage and (5) Phasing out the enhanced 
FMAP for Medicaid expansion states or eliminating Medicaid expansion all together (Kaiser 
Family Foundation, 2019).  
From our research, it was apparent that the ACA made major coverage gains for low-
income groups, but there was opportunity to enroll more individuals who were eligible. The 
positive gains in insurance would have been a good sign of success if there were signs that the 
gains would continue into 2018. However, by 2017, small declines in the percent insured 
occurred for both the 139-400% FPL and >400% FPL income groups. This was the first decrease 
in the percent insured since the implementation of the ACA and was attributable to plans to 
“repeal and replace” the ACA (Kliff, 2019). Any further eradication of the ACA’s current 
structure would put more low-income and vulnerable individuals at risk of losing coverage. Most 
of the focus for Republicans is reducing eligibility for Medicaid and insurance premiums. In our 
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research we were able to quantify the benefit of Medicaid expansion and the insurance subsides 
in increasing coverage for low-income adults in states that expanded Medicaid, which should be 
upheld in order to ensure individuals continue to have access to the health care system.   
Had non-expansion states expanded Medicaid, post-ACA insurance levels could have 
reached 75% for the <100% FPL group and 78% for the 100-138% FPL group. With non-
expansion states reaching levels of insurance like Medicaid expansion states, an estimated 2.3 
million more individuals living below 100% FPL and 1.9 million more individuals living 100-
138% FPL could have gained Medicaid coverage in non-expansion states. By not expanding 
Medicaid, non-expansion states left 4.1 million low-income Americans without options for 
affordable health care, especially at a time when health care costs continue to escalate 
nationwide Refer to Appendix AJ for a table where uninsured values are calculated. The Kaiser 
Family Foundation estimated that 2.2 million Americans with incomes <100% FPL in non-
expansion states fell into the Medicaid coverage gap, which was confirmed in our analysis to be 
2.2 million uninsured living <100% FPL in non-expansion states (Kaiser Family Foundation, 
2018). 
From a nursing perspective, reducing insurance coverage options by either retracting 
Medicaid expansion or lowering the percent of FPL subsidy levels when there are still 21.4 
million Americans uninsured (and counting) is not a viable policy option. In fact, the American 
Nurses Association (ANA) believes everyone deserves access to the highest quality of care 
(American Nurses Association, n.d.) The uninsured have been known to face worse health 
outcomes due to their inability to access the health care system, leading to inconsistent 
interaction with care. The greatest opportunity to improve accessibility and reduce costs for low-
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income families is to ensure individuals in non-expansion states gain access to Medicaid up to 
138% FPL.  
Since nationwide polls have expressed that Americans are overall concerned about health 
care costs, it is also imperative that any national health policy recommendation include a public 
option that will serve as a competitor to private insurance and drive down costs, instead of 
transitioning to a fully public health care system. In 2 of the 4 public option plans, premium tax 
credits are available for individuals living between 100-600% FPL, which extends beyond the 
ACA’s current 400% FPL. Even though the percent insured above 400% FPL is high, this will 
make more affordable coverage options available and address rising health care costs that many 
Americans are worried about. The public program “with opt out” limits out of pocket costs to 
$3,550/individual or $5,000/family; whereas the OOP costs in the 4 other public option plans 
limited annual costs to $7,900 in 2019 (Kaiser Family Foundation, 2019). The lesser OOP limit 
option would make health care more affordable for Americans across the country and would be 
an improvement; whereas the other four public options would keep the OOP expenses at the 
same rate as that of the ACA (Anderman, 2018). 
In addition, the ACA’s individual mandate must come back. Every member of society is 
a consumer of health care and this is the only way to ensure that people sign up for coverage. 
The individual mandate will also narrow disparities by race since all members of society would 
be expected to have health insurance coverage. Additional federal funding should be allocated to 
states that have high rates of uninsured; in order to ensure that enrolling in health care- either 
Medicaid or via the Insurance Marketplace-is not a barrier. The ACA did something similar to 
this by allocating federal funds for federal marketplace Navigators who were responsible for 
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providing outreach, education and enrollment assistance to eligible consumers (Pollitz, Tolbert & 
Diaz, 2018).  
Any future public insurance option should also include the 10 Essential Health Benefits 
that were implemented during the ACA period, which included coverage for preventative 
services (Kaiser Family Foundation, 2019). When preventive care is covered by insurance plans, 
it serves as an incentive for individuals to seek out this type of care. Since all insurance plans 
offer the 10 Essential Health Benefits due to the ACA (Kaiser Family Foundation, 2019), all 
plans should allow an individual to select a primary care provider within 60 days. If one is not 
selected, an in-network provider closest to the patient’s home address should be assigned to their 
health plan and communicated to the patient. It would be the responsibility of the health care 
system after that point to welcome the new patient to their care team. For many Americans, 
understanding health insurance is difficult as evidenced by 44% of first-time insurance 
marketplace buyers being unaware of the network configuration of the health insurance plan they 
chose (Anderman, 2018). By streamlining the insurance to PCP process, it will lead more 
individuals to accessing primary care.  
 Increasing Access to Primary Care 
Even though the ACA covered preventive care services, our research showed only a 1% 
increase in the PCP rate by the post-ACA period under study. This shows that either people were 
unaware of their insurance benefit, the process for obtaining a PCP was unclear, or this “free” 
preventive care was not enough of an incentive for an individual to find a PCP. The small gains 
in PCP were of concern as the point of having health insurance is to gain access to the health 
care system. Interestingly, our research showed that the ratio of whites with a PCP to whites with 
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insurance was lower than the PCP/INS ratio for blacks and Hispanics. This may be due to more 
whites living in rural areas than racial/ethnic minorities, where primary care resources are of low 
supply. However, Hispanics (who tend to be of lower-income strata) had the lowest PCP rates, 
which shows an opportunity to increase PCP levels for both low-income individuals and those 
living in rural areas. It’s important to improve access to a provider for these two areas that have 
been known to be low resourced areas for primary care providers.  
One way to approach this would be implement full practice authority for board certified 
Nurse Practitioners and Physician Assistants in every state across the country. To date, 22 states 
and D.C. allow NPs to practice to the full extent of their license. Most of the barriers to gaining 
full practice authority stem from physician vs. non-physician debate over the educational 
requirements needed to practice independently (Cheney, 2019). Most NPs (89%) are prepared to 
work in primary care and have a “proven track record” of providing equal or better quality of 
care at a lower cost, than their physician counterparts (American Association of Nurse 
Practitioners, 2019).  In fact, a recent study showed that more NPs provide primary care in low-
income and rural areas where there is a shortage of physicians, than any other provider (Xue, 
Smith & Spetz, 2019). In addition, the VA, the largest integrated health care organization, has 
already granted full practice authority to Nurse Practitioners across the country (Sofer, 2017), 
which was a major step for the nursing profession to gain more ground in providing care to 
underserved populations. 
Interestingly, NPs and PA’s make up the CVS Minute Clinic workforce with more than 
1,100 locations in 33 states and D.C; with a majority of their services costing less than $100 
(CVS Health, 2019). Of the services provided, prevention and wellness services are included, 
(including screening and monitoring for diabetes) (CVS Health, 2019).  CVS plans to transform 
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some of their stores and retail clinics into wellness hubs which has created controversy of 
whether primary care belongs in the traditional medical home model, or if convenient clinics can 
enhance access to and the delivery of primary care. A J.D. Power survey showed that 45% of 
respondents would consider getting primary care at a CVS clinic, with only 36% of individuals 
over the age of 65 reporting they would go to CVS for primary care. A benefit to providing 
primary care at a CVS Health Hub is that 85% of Americans live within 4 miles of a CVS store 
(Kodjack, 2019). This could not only increase access to a primary care provider, but increase the 
convenience for consumers. Having insurance plans include CVS Health providers or the entity 
as a covered provider could greatly increase the number of individuals who obtain primary care 
services. Most large employers (76%) already cover services received in retail clinics, with a 
small share providing financial incentives for employees to use these services (Tozi, 2018).  
 Improving Quality within Primary Care Practices 
From our study, it was apparent that the proportion of individuals who were aware of 
their pre-diabetes status was strikingly very low (<2%), compared to national estimates. This is a 
major public health problem as prediabetes is likely to become diabetes if left unmanaged. 
Managing diabetes is costly to the health system, including public programs where antidiabetics 
became the second largest source of Medicaid spending by 2017 (Mainly driven by the price of 
insulin) (Young, 2019). To date, there is not a Prediabetes Quality Measure, although in 2018 
one has been developed and proposed by the American Medical Association’s (AMA) 
Prediabetes Quality Measure Technical Expert Panel. This measure goes beyond screening for 
obesity, and is focused on increasing screening and follow-up testing for prediabetes; and 
providing those at risk with an intervention. The intervention must include: referral to a diabetes 
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prevention program that is CDC approved; referral to a registered dietician for nutrition therapy; 
or prescription for metformin (American Medical Association, 2018).  
Current federal regulations require states to develop and maintain a Quality Strategy, but 
the states can decide what are the priority areas. It would be in the best interest of states to 
implement a Quality strategy to address and include a primary care measure for prediabetes, such 
as the one developed by the AMA. Usually the Quality strategy is open to the public for 
comments. For example, the New York Department of Health (DoH) reviews their quality 
strategy every three years and places it on their public website for at least 30 days where 
stakeholders can provide comments on the content and strategic approach (The National DPP, 
2019). Health care providers, including nurses, should be aware of these public comment 
sessions and participate/advocate for prediabetes Quality Metrics to be included within the 
State’s Quality strategy.   
 Within the Primacy Care setting, there is great opportunity to improve the documentation 
of basic health measures (i.e. height and weight). Within the NAMCS dataset, there were about 
38% of clinic visits (weighted) that did not have a height, a weight or both documented. Without 
a height and weight, we were unable to calculate a BMI and categorize someone within a 
diabetes risk group. Potentially, documentation of height and weight could be added to the 
prediabetes quality measure proposed by the AMA since providers will only follow the 
prediabetes measure if a patient has a documented BMI. Or, primary care electronic medical 
records (if available) should flag a patient who does not have a current height and weight to 
remind the provider or ancillary staff to measure the patient during the visit and record it. In our 
study, only focusing on the unknown diabetes risk group, 52% of clinic visits had all electronic 
medical record keeping, 18% had partial electronic and partial paper record keeping and 30% 
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had only paper record keeping. As most of the clinic visits had access to an electronic medical 
record, a clinical reminder for height and weight should be reasonable.  
 Diversifying the Nursing (Health Care) Workforce 
Through our research, it became apparent that even after the passage of the ACA, 
Hispanics across the country continued to have the lowest levels of insurance and access to a 
primary care provider, and even the lowest levels of diabetes prevention education being 
provided to high-risk Hispanics, when compared to high-risk whites. One nursing specific 
intervention to address Hispanic health disparities is to reduce barriers into entry to the nursing 
profession for Hispanic students. It is integral to not only the mission of nursing as a profession 
to have a diverse workforce, but to the health of the Hispanic community to have greater 
representation within the health care workforce. 
 The American Nurses Association (ANA) and the National Association of Hispanic 
Nurses (NAHN) on June 21, 2019 proposed two recommendations for increasing the diversity of 
the nursing workforce, specifically targeting Hispanics who are underrepresented in nursing. The 
first recommendation was for states to allow Deferred-Action Childhood Arrivals (DACA) 
nursing students to sit for the NCLEX exam in all states, and the second requires nursing schools 
to make clear the inability for DACA students to sit for the NCLEX in their state (Zegers & 
Cuellar, 2019). There were about 690,000 individuals enrolled in DACA as of 2017, with more 
than 90% coming from Latin America (primarily Mexico) (Lopez & Krogstad, 2017). A major 
challenge to passing state-level legislation for DACA students includes the current political 
climate that is focused on ending the overall DACA program. The Supreme Court announced 
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that they will review three cases related to the legality of the Trump administration ending 
DACA, with a decision expected by June 2020 (Higgins, 2019).   
  Even if the recommendations and the collaborative advocacy efforts of the ANA and 
NAHN do not immediately lead to changes, these nursing organizations have taken a major leap 
in pushing their voices to national level policies. Especially for NAHN, a small non-profit 
organization that represents the health interests of the Hispanic community, this is an opportunity 
to continue to work with other nursing organizations to purse Hispanic interests at the national 
level, which include policy recommendations to improve health care access for Hispanics. Dr. 
Rouse (2017) points out, that given the size of the Hispanic population, Hispanic leaders should 
be able to inform and participate in national health care decision-making, but there is a notable 
absence of prominent Hispanic leadership at the national level capable of mobilizing Hispanics 
and advocating for their interests. Hispanic-serving organizations do exist and advocate for 
Hispanic interests, but none have reached the level of influence of organizations that have 
promoted the interests of African Americans (Rouse, 2017). This is apparent in the health care 
sector as the Trump’s administration did a “silent rollback” of Hispanic partnerships, which 
included removal of bilingual information on the government site. This rollback lessened the 
ability of Hispanic coalitions to work together to enroll more Hispanics in health care (Ollstein, 
2017).  ANA and NAHN have begun a partnership to build nursing’s voice on issues that affect 
the Hispanic community. Future engagement from other nursing organizations would only 
amplify nursing’s voice to the national level.   
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Methodological Challenges & Limitations 
 Overall Study Design 
This quasi-experimental study design was effective in studying the policy impact of the 
ACA’s two main coverage expansion provisions on increasing insurance coverage, access to 
primary care, and the delivery of diabetes prevention. A challenge to studying these three aims 
was finding one dataset that had all three outcomes of interest, which led to pursing two different 
federal datasets, BRFSS and NAMCS. Each dataset included yearly cross-sectional data. BRFSS 
included years 2012-2017; whereas NAMCS included years 2012-2015 only, leading to different 
years under study for the post-ACA period. Changes in the study design, from one with state-level 
estimates to regional estimates made the NAMCS study limited to 2014-2015 and for a small 
subset of states for the post-ACA period. Therefore, the post-ACA periods and state groups under 
study are different for aims 1-2 and aim 3. In addition, given the retrospective nature of secondary 
data analysis, challenges in the construction of specific key variables arose, which are discussed 
in the following paragraphs.  
 BRFSS Variable Construction 
 Insurance. Ideally, the primary outcome INS variable would have been constructed 
using data on the type of insurance held by each BRFSS respondent. However, this data was not 
available. Instead, the INS variable was a dichotomous “yes” or “no” variable to a question 
asking about having insurance- and “yes” included any type of insurance. To overcome this 
limitation, income levels were estimated by calculating the percent of federal poverty level (FPL) 
for each respondent by using respondent information on household income, household size and 
state of residency. Then, percent of FPL was used as a proxy for income in this study.  
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Income was categorized in four groups: (1) <100% FPL; (2) 100-138% FPL; (3) 139-
400% FPL and (4) >400% FPL. The four groups in this study were compared with known 
population estimates and were found to be comparable. Post-ACA changes in the <100% FPL 
were associated with increases in Medicaid enrollment, changes in the 100-138% FPL were 
associated with increases in Medicaid enrollment in the 28 expansion states or increases in 
subsidized private insurance in 19 non-expansion states; changes in 139-400% FPL were 
associated with increases in subsidized private insurance and increases in >400% FPL were 
associated with increases in private insurance enrollment.  
 PCP/Checkup in past year. The secondary outcome variable used PCP and Checkup in 
the past year to determine whether a respondent had access to primary health care. Having a PCP 
was the main focus in the BRFSS analysis but also had limitations. There may be an 
underreporting of having a PCP as the question focuses on having a personal doctor or health 
care provider but does not actually include the terms Nurse Practitioner or Physician Assistant. 
This is also an issue for the checkup question which only asks “About how long has it been since 
you last visited a doctor for a routine checkup?” (Appendix I), which may also prompt 
individuals to underreport primary care visits to non-physician providers. However, a personal 
doctor or health care provider could also be confused with a health care specialist which would 
lead to PCP being overstated to include physicians who are not primary care physicians.  
Additionally, checkups were analyzed on a yearly basis, but may not be the best measure 
of health care access as yearly checkups are not needed for otherwise young, healthy adults. A 
better increment of time may have been using every 2-3 years for checkup, but given the small 
number of years under study 2012-2017 and the fact that the data was not longitudinal, using the 
checkup in the past year as the outcome variable seemed to be the most logical approach.   
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 High Risk for Diabetes. A major limitation to studying the high-risk for diabetes group 
was the inability to accurately capture the group with prediabetes. The prediabetes group was an 
important group to capture but BRFSS did not have lab tests available that captured glucose or 
hemoglobin A1c levels to determine a respondent’s prediabetes status. The only question to 
capture prediabetes was the question that asked if a respondent had prediabetes, which was later 
found to be severely underreported in the descriptive statistics section. Therefore, only known 
prediabetes, gestational diabetes, BMI and known exercise were used to estimate the percentage 
of adults who were at high-risk for diabetes. This algorithm potentially underestimated the 
number of individuals at high risk for diabetes due to the reliance on critical self-reported 
information, such as height, weight and exercise routine; but allowed for the identification of a 
population that required adequate access to primary care. The measure could be improved upon 
by adding smoking and cardiovascular disease to the algorithm as this is commonly used in 
industry quality metrics focused on BMI (The National DPP, 2019).  
 Medicaid Expansion Status. Previous research has not been consistent on how the 
Medicaid expansion group was defined. In this study, since focus was on both Medicaid 
expansion up to 138% FPL and the insurance subsidies available to respondents living between 
100-400% FPL, the four states that expanded Medicaid beyond the 138% FPL were excluded as 
Medicaid expansion due to the ACA could not be studied. A dummy variable that accounted for 
changes in expansion status per state over time was initially created but was found to be highly 
correlated with the time. Therefore, the decision was made to include all states that expanded 
Medicaid by 2017 in the dummy variable. This was not expected to have a major impact in the 
analysis since most states that expanded Medicaid, did so by 2014.  
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 PCP Supply. PCP supply was a dichotomous variable that only took into account the 
state supply of primary care physicians in the pre-ACA period. As a result, we may be 
underestimating the supply of PCPs, especially in states that have full practice authority for non-
physician providers. A future study could also adjust for the supply of non-physician primary 
care providers per state.  
 NAMCS Variable Construction.  
 Classification of Preventive Care Visits. In the NAMCS analysis, there was an overall 
decline of 22% in preventive care visits by the post-ACA period (2014-2015). Reasons for this 
decline may have included the declining survey response rates NAMCS reported over time or the 
under capturing of primary care services provided by non-physician providers (Centers for 
Disease Control and Prevention, 2018; Lau et al., 2016). In fact, only 2 states (Washington and 
Arizona) in the 15-sample had full practice authority legislated for Nurse Practitioners 
(American Association of Nurse Practitioners, 2018). Therefore, the decline in preventive care 
visits is not generalizable as only 15 states were available for this analysis, compared to 47 states 
in the BRFSS sample. Additionally, the focus of this analysis was primarily accounting for 
physician-patient visits, which does not fully capture every preventive care visit available in the 
U.S.   
   Diabetes Screening and Prevention Education. In NAMCS from years 2012-2015, 
there were six lab tests that captured blood sugar levels: CMP, BMP, GLUCOSE, HGBA, FBG, 
A1C (with the last two tests being performed in the last year). However, CMP and BMP data 
was only captured in years 2014-2015 and A1C and FBG in the past 12 months was not captured 
in 2015. The inconsistent availability of data from year to year made it difficult to truly capture 
diabetes screening rates. The main analysis captured screening during a clinic visit, but a 
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provider could have forgone screening if a recent CMP, BMP, A1c or glucose reading was 
available in the past year. Furthermore, of the A1c and glucose data that was available in the past 
year, the actual date was not entered in the majority of patient visits, which made these two 
variables unreliable as we could not distinguish if the past year included 2013, the pre-ACA 
period. 
The three education topics for nutrition, exercise and weight reduction were consistent 
from year to year, although diabetes education was added in 2015; although this was not 
considered diabetes prevention as it included medication management.  
 High Risk for Diabetes. Another major limitation in studying the ACA effect on the 
delivery of diabetes prevention overall, and by expansion status was that most of the preventive 
care visits were missing heights and/or weights (32-41% from 2012-2015), leading to 
incalculable BMI’s for each patient visit. For this analysis the unknown diabetes risk group was 
created to capture this limitation and draws attention to the lack of documentation of heights and 
weights during a primary care visit. Although this section of the study could have been 
conducted by dropping the unknown diabetes risk group, this group did not appear to have the 
characteristics of a random sample and was kept in to acknowledge potential non-response bias 
where the screening rate may be higher than it actually is since those who were unknown were 
not considered in the denominator. To note, the unknown diabetes risk group was comprised of 
greater proportions of Hispanics, females and individuals aged 18 to 34.   
 Medicaid Expansion Status. As only 2012-2015 data was available, states that 
expanded Medicaid as of 2015 were included as expansion states, following similar logic as the 
BRFSS construction of this variable. A limitation to this was the small number of states available 
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for this study (only 15 states compared to 47 states in BRFSS). The Medicaid expansion group 
did not have representation of the Midwest or south. Future analysis may consider a dataset that 
has administrative and clinical data available within all states.  
Future Research 
 Exploring Differences in Insurance Coverage by Race  
Intuitively, future research would focus on building upon the initial analyses conducted 
using BRFSS. Racial/ethnic disparities (as measured as a statistically significant 10% difference 
between the reference group and the comparison group) were only measured for the 
PCP/checkup outcomes, but could also be explored for differences in INS by race. From our 
analysis, disparities in having a PCP were the greatest among whites and Hispanics, with 
Hispanics being 38% less likely to have a PCP in the post-ACA period when compared to their 
white counterparts. This racial/ethnic disparity must also exist by insurance status, which our 
initial logic model did not account for. If the goal is to increase overall health care access for all 
racial/ethnic groups, the Hispanic population is one group that needs additional attention given 
the low levels of insurance and PCP post-ACA.  
As we move into an election year and healthcare remains at the forefront, future research 
could include studying insurance and PCP levels among the 65+ older Hispanic population, 
relative to whites who are covered under Medicare. This could be done using the current BRFSS 
dataset by adding back in the 65+ older population. By doing so, more information on how 
universal coverage affects a specific age cohort of the Hispanic population would be provided, 
and if insurance and PCP rates are similar to those of whites under universal coverage.  This type 
of study would also provide maximum ceiling levels of insurance and PCP, which in our current 
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research was 95.83% insurance rate for the >400% FPL group (who are mainly covered by 
private insurance) and an average of 74.27% PCP rate, which a higher PCP rate of 90.69% 
among individuals with a known health condition. Again, a limitation to this study would be that 
insurance does not necessarily mean Medicare for this population. We could potentially 
supplement this future study with the Health and Retirement Study at the University of Michigan 
which provided more detailed information on insurance and health care access given it is a 
longitudinal study.  
 Exploring the INS to PCP uptake lag time  
In the current BRFSS study, only 4 years (2014-2017) were included in the post-ACA 
period, which could be expanded to include years 2018 and 2019 once the data is available. By 
adding additional years to this study, trends in insurance and PCP could be assessed, but also the 
relationship between insurance and PCP. Currently, it is unknown if there is a lag time between 
when someone signs up for insurance and when someone chooses a primary care provider. Focus 
would be placed on states that expanded Medicaid by 2014 as more years are available to study 
the uptake of a PCP post-ACA.    
 Exploring State Level Differences in Expansion Status 
When studying differences between non-expansion and Medicaid expansions states, each 
group was studied in aggregate and it was difficult to discern which states benefited the most 
from the ACA’s coverage expansion. In Table 97, the performance of the non-expansion group 
in aggregate was compared to the performance of the Medicaid expansion group in aggregate. 
However, the performance of individual states relative to changes that occurred in aggregate 
were also assessed. When each state’s change in insurance from pre-ACA to post-ACA was 
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plotted, a curvilinear function was estimated and used to derive an estimated post-ACA value 
that could be used to determine if a state reached its expected level of insurance. States that 
started at lower levels of insurance- had a greater opportunity to increase insurance levels within 
the state.  
The 5 states with the lowest levels of insurance in the pre-ACA period included: (1) 
Texas (67%); (2) Arkansas (71%); (3) Nevada (71%); (4) Florida (73%) and (5) Mississippi 
(79%). The two states that expanded Medicaid (Arkansas and Nevada) both out-performed their 
predicted insurance rates, while the three remaining non-expansion states performing below their 
predicted insurance rates. An area for future research is to compare the high-performers who 
started out with lower levels of insurance to those at the top. This comparison could shed light to 
how insurance and PCP levels changed according to how a state performed after ACA 
implementation. 
Another way to test state level differences to the national BRFSS dataset would be to 
include a measure of political climate assigned to each state. The current study did not control 
for this yet vastly impacts a state’s decision to expand Medicaid. Potential indicators could 
include the 2017 Cook Political Report Partisan Voter Index which measures how Democratic or 
Republican a district performed during presidential elections (The Cook Political Report, 2018) 
or The CATO Institute’s Freedom measure which ranks states individually by policies that shape 
personal and economic freedom (CATO Institute, 2019). The type of measure could provide 
additional information on how insurance and PCP levels changed given the political environment 
in the state.   
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 Capturing the High Risk for Diabetes Group 
A major challenge for this research was capturing the high risk for diabetes group given 
the low levels of awareness of prediabetes in the BRFSS sample, and the high number of missing 
height and weight values in the NAMCS dataset. Therefore, any discussion on the high risk for 
diabetes population is a crude estimate considering by relying on weight only, we may have not 
captured other individuals with known risk factors mentioned in the ADA Clinical Guidelines for 
Diabetes Screening. This is apparent as even individuals at no/low risk for diabetes were 
screened in our NAMCS study. This does not mean that they shouldn’t have been screened, it 
means that our method for capturing the high risk for diabetes group should probably include 
additional criteria. An additional possibility would be to do a sensitivity analysis where the high- 
risk for diabetes group also includes individuals with high blood pressure and age over 45. Or, 
individuals who are at no/low risk or unknown risk who are on metformin medication would be 
considered high-risk. This may help to move some of the no/low risk and unknown risk 
individuals into the high risk for diabetes group, if appropriate.   
Conclusion 
As health care continues to be a national priority this year, our research contributes to the 
growing evidence that the ACA’s Medicaid expansion and insurance subsidies increased access 
to health insurance coverage for millions of low-income adults across the United States. We then 
went a step further to link gains in insurance to primary care access, which was found to be 
limited, especially for individuals at high-risk for diabetes. As a result, this research highlighted 
the minimal role the ACA played in improving access to primary care, and the need to increase 
an individuals’ awareness of their high-risk status. It is therefore imperative that any health care 
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policy proposals not only reflect the benefits of expanded coverage for low-income adults, but 
include provisions that expand access to primary care and include quality measures to improve 
the delivery of preventive care across the U.S. Future research includes exploring systemic 
barriers for organizations and providers in order to understand the processes needed to improve 
preventive care delivery for high-risk populations.  
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APPENDIX A 
U.S. POVERTY RATES BY RACE/ETHNICITY: 1961-2015 
 
Figure A-1. U.S. poverty rates vary significantly by race and ethnicity: 1961-2015. Reprinted from 
https://www.irp.wisc.edu/faqs/faq3.htm (Institute for Research and Poverty, 2016).  
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APPENDIX B 
CONCENSUS CORE SET FOR COMPREHENSIVE DIABETES CARE 
Table B-1.  
Consensus Core Set for Comprehensive Diabetes Care for ACO and PCMH/Primary Care 
Measures.  
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APPENDIX C 
THE CONCEPTUAL MODEL OF NURSING AND HEALTH POLICY AND IHI TRIPLE 
FRAMEWORK  
 
Figure C-1. The Conceptual Model of Nursing and Health Policy and IHI Triple Framework to 
study the impact of ACA’s coverage expansion on the quality of diabetes prevention provided to 
high risk adults in the United States. 
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APPENDIX D 
MODIFIED QUALITY HEALTH OUTCOMES MODEL 
 
Figure D-1. Modified Quality Health Outcomes Model to study the impact of the ACA’s 
coverage expansion on the quality of diabetes prevention provided adults aged 18 to 64 at high 
risk for diabetes in the United States.  
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APPENDIX E 
PRISMA FLOW DIAGRAM 
 
Figure E-1. PRISMA Flow Diagram  
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APPENDIX H 
LIST OF PREDICTOR VARIABLES USED IN BRFSS ANALYSIS 
Table H-1.  
List of Predictor Variables used in BRFSS Analysis.  
 
 
 
 
 
 
 
Independent Variables Coding Acronym
Black (0) Non-Hispanic White
(1) Non-Hispanic Black BLK
Hispanic (0) Non-Hispanic White
(1) Hispanic, All Races HISP
whiteBLKhisp (0) Non-Hispanic White
(1) Non-Hispanic Black
(2)Hispanic WBH
Income (% FPL) (0) <100% FPL 
(1) =>100% or <=138% FPL 
(2) =>139% or <=400% FPL 
(2)  > 400% FPL INC
High Risk for Diabetes (0) No/Low Risk
(1) High Risk
(2) Diabetes HRD
Medicaid Expansion State (0) Non-expansion State
(1) Medicaid Expansion State EXP
Race/Ethnicity
Income 
Diabetes Risk
Medicaid Expansion State Status
334 
 
APPENDIX I 
BRFSS VARIABLE QUESTIONNAIRE  
Race (2012) 
Question 1. Are you Hispanic or Latino? 
1. Yes 
2. No 
7. Don’t know/Not Sure 
9.   Refused  
 
Question 2. Which one or more of the following would you say is your race?  
(Check all that apply).  
1. White 
2. Black or African American 
3. Asian 
4. Native Hawaiian or Other Pacific Islander 
5. American Indian or Alaska Native  
6. Other [Specific] ___________________ 
7. Don’t know/Not sure 
8. No additional choices 
9. Refused  
 
Question 3. (If more than one response to Q2, then continue).  
Which one of these groups would you say best represents your race? 
1. White 
2. Black or African American 
3. Asian 
4. Native Hawaiian or Other Pacific Islander 
5. American Indian or Alaska Native 
6. Other [specify] ____________ 
7. Don’t know/Not sure 
9.   Refused  
 
Computed Variable(s): _racegr2 (2012) and _racegr3 (2013-2017) 
1. White only, Non-Hispanic 
2. Black only, Non-Hispanic 
3. Other race only, Non-Hispanic 
4. Multiracial, Non-Hispanic 
5. Hispanic 
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9. Don’t know/Not sure/Refused  
  
 
Education (2012) 
Question 1. What is the highest grade or year of school you completed? 
1. Never attended school or only attended kindergarten 
2. Grades 1 through 8 (Elementary) 
3. Grades 9 through 11 (Some high school) 
4. Grade 12 or GED (High school graduate) 
5. College 1 year to 3 years (Some college or technical school) 
6. College 4 years or more (College graduate)  
7. Don’t know/Not sure 
9.   Refused  
 
Income (2012) 
Question 1. Is your annual household income from all sources- 
04. Less than $25,000 ($20,000 to less than $25,000) 
03. Less than $20,000 ($15,000 to less than $15,000) 
02. Less than $15,000 ($10,000 to less than $15,000) 
01. Less than $10,000  
05. Less than $35,000 ($25,000 to less than $35,000) 
06. Less than $50,000 ($35,000 to less than $50,000) 
07. Less than $75,000 ($50,000 to less than $75,000) 
08. $75,000 or more 
77. Don’t know/Not sure 
99. Refused  
 
Health Care Access (INS, PCP & PCA) 
 
Question 1 (INS). Do you have any kind of health care coverage, including health insurance, 
prepaid plans such as HMOs, government plans such as Medicare, or Indian Health Service? 
 
1. Yes 
2. No 
7. Don’t know/Not sure 
9. Refused 
 
Question 2 (PCP). Do you have one person that you think of as your personal doctor or health care 
provider? If “No”, is there more than one, or is there no person who you think of as your personal 
doctor or health care provider?  
 
1. Yes, only one 
2. More than one 
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3. No 
7. Don’t know/Not sure 
9. Refused 
Question 3 (PCA). About how long has it been since you last visited a doctor for a routine checkup? 
A routine checkup is a general physical exam, not an exam for a specific injury, illness, or 
condition. 
 
1. Within the past year (anytime less than 12 months ago) 
2. Within the past 2 years (1 year but less than 2 years ago) 
3. Within the past 5 years (2 years but less than 5 years ago) 
4. 5 or more years ago 
7. Don’t know/Not sure 
8. Never 
9. Refused 
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APPENDIX J 
THE BRFSS ALGORITHM FOR HIGH-RISK FOR DIABETES VARIABLE 
 
Figure J-1. The BRFSS Algorithm for High Risk for Diabetes (HRD) Variable.  
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APPENDIX K 
BRFSS CONTROL VARIABLES  
Table K-1.  
List of Control Variables used in BRFSS Analysis. 
 
Refer to Table L-1 for full list of chronic diseases. 
 
 
 
Control Variables Coding Acronym
Age (0) 18 to 34
(1) 35 to 44
(2) 45 to 54
(3) 55 to 64 AGEcat
Sex (0) Male
(1) Female FEM
Education (0) Less than HS
(1) HS Grad
(2) Some College
(3) College Grad EDU
Chronic Disease Count 0
1
2
3
4
5 CDcount
Self-Reported Health (0) Healthy
(1) Not Healthy SRH
PCP Supply (0) Adequate Supply
(1) Shortage SUPP
Primary Care Provider Supply
Demographics 
Limited Health Status 
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APPENDIX L 
BRFSS CHRONIC DISEASE VARIABLES 
Table L-1.  
Chronic Diseases in BRFSS CDcount control variable in Table K-1.  
 
 
 
 
 
 
 
 
 
 
 
 
Chronic Disease Variables Coding Acronym
Cancer 0= No
1= Yes CAN
COPD/Emphysema/Chronic Bronchitis 0= No
or Asthma 1= Yes RESP
Coronary Heart Disease or 0= No
Myocardial Infarction 1= Yes CAR
Kidney Disease 0= No
1= Yes KID
Stroke 0= No
1= Yes STK
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APPENDIX M 
BRFSS OUTCOME VARIABLES 
Table M-1.  
List of Outcome Variables used in BRFSS Analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dependent Variables Coding Acronym
Health Coverage (0) No INS
(1) Yes
Health Care Provider (0) No PCP
(1) Yes
Primary Care Access (0) Checkup > 1 year PCA
(1) Checkup < 1 year
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APPENDIX N 
NAMCS PATIENT RECORD FORM (FRONT) 
 
Figure N-1. 2012 NAMCS Patient Record Form (Front Side).   
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APPENDIX O 
NAMCS PATIENT RECORD FORM (BACK) 
 
Figure O-1. 2012 NAMCS Patient Record From (Back Side). 
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APPENDIX P  
NAMCS ALGORITHM FOR HIGH-RISK FOR DIABETES VARIABLE 
 
Figure P-1. NAMCS Algorithm for High Risk for Diabetes (HRD) Variable.  
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APPENDIX Q 
NAMCS OUTCOME VARIABLES 
Table Q-1.  
NAMCS Outcome Variables.  
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APPENDIX R 
NAMCS PREDICTOR VARIABLES 
Table R-1.  
NAMCS Predictor Variables.  
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APPENDIX S 
NAMCS CONTROL VARIABLES 
Table S-1.  
NAMCS Control Variables.  
Control Variables  Coding Acronym 
Age Continuous  AGE 
      
Gender 0= Male   
  1= Female GEN 
      
Chronic Disease 0= No Chronic Disease   
  1= At Least 1 Chronic Disease CDV 
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APPENDIX T 
NAMCS CHRONIC DISEASE VARIABLES 
Table T-1.  
NAMCS Chronic Disease Variables.  
 
Chronic Disease Variables Coding Acronym
Arthritis 0= No
1= Yes ART
Asthma 0= No
1= Yes AST
Cancer 0= No
1= Yes CAN
Chronic Renal Failure 0= No
1= Yes CRF
COPD 0= No
1= Yes COP
Depression 0= No
1= Yes DEP
Ischemic Heart Disease 0= No
1= Yes IHD
Stroke 0= No
1= Yes STK
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APPENDIX U 
STATE MEDICAID EXPANSION DECISIONS AND PCP SUPPLY 
Table U-1.  
Status of State Medicaid Expansion Decisions and PCP supply status for U.S. 50 states and D.C.  
 
 STATE
BRFSS 
CODE STATUS
SIGNED INTO 
LAW
KFF 
EXPANSION 
DATE GOVENOR COMMENTS PCP SUPPLY 
ALASKA 2 E 9/1/2015 9/1/2015 BILL WALKER (I) Low 
ARIZONA 4 E 6/17/2013 1/1/2014 JAN BREWER (R )
PRE-EXPANSION PARENTS 22% FPL, CHILDLESS 
ADULTS 100% FPL (ENROLLMENT FROZEN FROM '11-
'14), POST EXPANSION, 133% FPL Low 
ARKANSAS 5 E 4/23/2013 1/1/2014 MIKE BEEBE (D) Low 
CALIFORNIA 6 E 6/27/2013 1/1/2014 JERRY BROWN (D)
EARLY EXPANSION UP TO 200% IN SOME 
COUNTIES, NOT STATEWIDE- 7/1/2011 Adequate
COLORADO 8 E 5/13/2013 1/1/2014 JOHN HICKENLOOPER (D) Adequate
CONNECTICUT 9 E 1/1/2014 DANIEL MALLY (D)
EARLY EXPANSION UP TO 56 OR 68% DEPENDING 
ON REGION- 4/1/2010 Adequate
DELAWARE 10 E 7/1/2013 1/1/2014 JACK MARKELL (D)
EARLY EXPANSION UP TO 100% FPL FOR CHILDLESS 
ADULTS- 1996 Adequate
DISTRICT OF COLUMBIA 11 E 5/13/2010 1/1/2014 EARLY EXPANSION UP TO 200%- 7/1/2010 Adequate
HAWAII 15 E 1/1/2014 NEIL ABERCROMBIE (D)
EARLY EXPANSION UP TO 200% FOR ADULTS 
MEETING QUEST-ACE ELIGIBILITY- 2/2008; 
EXPANSION UP TO 133% FOR ALL OTHER ADULTS 
4/2012 Adequate
ILLINOIS 17 E 7/22/2013 1/1/2014 PAT QUINN (D) Adequate
INDIANA 18 E 1/27/2015 2/1/2015 Low
IOWA 19 E 12/12/2013 1/1/2014 TERRY BRANSTAD (R ) Adequate
KENTUCKY 21 E 9/3/2013 1/1/2014 STEVE BESHEAR (D) Low
LOUISIANA 22 E 1/12/2016 7/1/2016 JOHN BEL EDWARDS (D) Low
MARYLAND 24 E 5/5/2013 1/1/2014 MARTIN O'MALLEY (D) EARLY EXPANSION FOR JOBLESS PARENTS-116% FPL Adequate
MASSACHUSETTS 25 E 7/5/2013 1/1/2014 DEVAL PATRICK (D) EARLY EXPANSION UP TO 300% FPL- 2006 Adequate
MICHIGAN 26 E 9/16/2013 4/1/2014 RICK SNYDER (R ) Adequate
MINNESOTA 27 E 2/1/2013 1/1/2014 MARK DAYTON (D) EARLY EXPANSION UP TO 75%- 3/1/2011 Adequate
MONTANA 30 E 4/29/2015 1/1/2016 STEVE BULLOCK (D) Adequate
NEVADA 32 E 12/1/2012 1/1/2014 BRIAN SANDOVAL (R ) Low
NEW HAMPSHIRE 33 E 3/27/2014 8/15/2014 MAGGIE HASSAN (D) Adequate
NEW JERSEY 34 E 6/28/2013 1/1/2014 CHRIS CHRISTIE (R ) Adequate
NEW MEXICO 35 E 1/9/2013 1/1/2014 SUSANA MARTINEZ (R ) Adequate
NEW YORK 36 E 6/28/2012 1/1/2014 ANDREW CUOMO (D)
Pre-ACA, childless adults 100% FPL, parents 150% 
FPL Adequate
NORTH DAKOTA 38 E 4/1/2013 1/1/2014 JACK DARYMPLE (R ) Adequate
OHIO 39 E 10/21/2013 1/1/2014 JOHN KASICH (R ) Adequate
OREGON 41 E 1/1/2014 JOHN KITZHABER (D) EARLY EXPANSION UP TO 100% -1994 Adequate
PENNSYLVANIA 42 E 8/28/2014 1/1/2015 TOM CORBETT (R ) Adequate
RHODE ISLAND 44 E 7/3/2013 1/1/2014 LINCOLN CHAFEE (I) Adequate
VERMONT 50 E 7/1/2012 1/1/2014 EARLY EXPANSION UP TO 300% FPL SINCE 1996 Adequate
WASHINGTON 53 E 6/30/2013 1/1/2014 JAY INSLEE (D) Adequate
WEST VIRGINIA 54 E 5/1/2013 1/1/2014 EARL RAY TOMBLIN (D) Adequate
ALABAMA 1 N Low
FLORIDA 12 N Adequate
GEORGIA 13 N Low
IDAHO 16 N 11/1/2018 Little Low
KANSAS 20 N Adequate
MAINE 23 E 11/7/2017 1/10/2019 PAUL LEPAGE (R ) Adequate
MISSISSIPPI 28 N Low
MISSOURI 29 N Adequate
NEBRASKA 31 N 4/1/2019 Adequate
NORTH CAROLINA 37 N Low
OKLAHOMA 40 N Low
SOUTH CAROLINA 45 N Low
SOUTH DAKOTA 46 N Adequate
TENNESSEE 47 N Adequate
TEXAS 48 N Low
UTAH 49 N 4/1/2019 Low
VIRGINIA 51 E 5/31/2018 1/1/2019 NORTHAM Adequate
WISCONSIN 55 N Adequate
WYOMING 56 N Low
KEY: *States that will be excluded due to FPL > 138% pre-ACA
REFERENCES:
https://www.kff.org/medicaid/issue-brief/status-of-state-medicaid-expansion-decisions-interactive-map/
https://www.advisory.com/daily-briefing/resources/primers/medicaidmap
https://www.healthaffairs.org/doi/pdf/10.1377/hlthaff.2013.1087
https://www.urban.org/sites/default/files/publication/89536/2001222-aca_medicaid_expansion_led_to_widespread_reductions_in_uninsurance_among_poor_childless_adults.pdf
https://www.medicaid.gov/Medicaid-CHIP-Program-Information/By-Topics/Waivers/1115/downloads/vt/Global-Commitment-to-Health/vt-global-commitment-to-health-ext-req-cms-01012014-12312018-revised-052013.pdf
https://udspace.udel.edu/bitstream/handle/19716/21429/Overview%20of%20Medicaid%20in%20Delaware.pdf?sequence=1&isAllowed=y
https://www.medicaid.gov/Medicaid-CHIP-Program-Information/By-Topics/Waivers/1115/downloads/hi/QUEST-Expanded/hi-quest-expanded-ext-app-06292012.pdf
http://vitalysthealth.org/wp-content/uploads/2017/08/Medicaid0817.pdf
https://fas.org/sgp/crs/misc/R43564.pdf
https://data.hrsa.gov/topics/health-workforce/ahrf
https://www.rwjf.org/content/dam/farm/reports/issue_briefs/2011/rwjf69759
https://dhcf.dc.gov/sites/default/files/dc/sites/dhcf/publication/attachments/DCMedicaidAllianceFactSheet.pdf
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APPENDIX V 
CALCULATION FOR MEAN INCOME >$75,000 GROUP 
 BRFSS provides income as a categorical variable with the top-end income group open 
ended ($75,000+). This is problematic since a dollar term is needed to assign top-end BRFSS 
respondent households to a Federal Poverty Level (FPL) and ACA income group. To estimate the 
mean income for the greater than $75,000 income group, the following formula was used:  
(4) HINCg,t = HINC<75,g,t + p>75,g,t •Y>75,g,t   
• HINCg,t  = mean income for all households in the g-th race/ethnic group in year t (2012-
2017) 
• HINC<75,g,t = BRFSS sample weighted mean income for households in the g-th group in 
year t in j-th income category <$75,000 
• p>75,g,t = weighted proportion of households in g-th group in year t in income category 
>$75,000 
• Y>75,g,t  = mean (imputed) income in g-th group in year t with incomes >$75,000 
Solving for the mean income of the top end group: 
(5) Y>75,g,t =  {HINCg,t  - HINC<75,g,t } / p>75,g,t  
 Mean income for all households (HINCg,t) was taken from the Current Population Survey 
(CPS) Annual Social and Economic (ASEC) Supplement public data provided by the Bureau of 
Labor Statistics and the Census Bureau14. Mean incomes are available by year and by 
race/ethnicity. Whites are labeled as “white, non-Hispanic”, blacks as; “black only” and 
Hispanics as; “Hispanics, all races”. Top-end mean income (>$75,000) is imputed separately for 
 
14 Link to reference: https://www.census.gov/data/tables/time-series/demo/income-poverty/cps-
finc/finc-01.html  
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the three race/ethnic groups and by year to account for large differences in mean income.  
 Mean income (HINC<75,g,t) for the seven income categories below $75,000 was calculated 
using STATA command “svy: mean” and adjusting for weighted sample proportions by year and 
race/ethnicity to conform to mean Census incomes (HINCg,t) for the entire U.S. population, i.e.,  
(6) HINC<75,g,t =  Σpj,g,t • Yj,g,t/ Σpj,g,t 
Where pj,g,t = proportions of BRFSS weighted households in the j-th income category (j{1,7}) 
and Yj,g,t = mid-point value of the j-th BRFSS income category.  
 Imputed mean income of top end households in the g-th group in year t (Y>75,g,t; eq.2), was 
calculated by, first, subtracting the overall mean income of lower income groups from Census mean 
income and then dividing the difference by the BRFSS proportion of households with incomes 
>$75,000 using STATA “svy: tab”. Table 1 displays the results by race and year.  
 
 
 
 
 
 
 
 
 
351 
 
Table V-1.  
Calculated Mean Income in the U.S. population by year in the BRFSS dataset. (Note: “Y” is 
equal to the mean income of the $75K+ group for each racial/ethnic group).  
 
Sources: HINCg,t: http:/www.census.gov/data/tables/time-series/demo/income-poverty/cps-
finc/finc-01.html ; HINC<75,g,t, p>75,g,t: BRFSS Annual Surveys.  
 The mean household income for all races was $100,400 in 2017, a 21% increase over 
2012. The contribution of lower income groups to this overall mean was only $34,119 resulting 
in an imputed top-end income of $190,407 for 34.8% of BRFSS households with incomes 
>$75,000. Mean Census incomes for blacks and Hispanics were 37% and 35% below that of 
Whites. The proportion of whites in the BRFSS top-end income group was at least twice that of 
blacks and Hispanics.  
ALL RACES
Mean Income 
(HINCg,t)
Mean Income 
(HINC <75,g,t) P>75,g,t Y>75,g,t
2012 $82,843 $33,166.00 0.2849 $174,366.44
2013 $87,671 $33,033.93 0.2946 $185,461.88
2014 $88,765 $33,339.21 0.3058 $181,248.50
2015 $92,673 $34,215.38 0.3258 $179,427.93
2016 $97,357 $34,080.67 0.3365 $188,042.59
2017 $100,400 $34,119.18 0.3481 $190,407.41
WHITE, NON-HISPANIC
2012 $86,514 $36,244.15 0.3357 $149,746.35
2013 $96,869 $36,285.35 0.3488 $173,691.66
2014 $99,084 $36,504.06 0.3603 $173,688.43
2015 $102,209 $37,402.71 0.3829 $169,251.21
2016 $107,416 $37,160.76 0.3933 $178,630.16
2017 $110,888 $37,283.12 0.4083 $180,271.57
BLACK
2012 $55,189 $28,028.96 0.1592 $170,603.27
2013 $58,754 $27,973.41 0.1637 $188,030.48
2014 $60,358 $28,323.19 0.1735 $184,638.67
2015 $64,188 $29,086.57 0.1828 $192,020.95
2016 $67,966 $29,270.67 0.2036 $190,055.65
2017 $69,670 $29,588.43 0.2013 $199,113.61
HISPANIC
2012 $55,528 $26,938.09 0.1268 $225,472.48
2013 $61,151 $26,640.10 0.1375 $250,988.36
2014 $60,140 $26,689.13 0.1428 $234,249.79
2015 $66,339 $28,239.06 0.1561 $244,073.93
2016 $70,106 $28,281.83 0.1649 $253,633.54
2017 $72,321 $28,382.29 0.1752 $250,791.72
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Implications  
 The likelihood that we will correctly assign 65% of BRFSS respondents in the two less than 
400% FPL groups (i.e. Medicaid expansion group and middle-income subsidy groups) should be 
high. Using the midpoints of fairly narrow income categories, we should know their income levels 
within a narrow range. Moreover, the FPL level even for a household of 14 persons was $66,400 in 
2017, a figure somewhat below the $5,00 threshold for the top-end category that must be imputed. 
Finally, there is no need to adjust for race/ethnicity for household incomes <$75,000 as BRFSS 
respondents are reporting incomes within a narrow range as well as their race/ethnicity status.  
 The need to adjust for race/ethnicity becomes important in imputing incomes >$75,000 
given differences in imputed mean incomes in these groups. The effect of using three different top-
end income levels will be to increase slightly the mean household incomes for blacks and Hispanics 
relative to whites (as shown in Table 1, last column). This is counterintuitive until one realizes that 
minorities are less than one-half as likely to report incomes >$75,000.  
 Counteracting these high imputed top-end incomes will be systematic differences in family 
size by race/ethnicity. The average Hispanic household size is 3.25 people, with black households 
averaging 2.51 people; and white households averaging 2.37 people according to the 2017 U.S. 
Census Bureau15. Assuming these differences in family size are similar among BRFSS respondents, 
household total incomes will be reduced by 1/3.25 for Hispanics, ½.51 for blacks, and ½.37 for 
whites. Further assuming that family size differences are consistent throughout the income range, 
the per person top-end income for whites in 2017 will be $76,037 compared with $79,283 for blacks 
and $77,166 for Hispanics. And the still-higher figures for minorities will be applied to a much 
smaller proportion of top-end households. Hence, minorities will be even more common in the 
 
15 Link to U.S. Census Bureau household sizes as of 2017: http://demomemo.blogspot.com/2018/02/household-
size-by-race-and-hispanic.html  
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lower two ACA income groups.    
 In sum, blacks and Hispanics should fall disproportionately into the lower two ACA income 
categories as they are far more likely than whites to report incomes <$75,000. This effect is 
reinforced by their larger family sizes. Offsetting these effects to a very minor degree might be 
higher imputed incomes for minorities in the top-end income group of BRFSS if they continue to 
report the same relative family sizes.  
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APPENDIX W 
U.S. POVERTY GUIDELINES: 2012-2017 
Table W-1. 
 The 2017 Poverty Guidelines. (Source: https://aspe.hhs.gov/2017-poverty-guidelines).   
 
Persons in Family/Household Poverty Guideline 
1 $12,060
2 $16,240
3 $20,420
4 $24,600
5 $28,780
6 $32,960
7 $37,140
8 $41,320
9 $45,500
10 $49,680
11 $53,860
12 $58,040
13 $62,220
14 $66,400
Persons in Family/Household Poverty Guideline 
1 $15,060
2 $20,290
3 $25,520
4 $30,750
5 $35,980
6 $41,210
7 $46,440
8 $51,670
9 $56,900
10 $62,130
11 $67,360
12 $72,590
13 $77,820
14 $83,050
Persons in Family/Household Poverty Guideline
1 $13,860
2 $18,670
3 $23,480
4 $28,290
5 $33,100
6 $37,910
7 $42,720
8 $47,530
9 $52,340
10 $57,150
11 $61,960
12 $66,770
13 $71,580
14 $76,390
For families/households with more than 8 persons, 
add $5,230 for each additional person
Hawaii
For families/households with more than 8 persons, 
add $4,810 for each additional person
Alaska
2017 Poverty Guidelines for the 48 Contiguous States 
and the District of Columbia
For familes/households with more than 8 persons, 
add $4,180 for each additional person
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Table W-2.  
The 2016 Poverty Guidelines. (Source: https://www.peoplekeep.com/blog/2016-federal-poverty-
level-fpl-guidelines).  
 
Persons in Family/Household Poverty Guideline 
1 $11,880
2 $16,020
3 $20,160
4 $24,300
5 $28,440
6 $32,580
7 $36,730
8 $40,890
9 $45,050
10 $49,210
11 $53,370
12 $57,530
13 $61,690
14 $65,850
Persons in Family/Household Poverty Guideline 
1 $14,840
2 $20,020
3 $25,200
4 $30,380
5 $35,560
6 $40,740
7 $45,920
8 $51,120
9 $56,320
10 $61,520
11 $66,720
12 $71,920
13 $77,120
14 $82,320
Persons in Family/Household Poverty Guideline
1 $13,670
2 $18,430
3 $23,190
4 $27,950
5 $32,710
6 $37,470
7 $42,230
8 $47,010
9 $51,790
10 $56,570
11 $61,350
12 $66,130
13 $70,910
14 $75,690
2016 Poverty Guidelines for the 48 Contiguous States 
and the District of Columbia
For familes/households with more than 8 persons, 
add $4,160 for each additional person
Alaska
For families/households with more than 8 persons, 
add $5,200 for each additional person
Hawaii
For families/households with more than 8 persons, 
add $4,780 for each additional person
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Table W-3.   
The 2015 U.S. Poverty Guidelines. (Source: https://aspe.hhs.gov/2015-poverty-guidelines)  
 
Persons in Family/Household Poverty Guideline 
1 $11,770
2 $15,930
3 $20,090
4 $24,250
5 $28,410
6 $32,570
7 $36,730
8 $40,890
9 $45,050
10 $49,210
11 $53,370
12 $57,530
13 $61,690
14 $65,850
Persons in Family/Household Poverty Guideline 
1 $14,720
2 $19,920
3 $25,120
4 $30,320
5 $35,520
6 $40,720
7 $45,920
8 $51,120
9 $56,320
10 $61,520
11 $66,720
12 $71,920
13 $77,120
14 $82,320
Persons in Family/Household Poverty Guideline
1 $13,550
2 $18,330
3 $23,110
4 $27,890
5 $32,670
6 $37,450
7 $42,230
8 $47,010
9 $51,790
10 $56,570
11 $61,350
12 $66,130
13 $70,910
14 $75,690
2015 Poverty Guidelines for the 48 Contiguous States 
and the District of Columbia
For familes/households with more than 8 persons, 
add $4,160 for each additional person
Alaska
For families/households with more than 8 persons, 
add $5,200 for each additional person
Hawaii
For families/households with more than 8 persons, 
add $4,780 for each additional person
357 
 
Table W-4.  
The 2014 U.S. Poverty Guidelines. (Source: https://aspe.hhs.gov/2014-poverty-guidelines) 
 
Persons in Family/Household Poverty Guideline 
1 $11,670
2 $15,730
3 $19,790
4 $23,850
5 $27,910
6 $31,970
7 $36,030
8 $40,090
9 $44,150
10 $48,210
11 $52,270
12 $56,330
13 $60,390
14 $64,450
Persons in Family/Household Poverty Guideline 
1 $14,580
2 $19,660
3 $24,740
4 $29,820
5 $34,900
6 $39,980
7 $45,060
8 $50,140
9 $55,220
10 $60,300
11 $65,380
12 $70,460
13 $75,540
14 $80,620
Persons in Family/Household Poverty Guideline
1 $13,420
2 $18,090
3 $22,760
4 $27,430
5 $32,100
6 $36,770
7 $41,440
8 $46,110
9 $50,780
10 $55,450
11 $60,120
12 $64,790
13 $69,460
14 $74,130
2014 Poverty Guidelines for the 48 Contiguous States 
and the District of Columbia
For familes/households with more than 8 persons, 
add $4,060 for each additional person
Alaska
For families/households with more than 8 persons, 
add $5,080 for each additional person
Hawaii
For families/households with more than 8 persons, 
add $4,670 for each additional person
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Table W-5.  
The 2013 Poverty Guidelines. (Source: https://aspe.hhs.gov/2013-poverty-guidelines).   
 
Persons in Family/Household Poverty Guideline 
1 $11,490
2 $15,510
3 $19,530
4 $23,550
5 $27,570
6 $31,590
7 $35,610
8 $39,630
9 $43,650
10 $47,670
11 $51,690
12 $55,710
13 $59,730
14 $63,750
Persons in Family/Household Poverty Guideline 
1 $14,350
2 $19,380
3 $24,410
4 $29,440
5 $34,470
6 $39,500
7 $44,530
8 $49,560
9 $54,590
10 $59,620
11 $64,650
12 $69,680
13 $74,710
14 $79,740
Persons in Family/Household Poverty Guideline
1 $13,230
2 $17,850
3 $22,470
4 $27,090
5 $31,710
6 $36,330
7 $40,950
8 $45,570
9 $50,190
10 $54,810
11 $59,430
12 $64,050
13 $68,670
14 $73,290
2013 Poverty Guidelines for the 48 Contiguous States 
and the District of Columbia
For familes/households with more than 8 persons, 
add $4,020 for each additional person
Alaska
For families/households with more than 8 persons, 
add $5,030 for each additional person
Hawaii
For families/households with more than 8 persons, 
add $4,620 for each additional person
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Table W-6.  
The 2012 U.S. Poverty Guidelines. (Source: https://aspe.hhs.gov/2012-hhs-poverty-guidelines)  
 
Persons in Family/Household Poverty Guideline 
1 $11,170
2 $15,130
3 $19,090
4 $23,050
5 $27,010
6 $30,970
7 $34,930
8 $38,890
9 $42,850
10 $46,810
11 $50,770
12 $54,730
13 $58,690
14 $62,650
Persons in Family/Household Poverty Guideline 
1 $13,970
2 $18,920
3 $23,870
4 $28,820
5 $33,770
6 $38,720
7 $43,670
8 $48,620
9 $53,570
10 $58,520
11 $63,470
12 $68,420
13 $73,370
14 $78,320
Persons in Family/Household Poverty Guideline
1 $12,860
2 $17,410
3 $21,960
4 $26,510
5 $31,060
6 $35,610
7 $40,160
8 $44,710
9 $49,520
10 $54,330
11 $59,140
12 $63,950
13 $68,760
14 $73,570
2012 Poverty Guidelines for the 48 Contiguous States 
and the District of Columbia
For familes/households with more than 8 persons, 
add $3,960 for each additional person
Alaska
For families/households with more than 8 persons, 
add $4,950 for each additional person
Hawaii
For families/households with more than 8 persons, 
add $4,810 for each additional person
360 
 
APPENDIX X 
HANDLING SINGLE PRIMARY SAMPLING UNITS (PSU) IN BRFSS 
The years 2012 to 2017 BRFSS datasets were concatenated for this study. BRFSS 
documentation offers complex survey weighting to make the sample representative of the U.S. 
population. The problems with using this weighting in STATA 15 includes: 
1. BRFSS data need to be weighted to assure that analytic statistics (e.g. means, 
coefficients) conform to the national sample. Data must be reweighted due to the 
complex 2-level sampling, first by PSU, then by stratum, including those with a single 
PSU.  
2. BRFSS documentation does not provide example weighting codes for STATA. STATA 
15 can produce general statistics like means, medians, etc., but cannot produce variances 
and, hence, inference statistics (eg., chi2, t-stats) if any single PSU is within a stratum. 
This is because, even if several households are in the stratum, the weighting is required to 
have 2+ PSU’s to properly adjust the weights and preserve the extent of the variance. 
3. Very small PSU’s may not be able to support more than 1 stratum. 
4. A way to get around this problem was to: (1) identify all the single PSU’s and delete 
them; or (2) move the single PSU’s to a different stratum; or (3) use the STATA 
command “singleunit (method)” with the svyset STATA command.   
Initially, the STATA command “svydescribe” was used to identify all single PSU’s, but even 
after deleting them, in later analyses rogue singletons were found. Therefore, the automatic 
command was the preferred method. The STATA manual provides four methods (i.e. missing, 
certainty, scaled or centered) to handle strata with one sampling unit16.  For this analysis, the 
 
16 Link to STATA Manual: https://www.stata.com/manuals13/svysvyset.pdf  
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STATA command “singleunit (scaled)” was used; which uses the average of variances from the 
strata with multiple sampling units for each stratum with 1 PSU. The STATA weighting code 
that was used for all analyses was: 
svyset _psu [pweight= _llcpwt], strata (_ststr) singleunit (scaled) 
Refer to the STATA manual for additional information on commands for handling single PSUs.  
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APPENDIX Y 
BRFSS NON-REPORTED INCOMES DROPPED FROM SAMPLE 
 Income was the only variable that had greater than >5% of observations missing, for a 
total of 428,289 observations being dropped in a 2,765,318 observation sample. To gain a better 
understanding of who was being dropped, non-reported income respondents were weighted and 
cross-tabulated by race and education. Since the relationship between education and income is 
strong, Table 27 gives an approximation of who was being dropped from the national sample.  
Table Y-1.  
Sample of Non-reported Incomes (n=428,289) for Whites, Blacks, Hispanics and Other Races 
from Full BRFSS sample (n=2,765,318).  
 
The majority of respondents who did not report an income where white (60.13%), which is 
expected given whites are the largest racial/ethnic group in the sample. Interestingly, the 
distribution of whites, blacks and Hispanics in Table 27, resemble those of the national sample 
(with the missing income variables dropped), 64.14%, 11.59% and 15.32%; respectively. This 
would lead us to believe that the non-reported income variables are missing at random.  
 
 
 
Weighted Weighted Weighted Weighted Weighted
Less than HS 7.76 2.78 7.05 1.55 19.14
HS Grad 20.61 4.43 4.51 3.28 32.84
Some College 18.89 3.26 3.07 3.57 28.8
College Grad 12.87 1.35 1.14 3.85 19.22
Total  60.13 11.82 15.77 12.25 100
2012-2017 BRFSS Non-reported Incomes
Whites, % Blacks, % Hispanics, % Total, %Other, %
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APPENDIX Z 
CURVILINEAR FUNCTION GOODNESS OF FIT CALCULATIONS 
In order to determine if the curvilinear functions accurately estimate post-ACA insurance 
values, pre-ACA values of percent insured were inserted into the appropriate curvilinear function 
equation. The five states with the lowest pre-ACA percent insured were used and are displayed 
below in Table 26 in the text. Refer to the text for the interpretation of the results.   
Texas 
All states Equation: 
Y=25 + 0.942(66.53)- 0.0021 (66.53)2 
Y=   25 + 62.67 -9.30 
Y= 78.37 | Actual 73.75 
Non-expansion state equation: 
Y= -0.0073x2 + 1.91x -21  
Y= -0.0073 (66.53)2 + 1.91 (66.53) -21 
Y= -32.31 + 127.07 -21 
Y= 73.76 | Actual: 73.75  
 
Arkansas  
All State Equation: 
Y=25 + 0.942(70.99)- 0.0021 (70.99)2 
Y= 25 + 66.87 – 10.58 
Y= 81.29 | Actual: 86.06  
Expansion Equation: 
Y= 0.0243x2 -3.5453x + 216  
Y= 0.0243 (70.99)2 -3.5453(70.99) + 216  
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Y= 122.46 – 251.68 + 216 
Y = 86.78 | Actual: 86.06  
 
Nevada  
All State Equation: 
Y=25 + 0.942(71.14)- 0.0021 (71.14)2 
Y=25 + 67.01 – 10.63 
Y= 81.38 | Actual 90.04  
Expansion Equation: 
Y= 0.0243x2 -3.5453x + 216  
Y= 0.0243 (71.14)2 -3.5453(71.14) + 216  
Y= 122.98 – 252.21 + 216 
Y= 86.77 | Actual 90.04  
 
Florida  
All State Equation: 
Y=25 + 0.942(72.63)- 0.0021 (72.63)2 
Y= 25+ 68.42-11.08 
Y = 82.34 | Actual: 79.82 
Non-expansion state equation: 
Y= -0.0073x2 + 1.91x -21  
Y= -0.0073 (72.63)2 + 1.91 (72.63) -21 
Y=-38.51 + 138.72 -21 
Y= 79.21 | Actual 79.82  
Mississippi  
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All State Equation: 
Y=25 + 0.942(72.72)- 0.0021 (72.72)2 
Y= 25+ 68.50 – 11.11 
Y= 82.39 | Actual: 78.88 
Non-expansion state equation: 
Y= -0.0073x2 + 1.91x -21  
Y= -0.0073 (72.72)2 + 1.91 (72.72) -21 
Y= -38.60 + 138.90 – 21 
Y = 79.3 | Actual: 79.3  
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APPENDIX AA 
BRFSS DESCRIPTIVE STATISTICS BY TIME: 2012-2017 
Table AA-1.  
Mean Changes for Predictor and Control Variables by Time for 19-state Non-expansion Group.  
 
 
 
 
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA P Value
Variables n=89,949 n=102,209 n=92,004 n=84,656 n=86,727 n=88,577 n=192,158 n=351,964 X
2
Demographics
Income 
>400% FPL 35.15 36.32 33.06 34.48 35.99 36.72 35.73 35.07 p<0.05
139-400% FPL 37.08 36.63 41.48 41.65 41.91 41.30 36.85 41.58 p<0.001
100-138% FPL 9.29 9.14 8.71 8.52 8.26 8.10 9.22 8.40 p<0.001
<100% FPL 18.48 17.91 16.75 15.35 13.85 13.88 18.20 14.95 p<0.001
Race
Whites 66.10 65.72 66.36 65.48 65.51 65.31 65.91 65.67 0.4162
Blacks 17.41 17.29 17.13 17.33 16.92 17.20 17.35 17.15 0.3875
Hispanics 16.49 16.99 16.50 17.19 17.56 17.49 16.74 17.19 0.1073
Education
<HS 13.35 13.78 13.26 12.71 12.58 11.88 13.56 12.60 -
HS Grad 28.51 28.04 28.30 28.01 27.95 27.85 28.28 28.03 -
Some College 32.45 32.67 33.02 33.12 32.76 33.36 32.56 33.07 -
College Grad 25.70 25.51 25.42 26.16 26.72 26.91 25.60 26.30 p<0.001
Age
18 to 34 34.48 34.39 34.88 34.76 35.69 35.34 34.44 35.17 -
35 to 44 21.70 21.19 21.26 21.43 21.00 21.51 21.45 21.30 -
45 to 54 23.71 23.63 22.88 22.44 21.96 21.61 23.67 22.22 -
55 to 64 20.11 20.78 20.99 21.37 21.35 21.55 20.44 21.31 p<0.001
Sex
Male 51.77 51.39 51.61 51.89 52.07 51.80 51.58 51.84 -
Female 48.23 48.61 48.39 48.11 47.93 48.20 48.42 48.16 0.368
Health 
Diabetes Status
No/Low Risk 58.75 54.68 57.39 53.71 55.84 53.10 56.74 55.01 p<0.001
High Risk 33.00 37.02 34.22 37.95 35.77 38.37 34.99 36.58 p<0.001
Diabetes  8.25 8.30 8.39 8.33 8.40 8.54 8.28 8.42 p<0.001
Chronic Disease
0 80.71 80.26 80.36 80.25 80.35 80.03 80.49 80.25 -
1 15.27 15.92 15.73 15.99 15.93 15.93 15.59 15.89 -
2 3.19 2.93 3.07 2.93 2.97 3.15 3.06 3.03 -
3 0.65 0.70 0.67 0.66 0.63 0.68 0.68 0.66 -
4 0.15 0.14 0.16 0.15 0.10 0.20 0.15 0.16 -
5 0.04 0.03 0.00 0.01 0.01 0.02 0.03 0.01 p<0.05
Self Reported Health
Healthy 82.90 82.89 83.10 83.61 83.57 82.61 82.90 83.22 -
Unhealty 17.10 17.11 16.90 16.39 16.43 17.39 17.10 16.78 0.1507
State Level 
PCP Supply
Adequate 44.06 43.29 44.7 45.1 43.27 43.09 43.68 44.03 -
Low 55.94 56.71 55.30 54.90 56.73 56.91 56.32 55.97 0.1132
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Table AA-2.  
Mean Changes for Predictor and Control Variables by Time for 28-state Expansion Group. 
 
 
 
 
 
 
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA P Value
Variables n=135,522 n=130,865 n=120,861 n=106,506 n=128,019 n=117,642 n=266,387 n=473,028 X
2
Demographics
Income 
>400% FPL 39.70 40.87 37.29 40.31 40.85 42.56 40.29 40.26 0.9162
139-400% FPL 33.62 33.17 38.36 37.38 37.46 36.51 33.39 37.42 p<0.001
100-138% FPL 8.40 8.11 7.83 7.80 7.40 7.44 8.25 7.61 p<0.001
<100% FPL 18.29 17.85 16.53 14.51 14.30 13.49 18.07 14.70
Race
Whites 69.60 69.80 70.64 69.90 68.56 68.84 69.70 69.48 0.3327
Blacks 11.39 11.03 11.15 11.10 11.31 11.38 11.21 11.24 0.8513
Hispanics 19.01 19.16 18.20 19.00 20.13 19.78 19.09 19.28 0.1073
Education
<HS 13.52 13.84 13.02 12.52 12.84 12.40 13.68 12.70 -
HS Grad 27.71 27.46 27.75 27.52 27.43 27.50 27.59 27.55 -
Some College 32.15 32.24 32.14 32.19 32.21 32.20 32.19 32.18 -
College Grad 26.61 26.47 27.10 27.76 27.51 27.90 26.54 27.57 p<0.001
Age
18 to 34 34.59 34.53 34.41 35.07 5.53 34.75 34.56 34.94 -
35 to 44 21.15 20.34 20.75 20.58 20.69 20.88 20.74 20.73 -
45 to 54 23.77 23.80 23.29 22.73 21.96 21.91 23.78 22.46 -
55 to 64 20.49 21.33 21.55 21.62 21.82 22.46 20.91 21.87 p<0.001
Sex
Male 51.80 51.79 51.81 52.07 52.25 51.83 51.80 51.99 -
Female 48.20 48.21 48.19 47.93 47.75 48.17 48.20 48.01 0.385
Health 
Diabetes Status
No/Low Risk 60.37 57.78 58.86 56.97 58.88 55.69 59.07 57.60 p<0.001
High Risk 32.14 34.98 33.60 35.74 33.73 36.78 33.56 34.96 p<0.001
Diabetes  7.49 7.25 7.54 7.30 7.39 7.53 7.37 7.44 0.5237
Chronic Disease
0 80.09 79.54 79.50 80.74 79.95 79.88 79.81 80.01 -
1 16.46 17.12 16.93 15.89 16.46 16.50 16.79 16.45 -
2 2.67 2.73 2.85 2.71 2.78 2.92 2.70 2.82 -
3 0.68 0.53 0.64 0.57 0.69 0.55 0.60 0.61 -
4 0.09 0.08 0.07 0.08 0.12 0.14 0.09 0.10 -
5 0.02 0.00 0.01 0.01 0.02 0.01 0.01 0.01 0.0968
Self Reported Health
Healthy 83.92 83.86 84.16 84.64 84.32 83.75 83.89 84.21 -
Unhealty 16.08 16.14 15.84 15.36 15.68 16.25 16.11 15.79 0.0626
State Level 
PCP Supply
Adequate 84.54 84.86 83.94 84.65 84.65 84.33 84.70 84.39 -
Low 15.46 15.14 16.06 15.35 15.35 15.67 15.30 15.61 p<0.01
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APPENDIX AB 
BRFSS OUTCOME VARIABLES BY TIME: 2012-2017 
Table AB-1.  
Percent Insured by Income Group and Time for Full Analtyic Sample (50 States and D.C.).  
 
Table AB-2.  
Mean PCP or Checkup in Past Year by Race and Year for Full Analytic Sample.  
 
 
 
 
 
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
Mean (INS) BRFSS Sample Weighted % (Post/Pre ACA) X
2
U.S. Income  Groups
>400% FPL 105,863 94.56 94.91 95.97 95.95 96.00 95.67 94.73 95.89 1.22% p<0.001
139-400% FPL 87,251 76.70 76.99 82.71 84.31 85.14 83.50 76.85 83.91 9.19% p<0.001
100-138% FPL 18,751 60.63 63.19 71.75 75.29 73.33 75.73 61.89 74.00 19.57% 0.4793
<100% FPL 32,084 54.14 56.90 64.40 68.18 70.81 70.90 55.50 68.37 23.19% p<0.001
Analytic Sample
All 50 States 243,949 78.03 79.34 83.56 85.67 86.50 86.16 84.14 89.49 6.36% p<0.001
Mean INS by Income and Time (50 States)
2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
BRFSS Sample Weighted % (Post/Pre ACA) X2
U.S. Race/Ethnic Groups
Whites 199,386 79.26 77.69 78.09 78.95 78.58 77.54 78.48 78.28 -0.25% p<0.001
Blacks 24,977 72.73 71.86 74.60 75.04 75.64 75.21 72.30 75.12 3.90% p<0.01
Hispanics 19,586 58.65 56.95 58.58 61.33 60.54 60.59 57.80 60.27 4.27% p<0.001
Analytic Sample
All 50 States 243,949 74.70 73.16 74.23 75.24 74.77 74.06 73.93 74.57 0.87% p<0.001
U.S. Race/Ethnic Groups
Whites 199,386 62.31 63.24 64.54 64.44 65.34 64.04 62.77 64.59 2.90% p<0.01
Blacks 24,977 73.21 73.94 75.99 75.48 76.56 76.62 73.57 76.17 3.53% 0.7143
Hispanics 19,586 56.01 58.36 59.86 59.73 60.95 60.01 57.19 60.15 5.18% p<0.01
Analytic Sample
All 50 States 243,949 62.67 63.78 65.27 65.08 66.01 65.00 63.23 65.34 3.34% p<0.001
Mean Health Care Access by Race and Time (50 States)
2012
Mean (PCP)
Mean (Checkup)
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Table AB-3.  
Mean PCP or Checkup in the Past Year by Diabetes Risk and Year for Full Analytic Sample.  
 
 
 
 
 
 
 
 
 
 
 
 
2012 2013 2014 2015 2016 2017 Pre ACA Post ACA Growth Rate P Value
BRFSS Sample Weighted % (Post/Pre ACA) X
2
U.S. Diabetes Risk 
No/Low Risk 144,428 73.00 71.43 72.06 73.30 72.48 71.82 72.24 72.40 0.22% p<0.001
High Risk 77,818 74.47 72.69 74.35 74.78 74.99 73.81 73.54 74.47 1.26% p<0.001
Diabetes 21,703 88.93 88.25 89.94 91.47 91.01 90.78 88.60 90.79 2.47% p<0.01
Analytic Sample
All 50 States 243,949 74.70 73.16 74.23 75.24 74.77 74.06 73.93 74.57 0.87% p<0.001
U.S. Diabetes Risk 
No/Low Risk 144,428 60.36 61.58 62.77 62.76 63.50 62.34 60.95 62.85 3.12% p<0.001
High Risk 77,818 62.71 63.37 65.27 64.53 66.04 64.93 63.05 65.18 3.38% p<0.001
Diabetes 21,703 80.42 82.18 83.87 84.52 84.72 83.89 81.29 84.24 3.63% 0.1376
Analytic Sample
All 50 States 243,949 62.67 63.78 65.27 65.08 66.01 65.00 63.23 65.34 3.34% p<0.001
Mean Health Care Access by Diabetes Risk and Time (50 States)
Mean (PCP)
Mean (Checkup)
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APPENDIX AC 
BRFSSS DESCRIPTIVE STATISTICS 2013 VS. 2017 
Up to this point, focus has been placed on changes in outcomes that led to an increase in 
insurance and health care access in the pre vs. post-ACA periods. Here, descriptive statistics 
were run for the last pre-ACA year (2013) vs. the last post-ACA (2017), with an emphasis placed 
on changes in outcomes among the uninsured, and those who continue to have limited access to 
health care services. This appendix is important to consider given that even without insurance, 
individuals still have access to a PCP, as seen in some subgroups in Table 39.  Among the 
uninsured, 40% of respondents reported having a PCP in 2013, with 38% reporting having a PCP 
in 2017 (Table AC-1). Given the high percentage of uninsured with a PCP, one would think the 
U.S. primary care has the capacity to treat the uninsured. However, the number of uninsured 
individuals who report a PCP (40%, n=38,151 in 2013) is averaged for the nation and does not 
consider regional/state differences. The 40% of the uninsured with a PCP accounts 3.6% of the 
U.S. white, black and Hispanic adult population aged 18-64 in 2013 (~ 30 million people). The 
three outcomes of interest, (i.e. the uninsured, report of no PCP and report of no checkup in the 
past year) were stratified in more complex analytic tables by race, income, diabetes risk status 
and state expansion status in 2013 vs. 2017 to gain a better understanding of how the ACA 
impacted specific subgroups. 
Table AC-1.  
Percent PCP for Uninsured by Year (47-state Analytic Sample). (Sample size of uninsured is 
164,779 respondents aged 18-64 who are white, black or Hispanic). 
 
INSURANCE SAMPLE NEXP EXP TOTAL NEXP EXP TOTAL NEXP EXP TOTAL NEXP EXP TOTAL NEXP EXP TOTAL NEXP EXP TOTAL
n 16,038 21,535 37,573 18,469 19,682 38,151 12,921 12,271 25,192 10,521 9,076 19,597 11,534 10,114 21,648 12,361 10,257 22,618
Uninsured 164,779 40.24 41.60 40.99 39.19 40.37 39.84 37.86 40.22 39.06 37.53 42.40 39.89 38.89 41.01 39.92 35.74 40.99 38.21
% PCP (Yes, Provider)
2012 2013 2014 2015 2016 2017
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Changes in Outcomes by Diabetes Risk and by Race. In 2013, the weighted sample 
size included 147,246,499 whites, blacks and Hispanics aged 18-64. The weighted sample size in 
2017 was 146,120,516, a difference of 0.8% (Table AC-2). To note, there was a decline of about 
30,000 observations in the unweighted sample from 2013 to 2017; however, weighting adjusts 
the sample to be aligned with what is known about the population, which keeps the imputed total 
sample representative. The difference in the sampling distributions of the uninsured in both year 
groups was statistically significant (p<0.001) with a 33% decrease in the rate of being uninsured 
post ACA implementation. The availability of additional insurance options post ACA, in 
conjunction with the insurance mandate led to an increase in the number insured. The greatest 
decrease in the rate of being uninsured was seen among whites (37.3%), then blacks (36.8%). 
This is interesting as minorities were expected to have the greatest gains, given their lower 
income status when compared to whites. Whites may be benefiting even more so from the 
insurance subsidies, than minorities are.  
In terms of health care access, differences in the sampling distributions of having a PCP 
or having a checkup at 1 year were statistically significant (p<0.05 and p<0.001, respectively). 
There was a 3.4% decrease in the report of not having a PCP, where blacks reported the greatest 
gains in obtaining a PCP post ACA implementation (11.9%). There was also a 3.4% decrease in 
the report of not having a checkup in the past year, with blacks also reporting the greatest gains 
in having a yearly checkup (10.3%). To note, whites had the greatest uptake in insurance, but did 
not increase their rate of obtaining a PCP or having a yearly checkup. Despite the uptake in 
insurance coverage, ACA coverage expansion legislation did does not have a direct effect on 
having a provider or receiving a checkup in the past year, therefore, the percent change in 
insurance coverage and in health care access will not be 1:1. Additional factors need to be 
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considered with health care access, including, primary care provider supply, individual health 
status and individual demographics in order to see an increase in behaviors that lead to an 
increase in health care access.  However, blacks were the racial/ethnic group that increased their 
report of having a PCP and attending a yearly checkup post ACA implementation.  As stated 
earlier, this could be due to minorities living within urban areas with greater resources than in 
rural areas which are mainly occupied by whites.  
 Table AC-2 is then broken out into Table AC-3 and Table AC-4, differentiating 
between non-expansion and Medicaid expansion groups. Medicaid expansion states had the 
greatest overall decrease in the report of being uninsured (41.9%, p<0.001 vs. 23.6%, p<0.001) 
(Tables AC-2 and AC-4). In non-expansion states, the uninsured rate of blacks decreased by 
28.1%, compared to a decrease of 24.6% in whites and a decrease of 21.2% in Hispanics. 
Minorities are showing large declines in being uninsured within non-expansion states due to the 
availability of insurance subsides. Blacks and whites had the greatest decrease in the report of 
being uninsured in Medicaid expansion states, with a percent change of -48%. The almost 20 
percentage-point difference in the report of being uninsured for blacks and whites in Medicaid 
expansion states over non-expansion states is most likely due to an increase in Medicaid 
enrollment. Therefore, Medicaid expansion was needed in order for states to see a decrease in the 
report of no provider or no checkup in the past year. In Medicaid expansion states, changes in the 
report of health care access variables from 2013 to 2017 was statistically significant; whereas, in 
non-expansion states, the changes in the report of a PCP or a checkup in the past year from 2013 
to 2017 was not statistically significant (p=0.38 vs. p=0.95, respectively).  
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Table AC-2.  
Percent Change in Insurance, Health Care Access and Health Status by Race in All U.S. States 
from 2013 to 2017. 
 
 Health Status. Overall, the high risk for diabetes group increased post ACA 
implementation (4.7%, p<0.001) (Table AC-2). Blacks had the highest proportions of 
individuals at high risk for diabetes in 2013 and 2017, with Hispanics closely behind; however, 
Hispanics had the greatest increase (6.2%) in the proportion of individuals at high risk, when 
compared to whites (4.7%) or blacks (1.3%). Despite the increase in the number of Hispanics at 
high risk for diabetes, blacks had the greatest increase in the number of individuals with diabetes 
(6.5%). Whites and Hispanics also saw increases (3.4% and 0.4%, respectively). Although report 
of diabetes increased in 2017, this increase was not statistically significant (3.7%, p=0.08). 
 In non-expansion states, a greater proportion of individuals were at high risk for diabetes 
pre and post ACA (37% vs. 38%), than in Medicaid expansion states (35% vs. 37%). 
Interestingly, there was an increase in the proportion of high-risk individuals in Medicaid 
expansion states, when compared to the increase in non-expansion states (5.3% vs. 3.5%). This 
may be due to increased access to preventive care, where individuals would be screened for their 
high-risk status. Strikingly, there was a 1.4% decrease in the proportion of blacks who were at 
Sample Size Whites Blacks Hispanics Total Whites Blacks Hispanics Total White Blacks Hispanics Total 
Unweighted 203,958 23,913 21,001 248,872 174,642 20,869 21,145 216,656 -14.4% -12.7% 0.7% -12.9%
Weighted  100,951,827 19,628,949 26,665,722 147,246,499 98,917,460 19,911,112 27,291,943 146,120,516 -2.0% 1.4% 2.3% -0.8%
Outcomes
Uninsured 15.0 25.4 38.7 20.7 9.4 16.1 28.4 13.8 -37.3% -36.8% -26.7% -33.0% <0.001
No PCP 22.3 28.1 43.1 26.8 22.5 24.8 39.4 25.9 0.7% -11.9% -8.5% -3.4% <0.05
No Checkup 36.8 26.1 41.6 36.2 36.0 23.4 40.0 35.0 -2.2% -10.3% -4.0% -3.4%  <0.001
Diabetes Risk
High Risk 33.1 42.9 40.1 35.6 34.6 43.4 42.6 37.3 4.7% 1.3% 6.2% 4.7% <0.001
Diabetes
Diabetes Diagnosis 6.6 10.9 9.1 7.6 6.8 11.6 9.2 7.9 3.4% 6.5% 0.4% 3.7% 0.0812
Notes:
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S., proportions weighted by sampling fractions
2. Proportions are rounded and may not add up to 100
3. P value column: Pearson Chi-squre tests to assess differences in sample distribution between characteristic of interest and year (2013 vs. 2017)
p
All States
Percent Change
2013 to 2017
Pre ACA Post ACA
2013 2017
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high risk for diabetes from 2013-2017 in non-expansion states (Table AC-3). Better utilization 
of the health care system could be one reason for the decrease in high risk status among blacks, 
since they would be more aware of their actual health status. Further analytic tables are needed to 
discern what is causing the decrease in the high-risk group among blacks in Table AC-3.   
As increases in diabetes risk occurred post ACA, increases in the report of a diabetes 
diagnosis also occurred from 2013 to 2017 (Table AC-4). In Medicaid expansion states, there 
was a greater increase in the report of diabetes (3.8%), when compared to the report of diabetes 
in non-expansion states (3.0%). The greater increase in diabetes in expansion states may be 
attributed to more individuals being aware of their health status do to an increase in the 
proportions of individuals who gained insurance. Overall, in both expansion groups, pre/post 
changes in diabetes were not statistically significant.  The next set of tables that follow will 
stratify diabetes risk and the report of diabetes diagnosis with the outcomes of interest- insurance 
and health care access.  
Table AC-3.  
Percent Change in Insurance, Health Care Access and Health Status by Race in the U.S. Non-
expansion States from 2013 to 2017. 
 
Sample Size Whites Blacks Hispanics Total Whites Blacks Hispanics Total White Blacks Hispanics Total 
Unweighted 76,368 11,910 7,260 95,538 65,190 9,387 7,106 81,683 -14.6% -21.2% -2.1% -14.5%
Weighted  36,338,024 9,631,114 9,675,857 55,644,995 37,227,394 9,915,450 10,318,798 57,461,642 2.4% 3.0% 6.6% 3.3%
Outcomes
Uninsured 17.4 28.6 47.0 24.5 13.1 20.6 37.0 18.7 -24.6% -28.1% -21.2% -23.6% p<0.001
No PCP 25.4 30.1 47.2 26.8 26.3 29.1 46.7 25.9 3.5% -3.4% -1.1% -3.4% 0.3753
No Checkup 36.2 26.4 42.5 35.6 36.8 24.2 42.1 35.6 1.6% -8.3% -1.1% -0.1% 0.9452
Diabetes Risk
High Risk 34.3 43.8 40.4 37.0 35.7 43.2 43.0 38.3 4.1% -1.4% 6.3% 3.5% p<0.05
Diabetes
Diabetes Diagnosis 7.3 11.1 9.0 8.3 7.4 12.2 9.0 8.5 1.2% 9.8% 0.0% 3.0% 0.3755
Notes:
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S. non-expansion states, proportions weighted by sampling fractions
2: Non-expansion states: 19 states that did not expand Medicaid by end of 2017
3. Proportions are rounded and may not add up to 100
4. P value column: Pearson Chi-squre tests to assess differences in sample distribution between characteristic of interest and year (2013 vs. 2017)
p
Non-expansion States
2013 to 2017
Pre ACA Post ACA Percent Change
2013 2017
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Table AC-4.  
Percent Change in Insurance, Health Care Access and Health Status by Race in the U.S. 
Medicaid expansion states from 2013 to 2017. 
 
Changes in Outcomes by Diabetes Risk/Diagnosis. Among the high risk for diabetes 
group, there was a 33% decrease in the report of being uninsured, a 4% decrease in the report of 
no provider and a 4% decrease in the report of no checkup in the past year post-ACA. 
Interestingly, in the diabetes group, there was a 32% decrease in the report of being uninsured, a 
22% decrease in the report of no provider and a 10% decrease in the report of no checkup in the 
past year. The diabetes risk and diabetes diagnosis groups had similar decreases in the rates of 
the uninsured, but those with diabetes had better health care access in terms of having a provider 
or receiving a checkup in the past year. This is expected as diabetes is a chronic condition with 
symptoms due to elevated blood glucose levels, requiring further clinical management. 
Individuals in the high-risk group, although some may have elevated blood glucose levels, they 
are not at the severity of those with diabetes, and are typically asymptomatic, decreasing the 
urgency for health care services.  Changes in insurance and health care access among both 
diabetes groups post-ACA were statistically significant.  
Sample Size (SS) Whites Blacks Hispanics Total Whites Blacks Hispanics Total White Blacks Hispanics Total 
Weighted 118,905 11,828 13,323 144,056 101,444 11,291 13,320 126,055 -14.7% -4.5% 0.0% -12.5%
Unweighted 63,811,217 9,953,561 16,911,739 90,676,516 60,840,555 9,945,251 16,880,076 87,665,883 -4.7% -0.1% -0.2% -3.3%
Outcomes
Uninsured 13.62 22.27 33.9 18.35 7.09 11.57 23.02 10.67 -47.9% -48.0% -32.1% -41.9% p<0.001
No PCP 20.55 26.28 40.64 24.93 20.15 20.57 34.93 23.05 -1.9% -21.7% -14.1% -7.5% p<0.001
No Checkup 36.98 25.71 41.09 36.51 35.4 22.52 38.68 34.57 -4.3% -12.4% -5.9% -5.3% p<0.001
Diabetes Risk
High Risk 32.33 42.03 39.94 34.81 33.91 43.68 42.34 36.64 4.9% 3.9% 6.0% 5.3% p<0.001
Diabetes
Diabetes Diagnosis 6.1 10.6 9.2 7.2 6.4 11.0 9.3 7.5 4.3% 3.0% 0.8% 3.8% 0.1637
Notes:
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S. Medicaid expansion states, proportions weighted by sampling fractions
2: Medicaid expansion states: 31 states and D.C. that expanded Medicaid by end of 2017
3. Proportions are rounded and may not add up to 100
4. P value column: Pearson Chi-squre tests to assess differences in sample distribution between characteristic of interest and year (2013 vs. 2017)
p
Medicaid Expansion States
Pre ACA Post ACA Percent Change
2013 2017 2013 to 2017
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Table AC-5.  
Percent Change in Insurance and Health Care Access by Diabetes Status in all U.S. States from 
2013 to 2017. 
 
 The high-risk group living within Medicaid expansion states experienced greater 
decreases in the report of being uninsured (43%) post ACA than the high-risk group living 
within non-expansion states (22%). This was true also for the diabetes group, who had a greater 
decrease in the report of being uninsured in expansion states (40%), compared to those living 
within non-expansion states (26%). To note, despite having a 22% decrease in the report of being 
uninsured in non-expansion states, the high-risk group experienced a 0.1% increase in the report 
of having no PCP. The slight increase in the report of no PCP in non-expansion states was not 
seen in expansion states; rather, there was an 8% decrease in the report of no PCP. For both 
expansion groups, there was a decrease in the report of no checkup in the past year; however, 
this change was statistically significant only within Medicaid expansion states. As discussed 
earlier, the high-risk group has less clinical incentives to seek a provider or have a checkup when 
symptoms tend to be asymptomatic. Yet, the small changes in having a provider or receiving a 
Sample Size High Risk Diabetes High Risk Diabetes High Risk Diabetes High Risk Diabetes
Unweighted 87,515 21,519 79,816 19,806 -8.8% -8.0%
Weighted 52,472,679 11,188,052 54,506,119 11,513,505 3.9% 2.9%
Outcomes
Uninsured 22.99 17.41 15.49 11.78 -32.6% -32.3% <0.001 <0.001
No PCP 27.31 11.75 26.19 9.22 -4.1% -21.5% <0.05 <0.001
No Checkup 36.63 17.82 35.07 16.11 -4.3% -9.6% <0.05 0.0457
Notes:
2. Proportions are rounded and may not add up to 100
p p
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S., 
proportions weighted by sampling fractions
3. P value column: Pearson Chi-squre tests performed to assess differences in sample distribution between 
outcome of interest and health status by year (2013 vs. 2017)
All States
Pre ACA Post ACA Percent Change
2013 2017 2013 to 2017
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checkup in the past year for the high-risk group were statistically significant within both 
expansion groups.   
Table AC-6.  
Percent Change in Insurance and Health Care Access by Diabetes Status in U.S. Non-expansion 
States from 2013 to 2017. 
 
Table AC-7.  
Percent Change in Insurance and Health Care Access by Diabetes Status in U.S. Medicaid 
Expansion States from 2013 to 2017. 
 
Sample Size High Risk Diabetes High Risk Diabetes High Risk Diabetes High Risk Diabetes
Unweighted 34,686 9,192 30,824 7,938 -11.1% -13.6%
Weighted 20,585,596 4,613,210 22,005,759 4,908,904 6.9% 6.4%
Outcomes
Uninsured 27.06 21.41 21.08 15.76 -22.1% -26.4% <0.001 <0.001
No PCP 30.6 13.65 30.63 11.11 0.1% -18.6% <0.05 <0.001
No Checkup 36.49 17.77 36.07 16.96 -1.2% -4.6% 0.6089 0.5481
Notes:
2: Non-expansion states: 19 states that did not expand Medicaid by end of 2017
3. Proportions are rounded and may not add up to 100
Non-expansion States
p p
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S. non-
expansion states, proportions weighted by sampling fractions
4. P value column: Pearson Chi-squre tests performed to assess differences in sample distribution between 
outcome of interest and health status by year (2013 vs. 2017)
Pre ACA Post ACA Percent Change
2013 2017 2013 to 2017
Sample Size High Risk Diabetes High Risk Diabetes High Risk Diabetes High Risk Diabetes
Unweighted 49,376 11,618 45,387 11,116 -8.1% -4.3%
Weighted 31,565,898 6,513,686 32,122,170 6,533,971 1.8% 0.3%
Outcomes
Uninsured 20.41 14.55 11.68 8.76 -42.8% -39.8% <0.001 <0.001
No PCP 25.2 10.45 23.19 7.78 -8.0% -25.6% <0.001 <0.05
No Checkup 36.63 17.81 34.35 15.46 -6.2% -13.2% <0.001 <0.05
Notes:
2: Medicaid expansion states: 31 states and D.C. that expanded Medicaid by end of 2017
3. Proportions are rounded and may not add up to 100
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S. 
Medicaid expansion states, proportions weighted by sampling fractions
4. P value column: Pearson Chi-squre tests performed to assess differences in sample distribution between 
outcome of interest and health status by year (2013 vs. 2017)
p p
Medicaid Expansion States
Pre ACA Post ACA Percent Change
2013 2017 2013 to 2017
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Changes in Outcomes by Income. In the previous tables, differences in the outcomes of 
interest by diabetes health status and race were seen between non-expansion states and Medicaid 
expansion states. Key differences between expansion groups is based on the type of insurance 
coverage that was available to persons living within the lower income groups (<400% FPL). The 
next set of tables focus on pre/post ACA changes in insurance and health care access by income. 
As a reminder, income categories are as follows: (1) less than 100% FPL, (2) 100-138% FPL, (3) 
139-400 % FPL and (4) greater than 400% FPL. Sample sizes for each income group in 2013 and 
2017 are shown in Table AC-9. A weighted sample size is also provided that adjusts for 
differences in the unweighted sample sizes from 2013 to 2017. 
 Overall, the 100-138% FPL group experienced the greatest decrease in the report of being 
uninsured post ACA (34.1%, p<0.001). This is expected as this income group benefited from the 
insurance subsides, and in expansion states, this group further benefited from Medicaid 
expansion. For health care access, the less than 100% FPL group experienced the greatest 
decrease in the report of no PCP (18%, p<0.001), when compared to the other income groups. 
Interesting to note, those with high incomes saw an 19% increase in the report of not having a 
provider, despite having an 15% decrease in the report of being uninsured. The 100-138% FPL 
group saw the greatest decrease in the report of no checkup in the past year (14.6%, p<0.001) 
when compared to the other incomes. Again, the high-income group saw an increase in the report 
of no checkup in the past year (7%, p<0.001) despite seeing a reduction in the report of not 
having insurance. The increase in the report of no provider or checkup is not expected for the 
high-income group, given their low rates of being uninsured and higher educational levels when 
compared to lower income groups. One would think the higher income group would understand 
the importance of preventive care, even if they are healthy.  
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Table AC-8.  
Percent Change in Insurance and Health Care Access by Income in All U.S. States (2013 to 
2017). 
 
 Respondents living within 100-138% FPL in non-expansion states saw the greatest 
decrease in the report of being uninsured (-25%, p<0.001), when compared to the other income 
groups. In Medicaid expansion states, the less than 100% FPL saw the greatest decrease in the 
report of being uninsured (-45%, p<0.001), when compared to other income groups. The increase 
in insurance coverage seen in this group could be related to the state-led advocacy efforts to 
enroll low income groups in Medicaid. The Kaiser Family Foundation states that large increases 
in Medicaid enrollment occurred among individuals who were previously eligible for but not 
enrolled in Medicaid within expansion states. This effect is known as “woodwork” or “welcome 
matt” effect and describes why an increase in Medicaid enrollment occurred due to incentives to 
increase enrollment coverage by the ACA (Kaiser Family Foundation, 2018).  
 In non-expansion states, the less than 100% FPL group had the greatest decrease in the 
report of no PCP (10%, p<0.05) and no checkup (9%, p<0.05), when compared to higher income 
groups. The high-income group within non-expansion states had an increase of 18% in the report 
of no PCP and an increase of 10% in the report of no checkup by 2017. In Medicaid expansion 
states, the less than 100% FPL group also had the greatest decrease in the report of no PCP 
Sample Size <100% 100-138 139-400 >400% <100% 100-138 139-400 >400% <100% 100-138 139-401 >400% <100% 100-139 139-402 >400% 
Unweighted 32,474 19,089 88,404 108,905 22,686 15,083 86,109 92,778 -30.1% -21.0% -2.6% -14.8%
Weighted 26,065,869 12,428,403 50,593,838 58,158,389 19,712,611 11,138,114 55,818,432 59,451,359 -24.4% -10.4% 10.3% 2.2%
Outcomes
Uninsured 43.1 36.81 23.01 5.09 29.1 24.27 16.5 4.33 -32.5% -34.1% -28.3% -14.9% <0.001 <0.001 <0.001 <0.001
No PCP 41.45 37.19 29.5 15.77 34.05 32.96 29.42 18.68 -17.9% -11.4% -0.3% 18.5% <0.001 <0.001 0.8642 <0.001
No Checkup 42.5 42.54 38.32 30.21 37.19 36.32 36.89 32.24 -12.5% -14.6% -3.7% 6.7% <0.001 <0.001 <0.05 <0.001
Notes:
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S., proportions weighted by sampling fractions
2. Proportions are rounded and may not add up to 100
3. P value column: Pearson Chi-squre tests performed to assess differences in sample distribution between outcome of interest and income by year (2013 vs. 2017)
All States
p p p p
Pre ACA Post ACA Percent Change
2013 2017 2013 to 2017
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(25%, p<0.001), but the 100-138% FPL had the greatest decrease in the report of no checkup 
(19%, p<0.001). The high-income group within Medicaid expansion states saw an increase in the 
report of no PCP and no checkup as well. However, the report of no PCP was higher in Medicaid 
expansion states by 1.0 percentage point and the report of no checkup was lower in Medicaid 
expansion states by almost 5.0 percentage points than in non-expansion states. 
  It is interesting that the “welcome matt” effect may have played a major role in enrolling 
low-income adults in Medicaid within expansion states as the change in the uninsured decreased 
by 45% in the less than 100% FPL group, when compared to the decrease of 20% in the same 
group within non-expansion states. One would think that to see large gains in having a PCP or a 
checkup, many more people would need to have insurance coverage. However, the high-income 
group contradicts this; despite seeing increases in insurance, health care access is getting worse 
for this group. The ACA coverage expansion did not directly affect this income group, but one 
would think the “welcome matt” effect may have a small role in this group as well, in terms of 
encouraging people to sign up for coverage, and subsequently seeking access to health care 
services.  
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Table AC-9.  
Percent Change in Insurance and Health Care Access by Income in U.S. Non-expansion States 
(2013 to 2017). 
 
Table AC-10.  
Percent Change in Insurance and Health Care Access by Income in U.S. Medicaid Expansion 
states (2013 to 2017). 
 
Likelihood and Absolute Changes in Outcomes 
 In Tables AC-11 through AC-13, the relative risk, or risk ratio, is presented for each of 
the three outcomes of interest (i.e. uninsured, no PCP and no checkup in the past year). Relative 
risk (RR) was calculated by diving the probability of an outcome occurring in group 1, divided 
by the probability of an outcome occurring for group 2.  Group 2 is the reference group and has a 
RR of ***. For example, in the race/ethnicity category, whites are the reference group, and each 
RR is calculated by dividing a different racial/ethnic group’s percent uninsured by the percent 
Sample Size <100% 100-138 139-400 >400% <100% 100-138 130-400 >400% <100% 100-138 139-401 >400% <100% 100-139 139-402 >400% 
Unweighted 13,890 8,227 35,556 37,865 9,055 6,205 35,021 31,402 -34.8% -24.6% -1.5% -17.1%
Weighted 10,019,443 5,088,489 20,353,396 20,183,667 8,039,224 4,673,535 23,723,570 21,025,313 -19.8% -8.2% 16.6% 4.2%
Outcomes
Uninsured 50.7 42.1 25.5 6.0 40.6 31.5 20.2 5.8 -19.9% -25.1% -20.7% -3.8% <0.001 <0.001 <0.001 0.61
No PCP 44.8 38.9 32.2 18.2 40.3 39.3 33.3 21.4 -10.0% 1.0% 3.5% 17.7% <0.05 0.84 0.15 <0.001
No Checkup 42.8 41.9 37.9 28.2 39.1 38.5 37.8 31.1 -8.6% -8.1% -0.1% 10.0% <0.05 0.06 0.98 <0.001
Notes:
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S. non-expansion states, proportions weighted by sampling fractions
2: Non-expansion states: 19 states that did not expand Medicaid by end of 2017
3. Proportions are rounded and may not add up to 100
4. P value column: Pearson Chi-squre tests performed to assess differences in sample distribution between outcome of interest and income by year (2013 vs. 2017)
Non-Expansion States
p p p p2013 to 2017
Pre ACA Post ACA Percent Change
2013 2017
Sample Size <100% 100-138 139-400 >400% <100% 100-138 139-400 >400% <100% 100-138 139-401 >400% <100% 100-139 139-402 >400% 
Unweighted 17,688 10,178 48,951 67,239 12,813 8,307 46,969 57,966 -27.6% -18.4% -4.0% -13.8%
Weighted 15,939,395 7,264,436 29,867,090 37,605,595 11,575,125 6,400,703 31,671,215 38,018,840 -27.4% -11.9% 6.0% 1.1%
Outcomes
Uninsured 38.3 33.08 21.39 4.64 21.04 18.94 13.75 3.54 -45.1% -42.7% -35.7% -23.7% <0.001 <0.001 <0.001 <0.001
No PCP 39.4 36 27.66 14.49 29.69 28.37 26.55 17.2 -24.6% -21.2% -4.0% 18.7% <0.001 <0.001 0.0515 <0.001
No Checkup 42.26 42.88 38.53 31.24 35.82 34.67 36.11 32.88 -15.2% -19.1% -6.3% 5.2% <0.001 <0.001 <0.001 <0.05
Notes:
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S. Medicaid expansion states, proportions weighted by sampling fractions
2: Medicaid expansion states: 31 states and D.C. that expanded Medicaid by end of 2017
3. Proportions are rounded and may not add up to 100
4. P value column: Pearson Chi-squre tests performed to assess differences in sample distribution between outcome of interest and income by year (2013 vs. 2017)
Medicaid Expansion States
p p p p
Percent Change
2013 2017 2013 to 2017
Pre ACA Post ACA
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uninsured of whites. A RR>1 means the risk is increased; whereas a RR<1 means the risk of an 
outcome is decreased. The RR has statistical significance only if the 95% Confidence Interval 
(CI) does not include the value=1. In the RR tables, only the RR’s with statistical significance 
are in bold text. The 95% CI was calculated using a two-step process. First, a confidence interval 
was generated for Ln(RR), and then the antilog of the upper and lower limits of the CI for 
Ln(RR) was computed (Step 2) to give the 95% CI for the RR (Boston University School of 
Public Health, n.d). The confidence interval that is shown in the Tables AA-2 – AA-4 show the 
antilog upper and lower limits of the CI for Ln(RR).  
The following formula was used to calculate Step 1 CI of Ln(RR): 
 
Table AC-11.  
Computation of CI of Ln(RR) (Step 1). 
 
Refer to Appendix AC for a more detailed description of the RR calculation.  
When compared to whites, blacks and Hispanics were at an increased risk of being 
uninsured pre-ACA, with Hispanics being 2.6 times more likely to be uninsured than whites. In 
2017, Hispanics’ risk for being uninsured increased (RR=3.0) compared to whites, meaning 
Ln(RR) +/- 1.96 (n1-x1)/x1 (n2-x2)/x2
n1 n2
+
Uninsured Insured Total
Group 1 x1 n1-x1 n1
Group 2 
(Reference )
x2 n2-x2 n2
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whites benefited from the ACA. However, the likelihood of being uninsured post ACA for 
blacks when compared to whites remained the same, with blacks being 1.7 times more likely to 
be uninsured post ACA. Overall, whites were the least likely to be uninsured both pre and post 
ACA, with the disparity gap between whites and Hispanics widening post ACA. 
For the income category, the greater than 400% FPL group was the reference group as the 
ACA did not target this income level group. Lower income groups were at greater risk of being 
uninsured in 2013, with this risk being decreased by 2017. The group at increased risk of being 
uninsured pre-ACA were those living below 100% FPL, when compared to the >400% FPL 
income group, with a RR of 8.5. This is interesting because the ACA did not specifically target 
this income group, and even post ACA, the less than 100% FPL group continues to be at 
increased risk of being uninsured when compared to the greater than 400% FPL group and the 
relative risks of other income groups.   
From 2013 and 2017, there was no change in the relative risk of being uninsured between 
the high risk and diabetes groups versus the no/low risk for diabetes group. The high-risk group 
is 1.2 times more likely to be uninsured than individuals with no/low risk. Individuals with 
diabetes are 10% less likely to be uninsured than individuals at no/low risk. It is expected that 
individuals with a diagnosed chronic disease, such as diabetes, would be incentivized to seek 
insurance coverage. Whereas, those at high risk would be at higher risk of being uninsured since 
they may be unaware of their health status and are more likely to belong to demographic factors 
that put them at higher risk (i.e. minority status, low-income status).  
Individuals living within expansion states were 25% less likely to be uninsured compared 
to those living in non-expansion states in 2013. Medicaid expansion residents’ risk of being 
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uninsured decreased by 42% post ACA. This decrease in the risk of being uninsured among 
expansion states is expected as residents benefited from increased eligibility to Medicaid, where 
non-expansion states did not. The percent change among the 100-138% FPL group was the 
largest among all income groups, at 34.1% (Table AC-13).  
Table AC-12.  
Calculation of Relative Risk, Percent Change and Absolute Change in the Uninsured by 
Race/ethnicity, Income, Diabetes Status and Expansion Status from 2013 to 2017.  
 
The percent change column has been shown and discussed in previous sections, but is 
added to show the comparison to absolute changes. Absolute changes are the difference from 
2017 to 2013, multiplied by the category’s total population (2013 and 2017’s unweighted sample 
size) and 0.01, in order to convert the percentage change to a numerical change measured by n. 
In Table AC-13, the absolute change displays how many people in the analytic sample 
(unweighted n) either gained or lost insurance coverage from 2013 to 2017. In Tables AC-14 
Uninsured (%) Relative Risk 95% CI Unweighted (n) Uninsured (%) Relative Risk RR (95% CI)
Race/Ethnicity
Whites 203,958 15.0 *** *** 174,642 9.4 *** *** -37.3 -21201.6
Blacks 23,913 25.4 1.69 (1.65, 1.73) 20,869 16.1 1.71 (1.65, 1.77) -36.6 -4164.7
Hispanics 21,001 38.7 2.58 (2.53, 2.63) 21,145 28.4 3.02 (2.94, 3.10) -26.6 -4341.0
Income
<100% 32,474 43.1 8.47 (8.23, 8.71) 22,686 29.1 6.72 (6.48, 6.97) -32.5 -7722.4
100-138 19,089 36.8 7.23 (7.01, 7.46) 15,083 24.3 5.61 (5.38, 5.84) -34.1 -4285.2
139-400 88,404 23.0 4.52 (4.39, 4.65) 86,109 16.5 3.81 (3.68, 3.94) -28.3 -11360.8
>400% 108,905 5.1 *** *** 92,778 4.3 *** *** -14.9 -1532.8
Diabetes Status
No/Low Risk 139,838 19.6 *** *** 117,034 13.0 *** *** -33.6 -16927.9
High Risk 87,515 23.0 1.17 (1.15, 1.19) 79,816 15.5 1.19 (1.15, 1.19) -32.6 -12549.8
Diabetes  21,519 17.4 0.89 (0.86, 0.92) 19,806 11.8 0.91 (0.86, 0.92) -32.3 -2326.6
Expansion Status
Non-expansion 102,209 24.5 *** *** 88,577 18.7 *** *** -23.7 -11065.6
Expansion 146,663 18.4 0.75 (0.74, 0.76) 12,079 10.7 0.57 (0.74, 0.76) -41.9 -12191.4
Notes:
3. RR's in bold signifiy statistical significance (p<0.05)
RELATIVE RISK (UNINSURED)
Unweighted (n)
Percent 
Change
Pre ACA
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S., proportions weighted by sampling fractions
2017
Post ACA
2013
2. The (***) represents the reference group in each category
Absolute 
Change (n)
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and AC-15, the absolute change displays how many people in the analytic dataset either gained 
or lost a PCP or received or did not receive a checkup in the past year, respectively.  
 When focusing on health care access, Hispanics were 1.9 times more likely to not have a 
PCP in 2013 when compared to whites. This risk ratio decreased slightly in 2017 (RR=1.8). 
Blacks and whites did not differ in the likelihood in being uninsured in 2013, but by 2017, blacks 
were 10% more likely to not have a PCP than whites. Lower income groups were more likely to 
not have PCP pre and post ACA, when compared to the greater than 400% FPL group. The 
income group at greatest risk of not having a PCP was the <100% FPL group in 2013 and 2017.  
 Individuals at high risk of diabetes were 4% less likely to not have a PCP than the no/low 
risk group in 2013. This is interesting considering the high-risk group was at greater risk of not 
having insurance than the no/low risk group, yet was more likely to have a PCP. (Potentially 
paying out of pocket?) After the ACA, the high-risk group was 7% less likely to not have a PCP 
than the no/low risk group. The ACA also improved access to a PCP among individuals with 
diabetes, when compared to the no/low risk group.   
An individual with diabetes was 67% less likely to not have a PCP when compared to the 
no/low risk group in 2017. It appears that individuals with a diagnosis, such as diabetes, are more 
likely to have a provider, than those who do not have a chronic disease diagnosis. The slight 
increase in having a provider among the high-risk group may be related to some individuals 
being aware of their prediabetes or gestational diabetes status.  Unfortunately, for a majority of 
individuals within the high-risk group, and possibly for some in the diabetes group, many may be 
undiagnosed or asymptomatic for years, leading them to believe they do not need to see a PCP. 
386 
 
Therefore, the perception of being “healthy” would not lead to an incentive to seek a health care 
provider.  
Post ACA, individuals living within expansion states had a 11% decrease in not having a 
provider, when compared to those living in non-expansion states; this was a decrease of 7.5%. 
Table AC-13.  
Calculation of Relative Risk, Percent Change and Absolute Change in the Report of No PCP by 
Race/ethnicity, Income, Diabetes Status and Expansion Status from 2013 to 2017.  
 
 Health care access was also measured by an individual receiving checkup in the past 
year. Blacks reported more checkups in 2013 and 2017 than whites; whereas Hispanics reported 
less checkups in the past year, than whites in 2013 and 2017. Generally speaking, the low-
income groups were more likely to not have a checkup in 2013 or 2017 when compared to the 
high-income group.  
Individuals at high risk for diabetes were 7% less likely to not have a checkup in 2017, 
compared to the no/low risk group. Individuals with diabetes were 57% less likely to not have a 
No PCP (%) Relative Risk 95% CI No PCP (%) Relative Risk 95%CI
Race/Ethnicity
Whites 203,958 22.3 *** *** 174,642 22.5 *** *** 0.9 757.2
Blacks 23,913 28.1 1.26 (0.79, 2.02) 20,869 24.8 1.10 (1.07, 1.13) -11.7 -1477.8
Hispanics 21,001 43.1 1.93 (1.90, 1.97) 21,145 39.4 1.75 (1.71, 1.78) -8.6 -1559.4
Income
<100% 32,474 41.5 2.63 (2.58, 2.68) 22,686 34.1 1.82 (1.78, 1.86) -17.9 -4081.8
100-138 19,089 37.2 2.36 (2.30, 2.41) 15,083 33.0 1.76 (1.72, 1.81) -11.4 -1445.5
139-400 88,404 29.5 1.87 (1.84, 1.90) 86,109 29.4 1.57 (1.55, 1.60) -0.3 -139.6
>400% 108,905 15.8 *** *** 92,778 18.7 *** *** 18.5 5869.0
Diabetes Status
No/Low Risk 139,838 28.6 *** *** 117,034 28.2 *** *** -1.4 -1001.8
High Risk 87,515 27.3 0.96 (0.94, 0.97) 79,816 26.2 0.93 (0.92, 0.94) -4.1 -1874.1
Diabetes  21,519 11.8 0.41 (0.40, 0.43) 19,806 9.2 0.33 (0.31, 0.34) -21.5 -1045.5
Expansion Status
Non-expansion 102,209 26.8 *** *** 88,577 26.0 *** *** -3.0 -1526.3
Expansion 146,663 24.9 0.93 (0.92, 0.94) 128,079 23.1 0.89 (0.87, 0.90) -7.5 -5165.1
Notes:
3. RR's in bold signifiy statistical significance (p<0.05)
Post ACA
2017
Unweighted (n)
RELATIVE RISK (NO PCP)
Unweighted (n)
Percent 
Change
Absolute 
Change (n)
2013
Pre ACA
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S., proportions weighted by sampling fractions
2. The (***) represents the reference group in each category
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checkup in 2017, when compared to the no/low risk group. Again, having a chronic condition, 
such as diabetes increased the likelihood that someone would receive a checkup, when compared 
to those without diabetes. However, when comparing the RR of the diabetes group in Table AC-
14 and Table AC-15, individuals with diabetes were more likely to have a PCP, than receive a 
checkup.  
Overall, respondents in expansion states before the ACA were 3% more likely to not 
have a checkup than in non-expansion states. Post ACA, this changed with respondents in 
expansion states being 3% less likely to not have a checkup, when compared to those living in 
non-expansion states. In the following section, inferential statistics will be displayed to 
determine the probability that an observed difference between groups is dependable, once 
adjusted for other factors.  
Table AC-14.  
Calculation of Relative risk, Percent Change and Absolute Change in the Report of No Checkup 
in the Past Year by Race/ethnicity, Income, Diabetes Status and Expansion Status (2013 and 
2017). 
 
(summarized from Rosner, 6th ed., 2006, p. 636) 
No Checkup (%) Relative Risk RR (95% CI) No Checkup (%) Relative Risk RR (95% CI)
Race/Ethnicity
Whites 203,958 36.8 *** *** 174,642 36.0 *** *** -2.2 -3028.8
Blacks 23,913 26.1 0.71 (0.70, 0.73) 20,869 23.4 0.65 (0.63, 0.67) -10.3 -1209.1
Hispanics 21,001 41.6 1.13 (1.11, 1.15) 21,145 40.0 1.11 (1.09, 1.13) -3.8 -674.3
Income 0.0
<100% 32,474 42.5 1.41 (1.39, 1.43) 22,686 37.2 1.15 (1.13, 1.18) -12.5 -2929.0
100-138 19,089 42.5 1.41 (1.38, 1.43) 15,083 36.3 1.13 (1.10, 1.15) -14.6 -2125.5
139-400 88,404 38.3 1.27 (1.25, 1.28) 86,109 36.9 1.14 (1.13, 1.16) -3.7 -2495.5
>400% 108,905 30.2 *** *** 92,778 32.2 *** *** 6.7 4094.2
Diabetes Status 0.0
No/Low Risk 139,838 38.4 *** *** 117,034 37.7 *** *** -2.0 -1952.2
High Risk 87,515 36.6 0.95 (0.94, 0.96) 79,816 35.1 0.93 (0.92, 0.94) -4.3 -2610.4
Diabetes  21,519 17.8 0.46 (0.45, 0.48) 19,806 16.1 0.43 (0.41, 0.44) -9.6 -706.7
Expansion Status 0.0
Non-expansion 102,209 35.6 *** *** 88,577 35.6 *** *** 0.0 0.0
Expansion 146,663 36.5 1.03 (1.01, 1.04) 128,079 34.6 0.97 (0.96, 0.98) -5.3 -5330.0
Notes:
3. RR's in bold signifiy statistical significance (p<0.05)
Absolute 
Change (m.)
2017
RELATIVE RISK (NO CHECKUP)
Unweighted (n)
2. The (***) represents the reference group in each category
1. Analtyic sample: All BRFSS respondents aged 18-64 who are white, Hispanic or black living in the U.S., proportions weighted by sampling fractions
2013
Pre ACA Post ACA
U.S. Pop (m.)
Percent 
Change
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 Let the Relative Risk of two randomly determined fractions be:   RR = p1/p2 .  This ratio 
tends to be highly skewed and can be corrected, approximately, to a normal distribution by 
taking the difference of natural logs: 
(1) Ln[RR] =  lnp1  -  lnp2  .  
A confidence interval for the logged RR depends upon its standard error, or square root of the 
variance of eq.(1).  Variance can be decomposed as the sum of log-variances: 
(2) Var[lnRR]  =  Var[lnp1]  + Var[lnp2] 
In turn, the log-variance of a variable, X, can be closely approximated by 
(3) Var[lnX]  =  f’(X)2 x Var X  = VarX/X2 :  f’(X) = the derivative of the variable 
so that Var[lnp1] = (p1q1/n1)*(1/p1
2),  Var[lnp2] = (p2q2/n2)*(1/p2
2), where q1, q2 equal 1 minus p1 
and p2 , respectively.  Thus, the standard error, or square root, of the log-variance of RR is 
(4) SE[lnRR] = { (q1/p1)/(n1)  + (q2/p2)/(n2) }-1/2 . 
In words, the standard error of the log-variance of RR is the sum of ratios of “not p1-to-p1” and 
“not-p2-to-p2, weighted by the inverse of their sample sizes. 
 The 95% Confidence Interval surrounding the actual RR (= p1 /p2 ), is the exponentiated 
(exp) formula: 
(5) CI = exp{ lnRR +- 1.96*SE[lnRR]}. 
As an example, consider the Table XXX and the relative risk of being uninsured for 
Hispanics versus whites.  Uninsured (q) rates were 0.387 for Hispanics and 0.150 for 
whites in 2013, with RR(2013) = 0.387/0.15 = 2.58.  Corresponding rates were 0.284 and 
0.094 in 2017, four years later (0.284/0.094 = 3.02).  The ratios of insured to uninsured in 
eq.(4) were 1.58 for Hispanics and 5.66 for whites in 2013 and 2.52 and 9.64 for 2017.  
(Relative risk rises exponentially with lower uninsured rates).  These ratios are divided by 
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21,001 (2013) and 21,145 (2017) for Hispanics and 203,958 (2013) and 174,642 (2017) 
for whites, or the unweighted actual BRFSS sample sizes for the two years.  The standard 
errors of the logged RR for Hispanics versus whites were SQRT(0.000103) = 0.0101 in 
2013 and SQRT(0.000174) = 0.0132 in 2017, which results in the following lower and 
upper confidence intervals: 
2013:  CI[lower] = exp{ ln[(.387/.15)=2.58) – 1.96*0.0101 } = 2.53 
2013:  CI[upper] = exp{ ln[(.387/.15)=2.58) + 1.96*0.0101 } = 2.63 
2017:  CI[lower]  = exp{ ln[(.284/.094)=3.02) – 1.96*0.0132 } = 2.94 
2017:  CI[lower]  = exp{ ln[(.284/.094)=3.02) + 1.96*0.0132 } = 3.10. 
The confidence intervals are very narrow around the two RRs due to very low standard errors, 
which are the result of very large sample sizes.   
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APPENDIX AD 
LOGISTIC REGRESSIONS FOR ODDS OF INSURANCE 
Specific Aim 1a. Pre/Post-ACA Insurance Coverage Odds with ACA-Income 
Interactions. Refer to Chapter 4, page 171 for in text discussion. Full regression models 
available in Table AD-1.  
Specific Aim 1a. Annual ACA Insurance Coverage Odds Ratios with ACA-Income 
Interactions. Refer to Chapter 4, page 179 for in text discussion. Full regression models 
available in Table AD-2.  
Specific Aim 1b. Pre/Post-ACA Insurance Coverage Odds Ratios Controlling for 
Expansion Status. In Table AD-3, the expansion status variable was added to Specific Aim 1a’s 
full model to determine the effect of the ACA when controlling for expansion status. When 
adjusting for expansion status and other factors, individuals in the post-ACA period were 68% 
more likely to have insurance, then in the pre-ACA period. The ACA regression coefficient was 
about 3% higher than in Model 3. When the ACA*EXP interaction term was added in Model 5, 
it showed that individuals living in Medicaid expansion states post-ACA were 26% (p<0.001, 
1.21, 1.32 95% CI) more likely to have insurance than individuals in non-expansion states. The 
overall ACA effect on expansion states was the sum of the natural log of the ACA term (1.48) 
and the ACA*EXP term (1.26), then exponentiating the sum, which led to an ACA effect of 
86%. The post-ACA odds of having insurance for expansion states was 2.61, over non-expansion 
states. This was calculated by adding the natural log of EXP (1.40) to the ACA effect, then 
exponentiating the sum. Refer to Table AD-3 to view Models 1-5.  
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Specific Aim 1b. Annual ACA Insurance Coverage Odds Ratio Controlling for 
Expansion Status. In Table AD-4, the expansion status variable was added to Specific Aim 1a’s 
full model to determine the effect of the ACA when controlling for expansion status. When 
adjusting for expansion status and other factors, individuals in the post-ACA period were 46-
85% more likely to have insurance, then in the pre-ACA period. The time coefficients were 
marginally higher than the time coefficients (45-83%) in Model 3. When the YEAR*EXP 
interaction terms were added in Model 5, it showed that individuals living in Medicaid expansion 
states post-ACA were 15-40% (p<0.001) more likely to have insurance than individuals in non-
expansion states. In fact, the odds were gradually increasing over time, from 15% more likely in 
2014 to 40% more likely in 2017, than in non-expansion states in the post-ACA period.  
The overall annual ACA effect on expansion states was the sum of the natural log of the 
year term and the YEAR*EXP term, then exponentiating the sum. The overall ACA effect per 
year in odds was: 1.56 (2014); 1.74 (2015); 2.10 (2016); and 2.02 (2017). The post-ACA odds of 
having insurance for expansion states was 2.19 (2014); 2.43 (2015); 2.93 (2016); and 2.82 
(2017), over non-expansion states. This was calculated by adding the natural log of EXP to the 
overall ACA effect, then exponentiating the sum (for each year). Refer to Table AD-4 to view 
Models 1-5. 
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Table AD-1.  
Logistic Regression Models for Specific Aim 1a (i.e. odds of insurance using pre/post ACA 
indicator for 47-state analytic sample.  
 
 
 
 
 
 
Probability of Insurance  
(n=1,283,537)
Model 1                         
Odds Ratio
95% CI
Model 2                         
Odds Ratio
95% CI
Model 3                         
Odds Ratio
95% CI
Model 4                         
Odds Ratio
95% CI
Time
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.60** (1.57, 1.63) 1.61** (1.57, 1.64) 1.66** (1.62, 1.70) 1.34** (1.26, 1.42)
Income
>400% FPL Ref Ref Ref
139-400% FPL 0.21** (0.20, 0.21) 0.28** (0.27, 0.29) 0.25** (0.23, 0.26)
100-138% FPL 0.11** (0.10, 0.11) 0.17** (0.17, 0.18) 0.14** (0.13, 0.15)
<100% FPL 0.08** (0.08, 0.08) 0.15** (0.14, 0.16) 0.13** (0.12, 0.13)
ACA*Income
ACA* >400% FPL Ref
ACA* 139-400% FPL 1.21** (1.14, 1.30)
ACA* 100-138% FPL 1.40** (1.29, 1.53)
ACA* <100% FPL 1.35** (1.25, 1.45)
Other Variables
Race
Whites Ref Ref
Blacks 0.79** (0.77, 0.82) 0.79** (0.77, 0.82)
Hispanics 0.52** (0.51, 0.54) 0.52** (0.51, 0.53)
Education
Less than HS Ref Ref
HS Grad 1.61** (1.55, 1.66) 1.61** (.56, 1.67)
Some College 2.13** (2.06, 2.21) 2.13** (2.06, 2.21)
College Grad 3.66** (3.52, 3.81) 3.67** (3.52, 3.82)
Age
18 to 44 Ref Ref
45 to 64 1.43** (1.40, 1.47) 1.43** (1.40, 1.46)
Sex
Male Ref Ref
Female 1.42** (1.39, 1.45) 1.42** (1.39, 1.45)
Health Variables
Diabetes Status
No/Low Risk Ref Ref
High Risk 1.08** (1.05, 1.10) 1.08** (1.05, 1.10)
Diabetes 1.60** (1.53, 1.68) 1.60** (1.53, 1.68)
Chronic Disease
Count 0-5 1.26** (1.23, 1.29) 1.26** (1.23, 1.29)
Self Reported Health
Healthy Ref Ref
Unhealthy 0.88** (0.85, 0.91) 0.88** (0.85, 0.91)
Constant 3.61** (3.56, 3.66) 15.63** (15.15, 16.12) 4.92** (4.68, 5.17) 5.57** (5.24, 5.92)
F Statistic 2149** 5574** 2301** 1948**
Notes: 
1. Contains odds ratio for 47-state analtyic sample 
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AD-2.  
Logistic Regression Models for Specific Aim 1a (i.e. odds of insurance using 2014-2017-time 
dummies for 47-state sample).  
 
Probability of Insurance 
(n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
Year
2012 Ref Ref Ref Ref
2013 Ref Ref Ref Ref
2014 1.38** (1.34, 1.42) 1.44** (1.40, 1.49) 1.45** (1.41, 1.50) 1.34** (1.22, 1.47)
2015 1.63** (1.58, 1.68) 1.64** (1.59, 1.70) 1.70** (1.64, 1.75) 1.36** (1.24, 1.49)
2016 1.75** (1.69, 1.80) 1.73** (1.68, 1.79) 1.83** (1.77, 1.89) 1.40** (1.28, 1.52)
2017 1.69** (1.64, 1.75) 1.64** (1.59, 1.69) 1.71** (1.64, 1.77) 1.27** (1.17, 1.38)
Income
>400% FPL Ref Ref Ref
139-400% FPL 0.21** (0.20, 0.21) 0.28** (0.27, 0.29) 0.25** (0.23, 0.26)
100-138% FPL 0.11** (0.10, 0.11) 0.17** (0.17, 0.18) 0.14** (0.13, 0.15)
<100% FPL 0.08** (0.08, 0.09) 0.15** (0.15, 0.16) 0.13** (0.12, 0.14)
Year*Income
2014* >400% FPL Ref
2014 * 139-400% FPL 1.08 (0.98, 1.19)
2014* 100-138% FPL 1.21* (1.07, 1.37)
2014* <100% FPL 1.08 (0.97, 1.20)
2015* >400% FPL Ref
2015 * 139-400% FPL 1.22** (1.10, 1.35)
2015* 100-138% FPL 1.47** (1.29, 1.67)
2015* <100% FPL 1.32** (1.18, 1.48)
2016* >400% FPL Ref
2016 * 139-400% FPL 1.30** (1.18, 1.44)
2016* 100-138% FPL 1.35** (1.19, 1.52)
2016* <100% FPL 1.49** (1.34, 1.66)
2017* >400% FPL Ref
2017 * 139-400% FPL 1.26** (1.15, 1.39)
2017* 100-138% FPL 1.65** (1.45, 1.87)
2017* <100% FPL 1.62** (1.45, 1.81)
Other Variables
Race
Whites Ref Ref
Blacks 0.79** (0.77, 0.82) 0.79** (0.77, 0.82)
Hispanics 0.52** (0.50, 0.53) 0.52** (0.50, 0.53)
Education
Less than HS Ref Ref
HS Grad 1.61** (1.56, 1.66) 1.61** (1.56, 1.67)
Some College 2.13** (2.06, 2.21) 2.14** (2.06, 2.21)
College Grad 3.66** (3.52, 3.81) 3.67** (3.53, 3.82)
Age
18 to 44 Ref Ref
45 to 64 1.43** (1.40, 1.47) 1.43** (1.40, 1.46)
Sex
Male Ref Ref
Female 1.42** (1.39, 1.45) 1.42** (1.39, 1.45)
Diabetes Status
No/Low Risk Ref Ref
High Risk 1.08** (1.05, 1.10) 1.08** (1.05, 1.10)
Diabetes 1.60** (1.53, 1.68) 1.60** (1.53, 1.68)
Chronic Disease
Count 0-5 1.26** (1.23, 1.29) 1.26** (1.23, 1.29)
Self Reported Health
Healthy Ref Ref
Unhealthy 0.88** (0.85, 0.91) 0.88** (0.85, 0.91)
Constant 3.61** (3.56, 3.66) 15.60** (15.13, 16.09) 4.91** (4.67, 5.16) 5.57** (5.24, 5.92)
F Statistic 574** 3192** 1918** 1175**
Notes: 
1. Contains odds ratio for 47-state analtyic sample 
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AD-3.  
Logisitic Regression Models by Income for Specific Aim 1b (i.e. odds of insurance using 
Pre/Post-ACA indicator by Expansion Status for 47-state sample). 
  
 
 
 
 
 
 
 
 
 
 
 
 
Probability of Insurance 
by Income Group
Income <100% 
FPL                      
Odds Ratio 
(n=152,358)
95% CI
Income 
<100% FPL                      
Odds Ratio 
(n=152,358)
95% CI
Income 100-
138% FPL                      
Odds Ratio 
(n=94,466)
95% CI
Income 100-
138% FPL                      
Odds Ratio 
(n=94,466)
95% CI
Income 139-
400% FPL                     
Odds Ratio 
(n=500,262)
95% CI
Income 139-
400% FPL                     
Odds Ratio 
(n=500,262)
95% CI
Income >400% 
FPL                      
Odds Ratio 
(n=576,687)
95% CI
Income 
>400% FPL                      
Odds Ratio 
(n=576,687)
95% CI
ACA
Pre ACA Ref Ref Ref Ref Ref Ref Ref Ref
Post ACA 1.85** (1.77, 1.93) 1.48** (1.39, 1.58) 1.88** (1.77, 1.99) 1.62** (1.49, 1.77) 1.64** (1.59, 1.69) 1.49** (1.42, 1.56) 1.36** (1.28, 1.45) 1.27** (1.15, 1.40)
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref Ref Ref
Expansion  2.28** (2.18, 2.38) 1.82** (1.70, 1.95) 1.76** (1.66, 1.87) 1.50** (1.37, 1.64) 1.36** (1.32, 1.40) 1.21** (1.15, 1.27) 1.30** (1.22, 1.38) 1.21** (1.10, 1.34)
Interaction Term
ACA*EXP 1.47** (1.34, 1.60) 1.31** (1.16, 1.47) 1.20** (1.2, 1.28) 1.12 (0.99, 1.27)
Other Variables
Race
Whites Ref Ref Ref Ref Ref Ref Ref Ref
Blacks 0.94* (0.89, 0.99) 0.94* (0.89, 0.99) 0.99 (0.91, 1.07) 0.99 (0.91, 1.06) 0.78** (0.75, 0.82) 0.78** (0.75, 0.82) 0.64** (0.58, 0.71) 0.64** (0.58, 0.71)
Hispanics 0.46** (0.44, 0.49) 0.46** (0.44, 0.49) 0.56** (0.52, 0.60) 0.56** (0.52, 0.60) 0.52** (0.50, 0.55) 0.52** (0.50, 0.55) 0.49** (0.44, 0.54) 0.49** (0.44, 0.54)
Sex
Male Ref Ref Ref Ref Ref Ref Ref Ref
Female 1.40** (1.34, 1.47) 1.40** (1.34, 1.47) 1.34** (1.27, 1.43) 1.35** (1.27, 1.43) 1.40** (1.35, 1.44) 1.39** (1.35, 1.44) 1.58** (1.48, 1.68) 1.58** (1.48, 1.68)
Age
18 to 44 Ref Ref Ref Ref Ref Ref Ref Ref
45 to 64 1.17** (1.11, 1.22) 1.17** (1.11, 1.22) 1.32** (1.24, 1.41) 1.33** (1.24, 1.41) 1.50** (1.45, 1.55) 1.50** (1.45, 1.55) 1.79** (1.69, 1.90) 1.79** (1.69, 1.90)
Education
Less than HS Ref Ref Ref Ref Ref Ref Ref Ref
HS Grad 1.34** (1.27, 1.42) 1.34** (1.27, 1.42) 1.54** (1.42, 1.67) 1.54** (1.42, 1.67) 2.05** (1.95, 2.16) 2.05** (1.95, 2.16) 2.25** (1.97, 2.56) 2.25** (1.97, 2.56)
Some College 1.66** (1.57, 1.76) 1.66** (1.57, 1.77) 1.95** (1.79, 2.12) 1.95** (1.79, 2.12) 2.75** (2.60, 2.90) 2.75** (2.60, 2.90) 3.43** (3.02, 3.90) 3.44** (3.03, 3.90)
College Grad 1.87** (1.73, 2.02) 1.87** (1.73, 2.02) 2.35** (2.12, 2.60) 2.35** (2.12, 2.60) 4.48** (4.23, 4.75) 4.49** (4.23, 4.75) 7.75** (6.83, 8.79) 7.75** (6.83, 8.79)
Diabetes Status
No/Low Risk Ref Ref Ref Ref Ref Ref Ref Ref
High Risk 1.04 (1.00, 1.09) 1.04 (1.00, 1.09) 1.12** (1.06, 1.19) 1.12** (1.06, 1.19) 1.11** (1.08, 1.15) 1.11** (1.08, 1.15) 2.25** (1.97, 2.56) 1.08* (1.01, 1.15)
Diabetes 1.66** (1.53, 1.80) 1.66** (1.53, 1.80) 1.61** (1.45, 1.80) 1.61** (1.45, 1.80) 1.67** (1.56, 1.79) 1.67** (1.56, 1.79) 1.53** (1.33, 1.76) 1.53** (1.33, 1.76)
Chronic Disease
Count 0-5 1.36** (1.31, 1.41) 1.36** (1.31, 1.41) 1.35** (1.28, 1.42) 1.35** (1.27, 1.42) 1.18** (1.14, 1.22) 1.18** (1.14, 1.22) 1.09* (1.02, 1.18) 1.09* (1.02, 1.18)
Self Reported Health
Healthy Ref Ref Ref Ref Ref Ref Ref Ref
Unhealthy 0.98 (0.94, 1.03) 0.99 (0.94, 1.04) 0.96 (0.89, 1.03) 0.96 (0.89, 1.03) 0.80** (0.76, 0.83) 0.80** (0.76, 0.83) 0.77** (0.69, 0.86) 0.77** (0.69, 0.86)
Constant 0.52** (0.48, 0.56) 0.59** (0.55, 0.64) 0.58** (0.52, 0.64) 0.63** (0.57, 0.71) 0.94 (0.89, 1.00) 1.01 (0.94, 1.07) 2.78** (2.43, 3.17) 2.89** (2.51, 3.34)
F Statistic 308** 286** 143** 133** 538** 499** 231** 214**
Notes: 
1. Contains odds ratio for 47-state analtyic sample 
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AD-4.  
Logistic Regression Models by Income for Specific Aim 1b (i.e. odds of insurance using 2014-
2017-time dummies by expansion status for 47-state sample). 
 
 
Probability of Insurance 
(Non-expansion vs. 
Expansion)
Income 
<100% FPL                      
Log Odds 
95% CI
Income 
<100% FPL                      
Log Odds 
95% CI
Income 100-
138% FPL                      
Log Odds 
95% CI
Income 100-
138% FPL                      
Log Odds 
95% CI
Income 139-
400% FPL                     
Log Odds 
95% CI
Income 139-
400% FPL                     
Log Odds 
95% CI
Income 
>400% FPL                      
Log Odds 
95% CI
Income 
>400% FPL                      
Log Odds 
95% CI
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref Ref Ref
Expansion  2.28** (2.19, 2.39) 1.82** (1.70, 1.95) 1.76** (1.66, 1.87) 1.50** (1.37, 1.64) 1.36** (1.32, 1.40) 1.21** (1.15, 1.27) 1.30** (1.22, 1.38) 1.21** (1.10, 1.34)
Year
2012 Ref Ref Ref Ref Ref Ref Ref Ref
2013 Ref Ref Ref Ref Ref Ref Ref Ref
2014 1.48** (1.39, 1.57) 1.26** (1.16, 1.37) 1.63** (1.50, 1.77) 1.53** (1.36, 1.73) 1.46** (1.39, 1.52) 1.38** (1.29, 1.47) 1.36** (1.24, 1.49) 1.38** (1.19, 1.61)
2015 1.88** (1.76, 2.00) 1.54** (1.40, 1.70) 2.00** (1.83, 2.18) 1.77** (1.55, 2.02) 1.68** (1.60, 1.77) 1.54** (1.43, 1.66) 1.39** (1.27, 1.52) 1.39** (1.19, 1.61)
2016 2.11** (1.97, 2.25) 1.61** (1.45, 1.78) 1.88** (1.72, 2.05) 1.52** (1.33, 1.73) 1.85** (1.76, 1.94) 1.69** (1.57, 1.82) 1.42** (1.30, 1.55) 1.30** (1.13, 1.50)
2017 2.11** (1.97, 2.27) 1.61** (1.44, 1.80) 2.07** (1.88, 2.27) 1.69** (1.46, 1.95) 1.62** (1.54, 1.70) 1.38** (1.28, 1.49) 1.29** (1.18, 1.40) 1.09 (0.95, 1.25)
Year*EXP
2012*EXP Ref Ref Ref Ref
2013*EXP Ref Ref Ref Ref
2014*EXP 1.31** (1.16, 1.47) 1.11 (0.94, 1.31) 1.11* (1.01, 1.21) 0.97 (0.81, 1.18)
2015*EXP 1.42** (1.24, 1.61) 1.25* (1.05, 1.49) 1.18* (1.07, 1.30) 1.00 (083, 1.20)
2016*EXP 1.61** (1.41, 1.84) 1.49** (1.25, 1.78) 1.18* (1.07, 1.29) 1.17 (0.98, 1.40)
2017*EXP 1.62** (1.40, 1.88) 1.46** (1.21, 1.76) 1.35** (1.22, 1.48) 1.34* (1.13, 1.59)
Other Variables
Race
Whites Ref Ref Ref Ref Ref Ref Ref Ref
Blacks 0.93* (0.88, 0.99) 0.93* (0.89, 0.99) 0.99 (0.91, 1.07) 0.98 (0.91, 1.06) 0.78** (0.75, 0.82) 0.78** (0.75, 0.82) 0.64** (0.58, 0.71) 0.64** (0.58, 0.71)
Hispanics 0.46** (0.44, 0.48) 0.46** (0.44, 0.48) 0.56** (0.52, 0.60) 0.56** (0.52, 0.60) 0.52** (0.50, 0.55) 0.52** (0.50, 0.54) 0.49** (0.44, 0.54) 0.49** (0.44, 0.54)
Sex
Male Ref Ref Ref Ref Ref Ref Ref Ref
Female 1.40** (1.34, 1.47) 1.40** (1.34, 1.47) 1.34** (1.27, 1.42) 1.34** (1.27, 1.43) 1.39** (1.35, 1.44) 1.39** (1.35, 1.44) 1.58** (1.48, 1.68) 1.58** (1.48, 1.68)
Age
18 to 44 Ref Ref Ref Ref Ref Ref Ref Ref
45 to 64 1.17** (1.11, 1.22) 1.17** (1.11, 1.22) 1.33** (1.24, 1.41) 1.33** (1.25, 1.41) 1.50** (1.46, 1.55) 1.50** (1.45, 1.55) 1.79** (1.69, 1.90) 1.80** (1.69, 1.90)
Education
Less than HS Ref Ref Ref Ref Ref Ref Ref Ref
HS Grad 1.34** (1.27, 1.42) 1.34** (1.27, 1.42) 1.54** (1.42, 1.67) 1.54** (1.42, 1.67) 2.05** (1.95, 2.16) 2.06** (1.95, 2.17) 2.25** (1.98, 2.56) 2.25** (1.98, 2.56)
Some College 1.67** (1.57, 1.77) 1.67** (1.57, 1.77) 1.95** (1.79, 2.12) 1.95** (1.79, 2.12) 2.75** (2.61, 2.90) 2.75** (2.61, 2.91) 3.44** (3.02, 3.90) 3.44** (3.03, 3.91)
College Grad 1.87** (1.73, 2.02) 1.87** (1.73, 2.02) 2.36** (2.13, 2.61) 2.36** (2.13, 2.61) 4.49** (4.24, 4.76) 4.50** (4.24, 4.77) 7.75** (6.84, 8.79) 7.77** (6.85, 8.82)
Diabetes Status
No/Low Risk Ref Ref Ref Ref Ref Ref Ref Ref
High Risk 1.65** (1.52, 1.79) 1.04 (0.99, 1.09) 1.12** (1.05, 1.19) 1.12** (1.05, 1.19) 1.11** (1.07, 1.15) 1.11** (1.07, 1.15) 1.08* (1.01, 1.15) 1.08* (1.01, 1.15)
Diabetes 1.65** (1.52, 1.79) 1.65** (1.53, 1.80) 1.61** (1.44, 1.79) 1.61** (1.44, 1.80) 1.67** (1.56, 1.79) 1.67** (1.56, 1.79) 1.53** (1.33, 1.76) 1.53** (1.33, 1.76)
Chronic Disease
Count 0-5 1.36** (1.31, 1.41) 1.36** (1.31, 1.41) 1.35** (1.28, 1.42) 1.35** (1.28, 1.42) 1.18** (1.14, 1.22) 1.18** (1.14, 1.22) 1.10* (1.02, 1.18) 1.10* (1.02, 1.18)
Self Reported Health
Healthy Ref Ref Ref Ref Ref Ref Ref Ref
Unhealthy 0.98 (0.93, 1.03) 0.99 (0.94, 1.04) 0.96 (0.89, 1.03) 0.96 (0.89, 1.03) 0.80** (0.76, 0.83) 0.80** (0.76, 0.83) 0.77** (0.69, 0.86) 0.77** (0.69, 0.86)
Constant 0.52** (0.48, 0.56) 0.59** (0.55, 0.64) 0.58** (0.52, 0.64) 0.64** (0.57, 0.71) 0.95 (0.89, 1.00) 1.01 (0.94, 1.07) 2.77** (2.43, 3.17) 2.89** (2.50, 3.33)
F Statistic 258** 207** 118** 94** 441** 353** 188** 150**
Notes: 
1. Contains odds ratio for 47-state analtyic sample 
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
4. Separate model run per income level 
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Discussion on Additional Regression Coefficients 
Expanding health insurance options to low-income adults who were previously uninsured 
was the main goal of the ACA because having insurance is the first step to ensuring access to the 
health care system. However, differences in insurance coverage did not only exist among income 
groups. Table AD-5 summarizes all regression coefficients for demographic and health status 
variables in this analysis. Of particular focus for the next section are two variables: race and 
diabetes risk status. Overall racial/ethnic minorities were less likely to have insurance when 
compared to whites; with Hispanics being 48% less likely to have insurance. The overall odds 
are averaged over 6 years.  
Interestingly, when stratifying by income, disparities in insurance coverage among whites 
and minorities groups were the worst for the highest income group, after adjusting for other 
factors, including education in the pre-ACA period. In the pre-ACA period, the insurance gap 
between whites and blacks was narrow, with widening occurring at higher incomes. This was not 
the case for Hispanics, disparities between whites and Hispanics were stark in the pre-ACA 
period. 
 In the post-ACA period, blacks were 6% more likely to have insurance coverage than 
whites; whereas Hispanics were 30% less likely to have insurance coverage compared to whites, 
when adjusting for other factors. These odds were calculated using the following formula:  
Example Overall ACA effect for Blacks: 
• Exp{ln(0.79)+ln(1.34)}=1.0586 
The odds of insurance in the post ACA period for blacks when compared to whites by income 
group was: 
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• <100% FPL: 39% more likely; 
• 100-138% FPL: 60% more likely; 
• 139-400% FPL: 16% more likely; 
• >400% FPL: 19% less likely.  
The odds of insurance in the post ACA period for Hispanics when compared to whites by income 
group was: 
• <100% FPL: 32% less likely; 
• 100-138% FPL: 9% less likely; 
• 139-400% FPL: 23% less likely; 
• >400% FPL: 38% less likely.  
The ACA improved insurance overall coverage for minorities, with blacks benefiting well above 
the white reference group. Opportunities still exist to close the coverage gap between whites and 
Hispanics post-ACA.  As the odds ratio coefficients for expansion status range from 27-69% 
more than in non-expansion states, it is apparent that minorities made larger insurance gains in 
expansion states as well.   
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Table AD-5.  
Summary Table Comparing Overall Logistic Coefficients for Demographic and Health Status 
Variables to Logistic Coefficient for Subgroups by Income Group.  
 
 For the high risk for diabetes group, the odds of having insurance ranged from 4-12% 
over the no/low risk in the pre-ACA period, when adjusting for other factors. High risk 
individuals with a higher income (>100% FPL) had higher odds of having insurance in the pre-
ACA period, yet it was still relatively low. Post-ACA gains in insurance coverage seemed to 
benefit the high-risk group. High risk individuals in the <100% FPL group were 54% more likely 
to have insurance than those at no/low risk when adjusting for other variables. In fact, all high-
risk groups made gains in insurance coverage post-ACA over the no/low risk group: 
TABLE AD-
1 ODDS 
RATIOS
COVARIATE OVERALL <100% 100-138% 139-400% >400%
Blacks 0.79 0.94 0.99 0.78 0.64
Hispanics 0.52 0.46 0.56 0.52 0.49
Female 1.42 1.40 1.35 1.39 1.58
45-64 1.43 1.17 1.33 1.50 1.79
HS Grad 1.61 1.34 1.54 2.05 2.25
Some College 2.13 1.66 1.95 2.75 3.44
College Grad 3.67 1.87 2.35 4.49 7.75
High Risk 1.08 1.04 1.12 1.11 1.08
Diabetes 1.60 1.66 1.61 1.67 1.53
CD Count 0-5 1.26 1.36 1.35 1.18 1.09
Unhealthy 0.88 0.99 0.96 0.80 0.77
Post-ACA 1.34 1.48 1.62 1.49 1.27
EXP - 1.82 1.50 1.21 1.21
ACA*EXP - 1.47 1.31 1.20 1.12
Note(s):
1. Data sources from stepwise regression in Tables AD-1 and AD-3 
TABLE AD-3 ODDS RATIOS BY INCOME 
GROUP (% FPL)
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• <100% FPL: 54% more likely;   
• 100-138% FPL: 81% more likely; 
• 139-400% FPL: 65% more likely; 
• >400% FPL: 37% more likely. 
 
As the odds ratio coefficients for expansion status range from 27-69% more than in non-
expansion states, it is apparent that high risk individuals made larger insurance gains in 
expansion states as well. In the next section, the impact of the ACA on increasing health care 
access for racial/ethnic minorities and those at high risk for diabetes will be explored.  
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APPENDIX AE 
LOGISTIC REGRESSIONS FOR ODDS OF PCP BY INS AND RACE 
 Introduction to Specific Aim 2-Health Care Access. This section begins with 
describing the impact of insurance on the odds of having a PCP. Refer to Chapter 4, page 190 for 
in-text discussion. Full regression models using pre/post-ACA indicator available in Table AE-1. 
Full regression models using time dummy variables are available in Table AE-2. After 2014, 
there was a 6% decline of in the report of having a PCP from 2014 to 2017 among individuals 
who reported having insurance coverage.  
 Specific Aim 2a. Pre/Post-ACA Health Care Access Odds with ACA-Race 
Interactions. Refer to Chapter 4, page 201 for in-text discussion. Full regression models 
available in Table AE-3. 
 Specific Aim 2a. Annual ACA PCP Odds Ratios with ACA-Race Interactions. Refer 
to Chapter 4, page 207 for in-text discussion. Full regression models available in Table AE-4.  
Specific Aim 2b. Pre/Post-ACA Odds Ratios for PCP Controlling for Expansion 
Status by Race Group. Refer to Chapter 4, page 210 for in-text discussion. Full regression 
models available in Table AE-5. 
Specific Aim 2b. Annual ACA PCP Odds Ratios Controlling for Expansion Status 
by Race Group. Full regression models using time variables are available in Table AE-6. 
Although whites and Hispanics time tends were not statistically significant, the odds of having a 
PCP in expansion states was increasing slightly for whites, and at a faster rate for Hispanics in 
2016. In 2014, blacks were 7% more likely to have a PCP than whites within expansion states, 
and the rate continued to increase in the post-ACA period to a likelihood of having a PCP at 18% 
for blacks in expansion states by 2017.  
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Table AE-1.  
Logistic Regression Models for the Odds of having a PCP by INS status using Pre/post ACA 
Indicator for 47-state Analytic Sample.  
 
 
 
Probability of Having a 
PCP (n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.03** (1.02, 1.05) 1.04** (1.02, 1.05) 0.90** (0.88, 0.91) 1.01 (0.97, 1.05)
Insurance
Uninsured Ref Ref
Insured 5.33** (5.21, 5.46) 5.88** (5.67, 6.09)
ACA*INS
ACA*INS 0.85** (0.81, 0.89)
Other Variables
Race
Whites Ref Ref Ref
Blacks 0.86** (0.84, 0.88) 0.95* (0.93, 0.98) 0.95* (0.93, 0.98)
Hispanics 0.56** (0.54, 0.57) 0.69** (0.67, 0.71) 0.69** (0.67, 0.71)
Education
Less than HS Ref Ref Ref
HS Grad 1.62** (1.57, 1.67) 1.31** (1.27, 1.36) 1.31** (1.27, 1.36)
Some College 2.04** (1.98, 2.11) 1.49** (1.44, 1.54) 1.49** (1.44, 1.54)
College Grad 2.83** (2.74, 2.92) 1.78** (1.72, 1.84) 1.78** (1.72, 1.85)
Age
18 to 44 Ref Ref Ref
45 to 64 2.50** (2.46, 2.55) 2.39** (2.34, 2.43) 2.39** (2.34, 2.43)
Sex
Male Ref Ref Ref
Female 1.94** (1.91, 1.98) 1.96** (1.92, 1.99) 1.96** (1.92, 1.99)
Diabetes Status
No/Low Risk Ref Ref Ref
High Risk 1.18** (1.15, 1.20) 1.18** (1.16, 1.20) 1.18** (1.16, 1.20)
Diabetes 2.98** (2.84, 3.13) 2.88** (2.74, 3.02) 2.88** (2.74, 3.02)
Chronic Disease
Count 0-5 1.39** (1.36, 1.42) 1.36** (1.33, 1.39) 1.36** (1.33, 1.39)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 0.93** (0.90, 0.95) 1.03* 1.00, 1.06) 1.03* (1.00, 1.06)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.74** (0.73, 0.75) 0.81** (0.80, 0.83) 0.81** (0.80, 0.83)
Constant 2.79** (2.75, 2.83) 0.85** (0.82, 0.88) 0.30** (0.29, 0.32) 0.28** (0.27, 0.30)
F Statistic 16** 2285** 3070** 2877**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AE-2.  
Logistic Regression Models for the likelihood of having a PCP by INS Status using 2012-2017 
Time Dummy Variables; 47-state analytic sample.  
 
Probability of Having a 
PCP (n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
ACA
2012 Ref Ref Ref Ref
2013 Ref Ref Ref Ref
2014 1.01 (0.99, 1.04) 1.01 (0.98, 1.03) 0.91** (0.89, 0.93) 0.98 (0.93, 1.04)
2015 1.07** (1.05, 1.10) 1.08** (1.05, 1.10) 0.93** (0.91, 9.96) 1.06 (0.99, 1.13)
2016 1.05** (1.02, 1.07) 1.06** (1.03, 1.09) 0.89** (0.87, 0.92) 1.06 (1.00, 1.12)
2017 1.01 (0.99, 1.04) 1.00 (0.98, 1.03) 0.85** (0.83, 0.87) 0.95 (0.89, 1.01)
Insurance
Uninsured Ref ref
Insured 5.34** (5.22, 5.47) 5.88** (5.67, 6.09)
ACA*INS
2012*INS Ref
2013*INS Ref
2014*INS 0.90* (0.84, 0.96)
2015*INS 0.84** (0.78, 0.90)
2016*INS 0.80** (0.75, 0.90)
2017*INS 0.86** (0.80, 0.92)
Other Variables
Race
Whites Ref Ref Ref
Blacks 0.86** (0.83, 0.88) 0.95* (0.93, 0.98) 0.95* (0.93, 0.98)
Hispanics 0.55** (0.54, 0.57) 0.69** (0.67, 0.71) 0.69** (0.67, 0.71)
Education
Less than HS Ref Ref Ref
HS Grad 1.62** (1.57, 1.67) 1.31** (1.27, 1.36) 1.31** (1.27, 1.36)
Some College 2.04** (1.98, 2.11) 1.49** (1.44, 1.54) 1.49** (1.43, 1.54)
College Grad 2.83** (2.74, 2.92) 1.79** (1.72, 1.85) 1.79** (1.73, 1.85)
Age
18 to 44 Ref Ref Ref
45 to 64 2.50** (2.46, 2.55) 2.39** (2.34, 2.43) 2.39** (2.34, 2.43)
Sex
Male Ref Ref Ref
Female 1.94** (1.91, 1.98) 1.96** (1.92, 1.99) 1.96** (1.92, 1.99)
Diabetes Status
No/Low Risk Ref Ref Ref
High Risk 1.18** (1.15, 1.20) 1.18** (1.16, 1.20) 1.18** (1.16, 1.20)
Diabetes 2.98** (2.84, 3.13) 2.88** (2.74, 3.02) 2.88** (2.74, 3.02)
Chronic Disease
Count 0-5 1.39** (1.36, 1.42) 1.36** (1.33, 1.39) 1.36** (1.33, 1.39)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 0.93** (0.90, 9.96) 1.03* (1.00, 1.06) 1.03* (1.00, 1.06)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.93** (0.90, 0.96) 0.81** (0.80, 0.83) 0.81** (0.80, 0.83)
Constant 2.79** (2.75, 2.83) 0.85** (0.82, 0.88) 0.30** (0.29, 0.32) 0.28** (0.27, 0.30)
F Statistic 10** 1858** 2532** 2061**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AE-3.  
Regression Models for the Likelihood of having a PCP by Race/ethnicity, using Pre/post ACA 
Indicator; 47-state Analytic Sample. 
 
 
Probability of Having a 
PCP (n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.03** (1.02, 1.05) 0.89** (0.87, 0.91) 0.90** (0.88, 0.91) 0.87** (0.85, 0.89)
Race
Whites Ref Ref
Blacks 0.95* (0.93, 0.98) 0.89** (0.85, 0.93)
Hispanics 0.69** (0.67, 0.71) 0.66** (0.63, 0.69)
ACA*Race
ACA*whites Ref
ACA*blacks 1.11** (1.05, 1.18)
ACA*hispanics 1.08* (1.02, 1.14)
Other Variables 
Insurance
Uninsured Ref Ref Ref
Insured 5.57** (5.44, 5.71) 5.33** (5.21, 5.46) 5.33** (5.21, 5.46)
Education
Less than HS Ref Ref Ref
HS Grad 1.44** (1.39, 1.49) 1.31** (1.27, 1.36) 1.31** (1.27, 1.36)
Some College 1.66** (1.60, 1.71) 1.49** (1.44, 1.54) 1.49** (1.43, 1.54)
College Grad 2.02** (1.96, 2.10) 1.78** (1.72, 1.85) 1.78** (1.72, 1.85)
Age
18 to 44 Ref Ref Ref
45 to 64 2.46** (2.42, 2.51) 2.39** (2.34, 2.43) 2.39** (2.34, 2.43)
Sex
Male Ref Ref Ref
Female 1.94** (1.91, 1.98) 1.96** (1.92, 1.99) 1.96** (1.92, 1.99)
Diabetes Status
No/Low Risk Ref Ref Ref
High Risk 1.16** (1.14, 1.19) 1.18** (1.16, 1.20) 1.18** (1.17, 1.20)
Diabetes 2.890** (2.67, 2.93) 2.88** (2.74, 3.02) 2.88** (2.74, 3.02)
Chronic Disease
Count 0-5 1.40** (1.39, 1.43) 1.36** (1.33, 1.39) 1.36** (1.33, 1.39)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 1.01 (0.98, 1.04) 1.03* (1.00, 1.06) 1.03* (1.00, 1.06)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.82** (0.80, 0.83) 0.81** (0.80, 0.83) 0.81** (0.80, 0.83)
Constant 2.79** (2.75, 2.83) 0.25** (0.24, 0.26) 0.30** (0.29, 0.32) 0.31** (0.30, 0.32)
F Statistic 16** 3576** 3070** 2686**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AE-4.  
Logistic Regressions using Time Dummy Variables (2014-2017) for the Likelihood of having a 
PCP Post-ACA. 
 
Probability of Having a 
PCP (n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
Year
2012 Ref Ref Ref Ref
2013 Ref Ref Ref Ref
2014 1.01 (0.99, 1.04) 0.91** (0.89, 0.93) 0.91** (0.89, 0.93) 0.89** (0.87, 0.92)
2015 1.07** (1.05, 1.10) 0.93** (0.90, 0.95) 0.93** (0.91, 0.96) 0.90** (0.87, 0.93)
2016 1.05** (1.02, 1.07) 0.88** (0.86, 0.91) 0.90** (0.87, 0.92) 0.87** (0.84, 0.89)
2017 1.01 (0.99, 1.04) 0.84** (0.82, 0.87) 0.85** (0.83, 0.87) 0.81** (0.79, 0.84)
Race
Whites Ref Ref
Blacks 0.95* (0.93, 0.98) 0.89** (0.85, 0.93)
Hispanics 0.69** (0.67, 0.71) 0.66** (0.63, 0.69)
Year*Race
2014*whites Ref
2014 *blacks 1.10* (1.01, 1.19)
2014*hispanics 1.03 (0.96, 1.11)
2015*whites Ref
2015 *blacks 1.07 (0.98, 1.17)
2015*hispanics 1.11* (1.03, 1.20)
2016*whites Ref
2016 *blacks 1.12* (1.03, 1.22)
2016*hispanics 1.07 (0.99, 1.15)
2017*whites Ref
2017 *blacks 1.15* (1.06, 1.25)
2017*hispanics 1.11* (1.03, 1.20)
Other Variables
Insurance
Uninsured Ref Ref Ref
Insured 5.58** (5.45, 5.71) 5.34** (5.22, 5.47) 5.34** (5.21, 5.46)
Education
Less than HS Ref Ref Ref
HS Grad 1.44** (1.39, 1.49) 1.31** (1.27, 1.36) 1.31** (1.27, 1.36)
Some College 1.65** (1.60, 1.71) 1.49** (1.44, 1.54) 1.49** (1.44, 1.54)
College Grad 2.03** (1.96, 2.10) 1.79** (1.72, 1.84) 1.79** (1.73, 1.85)
Age
18 to 44 Ref Ref Ref
45 to 64 2.46** (2.41, 2.51) 2.39** (2.34, 2.43) 2.39** (2.34, 2.43)
Sex
Male Ref Ref Ref
Female 1.94** (1.91, 1.98) 1.96** (1.92, 1.99) 1.96** (1.92, 1.99)
Diabetes Status
No/Low Risk Ref Ref Ref
High Risk 1.16** (1.14, 1.89) 1.18** (1.6, 1.20) 1.18** (1.16, 1.20)
Diabetes 2.80** (2.67, 2.94) 2.88** (2.74, 3.02) 2.88** (2.74, 3.02)
Chronic Disease
Count 0-5 1.40** (1.37, 1.43) 1.36** (1.33, 1.39) 1.36** (1.33, 1.39)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 1.01 (0.98, 1.04) 1.03* (1.00, 1.06) 1.03* (1.00, 1.06)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.82** (0.80, 0.83) 0.81** (0.80, 0.83) 0.81** (0.80, 0.83)
Constant 2.79** (2.75, 2.83) 0.24** (0.24, 0.25) 0.30** (0.29, 0.32) 0.31** (0.30, 0.32)
F Statistic 10** 2865** 2532** 1723**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AE-5.  
Logistic Regression Models for the Odds of having a PCP Post-ACA by Race and Expansion 
Status, using Pre/post-ACA Indicator; 47-state analytic sample. 
 
 
 
 
 
 
 
 
Probability of PCP 
(Logistic)
Whites Only         
(n=1,048, 152)
95% CI
Whites Only         
(n=1,048, 152)
95% CI
Blacks Only 
(n=121,844)
95% CI
Blacks Only 
(n=121,844)
95% CI
Hispanics Only    
(n=113,541)
95% CI
Hispanics Only    
(n=113,541)
95% CI
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref
Expansion  1.16** (1.14, 1.19) 1.15** (1.12, 1.19) 1.17** (1.10, 1.24) 1.08 (0.98, 1.18) 1.17** (1.10, 1.24) 1.09 (0.99, 1.20)
ACA
Pre ACA Ref Ref Ref Ref Ref Ref
Post ACA 0.88** (0.86, 0.89) 0.87** (0.84, 0.90) 0.95 (0.90, 1.00) 0.90* (0.83, 0.97) 0.93* (0.89, 0.98) 0.87* (0.80, 0.95)
Interaction Term
ACA*EXP 1.01 (0.97, 1.06) 1.13* (1.01, 1.26) 1.11 (1.00, 1.23)
Other Variables
PCP Supply
Adequate Ref Ref Ref Ref Ref Ref
Low Supply 0.88** (0.86, 0.90) 0.88** (0.86, 0.90) 0.85** (0.80, 0.90) 0.85** (0.80, 0.90) 0.85** (0.80, 0.90) 0.85** (0.80, 0.90)
ACA
Pre ACA Ref Ref Ref Ref Ref Ref
Post ACA 0.88** (0.86, 0.89) 0.87** (0.84, 0.90) 0.95 (0.90, 1.00) 0.90* (0.83, 0.97) 0.93* (0.89, 0.98) 0.87* (0.80, 0.95)
Insurance
Uninsured Ref Ref Ref Ref Ref Ref
Insured 4.97** (4.83, 5.11) 4.97** (4.83, 5.11) 6.00** 5.64, 6.38) 6.00** (5.63, 6.37) 5.48** (5.20, 5.78) 5.48** (5.20, 5.78)
Sex
Male Ref Ref Ref Ref Ref Ref
Female 1.96** (1.92, 2.00) 1.96** (1.92, 2.00) 1.99** (1.89, 2.10) 1.99** (1.89, 2.10) 1.94** (1.85, 2.03) 1.94** (1.85, 2.03)
Age
18 to 44 Ref Ref Ref Ref Ref Ref
45 to 64 2.52** (2.47, 2.57) 2.52** (2.47, 2.57) 2.48** (2.34, 2.63) 2.48** (2.34, 2.63) 1.97** (1.87, 2.08) 1.97** (1.87, 2.08)
Education
Less than HS Ref Ref Ref Ref Ref Ref
HS Grad 1.19** (1.14, 1.25) 1.19** (1.14, 1.25) 1.24** (1.13, 1.37) 1.24** (1.13, 1.37) 1.39** (1.30, 1.48) 1.39** (1.30, 1.48)
Some College 1.34** (1.28, 1.41) 1.34** (1.28, 1.41) 1.40** (1.27, 1.54) 1.40** (1.27, 1.54) 1.64** (1.53, 1.75) 1.64** (1.52, 1.75)
College Grad 1.56** (1.49, 1.63) 1.56** (1.49, 1.63) 2.14** (1.94, 2.37) 2.14** (1.93, 2.37) 2.15** (1.99, 2.31) 2.15** (1.99, 2.31)
Diabetes Status
No/Low Risk Ref Ref Ref Ref Ref Ref
High Risk 1.20** (1.18, 1.23) 1.20** (1.18, 1.23) 1.20** (1.13, 1.27) 1.20** (1.13, 1.27) 1.11** (1.06, 1.17) 1.11** (1.06, 1.17)
Diabetes 3.10* (2.92, 3.27) 3.10** (2.92, 3.28) 2.85* (2.53, 3.22) 2.89** (2.54, 3.22) 2.75** (2.47, 3.06) 2.75** (2.47, 3.06)
Chronic Disease
Count 0-5 1.34** (1.31, 1.37) 1.34** (1.31, 1.37) 1.33** (1.25, 1.41) 1.33** (1.25, 1.41) 1.37** (1.28, 1.45) 1.36** (1.28, 1.45)
Self Reported Health
Healthy Ref Ref Ref Ref Ref Ref
Unhealthy 1.04* (1.01, 1.08) 1.04* (1.01, 1.08) 1.04 (0.96, 1.12) 1.04 (0.97, 1.12) 1.03 (0.97, 1.10) 1.03 (0.97, 1.10)
Constant 0.31** (0.30, 0.33) 0.31** (0.30, 0.33) 0.23** (0.20, 0.26) 0.24** (0.21, 0.27) 0.18** (0.17, 0.20) 0.19** (0.17, 0.21)
F Statistic 2324** 2159** 449** 417** 543** 505**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AE-6.  
Logistic Regression Models for the Odds of having a PCP Post-ACA by Race and Expansion 
Status, using Pre/post-ACA Indicator; 47-state analytic sample. 
 
Probability of PCP (Logistic)
Whites Only         
(n=1,048, 152)
95% CI
Whites Only         
(n=1,048, 152)
95% CI
Blacks Only 
(n=121,844)
95% CI
Blacks Only 
(n=121,844)
95% CI
Hispanics Only    
(n=113,541)
95% CI
Hispanics Only    
(n=113,541)
95% CI
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref
Expansion  1.16** (1.14, 1.19) 1.15** (1.12, 1.20) 1.17** (1.10, 1.24) 1.08 (0.92, 1.18) 1.17** (1.10, 1.24) 1.09 (1.00, 1.20)
Years
2012 Ref Ref Ref Ref Ref Ref
2013 Ref Ref Ref Ref Ref Ref
2014 0.90** (0.87, 0.93) 0.92** (0.88, 0.96) 0.97 (0.90, 1.05) 0.94 (0.84, 1.05) 0.92* (0.86, 0.99) 0.87* (0.77, 0.97)
2015 0.91* (0.88, 0.94) 0.89** (0.85, 0.93) 0.95 (0.88, 1.04) 0.87* (0.77, 0.97) 1.00 (0.93, 1.08) 0.98 (0.86, 1.11)
2016 0.88** (0.85, 0.90) 0.88** (0.84, 0.92) 0.96 (0.88, 1.04) 0.93 (0.83, 1.05) 0.92* (0.86, 0.99) 0.84* (0.74, 0.96)
2017 0.82** (0.80, 0.85) 0.81** (0.77, 0.85) 0.92* (0.85, 1.00) 0.85* (0.76, 0.95) 0.90* (0.84, 0.97) 0.82* (0.72, 0.94)
Interaction Terms
2012*EXP Ref Ref Ref
2013*EXP Ref Ref Ref
2014*EXP 0.97 (0.92, 1.03) 1.07 (0.91, 1.25) 1.1 (0.95, 1.27)
2015*EXP 1.04 (0.98, 1.11) 1.23* (1.05, 1.45) 1.04 (0.89, 1.21)
2016*EXP 1.00 0.95, 1.06) 1.06 (0.90, 1.24) 1.15 (0.98, 1.34)
2017*EXP 1.04 (0.98, 1.10) 1.18* (1.01, 1.38) 1.15 (0.98, 1.35)
Other Variables
Insurance
Uninsured Ref Ref Ref Ref Ref Ref
Insured 4.98** (4.84, 5.11) 4.97** (4.84, 5.11) 6.00** (5.64, 6.38) 6.00** (5.64, 6.40) 5.48** (5.20, 5.78) 5.48** (5.20, 5.78)
PCP Supply
Adequate Ref Ref Ref Ref Ref Ref
Low Supply 0.88** (0.86, 0.90) 0.88** (0.86, 0.90) 0.85** (0.80, 0.90) 0.84** (0.80, 0.90) 0.85** (0.80, 0.90) 0.85** (0.80, 0.90)
Sex
Male Ref Ref Ref Ref Ref Ref
Female 1.96** (1.92, 2.00) 1.96** (1.92, 2.00) 1.99** (1.89, 2.10) 1.99** (1.89, 2.10) 1.94** (1.85, 2.03) 1.94** (1.85, 2.03)
Age
18 to 44 Ref Ref Ref Ref Ref Ref
45 to 64 2.52** (2.47, 2.57) 2.52** (2.47, 2.57) 2.48** (2.34, 2.63) 2.48** (2.34, 2.63) 1.97** (1.87, 2.08) 1.97** (1.87, 2.08)
Education
Less than HS Ref Ref Ref Ref Ref Ref
HS Grad 1.19** (1.14, 1.25) 1.19** (1.14, 1.25) 1.25** (1.13, 1.37) 1.24** (1.13, 1.37) 1.39** (1.30, 1.49) 1.39** (1.30, 1.49)
Some College 1.34** (1.28, 1.41) 1.34** (1.28, 1.41) 1.40** (1.27, 1.54) 1.40** (1.27, 1.54) 1.64** (1.53, 1.75) 1.63** (1.53, 1.750
College Grad 1.56** (1.49, 1.64) 1.56** (1.49, 1.64) 2.14** (1.94, 2.37) 2.14** (1.94, 2.37) 2.15** (1.99, 2.32) 2.15** (1.99, 2.32)
Diabetes Status
No/Low Risk Ref Ref Ref Ref Ref Ref
High Risk 1.20** (1.18, 1.23) 1.20** (1.18, 1.23) 1.20** (1.13, 1.27) 1.20** (1.14, 1.27) 1.11** (1.06, 1.17) 1.11** (1.06, 1.17)
Diabetes 3.10** (2.93, 3.38) 3.10** (2.93, 3.28) 2.86** (2.54, 3.22) 2.86** (2.54, 3.22) 2.75** (2.48, 3.06) 2.75** (2.48, 3.06)
Chronic Disease
Count 0-5 1.34** (1.31, 1.37) 1.34** (1.31, 1.37) 1.33** (1.25, 1.41) 1.33** (1.25, 1.41) 1.36** (1.28, 1.45) 1.36** (1.28, 1.45)
Self Reported Health
Healthy Ref Ref Ref Ref Ref Ref
Unhealthy 1.04* (1.01, 1.08) 1.04* (1.01, 1.08) 1.04 (0.97, 1.12) 1.04* (0.97, 1.12) 1.03 (0.97, 1.10) 1.03 (0.97, 1.10)
Constant 0.31** (0.30, 0.33) 0.31** (0.30, 0.33) 0.23** (0.20, 0.26) 0.24** (0.21, 0.27) 0.18** (0.17, 0.20) 0.19** (0.17, 0.21)
F Statistic 1894** 1515** 366** 292** 443** 355**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Discussion on Additional Regression Coefficients 
To gain a better understanding of how the three race/ethnic models differ, Table AE-7 provides 
a summary of logistic odds ratios for the demographic, health status and state level variables for 
each group, including the overall odds ratios. These coefficients are also compared with a single, 
overall model of PCP access from Table AE-3, which assumes equal coefficients across the 
three groups. Higher coefficients for one race/ethnic group indicate that certain variables have a 
larger effect in gaining access to a PCP.  
 Insurance coverage and college play a larger role in having a PCP for minorities than 
whites. Age appears to play a smaller role in having a PCP for Hispanics than either whites or 
blacks. The effects of health status or PCP supply on having a PCP vary little across race/ethnic 
groups.   
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Table AE-7.  
Summary Table Comparing Overall Logistic Odds Ratios for Demographic, Health Status and 
State Level Variables to Odds Ratios by Racial/ethnic Subgroups. 
 
In Table AE-7, overall regression model taken from Table AE-3; Odds Ratios by Race taken 
from Table AE-5.  
Evaluating ACA Effects for Complex PCP Regressions by Race and INS Status. In 
this section, a sensitivity analysis was conducted using complex regression models that included 
three key interaction terms: ACA*INS; ACA*Race; and ACA*INS*Race. The key coefficients 
for the regression models in Table AE-8 include: 
TABLE AE-
3 ODDS 
RATIOS
COVARIATE OVERALL WHITES BLACKS HISPANICS
Insured 5.88** 4.97** 6.00** 5.48**
Female 1.96** 1.96** 1.99** 1.94**
45-64 2.39** 2.52** 2.48** 1.97**
HS Grad 1.31** 1.19** 1.24** 1.39**
Some College 1.49** 1.34** 1.40** 1.64**
College Grad 1.78** 1.56** 2.14** 2.15**
High Risk 1.18** 1.20** 1.20** 1.11**
Diabetes 2.88** 3.10** 2.89** 2.75**
CD Count 0-5 1.36** 1.34** 1.33** 1.36**
Unhealthy 1.03* 1.04* 1.04 1.03
PCP Supply 0.81** 0.88** 0.85** 0.85**
Post-ACA 0.87** 0.87** 0.90* 0.87**
EXP - 1.15** 1.08 1.09
ACA*EXP - 1.01 1.13* 1.11
Notes:
P value <0.001 (**), P value <0.05 (*)
TABLE AE-5 ODDS RATIOS BY 
RACE
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• Post-ACA=1.00 
• ACA*INS= 0.84 
• ACA*Black= 1.05 
• ACA*Hispanic= 1.00 
• ACA*INS*Black= 1.26 (uninsured); 1.27 (insured) 
• ACA*INS*Hispanic= 1.16 (uninsured); 1.22 (insured).  
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Table AE-8.  
Complex Logistic Regression Models for the likelihood of having a PCP by INS, Race/Ethnicity, 
and Pre/Post-ACA; 47-state sample.  
 
Probability of Having a 
PCP (n=1,283,537) 
Model 1                      
Odds Ratio
Model 2                      
Odds Ratio
Model 3                      
Odds Ratio
Model 4                      
Odds Ratio
Model 5                      
Odds Ratio
95% CI
Model 6                      
Odds Ratio
95% CI
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref
Post-ACA 1.03** 0.89** 0.90** 0.87** 0.98 (p= 0.325) (0.94, 1.02) 1.00 (p=0.843) (0.96, 1.05)
Insurance
Uninsured Ref Ref Ref Ref Ref
Insured 5.57** 5.33** 5.33** 5.84** (5.63, 6.05) 5.41** (5.20, 5.63)
Race
Whites Ref Ref Ref Ref
Blacks 0.95* 0.89** 0.90** (0.86, 0.94) 0.77** (0.71, 0.84)
Hispanics 0.69** 0.66** 0.67** (0.64, 0.70) 0.60** (0.56, 0.65)
ACA*Race
ACA*whites Ref Ref Ref
ACA*blacks 1.11** 1.09* (1.03, 1.16) 1.05 (p=0.366) (0.94, 1.18)
ACA*hispanics 1.08* 1.05 (p=0.09) (0.99, 1.11) 1.00 (p=0.965) (0.91, 1.10)
ACA*INS
ACA*INS 0.86** (0.82, 0.90) 0.84** (0.80, 0.89)
ACA*INS*Race
ACA*blacks (uninsured) 1.26** (1.14, 1.39)
ACA*blacks (insured) 1.27** (1.17, 1.38)
ACA*hisps (uninsured) 1.16* (1.06, 1.28)
ACA*hisps (insured) 1.22** (1.13, 1.31)
Other Variables 
Education
Less than HS Ref Ref Ref Ref Ref
HS Grad 1.44** 1.31** 1.31** 1.31** (1.27, 1.36) 1.31** (1.26, 1.35)
Some College 1.66** 1.49** 1.49** 1.49** (1.43, 1.54) 1.48** (1.43, 1.54)
College Grad 2.02** 1.78** 1.78** 1.79** (1.72, 1.85) 1.79** (1.72, 1.85)
Age
18 to 44 Ref Ref Ref Ref Ref
45 to 64 2.46** 2.39** 2.39** 2.39** (2.34, 2.43) 2.39** (2.34, 2.43)
Sex
Male Ref Ref Ref Ref Ref
Female 1.94** 1.96** 1.96** 1.96** (1.92, 1.99) 1.96** (1.92, 1.99)
Diabetes Status
No/Low Risk Ref Ref Ref Ref Ref
High Risk 1.16** 1.18** 1.18** 1.18** (1.15, 1.20) 1.18** (1.16, 1.20)
Diabetes 2.890** 2.88** 2.88** 2.88** (2.74, 3.02) 2.88** (2.75, 3.03)
Chronic Disease
Count 0-5 1.40** 1.36** 1.36** 1.36** (1.33, 1.39) 1.36** (1.33, 1.39)
Self Reported Health
Healthy Ref Ref Ref Ref Ref
Unhealthy 1.01 1.03* 1.03* 1.03* (1.00, 1.06) 1.03* (1.001, 1.06)
PCP Supply
Adequate Supply Ref Ref Ref Ref Ref
Low Supply 0.82** 0.81** 0.81** 0.81** (0.80, 0.83) 0.81** (0.80, 0.83)
Constant 2.79** 0.25** 0.30** 0.31** 0.29** (0.28, 0.30) 0.31** (0.29, 0.32)
F Statistic 16** 3576** 3070** 2686** 2537** 2102**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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As discussed in the text, the minority groups show different ACA effects from whites. The ACA 
effects are: 
Table AE-9.  
ACA Effects by Race for the Odds of having a PCP using Complex Logistic Regression Analysis; 
47-state sample.  
 
These ACA effects are holding many influential demographic and health variables constant, 
including the baseline effect (5.41) of insurance. If a black or Hispanic person has insurance- 
their odds of having a PCP is much higher than their peer who is uninsured.  
 A sizable downward ACA effect occurred in the strength of insurance coverage resulting 
in having a PCP (-13%, Model 4). This decline was almost completely offset for uninsured 
Hispanics who experienced only a 2% decline in having a PCP, i.e., e{ln0.84 + ln1.16}= 0.98 
and was reversed to a minor extent for insured Hispanics, i.e., 3% (Table AE-9).  
 
 
 
Whites Blacks Hispanics
Insured 0.84 1.12 1.03
Uninsured 1.00 1.11 0.98
Notes 
1. Insured whites: e{ln1.00 + ln0.84} = 0.84
2. Uninsured whites: 1.00
3. Insured blacks: e{ln1.0 + ln0.84 + ln1.05 + ln1.27}= 1.21
4. Uninsured blacks: e{ln1.0 + ln0.84 + ln1.05 + ln1.26}= 1.11
5. Insured Hispanics: e{ln1.0 + ln0.84 + ln1.0 + ln1.22}= 1.025
6. Uninsured Hispanics: e{ln1.0 + ln0.84 + ln1.0 + ln1.16} =0.975
Post ACA
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APPENDIX AF 
LOGISTIC REGRESSIONS FOR ODDS OF CHECKUP BY INS AND RACE 
Introduction to Specific Aim 2-Health Care Access. This section begins with 
describing the impact of insurance on the odds of having a Checkup in the past year. Refer to 
Chapter 4, page 190 for in text discussion. Full regression models available in Table AF-1. 
Full regression models using time dummy variables are available in Table AF-2. After 2014, 
there was a 6% decline of in the report of having a Checkup in the past year from 2014 to 2017 
among individuals who reported having insurance coverage.  
 Specific Aim 2a. Pre/Post-ACA Health Care Access Odds with ACA-Race 
Interactions. Refer to Chapter 4, page 201 for in-text discussion. Full regression models 
available in Table AF-3. 
 Specific Aim 2a. Annual ACA Checkup Odds Ratios with ACA-Race Interactions. 
Refer to Chapter 4, page 209 for in-text discussion. Full regression models in Table AF-4.  
Specific Aim 2b. Pre/Post-ACA Odds Ratios for Checkup Controlling for Expansion 
Status by Race Group. Refer to Chapter 4, page 214 for in-text discussion. Full regression 
models in Table AF-5. 
Specific Aim 2b. Annual ACA Checkup Odds Ratios Controlling for Expansion 
Status by Race Group. Full regression models using time variables are available in Table AF-6. 
Overall time tends for all races were not statistically significant, except for whites living in 
expansion states with a 7% increased likelihood of having a checkup when compared to whites 
in non-expansion states by 2017. Rates of having a checkup increased for both blacks and 
whites, however, Hispanics experienced a 3% decline in the likelihood of having a checkup in 
the past year when compared to non-expansion states by 2017.   
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Table AF-1.  
Logistic Regression Models for the Odds of having a Checkup in the past year using pre/post-
ACA indicator; 47-state Sample.  
 
 
 
Probability of Checkup 
(n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.10** (1.08, 1.12) 1.10** (1.09, 1.12) 1.01 (0.99, 1.03) 1.11** (1.07, 1.16)
Insurance
Uninsured Ref Ref
Insured 3.49** (3.41, 3.57) 3.75** (3.63, 3.88)
ACA*INS
ACA*INS 0.89** (0.85, 0.92)
Other Variables
Race
Whites Ref Ref Ref
Blacks 1.81** (1.76, 1.85) 2.02** (1.97, 2.07) 2.02** (1.97, 2.08)
Hispanics 1.00 (0.98, 1.02) 1.21** (1.18, 1.24) 1.21** (1.18, 1.24)
Education
Less than HS Ref Ref Ref
HS Grad 1.35** (1.31, 1.39) 1.13** (1.10, 1.17) 1.13** (1.10, 1.17)
Some College 1.42** (1.38, 1.46) 1.10** (1.07, 1.14) 1.11** (1.07, 1.14)
College Grad 1.67** (1.62, 1.72) 1.19** (1.15, 1.22) 1.19** (1.15, 1.22)
Age
18 to 44 Ref Ref Ref
45 to 64 1.66** (1.64, 1.69) 1.57** (1.55, 1.60) 1.57** (1.55, 1.60)
Sex
Male Ref Ref Ref
Female 1.51** (1.49, 1.53) 1.49** (1.47, 1.51) 1.49** (1.47, 1.51)
Diabetes Status
No/Low Risk Ref Ref Ref
High Risk 1.08** (1.06, 1.10) 1.08** (1.06, 1.09) 1.08** (1.06, 1.10)
Diabetes 2.52** (2.43, 2.61) 2.43** (2.34, 2.51) 2.43** (2.34, 2.51)
Chronic Disease
Count 0-5 1.23** (1.21, 1.25) 1.20** (1.18, 1.22) 1.20** (1.18, 1.22)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 0.92** (0.90, 0.94) 0.98 (0.96, 1.00) 0.98 (0.96, 1.00)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.91** (0.89, 0.92) 0.98* (0.96, 0.99) 0.98* (0.96, 0.99)
Constant 1.70** (1.68, 1.72) 0.69** (0.67, 0.71) 0.32** (0.30, 0.33) 0.30** (0.89, 0.31)
F Statistic 158** 1229** 1827** 1706**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AF-2.  
Logistic Regression Models for the likelihood of having a Checkup in the past year by INS Status 
using 2012-2017 Time Dummy Variables; 47-state analytic sample.  
 
Probability of 
Having a Checkup 
(n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
ACA
2012 Ref Ref Ref Ref
2013 Ref Ref Ref Ref
2014 1.09** (1.07, 1.12) 1.10** (1.07, 1.12) 1.03* (1.01, 1.06) 1.09* (1.03, 1.15)
2015 1.09** (1.06, 1.11) 1.09** (1.06, 1.11) 0.99 (0.97, 1.02) 1.12** (1.06, 1.19)
2016 1.13** (1.11, 1.16) 1.14** (1.12, 1.17) 1.03* (1.01, 1.05) 1.17** (1.10, 1.25)
2017 1.08** (1.06, 1.11) 1.08** (1.06, 1.11) 0.98 (0.96, 1.00) 1.08* (1.01, 1.15)
Insurance
Uninsured Ref Ref
Insured 3.49** (3.41, 3.57) 3.75** (3.63, 3.88)
ACA*INS
2012*INS Ref
2013*INS Ref
2014*INS 0.94* (0.88, 1.00)
2015*INS 0.86** (0.80, 0.92)
2016*INS 0.85** (0.80, 0.91)
2017*INS 0.89* (0.83, 0.95)
Race
Whites Ref Ref Ref
Blacks 1.81** (1.76, 1.85) 2.02** (1.97, 2.07) 2.02** (1.97, 2.08)
Hispanics 1.00 (0.98, 1.02) 1.21** (1.18, 1.24) 1.21** (1.18, 1.24)
Education
Less than HS Ref Ref Ref
HS Grad 1.35** (1.31, 1.39) 1.13** (1.10, 1.17) 1.13** (1.10, 1.17)
Some College 1.42** (1.38, 1.46) 1.10** (1.07, 1.14) 1.11** (1.07, 1.14)
College Grad 1.67** (1.62, 1.72) 1.19** (1.15, 1.22) 1.19** (1.15, 1.22)
Age
18 to 44 Ref Ref Ref
45 to 64 1.66** (1.64, 1.69) 1.57** (1.55, 1.60) 1.57** (1.55, 1.60)
Sex
Male Ref Ref Ref
Female 1.51** (1.49, 1.54) 1.49** (1.47, 1.51) 1.50** (1.47, 1.51)
Diabetes Status
No/Low Risk Ref Ref Ref
High Risk 1.08** (1.06, 1.10) 1.08** (1.06, 1.09) 1.08** (1.6, 1.09)
Diabetes 2.52** (2.43, 2.61) 2.43** (2.34, 2.52) 2.43** (2.34, 2.52)
Chronic Disease
Count 0-5 1.23** (1.21, 1.25) 1.20** (1.18, 1.22) 1.20** (1.18, 1.22)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 0.92** (0.90, 0.94) 0.98 (0.96, 1.00) 0.98* (0.96, 1.00)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.91** (0.89, 0.92) 0.98* (0.96, 1.00) 0.98* (0.96, 0.99)
Constant 1.70** (1.68, 1.72) 0.69** (0.67, 0.71) 0.32** (0.30, 0.33) 0.30** (0.29, 0.31)
F Statistic 44** 1000** 1507** 1222**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AF-3.  
Logistic Regression Models for the likelihood of having a Checkup in the past year by 
race/ethnicity, using pre/post ACA indicator; 47-state analytic sample. 
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Table AF-4.  
Logistic Regression Models for the likelihood of having a Checkup in the past year by 
race/ethnicity, using Time Dummies (2014-2017); 47-state analytic sample.  
 
 
Probability of Checkup 
(n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
Year
2012 Ref Ref Ref Ref
2013 Ref Ref Ref Ref
2014 1.09** (1.07, 1.12) 1.03* (1.01, 1.06) 1.03* (1.01, 1.06) 1.03* (1.01, 1.06)
2015 1.09** (1.06, 1.11) 1.00 (0.97, 1.02) 0.99 (0.97, 1.02) 1.00 (0.98, 1.02)
2016 1.13** (1.11, 1.16) 1.04* (1.01, 1.06) 1.03* (1.01, 1.05) 1.04* (1.01, 1.06)
2017 1.08** (1.06, 1.11) 0.98 (0.96, 1.01) 0.98 (0.96, 1.00) 0.98 (0.96, 1.00)
Race
Whites Ref Ref
Blacks 2.02** (1.97, 2.07) 2.03** (1.94, 2.12)
Hispanics 1.21** (1.18, 1.24) 1.22** (1.17, 1.27)
Year*Race
2014*whites Ref
2014 *blacks 1.00 (0.92, 1.08)
2014*hispanics 1.01 (0.94, 1.08)
2015*whites Ref
2015 *blacks 0.97 (0.89, 1.05)
2015*hispanics 0.99 (0.92, 1.06)
2016*whites Ref
2016 *blacks 0.98 (0.90, 1.06)
2016*hispanics 0.99 (0.92, 1.06)
2017*whites Ref
2017 *blacks 1.03 (0.95, 1.12)
2017*hispanics 0.98 (0.91, 1.06)
Other Variables
Insurance
Uninsured Ref Ref Ref
Insured 3.30** (3.23, 3.37) 3.49** (3.41, 3.57) 3.49** (3.41, 3.57)
Education
Less than HS Ref Ref Ref
HS Grad 1.11** (1.07, 1.14) 1.13** (1.10, 1.17) 1.13** (1.10, 1.17)
Some College 1.07** (1.04, 1.10) 1.10** (1.07, 1.14) 1.10** (1.07, 1.14)
College Grad 1.11** (1.08, 1.15) 1.19** (1.15, 1.22) 1.19** (1.45, 1.22)
Age
18 to 44 Ref Ref Ref
45 to 64 1.52** (1.50, 1.54) 1.57** (1.55, 1.60) 1.57** (1.55, 1.60)
Sex
Male Ref Ref Ref
Female 1.51** (1.49, 1.53) 1.49** (1.47, 1.51) 1.49** (1.47, 1.51)
Diabetes Status
No/Low Risk Ref Ref Ref
High Risk 1.11** (1.10, 1.13) 1.08** (1.06, 1.09) 1.08** (1.06, 1.09)
Diabetes 2.55** (2.46, 2.64) 2.43** (2.34, 2.52) 2.43** (2.34, 2.52)
Chronic Disease
Count 0-5 1.19** (1.17, 1.21) 1.20** (1.18, 1.22) 1.20** (1.18, 1.22)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 1.00 (0.97, 1.02) 0.98 (0.96, 1.00) 0.98 (0.96, 1.00)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 1.01 (0.99, 1.02) 0.98 (0.96, 1.00) 0.98* (0.96, 0.99)
Constant 1.70** (1.68, 1.72) 0.38** (0.37, 0.39) 0.32** (0.30, 0.33) 0.31** (0.30, 0.33)
F Statistic 44** 1559** 1507** 1026**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05 (*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AF-5.  
Logistic Regression Models for the Odds of having a Checkup in the past year Post-ACA by Race 
and Expansion Status, using Pre/post-ACA Indicator; 47-state analytic sample. 
 
 
 
 
 
 
 
Probability of Checkup 
(Logistic)
Whites Only         
(n=1,048, 152)
95% CI
Whites Only         
(n=1,048, 152)
95% CI
Blacks Only 
(n=121,844)
95% CI
Blacks Only 
(n=121,844)
95% CI
Hispanics Only    
(n=113,541)
95% CI
Hispanics Only    
(n=113,541)
95% CI
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref
Expansion  0.91** (0.90, 0.93) 0.90** (0.87, 0.92) 0.94* (0.89, 0.99) 0.91 (0.83, 0.99) 0.88** (0.84, 0.93) 0.89* (0.81, 0.97)
ACA
Pre ACA Ref Ref Ref Ref Ref Ref
Post ACA 1.01 (0.99, 1.02) 0.99 (0.96, 1.02) 1.01 (0.96, 1.06) 0.98 (0.92, 1.06) 1.02 (0.97, 1.06) 1.02 (0.94, 1.11)
Interaction Term
ACA*EXP 1.03 (0.99, 1.06) 1.05 (0.95, 1.16) 1.00 (0.90, 1.10)
Other Variables
Insurance
Uninsured Ref Ref Ref Ref Ref Ref
Insured 3.81** (3.71, 3.91) 3.81** (3.71, 3.91) 3.38** (3.12, 3.58) 3.38** (3.19, 3.58) 3.13** (2.98, 3.29) 3.13** (2.98, 3.29)
PCP Supply
Adequate Ref Ref Ref Ref Ref Ref
Low Supply 0.95** (0.93, 0.96) 0.95** (0.93, 0.96) 0.93* (0.88, 0.98) 0.93* (0.88, 0.98) 0.89** (0.84, 0.94) 0.89** (0.84, 0.94)
Sex
Male Ref Ref Ref Ref Ref Ref
Female 1.44** (1.42, 1.46) 1.44** (1.42, 1.46) 1.59** (1.51, 1.67) 1.59** (1.51, 1.67) 1.64** (1.57, 1.72) 1.64** (1.57, 1.72)
Age
18 to 44 Ref Ref Ref Ref Ref Ref
45 to 64 1.62** (1.59, 1.64) 1.62** (1.59, 1.64) 1.54** (1.46, 1.62) 1.54** (1.46, 1.62) 1.42** (1.35, 1.49) 1.42** (1.35, 1.49)
Education
Less than HS Ref Ref Ref Ref Ref Ref
HS Grad 1.11** (1.07, 1.15) 1.11** (1.07, 1.15) 1.10* (1.00, 1.20) 1.10* (1.00, 1.20) 1.16** (1.10, 1.24) 1.16** (1.10, 1.24)
Some College 1.12** (1.07, 1.16) 1.11** (1.07, 1.16) 0.98 (0.89, 1.07) 0.98 (0.89, 1.07) 1.09* (1.02, 1.16) 1.09* (1.02, 1.16)
College Grad 1.18** (1.13, 1.22) 1.18** (1.13, 1.22) 1.08 (0.99, 1.19) 1.08 (0.99, 1.19) 1.24** (1.16, 1.33) 1.24** (1.16, 1.33)
Diabetes Status
No/Low Risk Ref Ref Ref Ref Ref Ref
High Risk 1.10** (1.08, 1.12) 1.10** (1.08, 1.12) 1.07* (1.02, 1.13) 1.07* (1.02, 1.13) 0.98 (0.93, 1.03) 0.98 (0.93, 1.03)
Diabetes 2.58** (2.48, 2.68) 2.58** (2.48, 2.68) 2.33** (2.11, 2.57) 2.33** (2.11, 2.57) 2.14** (1.95, 2.36) 2.14** (1.95, 2.36)
Chronic Disease
Count 0-5 1.22** (1.20, 1.24) 1.22** (1.20, 1.24) 1.19** (1.13, 1.25) 1.19** (1.13, 1.25) 1.13** (1.07, 1.19) 1.13** (1.07, 1.19)
Self Reported Health
Healthy Ref Ref Ref Ref Ref Ref
Unhealthy 1.01 (0.99, 1.04) 1.01 (0.99, 1.04) 0.85** (0.79, 0.91) 0.85** (0.79, 0.91) 0.99 (0.94, 1.05) 0.99 (0.94, 1.05)
Constant 0.31** (0.30, 0.33) 0.31** (0.30, 0.33) 0.74** (0.66, 0.83) 0.75** (0.67, 0.85) 0.47** (0.43, 0.51) 0.47** (0.42, 0.51)
F Statistic 1569** 1457** 233** 217** 286** 265**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AF-6.  
Logistic Regression Models for the Odds of having a Checkup in the past year Post-ACA by Race 
and Expansion Status, using 2014-2017 Time Dummies; 47-state analytic sample. 
 
Probability of 
Checkup (Logistic)
Whites Only         
(n=1,048, 
152)
95% CI
Whites Only         
(n=1,048, 152)
95% CI
Blacks Only 
(n=121,844)
95% CI
Blacks Only 
(n=121,844)
95% CI
Hispanics 
Only    
(n=113,541)
95% CI
Hispanics 
Only    
(n=113,541
)
95% CI
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref
Expansion  0.91** (0.90, 0.93) 0.90** (0.87, 0.92) 0.94* (0.89, 0.99) 0.91* (0.83, 0.99) 0.88** (0.84, 0.93) 0.89* (0.82, 0.97)
Years
2012 Ref Ref Ref Ref Ref Ref
2013 Ref Ref Ref Ref Ref Ref
2014 1.03* (1.01, 1.05) 1.03 (0.99, 1.07) 1.03 (0.96, 1.11) 1.02 (0.92, 1.13) 1.05 (0.98, 1.12) 1.00 (0.90, 1.11)
2015 0.99 (0.97, 1.02) 0.98 (0.95, 1.02) 0.97 (0.90, 1.04) 0.94 (0.84, 1.04) 1.00 (0.94, 1.07) 1.03 (0.92, 1.15)
2016 1.03* (1.01, 1.05) 1.01 (0.97, 1.05) 1.02 (0.94, 1.10) 0.98 (0.88, 1.09) 1.04 (0.97, 1.11) 1.07 (0.95, 1.21)
2017 0.97* (0.95, 1.00) 0.94* (0.90, 0.97) 1.02 (0.94, 1.10) 1.004 (0.90, 1.12) 0.98 (0.91, 1.05) 0.97 (0.86, 1.10)
Interaction Terms
2012*EXP Ref Ref Ref
2013*EXP Ref Ref Ref
2014*EXP 1.00 (0.96, 1.05) 1.03 (0.89, 1.19) 1.07 (0.94, 1.23)
2015*EXP 1.01 (0.97, 1.07) 1.07 (0.92, 1.24) 0.96 (0.83, 1.10)
2016*EXP 1.03 (0.98, 1.08) 1.07 (0.93, 1.25) 0.95 (0.82, 1.09)
2017*EXP 1.07* (1.01, 1.12) 1.03 (0.88, 1.19) 1.01 (0.87, 1.17)
Other Variables
Insurance
Uninsured Ref Ref Ref Ref Ref Ref
Insured 3.81** (3.71, 3.91) 3.81** (3.71, 3.91) 3.38** (3.19, 3.59) 3.38** (3.19, 3.59) 3.14** (2.98, 3.30) 3.14** (0.99, 3.30)
PCP Supply
Adequate Ref Ref Ref Ref Ref Ref
Low Supply 0.95** (0.93, 0.96) 0.95** (0.93, 0.97) 0.93* (0.88, 0.98) 0.93* (0.88, 0.98) 0.89** (0.84, 0.94) 0.89** (0.84, 0.94)
Sex
Male Ref Ref Ref Ref Ref Ref
Female 1.44** (1.42, 1.46) 1.44** (1.42, 1.46) 1.59** (1.51, 1.67) 1.59** (1.51, 1.67) 1.64** (1.57, 1.72) 1.64** (1.57, 1.72)
Age
18 to 44 Ref Ref Ref Ref Ref Ref
45 to 64 1.61** (1.59, 1.64) 1.62** (1.59, 1.64) 1.54** (1.46, 1.62) 1.54** (1.46, 1.62) 1.42** (1.35, 1.49) 1.42** (1.35, 1.49)
Education
Less than HS Ref Ref Ref Ref Ref Ref
HS Grad 1.11** (1.07, 1.16) 1.11** (1.07, 1.16) 1.10* (1.01, 1.20) 1.10* (1.00, 1.20) 1.16** (1.10, 1.24) 1.16** (1.10, 1.24)
Some College 1.11** (1.07, 1.16) 1.11** (1.07, 1.16) 0.98 (0.90, 1.07) 0.98 (0.89, 1.07) 1.09* (1.02, 1.16) 1.09* (1.02, 1.16)
College Grad 1.18** (1.13, 1.22) 1.18** (1.13, 1.23) 1.08 (0.99, 1.19) 1.08 (0.99, 1.19) 1.24** (1.16, 1.33) 1.24** (1.16, 1.33)
Diabetes Status
No/Low Risk Ref Ref Ref Ref Ref Ref
High Risk 1.10** (1.08, 1.12) 1.10** (1.08, 1.12) 1.07* (1.02, 1.13) 1.07* (1.02, 1.13) 0.98 (0.94, 1.03) 0.98 (0.94, 1.03)
Diabetes 2.58** (2.48, 2.68) 2.58** (2.48, 2.68) 2.33** (2.11, 2.58) 2.33** (2.11, 2.58) 2.15** (1.95, 2.36) 2.15** (1.94, 2.36)
Chronic Disease
Count 0-5 1.22** (1.20, 1.24) 1.22** (1.20, 1.24) 1.19** (1.13, 1.25) 1.19** (1.13, 1.25) 1.13** (1.07, 1.19) 1.13** (1.07, 1.19)
Self Reported Health
Healthy Ref Ref Ref Ref Ref Ref
Unhealthy 1.01 (0.99, 1.04) 1.01 (0.99, 1.04) 0.85** (0.79, 0.91) 0.85** (0.79, 0.91) 0.99 (0.94, 1.05) 0.99 (0.94, 1.05)
Constant 0.31** (0.30, 0.32) 0.31** (0.30, 0.33) 0.74** (0.66, 0.83) 0.75** (0.67, 0.85) 0.47** (0.43, 0.51) 0.57** (0.42, 0.51)
F Statistic 1278** 1023** 190** 152** 233** 187**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05 (*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Since baseline pre-ACA checkup rates are known from Part III, Tables 35 and 36, and 
the (estimated) change in the percent with a checkup due to the ACA is known (per the 
regression odds ratios, these values were used to calculate average odds ratios for persons living 
in expansion and non-expansion states by race group (Table AF-7).  
Table AF-7.  
Conversion of Marginal Odds Ratios for Checkup to Average Odds Ratios for Checkup in Non-
expansion and Expansion States by Race.  
 
First, the pre-ACA percentages by Checkup and expansion status were converted to odds 
ratios using the following formula: 
(7) OR= Percent insured/(1-percent insured) 
• Example: [Non-expansion, whites, pre-ACA] = 1.709= (0.6309)/(1-0.6309).   
The OR’s in Rows 1 and 2 in Table AF-7 become the base upon which logistic marginal effects 
are constructed. Rows 1 and 2 are reproduced in Rows 3 and 6 for comparison purposes in non-
Row Odds Whites Blacks  Hispanics
1 NEXP-pre 1.709 2.740 1.268
2 EXP-pre 1.643 2.792 1.356
3 Pre-ACA 1.709 2.740 1.268
4 Post-ACA 1.692 2.685 1.293
5 Post/Pre 0.990 0.980 1.020
6 Pre-ACA 1.643 2.792 1.356
7 Post-ACA 1.464 2.490 1.231
8 Post/Pre 0.891 0.8918 0.9078
EXP ODDS RATIOS W/ PRE-ACA %CKUP ODDS
Non-EXP
EXP
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expansion and expansion states separately. Post-ACA Ors, or ACA effects, by expansion status 
(Rows 4 and 7) were calculated using the following formulas:  
(8) OR[NEXP]= exp (LN(ACA OR) + LN(NEXP-pre)) 
• Example: [Non-expansion, whites, post-ACA] =1.692= 
Exp{(LN(1.709)+LN(0.99)} 
(9) OR[EXP] = exp((LN(ACA OR) + LN(ACA*EXP OR) + LN(EXP-pre)) 
• Example: [Expansion, whites, post-ACA] =1.464= Exp{(LN(1.643) + 
LN(0.99)+ LN(0.90)}.  
The EXP coefficient is not included in calculating OR(EXP) because it is already included in the 
pre-ACA baseline insurance rate.  
  Then Rows 5 and 8 show the post-ACA Checkup gains over the pre-ACA period. There 
were no gains in having a Checkup in the post-ACA period for any racial/ethnic group, or 
between expansion and non-expansion states given interaction terms that were not statistically 
significant. In general, blacks had greater odds in having a checkup when compared to the other 
two groups, with Hispanics being the least likely of the three groups to have a checkup in the 
past year.  
 In the descriptive data, 2-5% gains in having a checkup existed; however, when adjusting 
for other factors in the regression model, the overall effect of the ACA decreased and was found 
to be statistically insignificant. In the analysis differentiating between expansion status, the ACA 
was not a factor in changing the likelihood of having a checkup in the past year for all race 
groups in expansion and non-expansion states. Referring to the odds ratios in Table AF-7, blacks 
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were more likely than whites or Hispanics to have a checkup in the past year in both expansion 
and non-expansion states.  
To gain a better understanding of each racial/ethnic group and why blacks may have 
higher odds of having a checkup than whites or Hispanics, Table AF-8 provides a summary of 
all variables included in the models for determining the likelihood of having a checkup by race 
and expansion status.    
Table AF-8.  
Summary Table Comparing Overall Logistic Odds Ratios for Demographic, Health Status and 
State-Level Variables for Checkup to Odds Ratios by Racial/ethnic Subgroups. 
 
In Table AF-8, see Table AF-3 for Overall Model; See Table AF-5 for Models by Race.  
TABLE AF-
3 ODDS 
RATIOS
COVARIATE OVERALL WHITES BLACKS HISPANICS
Insured 3.49** 3.81** 3.38** 3.13**
Female 1.49** 1.44** 1.59** 1.64**
45-64 1.57** 1.62** 1.54** 1.42**
HS Grad 1.13** 1.11** 1.10* 1.16**
Some College 1.10** 1.11** 0.98 1.09*
College Grad 1.19** 1.18** 1.08 1.24**
High Risk 1.08** 1.10** 1.07* 0.98
Diabetes 2.43** 2.58** 2.33** 2.14**
CD Count 0-5 1.20** 1.22** 1.19** 1.13**
Unhealthy 0.98 1.01 0.85** 0.99
PCP Supply 0.98* 0.95** 0.93* 0.89**
Post-ACA 1.01 0.99 0.98 1.02
EXP - 0.90** 0.91 0.89*
ACA*EXP - 1.03 1.05 1.00
Notes:
1. P value <0.001 (**), P value <0.05 (*)
TABLE AF-5 ODDS RATIOS BY 
RACE
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The summary table shows that the likelihood of having a checkup for blacks with a college 
education is no different than for blacks with less than a HS degree. Since it would be expected 
that higher education would lead to better preventive care access (as seen with whites and 
Hispanics), the fact that blacks at lower ends of the education spectrum have similar access to 
preventive care may led one to believe that this is leading to the greater odds in having a 
checkup, seen in Table AF-8. It’s also interesting that blacks seem to be more aware of their 
health status given that the self-reported health variable in the black regression model is 
statistically significant, showing that those reporting poor health being less likely to have a 
checkup in the past year. However, for whites and Hispanics, there is no difference in the 
likelihood of having a checkup between those who report being healthy vs. unhealthy.  
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APPENDIX AG 
LOGISTIC REGRESSIONS FOR ODDS OF PCP BY DIABETES RISK STATUS 
 Specific Aim 2a. Pre/Post-ACA PCP Odds with ACA-Risk Interactions. Refer to 
Chapter 4, page 216 for in-text discussion. Full regression models available in Table AG-1. 
 Specific Aim 2a. Annual ACA PCP Odds Ratios with ACA-Risk Interactions. Refer 
to Chapter 4, page 222 for in-text discussion. Full regression models in Table AG-2.  
Specific Aim 2b. Pre/Post-ACA Odds Ratios for PCP Controlling for Expansion 
Status by Risk Group. Refer to Chapter 4, page 225 for in-text discussion. Full regression 
models in Table AG-3. 
Specific Aim 2b. Annual ACA PCP Odds Ratios Controlling for Expansion Status 
by Risk Group. Full regression models using time variables are available in Table AG-4. 
Overall time tends for all diabetes risk groups were not statistically significant, except for the 
no/low risk group living in expansion states with a 10% increased likelihood of having a checkup 
when compared to the no/low risk group in non-expansion states by 2017. Rates of having a 
checkup increased for all groups, with the diabetes group experiencing a 19% increased 
likelihood in having a PCP when compared to the diabetes group in non-expansion states- 
however, this was not statistically significant.  
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Table AG-1.  
Logistic Regression Models for the likelihood of having a PCP by Diabetes Risk, using pre/post 
ACA indicator; 47-state analytic sample. 
 
 
Probability of Having a 
PCP (n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.03** (1.02, 1.05) 0.90** (0.88, 0.91) 0.90** (0.88, 0.91) 0.88** (0.86, 0.90)
Diabetes Status
No/Low Risk Ref Ref
High Risk 1.18* (1.16, 1.20) 1.16** (1.13, 1.20)
Diabetes 2.88** (2.74, 3.02) 2.56** (2.37, 2.76)
ACA*Diabetes Risk
ACA*no/low risk Ref
ACA*high risk 1.02 (0.98, 1.06)
ACA*diabetes 1.20** (1.09, 1.32)
Other Variables
Race
Whites Ref Ref Ref
Blacks 0.99 (0.96, 1.02) 0.95* (0.93, 0.98) 0.95* (0.93, 0.98)
Hispanics 0.71** (0.69, 0.73) 0.69** (0.67, 0.71) 0.69** (0.67, 0.71)
Education
Less than HS Ref Ref Ref
HS Grad 1.29** (1.25, 1.34) 1.31** 1.27, 1.36) 1.31** (1.27, 1.36)
Some College 1.47** (1.41, 1.51) 1.49** (1.44, 1.54) 1.49** (1.44, 1.54)
College Grad 1.71** (1.65, 1.77) 1.78** (1.72, 1.85) 1.78** (1.72, 1.85)
Age
18 to 44 Ref Ref Ref
45 to 64 2.58** (2.53, 2.63) 2.39** (2.34, 2.43) 2.39** (2.34, 2.43)
Sex
Male Ref Ref Ref
Female 1.94** (1.90, 1.97) 1.96** (1.92, 1.99) 1.96** (1.92, 1.99)
Insurance
Uninsured Ref Ref Ref
Insured 5.36** (5.24, 5.49) 5.33** (5.21, 5.46) 5.33** (5.21, 5.46)
Chronic Disease
Count 0-5 1.41** (1.39, 1.44) 1.36** (1.33, 1.39) 1.36** (1.33, 1.39)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 1.17** (1.14, 1.20) 1.03* (1.00, 1.06) 1.03* (1.00, 1.06)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.82** (0.81, 0.84) 0.81** (0.80, 0.83) 0.81** (0.80, 0.83)
Constant 2.79** (2.75, 2.83) 0.32** (0.31, 0.34) 0.30** (0.29, 0.33) 0.31** (0.29, 0.32)
F Statistic 16** 3559** 3070** 2687**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AG-2.  
Logistic Regression Models for the likelihood of having a PCP in the past year by Diabetes Risk, 
using Time Dummies (2014-2017); 47-state analytic sample. 
 
Probability of Having a 
PCP (n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
Year
2012 Ref Ref Ref Ref
2013 Ref Ref Ref Ref
2014 1.01 (0.99, 1.04) 0.91** (0.89, 0.93) 0.91** (0.89, 0.93) 0.90** (0.87, 0.93)
2015 1.07** (1.05, 1.10) 0.93** (0.91, 0.96) 0.93** (0.91, 0.96) 0.92** (0.89, 0.96)
2016 1.05** (1.02, 1.07) 0.89** (0.87, 0.92) 0.89** (0.87, 0.92) 0.87** (0.84, 0.90)
2017 1.01 (0.99, 1.04) 0.86** (0.83, 0.88) 0.85** (0.83, 0.87) 0.84** (0.81, 0.87)
Diabetes Status
No/Low Risk Ref Ref
High Risk 1.18** (1.16, 1.20) 1.16** (1.13, 1.20)
Diabetes 2.88** (2.74, 3.02) 2.56** (2.37, 2.76)
Year*Diabetes Status 
2014*no/low risk Ref
2014*high risk 1.02 (0.97, 1.08)
2014*diabetes 1.10 (0.97, 1.26)
2015*no/low risk Ref
2015*high risk 1.00 (0.95, 1.06)
2015*diabetes 1.21* (1.04, 1.41)
2016*no/low risk Ref
2016*high risk 1.05 (0.99, 1.11)
2016*diabetes 1.22* (1.06, 1.42)
2017*no/low risk Ref
2017*high risk 1.02 (0.96, 1.08)
2017*diabetes 1.29* (1.11, 1.49)
Other Variable
Race
Whites Ref Ref Ref
Blacks 0.99 (0.96, 1.02) 0.95* (0.93, 0.98) 0.95* (0.93, 0.98)
Hispanics 0.71** (0.69, 0.73) 0.69** (0.67, 0.71) 0.69** (0.67, 0.71)
Education
Less than HS Ref Ref Ref
HS Grad 1.29** (1.25, 1.34) 1.13** (1.27, 1.36) 1.31** (1.27, 1.36)
Some College 1.46** (1.41, 1.51) 1.49** (1.44, 1.54) 1.49** (1.44, 1.54)
College Grad 1.71** (1.66, 1.77) 1.79** (1.72, 1.85) 1.79** (1.72, 1.85)
Age
18 to 44 Ref Ref Ref
45 to 64 2.58** (2.53, 2.63) 2.39** (2.34, 2.43) 2.39** (2.34, 2.43)
Sex
Male Ref Ref Ref
Female 1.94** (1.90, 1.97) 1.96** (1.92, 1.99) 1.96** (1.92, 1.99)
Insurance
Uninsured Ref Ref Ref
Insured 5.37** (5.24, 5.49) 5.34** (5.22, 5.47) 5.34** (5.22, 5.47)
Chronic Disease
Count 0-5 1.41** (1.38, 1.44) 1.36** (1.33, 1.39) 1.36** (1.33, 1.39)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 1.17** (1.14, 1.20) 1.03* (1.00, 1.06) 1.03* (1.00, 1.06)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.82** (0.81, 0.84) 0.81** (0.80, 0.83) 0.81** (0.80, 0.83)
Constant 2.79** (2.75, 2.83) 0.32** (0.31, 0.34) 0.30** (0.29, 0.32) 0.31** (0.29, 0.32)
F Statistic 10** 2850** 2532** 1723**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AG-3.  
Logistic Regression Models for the Odds of having a PCP by Diabetes Risk and Expansion 
Status, using Pre/post-ACA Indicator; 47-state analytic sample. 
 
Probability of Having a 
PCP (n=1,283,537)    
Odds Ratios 
Low Risk 95% CI Low Risk 95% CI High Risk 95% CI High Risk 95% CI Diabetes 95% CI Diabetes 95% CI
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref
Expansion  1.16** (1.14, 1.19) 1.14** (1.09, 1.19) 1.17** (1.13, 1.21) 1.12** (1.07, 1.18) 1.13* (1.0, 1.24) 1.06 (0.91, 1.23)
ACA
Pre ACA Ref Ref Ref Ref Ref Ref
Post ACA 0.89** (0.87, 0.91) 0.87** (0.84, 0.90) 0.90** (0.87, 0.93) 0.87** (0.83, 0.92) 1.04 (0.95, 1.15) 0.99 (0.86, 1.14)
Interaction Term
ACA*EXP 1.03 (0.98, 1.09) 1.06 (0.99, 1.13) 1.11 (0.92, 1.34)
Other Variables
Insurance
Uninsured Ref Ref Ref Ref Ref Ref
Insured 5.11** (4.95, 5.27) 5.11** (4.95, 5.27) 5.45** (5.25, 5.66) 5.45** (5.24, 5.66) 6.20** (5.60, 6.86) 6.19** (5.60, 6.86)
PCP Supply
Adequate Ref Ref Ref Ref Ref Ref
Low Supply 0.87** (0.85, 0.89) 0.87** (0.85, 0.89) 0.86** (0.83, 0.89) 0.86** (0.83, 0.89) 0.91 (0.82, 1.01) 0.91 (0.82, 1.01)
Race
Whites Ref Ref Ref Ref Ref Ref
Blacks 0.97 (0.93, 1.01) 0.97 (0.94, 1.01) 0.95* (0.91, 0.995) 0.95* (0.91, 0.995) 0.86* (0.77, 0.98) 0.86* (0.77, 0.97)
Hispanics 0.72** (0.70, 0.75) 0.72** (0.70, 0.75) 0.65** (0.62, 0.68) 0.65** (0.62, 0.68) 0.56** (0.50, 0.62) 0.56** (0.50, 0.62)
Sex
Male Ref Ref Ref Ref Ref Ref
Female 1.98** (1.94, 2.03) 1.98** (1.94, 2.03) 1.97** (1.91, 2.04) 1.97** (1.91, 2.04) 1.52** (1.38, 1.67) 1.52** (1.38, 1.67)
Age
18 to 44 Ref Ref Ref Ref Ref Ref
45 to 64 2.43** (2.38, 2.49) 2.43** (2.38, 2.49) 2.36** (2.29, 2.43) 2.36** (2.27, 2.43) 2.04** (1.84, 2.26) 2.04** (1.84, 2.26)
Education
Less than HS Ref Ref Ref Ref Ref Ref
HS Grad 1.29** (1.23, 1.36) 1.29** (1.23, 1.36) 1.32** (1.26, 1.39) 1.32** (1.26, 1.39) 1.24* (1.09, 1.41) 1.24* (1.09, 1.41)
Some College 1.45** (1.38, 1.52) 1.45** (1.38, 1.52) 1.53** (1.45, 1.61) 1.53** (1.45, 1.61) 1.47** (1.29, 1.68) 1.47** 1.29, 1.68)
College Grad 1.73** (1.64, 1.81) 1.73** (1.64, 1.81) 1.91** (1.81, 2.02) 1.91** (1.81, 2.02) 1.93** (1.66, 2.24) 1.93** (1.66, 2.24)
Chronic Disease
Count 0-5 1.38** (1.34, 1.42) 1.38** (1.34, 1.42) 1.41** (1.36, 1.46) 1.41** (1.36, 1.46) 1.11** (1.05, 1.18) 1.11** (1.05, 1.18)
Self Reported Health
Healthy Ref Ref Ref Ref Ref Ref
Unhealthy 1.00 (0.96, 1.05) 1.00 (0.96, 1.05) 1.08** (1.04, 1.13) 1.08** (1.04, 1.13) 0.92 (0.83, 1.02) 0.92 0.83, 1.02)
Constant 0.28** (0.27, 0.30) 0.27** (0.27, 0.30) 0.31** (0.29, 0.33) 0.31** (0.29, 0.34) 1.02 (0.84, 1.23) 1.05 (0.86, 1.29)
F Statistic 1838** 1707** 1214** 1128** 176** 163**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AG-4.  
Logistic Regression Models for the Odds of having a PCP by Diabetes Risk and Expansion Status, 
using (2014-2017) Time Dummy Variables; 47-state analytic sample. 
 
Probability of PCP (Logistic)    
(n=1,283,537)
Low Risk 95% CI High Risk 95% CI Diabetes 95% CI
Expansion Status
Non-expansion Ref Ref Ref
Expansion  1.14** (1.09, 1.19) 1.12** (1.07, 1.18) 1.06 (0.91, 1.23)
Years
2012 Ref Ref Ref
2013 Ref Ref Ref
2014 0.91** (0.86,0.96) 0.91* (0.85, 0.98) 0.92 (0.77, 1.11)
2015 0.91* (0.86, 0.96) 0.88* (0.82, 0.95) 1.00 (0.80, 1.25)
2016 0.87** (0.83, 0.92) 0.86** (0.80, 0.93) 1.07 (0.85, 1.35)
2017 0.80** (0.75, 0.84) 0.83** (0.77, 0.90) 0.97 (0.78, 1.20)
Interaction Terms
2012*EXP Ref Ref Ref
2013*EXP Ref Ref Ref
2014*EXP 0.99 (0.93, 1.06) 1.01 (0.93, 1.11) 1.11 (0.86, 1.44)
2015*EXP 1.04 (0.97, 1.12) 1.10 (1.00, 1.20) 1.21 (0.90, 1.62)
2016*EXP 1.01 (0.94, 1.08) 1.11* (1.01, 1.21) 0.95 (0.71, 1.27)
2017*EXP 1.10* (1.02, 1.18) 1.04 (0.94, 1.14) 1.19 (0.90, 1.58)
Insurance
Uninsured Ref Ref Ref
Insured 5.11** (4.96, 5.28) 5.45** (5.25, 5.66) 6.18** (5.59, 6.84)
Other Varibles
PCP Supply
Adequate Ref Ref Ref
Low Supply 0.87** (0.85, 0.89) 0.86** (0.83, 0.89) 0.91 (0.82, 1.01)
Race
Whites Ref Ref Ref
Blacks 0.97 (0.93, 1.01) 0.95* (0.91, 0.99) 0.86* (0.77, 0.98)
Hispanics 0.72** (0.70, 0.75) 0.65** (0.62, 0.68) 0.56** (0.50, 0.62)
Sex
Male Ref Ref
Female 1.98** (1.94, 2.03) 1.97** (1.91, 2.04) 1.52** (1.38, 1.67)
Age
18 to 44 Ref Ref Ref
45 to 64 2.43** (2.38, 2.49) 2.36** (2.29, 2.43) 2.04** (1.84, 2.56)
Education
Less than HS Ref Ref rEF
HS Grad 1.29** (1.23, 1.36) 1.32** (1.26, 1.40) 1.24* (1.10, 1.41)
Some College 1.45** (1.38, 1.52) 1.53** (1.45, 1.62) 1.47** (1.29, 1.69)
College Grad 1.73** (1.65, 1.82) 1.91** (1.81, 2.02) 1.93** (1.66, 2.24)
Chronic Disease
Count 0-5 1.38** (1.34, 1.42) 1.41** (1.36, 1.46) 1.11** (1.05, 1.18)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 1.00 (0.96, 1.05) 1.08** (1.04, 1.13) 0.92 (0.83, 1.02)
Constant 0.29** (0.27, 0.30) 0.31** (0.29, 0.34) 1.05 (0.86, 1.29)
F Statistic 1199** 792** 115**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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To gain a better understanding of how the three diabetes group models differ, Table AG-
5 provides a summary of logistic odds ratios for the demographic, health status and state level 
variables for each group, including the overall odd ratios. These coefficients are also compared 
with a single, overall model of PCP (Table AG-1), which assumes equal coefficients across the 
three groups. Higher coefficients for one diabetes risk group indicates that certain variables have 
a larger effect in gaining access to a PCP.  
A combination of being female, being 45 or older, being a college graduate, being 
minority, having a chronic disease and/or report of being unhealthy played a larger role in having 
a PCP for the two risk groups than those with reported diabetes. Insurance seemed to play the 
biggest role in having a PCP for individuals with reported diabetes (6.19, p<0.001), although the 
high-risk group and no/low risk groups also had larger regression coefficients, showing that 
insurance is the most important variable determining the likelihood of having a PCP.  
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Table AG-5.  
Summary Table Comparing Overall Logistic Odds Ratios for Demographic, Health Status and 
State Level Variables to Odds Ratios by Diabetes Risk Status.  
 
Evaluating ACA Effects for Complex PCP Regressions by Diabetes Risk and INS 
Status. In this section, a sensitivity analysis was conducted using complex regression models 
that included three key interaction terms: ACA*INS; ACA*Risk; and ACA*INS*Risk. The key 
coefficients for the regression models in Table AG-6 include: 
• Post-ACA=1.01 
• ACA*INS= 0.85 
• ACA*High-risk= 0.99 
TABLE AG-
1 ODDS 
RATIOS
COVARIATE OVERALL NO/LOW HIGH DIABETES
Insured 5.33** 5.11** 5.45** 6.19**
Female 1.96** 1.98** 1.97** 1.52**
45-64 2.39** 2.43** 2.36** 2.04**
HS Grad 1.31** 1.29** 1.32** 1.24*
Some College 1.49** 1.45** 1.53** 1.47**
College Grad 1.78** 1.73** 1.91** 1.93**
Blacks 0.95* 0.97 0.95* 0.86*
Hispanics 0.69** 0.72** 0.65** 0.56**
CD Count 0-5 1.36** 1.38** 1.41** 1.11**
Unhealthy 1.03* 1.00 1.08** 0.92
PCP Supply 0.81** 0.87** 0.86** 0.91
Post-ACA 0.87** 0.87** 0.99
EXP - 1.14** 1.12** 1.06
ACA*EXP - 1.03 1.06 1.11
Notes:
1. Data source from PCP stepwise regressions, full model Table AG-1
2. Data source from full model stratified by race, see Table AG-3
3. P value <0.001 (**), P value <0.05 (*)
TABLE AG-3 ODDS RATIOS BY 
DIABETES RISK
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• ACA*Diabetes= 1.11 
• ACA*INS*High-risk= 1.10 (uninsured); 1.11 (insured) 
• ACA*INS*Diabetes= 1.29 (uninsured); 1.33 (insured) 
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Table AG-6.  
Complex Logistic Regression Models for the Likelihood of having a PCP by INS, Diabetes Risk, 
and Pre/post-ACA; 47-state sample.  
 
Probability of Having a 
PCP (n=1,283,537) 
Model 1                      
Odds Ratio
Model 2                      
Odds Ratio
Model 3                      
Odds Ratio
Model 4                      
Odds Ratio
Model 5                      
Odds Ratio
95% CI
Model 6                      
Odds Ratio
95% CI
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref
Post-ACA 1.03** 0.90** 0.90** 0.88** 0.99 p=0.807 (0.95, 1.04) 1.01 p=0.840 (0.95, 1.06)
Insurance
Uninsured Ref Ref Ref
Insured 5.33** 5.86** (5.65, 6.07) 5.59** (5.33, 5.86)
Diabetes Status
No/Low Risk Ref Ref Ref Ref
High Risk 1.18* 1.16** 1.17** (1.13, 1.21) 1.10* (1.03, 1.17)
Diabetes 2.88** 2.56** 2.59** (2.40, 2.80) 2.24** (1.97, 2.53)
ACA*Risk
ACA*no/low risk Ref Ref Ref
ACA*highrisk 1.02 1.01 p=0.553 (0.97, 1.05) 0.99 p=0.89 (0.91, 1.08)
ACA*diabetes 1.20** 1.17* (1.07, 1.29) 1.11 p=0.205 (0.94, 1.32)
ACA*INS
ACA*INS 0.85** (0.82, 0.89) 0.85** (0.80, 0.90)
ACA*INS*Risk
ACA*no/low risk Ref
ACA*highrisk (uninsured) 1.10* (1.02, 1.18)
ACA*highrisk (insured) 1.11* (1.04, 1.18)
ACA*diabetes (uninsured) 1.29* (1.10, 1.51)
ACA*diabetes (insured) 1.33** (1.16, 1.52)
Other Variables
Race
Whites Ref Ref Ref Ref Ref
Blacks 0.99 0.99 0.95* 0.95* (0.92, 0.98) 0.95* (0.93, 0.98)
Hispanics 0.71** 0.71** 0.69** 0.69** (0.67, 0.71) 0.69** (0.67, 0.71)
Education
Less than HS Ref Ref Ref Ref Ref
HS Grad 1.29** 1.29** 1.31** 1.31** (1.27, 1.36) 1.31** (1.26, 1.36)
Some College 1.47** 1.47** 1.49** 1.49** (1.44, 1.54) 1.49** (1.43, 1.54)
College Grad 1.71** 1.71** 1.78** 1.79** (1.73, 1.85) 1.79** (1.73, 1.85)
Age
18 to 44 Ref Ref Ref Ref Ref
45 to 64 2.58** 2.58** 2.39** 2.39** (2.34, 2.43) 2.39** (2.34, 2.43)
Sex
Male Ref Ref Ref Ref Ref
Female 1.94** 1.94** 1.96** 1.96** (1.92, 1.99) 1.96** (1.92, 1.99)
Chronic Disease
Count 0-5 1.41** 1.41** 1.36** 1.36** (1.33, 1.39) 1.36** (1.33, 1.39)
Self Reported Health
Healthy Ref Ref Ref Ref Ref
Unhealthy 1.17** 1.17** 1.03* 1.03* (1.00, 1.06) 1.03* (1.00, 1.06)
PCP Supply
Adequate Supply Ref Ref Ref Ref Ref
Low Supply 0.82** 0.82** 0.81** 0.81** (0.80, 0.83) 0.81** (0.80, 0.83)
Constant 2.79** 0.32** 0.32** 0.30** 0.29** (0.27, 0.30) 0.30** (0.28, 0.31)
F Statistic 16** 3559** 3559** 3070** 2540** 2061**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Individuals at high-risk and with diabetes have different ACA effects on PCP than the no/low 
risk group. The ACA effects are: 
Table AG-7.  
ACA Effects by Diabetes Risk for the Odds of having a PCP using Complex Logistic Regression 
Analysis; 47-state sample.  
 
These ACA effects are holding many influential demographic and health variables constant, 
including the baseline effect (5.41) of insurance. Interesting to note, if a no/low risk or high-risk 
person has insurance- their odds of having a PCP is much lower than their peers with insurance. 
The opposite is true for individuals with diabetes, as the insured had a 3-percentage point higher 
likelihood of having a PCP than their uninsured peer.   
    
 
 
 
No/Low High Diabetes
Insured 0.86 0.94 1.27
Uninsured 1.01 1.07 1.23
Notes 
1. Insured no/low: exp{ln1.01 + ln0.85} = 0.84
2. Uninsured no/low: 1.01
3. Insured high-risk: exp{ln1.01 + ln0.85 + ln0.99 + ln1.11}= 0.94
4. Uninsured high-risk: exp{ln1.01 + ln0.85 + ln0.99 + ln1.26}= 1.07
5. Insured Diabetes: exp{ln1.01 + ln0.85 + ln1.11 + ln1.33}= 1.27
6. Uninsured Hispanics: exp{ln1.01 + ln0.85 + ln1.11 + ln1.29} =0.975
Post ACA
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APPENDIX AH  
LOGISTIC REGERSSIONS FOR ODDS OF CHECKUP IN THE PAST YEAR BY 
DIABETES RISK STATUS  
 Specific Aim 2a. Pre/Post-ACA Odds Ratios of Checkup with ACA-Risk 
Interactions. Refer to Chapter 4, page 216 for in-text discussion. Full regression models 
available in Table AH-1. 
 Specific Aim 2a. Annual ACA Odds Ratios of Checkup with ACA-Risk Interactions. 
Refer to Chapter 4, page 223 for in-text discussion. Full regression models in Table AH-2.  
Specific Aim 2b. Pre/Post-ACA Odds Ratios for Checkup Controlling for Expansion 
Status by Risk Group. Refer to Chapter 4, page 229 for in-text discussion. Full regression 
models in Table AH-3. 
Specific Aim 2b. Annual ACA Odds Ratios of Checkup Controlling for Expansion 
Status by Risk Group. Full regression models using time variables are available in Table AH-
4. Overall time tends individuals living within expansion or non-expansion states were not 
statistically significant; however, the no/low risk group living in expansion states experienced a 
10% increased likelihood of having a checkup in 2017 when compared to the no/low risk group 
in non-expansion states. The high-risk group in expansion states also saw a 11% increased 
likelihood of having a checkup over their peers in non-expansion states but declined by 2017.    
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Table AH-1.  
Logistic Regression Models for the likelihood of having a Checkup by Diabetes Risk, using 
pre/post ACA indicator; 47-state analytic sample.  
 
 
Probability of Checkup 
(n=1,283,537) 
Model 1   
Odds Ratio
95% CI
Model 2   
Odds Ratio
95% CI
Model 3   
Odds Ratio
95% CI
Model 4   
Odds Ratio
95% CI
ACA
Pre-ACA Ref Ref Ref Ref
Post-ACA 1.10** (1.08, 1.12) 1.01 (0.99, 1.03) 1.01 (0.99, 1.03) 1.01 (0.99, 1.03)
Diabetes Status
No/Low Risk Ref Ref
High Risk 1.08** (1.06, 1.09) 1.08** (1.05, 1.11)
Diabetes 2.43** (2.34, 2.51) 2.28** (2.15, 2.42)
ACA*Diabetes Risk
ACA*no/low risk Ref
ACA*high risk 1.00 (0.96, 1.03)
ACA*diabetes 1.10* (1.02, 1.18)
Other Variables
Insurance
Uninsured Ref Ref Ref
Insured 3.52** (3.44, 3.60) 3.49** (3.41, 3.57) 3.49** (3.41, 3.57)
Race
Whites Ref Ref Ref
Blacks 2.07** (2.02, 2.13) 2.02** (1.97, 2.07) 2.02** (1.97, 2.07)
Hispanics 1.24** (1.21, 1.27) 1.21** (1.18, 1.24) 1.21** (1.18, 1.24)
Education
Less than HS Ref Ref Ref
HS Grad 1.12** (1.09, 1.16) 1.13** (1.10, 1.17) 1.13** (1.10, 1.17)
Some College 1.15** (1.12, 1.19) 1.10** (1.07, 1.14) 1.10** (1.07, 1.14)
College Grad 1.15** (1.12, 1.19) 1.19** (1.15, 1.22) 1.19** (1.15, 1.22)
Age
18 to 44 Ref Ref Ref
45 to 64 1.68** (1.65, 1.70) 1.57** (1.55, 1.60) 1.57** (1.55, 1.60)
Sex
Male Ref Ref Ref
Female 1.47** (1.45, 1.50) 1.49** (1.47, 1.51) 1.49** (1.47, 1.51)
Chronic Disease
Count 0-5 1.25** (1.23, 1.27) 1.20** (1.18, 1.22) 1.20** (1.18, 1.22)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 1.09** (1.07, 1.12) 0.98 (0.96, 1.00) 0.98 (0.96, 1.00)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.98 (0.97, 1.00) 0.98** (0.96, 0.99) 0.98* (0.96, 0.99)
Constant 1.70** (1.68, 1.72) 0.33** (0.31, 0.34) 0.32** (0.30, 0.33) 0.32** (0.30, 0.33)
F Statistic 158** 2050** 1827** 1598**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AH-2.  
Logistic Regression Models for the likelihood of having a Checkup in the past year by Diabetes 
Risk, using Time Dummies (2014-2017); 47-state analytic sample. 
 
Probability of Checkup 
(n=1,283,537) 
Model 1                      
Odds Ratio
95% CI
Model 2                      
Odds Ratio
95% CI
Model 3                      
Odds Ratio
95% CI
Model 4                      
Odds Ratio
95% CI
Year
2012 Ref Ref Ref Ref
2013 Ref Ref Ref Ref
2014 1.09** (1.07, 1.12) 1.03* (1.01, 1.06) 1.03* (1.01, 1.06) 1.03* (1.00, 1.06)
2015 1.09** (1.06, 1.11) 1.00 (0.97, 1.02) 0.99 (0.97, 1.02) 1.00 (0.97, 1.03)
2016 1.13** (1.11, 1.16) 1.03* (1.01, 1.05) 1.03* (1.01, 1.05) 1.02 (0.99, 1.05)
2017 1.08** (1.06, 1.11) 0.98 (0.96, 1.00) 0.98 (0.96, 1.00) 0.97* (0.94, 0.99)
Diabetes Status
No/Low Risk Ref Ref
High Risk 1.08** (1.06, 1.09) 1.08** (1.05, 1.11)
Diabetes 2.43** (2.34, 2.52) 2.28** (2.15, 2.42)
Year*Diabetes Status 
2014*no/low risk Ref
2014*high risk 0.99 (0.95, 1.04)
2014*diabetes 1.06 (0.97, 1.18)
2015*no/low risk Ref
2015*high risk 0.98 (0.93, 1.02)
2015*diabetes 1.11* (1.01, 1.24)
2016*no/low risk Ref
2016*high risk 1.01 (0.96, 1.06)
2016*diabetes 1.12* (1.00, 1.25)
2017*no/low risk Ref
2017*high risk 1.02 (0.97, 1.07)
2017*diabetes 1.1 (0.98, 1.23)
Other Variables
Insurance
Uninsured Ref Ref Ref
Insured 3.52** (3.44, 3.60) 3.49** (3.41, 3.57) 3.49** (3.41, 3.57)
Race
Whites Ref Ref Ref
Blacks 2.07** (2.02, 2.13) 2.02** (1.97, 2.07) 2.02** (1.97, 2.07)
Hispanics 1.24** (1.21, 1.27) 1.21** (1.18, 1.24) 1.21** (1.18, 1.24)
Education
Less than HS Ref Ref Ref
HS Grad 1.12** (1.09, 1.16) 1.13** (1.10, 1.17) 1.13** (1.10, 1.17)
Some College 1.09** (1.06, 1.13) 1.10** (1.07, 1.14) 1.10** (1.07, 1.14)
College Grad 1.15** (1.12, 1.19) 1.19** (1.15, 1.22) 1.19** (1.15, 1.22)
Age
18 to 44 Ref Ref Ref
45 to 64 1.68** (1.65, 1.70) 1.57** (1.55, 1.60) 1.57** (1.55, 1.60)
Sex
Male Ref Ref Ref
Female 1.47** (1.45, 1.50) 1.49** (1.47, 1.51) 1.49** (1.47, 1.51)
Chronic Disease
Count 0-5 1.25** (1.23, 1.27) 1.20** (1.18, 1.22) 1.20** (1.18, 1.22)
Self Reported Health
Healthy Ref Ref Ref
Unhealthy 1.09** (1.07, 1.12) 0.98 (0.96, 1.00) 0.98 (0.96, 1.00)
PCP Supply
Adequate Supply Ref Ref Ref
Low Supply 0.99* (0.97, 1.00) 0.98* (0.96, 0.99) 0.98* (0.96, 0.99)
Constant 1.70** (1.68, 1.72) 0.32** (0.31, 0.34) 0.32** (0.30, 0.33) 0.32** (0.30, 0.33)
F Statistic 44** 1642** 1507** 1027**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AH-3.  
Logistic Regression Models for the Odds of having a Checkup by Diabetes Risk and Expansion 
Status, using Pre/post-ACA Indicator; 47-state analytic sample. 
 
 
 
 
 
 
 
Probability of 
Checkup (Logistic)
Low Risk                         
(no interacton 
term)
95% CI
Low Risk  
(n=721,552)
95% CI
High Risk                      
(no interaction 
term)
95% CI
High Risk  
(n=445,547)
95% CI
Diabetes                          
(no interaction 
term)
95% CI
Diabetes  
(n=116,438)
95% CI
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref
Expansion  0.90** (0.88, 0.92) 0.89** (0.86, 0.92) 0.92** (0.90, 0.95) 0.91** (0.87, 0.95) 0.92* (0.86, 0.98) 0.89 (0.80, 1.00)
ACA
Pre ACA Ref Ref Ref Ref Ref Ref
Post ACA 1.00 (0.98, 1.03) 0.99 (0.96, 1.02) 1.00 (0.97, 1.03) 0.99 (0.95, 1.03) 1.10* (1.02, 1.18) 1.07 (0.96, 1.20)
Interaction Term
ACA*EXP 1.02 (0.98, 1.07) 1.02 (0.97, 1.08) 1.04 (0.90, 1.20)
Insurance
Uninsured Ref Ref Ref Ref Ref Ref
Insured 3.46** (3.36, 3.57) 3.46** (3.36, 3.57) 3.57** (3.44, 3.70) 3.56** (3.44, 3.70) 3.63** (3.32, 3.96) 3.62** (3.32, 3.95)
PCP Supply
Adequate Ref Ref Ref Ref Ref Ref
Low Supply 0.94** (0.92, 0.96) 0.94** (0.92, 0.96) 0.93** (0.91, 0.96) 0.93** (0.91, 0.96) 0.92* (0.86, 0.96) 0.92* (0.86, 0.99)
Race
Whites Ref Ref Ref Ref Ref Ref
Blacks 2.04** (1.96, 2.11) 2.04** (1.96, 2.11) 2.01** (1.93, 2.09) 2.01** (1.93, 2.09) 1.77** (1.61, 1.95) 1.77** (1.61, 1.95)
Hispanics 1.29** (1.25, 1.34) 1.15** (1.11, 1.20) 1.15** (1.11, 1.20) 0.97 (0.88, 1.07) 0.97 (0.88, 1.07)
Sex
Male Ref Ref Ref Ref Ref Ref
Female 1.56** (1.53, 1.59) 1.56** (1.53, 1.59) 1.46** (1.43, 1.50) 1.46** (1.43, 1.50) 1.07 (1.00, 1.14) 1.07 (1.00, 1.14)
Age
18 to 44 Ref Ref Ref Ref Ref Ref
45 to 64 1.51** (1.48, 1.53) 1.51** (1.48, 1.53) 1.67** (1.63, 1.71) 1.67** (1.63, 1.71) 1.56** (1.44, 1.70) 1.56** (1.44, 1.70)
Education
Less than HS Ref Ref Ref Ref Ref Ref
HS Grad 1.17** (1.11, 1.22) 1.16** (1.11, 1.22) 1.09** (1.04, 1.14) 1.09** (1.04, 1.14) 1.04 (0.94, 1.16) 1.04 (0.94, 1.16)
Some College 1.13** (1.08, 1.18) 1.13** (1.08, 1.18) 1.07* (1.02, 1.12) 1.07* (1.02, 1.12) 0.98 (0.88, 1.09) 0.98 (0.88, 1.09)
College Grad 1.20** (1.15, 1.25) 1.20** (1.15, 1.25) 1.19** (1.14, 1.25) 1.19** (1.14, 1.25) 1.06 (0.95, 1.18) 1.06 (0.95, 1.18)
Chronic Disease
Count 0-5 1.22** (1.20, 1.25) 1.22** (1.19, 1.25) 1.24** (1.21, 1.27) 1.24** (1.21, 1.27) 1.05* (1.00, 1.09) 1.04* (1.00, 1.09)
Self Reported Health
Healthy Ref Ref Ref Ref Ref Ref
Unhealthy 1.00 (0.96, 1.03) 1.00 (0.96, 1.03) 1.02 (0.98, 1.06) 1.02 (0.98, 1.06) 0.78** (0.73, 0.84) 0.78** (0.73, 0.84)
Constant 0.33** (0.31, 0.35) 0.33** (0.32, 0.35) 0.36** (0.34, 0.38) 0.36** (0.34, 0.38) 1.23* (1.06, 1.44) 1.25* (1.07, 1.47)
F Statistic 968** 899** 713** 662** 109** 101**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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Table AH-4.  
Logistic Regression Models for the Odds of having a Checkup by Diabetes Risk and Expansion 
Status, using (2014-2017) Time Dummy Variables; 47-state analytic sample. 
 
 
Probability of Checkup 
(Logistic)
Low Risk                         
(no 
interacton 
term)
95% CI
Low Risk  
(n=721,552)
95% CI
High Risk                      
(no 
interaction 
term)
95% CI
High Risk  
(n=445,547)
95% CI
Diabetes                          
(no interaction 
term)
95% CI
Diabetes  
(n=116,438)
95% CI
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref
Expansion  1.16** (1.14, 1.19) 1.14** (1.09, 1.19) 1.17** (1.13, 1.21) 1.12** (1.07, 1.18) 1.13* (1.02, 1.24) 1.06 (0.91, 1.23)
Years
2012 Ref Ref Ref Ref Ref Ref
2013 Ref Ref Ref Ref Ref Ref
2014 0.90** (0.87, 0.93) 0.91** (0.86, 0.96) 0.92** (0.88, 0.96) 0.91* (0.85, 0.98) 0.98 (0.86, 1.11) 0.92 (0.77, 1.11)
2015 0.93** (0.90, 0.96) 0.91* (0.86, 0.96) 0.93* (0.89, 0.97) 0.88* (0.82, 0.95) 1.10 (0.95, 1.28) 1.00 (0.80, 1.25)
2016 0.87** (0.85, 0.91) 0.87** (0.83, 0.92) 0.91** (0.87, 0.96) 0.86** (0.80, 0.93) 1.04 (0.90, 1.21) 1.07 (0.85, 1.35)
2017 0.84** (0.81, 0.87) 0.80** (0.75, 0.84) 0.85** (0.81, 0.89) 0.83** (0.77, 0.90) 1.06 (0.92, 1.22) 0.97 (0.78, 1.20)
Interaction Terms
2012*EXP Ref Ref Ref
2013*EXP Ref Ref Ref
2014*EXP 0.99 (0.93, 1.06) 1.01 (0.93, 1.11) 1.11 (0.86, 1.44)
2015*EXP 1.04 (0.97, 1.12) 1.10 (1.00, 1.21) 1.21 (0.90, 1.62)
2016*EXP 1.01 (0.94, 1.08) 1.11* (1.01, 1.21) 0.95 (0.71, 1.27)
2017*EXP 1.10* (1.02, 1.18) 1.04 (0.94, 1.14) 1.19 (0.90, 1.58)
Other Variables
Insurance
Uninsured Ref Ref Ref Ref Ref Ref
Insured 5.12** (4.96, 5.28) 5.11** (4.96, 5.28) 5.45** (5.25, 5.67) 5.45** (5.25, 5.66) 6.18** (5.59, 6.85) 6.18** (5.59, 6.84)
PCP Supply
Adequate Ref Ref Ref Ref Ref Ref
Low Supply 0.87** (0.85, 0.89) 0.87** (0.85, 0.89) 0.86** (0.83, 0.89) 0.87** (0.83, 0.89) 0.91 (0.82, 1.01) 0.91 (0.82, 1.01)
Race
Whites Ref Ref Ref Ref Ref Ref
Blacks 0.97 (0.93, 1.01) 0.97 (0.93, 1.01) 0.95* (0.91, 0.995) 0.95* (0.92, 0.99) 0.86* (0.77, 0.98) 0.86* (0.77, 0.98)
Hispanics 0.72** (0.70, 0.75) 0.72** (0.70, 0.75) 0.65** (0.62, 0.68) 0.65** (0.62, 0.68) 0.56** (0.50, 0.62) 0.56** (0.50, 0.62)
Sex
Male Ref Ref Ref Ref Ref Ref
Female 1.98** (1.94, 2.03) 1.98** (1.94, 2.03) 1.97** (1.91, 2.04) 1.97** (1.91, 2.04) 1.52** (1.38, 1.67) 1.52** (1.38, 1.67)
Age
18 to 44 Ref Ref Ref Ref Ref Ref
45 to 64 2.43** (2.38, 2.49) 2.43** (2.38, 2.49) 2.36** (2.29, 2.43) 2.36** (2.29, 2.43) 2.04** (1.84, 2.26) 2.04** (1.84, 2.26)
Education
Less than HS Ref Ref Ref Ref Ref Ref
HS Grad 1.29** (1.23, 1.36) 1.29** (1.23, 1.36) 1.32** (1.26, 1.40) 1.32** (1.26, 1.40) 1.24* (1.10, 1.41) 1.24* (1.10, 1.41)
Some College 1.45** (1.38, 1.52) 1.45** (1.38, 1.52) 1.53** (1.45, 1.62) 1.53** (1.45, 1.62) 1.47** (1.29, 1.68) 1.47** (1.29, 1.69)
College Grad 1.73** (1.64, 1.81) 1.73** (1.65, 1.82) 1.91** (1.81, 2.02) 1.91** (1.81, 2.02) 1.93** (1.66, 2.24) 1.93** (1.66, 2.24)
Chronic Disease
Count 0-5 1.38** (1.34, 1.42) 1.38** (1.34, 1.42) 1.41** (1.36, 1.46) 1.41** (1.36, 1.46) 1.11** (1.05, 1.18) 1.11** (1.05, 1.18)
Self Reported Health
Healthy Ref Ref Ref Ref Ref Ref
Unhealthy 1.00 (0.96, 1.05) 1 (0.96, 1.05) 1.08** (1.04, 1.13) 1.08** (1.04, 1.13) 0.92 (0.83, 1.01) 0.92 (0.84, 1.02)
Constant 0.28** (0.27, 0.30) 0.29** (0.27, 0.30) 0.31** (0.29, 0.33) 0.31** (0.29, 0.34) 1.02 (0.84, 1.23) 1.05 (0.86, 1.29)
F Statistic 1497** 1199** 987** 792** 143** 115**
Notes:
1. Contains odds ratios for 47-state analytic sample
2. P values: p<0.001 (**); p<0.05(*)
3. Svy weighted logistic regression models, values indicate odds ratios
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 Since baseline pre-ACA Checkup rates are known from Part II, Tables 39 and 40, they 
can be used to calculate average odds ratios for persons living in expansion and non-expansion 
states by diabetes risk group (Table AI-5).  
Pre-ACA. First, the pre-ACA percentages for Checkup by diabetes risk and expansion 
status were converted to odds ratios using the following formula and rates from Tables 39 and 
40:17 
(10) OR-pre= Percent insured/(1-percent insured) 
• Example: OR [Non-expansion, no/low risk, pre-ACA] = 0.6142/(1-0.6142)= 
1.592.  
The OR’s in Rows 1 and 2 in Table AI-5 become the base upon which logistic marginal ACA 
effects are constructed. Rows 1 and 2 are reproduced in Rows 3 and 6 for comparison purposes 
in non-expansion and expansion states separately. 
Post-ACA. Post-ACA Ors, or ACA effects, by expansion status (Rows 4 and 7) were 
calculated using the following formulas:  
(11) OR[NEXP]-post= exp{(ln(ACA OR) + ln(NEXP-pre)} 
• Example OR [Non-expansion, no/low risk, post-ACA] = exp{ln(1.592) + 
ln(0.99)}= 1.576 
(12) OR[EXP]-post = exp((ln(ACA OR) + ln(ACA*EXP OR) + ln(EXP-pre)) 
• Example OR [Expansion, whites, post-ACA] =exp{ln(1.514) + ln(0.99) + 
ln(0.89)=1.334. 
 
17 An alternative is to multiply mean values for each variable by race, times its corresponding logit coefficient, add 
the logit constant term, and exponentiate the sum.   
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The EXP coefficient is not included in calculating the post-ACA odds ratio, e.g, OR[EXP], 
because its effect is already included in the pre-ACA baseline insurance rate, EXP-pre. Then, 
Rows 5 and 8 show the post-ACA PCP gains over the pre-ACA period.   
Table AH-5.  
Conversion of Marginal Odds Ratios for Checkup to Average Odds Ratios for Checkup in Non-
expansion and Expansion States by Diabetes Risk.  
 
 In the pre-ACA period, individuals with reported diabetes had greater odds of having a 
checkup in the past year, when compared to those at no/low risk or high-risk. For the analysis 
differentiating between expansion status, the ACA was not a factor in changing the likelihood of 
having a checkup in the past year for any diabetes risk group. Referring to the odds ratios in 
Table AH-5, individuals with reported diabetes were more likely than those at low or high-risk 
to have a checkup in the past year in both expansion and non-expansion states. The regression 
adjusted decrease in the likelihood of having a checkup in the past year was 10 % (0.90/0.99, 
Table AH-5) less for the high-risk in expansion states, compared to those in non-expansion 
states. The decrease in the report of checkups is due to the declining checkup/INS ratio.  
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To gain a better understanding of each diabetes risk group, Table AH-6 provides a 
summary of all variables included in the models for determining the likelihood of having a 
checkup by diabetes risk and expansion status.    
Table AH-6.  
Summary Table Comparing Overall Logistic Odds Ratios for Demographic, Health Status and 
State-Level Variables for Checkup to Odds Ratios by Diabetes Risk Status.  
 
Insurance status is again, the most important variable determining the likelihood of having a 
Checkup in the past year as the regression coefficient is the largest in all diabetes risk groups. 
The next variable that is important is minority status, with blacks who are at low and high risk, 
having greatest odds of having a PCP, over whites. Also, college education increased the 
TABLE AH-
1 ODDS 
RATIOS
COVARIATE OVERALL NO/LOW HIGH DIABETES
Insured 3.49** 3.46** 3.56** 3.62**
Female 1.49** 1.56** 1.46** 1.07
45-64 1.57** 1.51** 1.67** 1.56**
HS Grad 1.13** 1.16** 1.08** 1.04
Some College 1.10** 1.13** 1.07* 0.98
College Grad 1.19** 1.20** 1.19** 1.06
Blacks 2.02** 2.04* 2.01** 1.77**
Hispanics 1.21** 1.29** 1.15** 0.97
CD Count 0-5 1.20* 1.22** 1.24** 1.04*
Unhealthy 0.98 1.00 1.02 0.78**
PCP Supply 0.98* 0.94** 0.93** 0.92*
Post-ACA 0.99 0.99 1.07
EXP - 0.89** 0.91** 0.89
ACA*EXP - 1.02 1.02 1.04
Notes:
1. Data source from Checkup stepwise regressions, full model Table AG-1
2. Data source from full model stratified by race, see Table AH-3
3. P value <0.001 (**), P value <0.05 (*)
TABLE AH-3 ODDS RATIOS BY 
DIABETES RISK GROUP
441 
 
likelihood of having a PCP for the no/low and high-risk individuals, but was found to be 
statistically insignificant for individuals who reported having diabetes.   
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APPENDIX AI 
NAMCS DESCRIPTIVES STATISTICS  
Table AI-1.  
Descriptive Statistics by Diabetes Risk for Full Sample.  
 
 
 
 
 
 
 
Pre-ACA Post-ACA p Pre-ACA Post-ACA p Pre-ACA Post-ACA p Pre-ACA Post-ACA p
n=875 n=614 n=1,738 n=1,408 n=335 n=272 n=2,101 n=1,631
Race/Ethnicity 0.2266 0.7843 0.4341 0.5961
Whites 79.16 71.96 -9.10% 69.79 66.54 -4.66% 71.49 61.29 -14.27% 63.27 58.58 -7.41%
Blacks 7.27 6.97 -4.13% 15.00 17.08 13.87% 13.71 17.59 28.30% 11.67 11.14 -4.54%
Hispanics 13.58 21.08 55.23% 15.21 16.38 7.69% 14.80 21.11 42.64% 25.06 30.28 20.83%
Age 0.5824 0.1115 0.9886 0.8471
18 to 34 36.29 39.07 7.66% 24.22 21.61 -10.78% 13.49 12.70 -5.86% 59.66 60.10 0.74%
35 to 44 17.98 18.57 3.28% 20.41 22.24 8.97% 16.36 15.24 -6.85% 15.17 15.64 3.10%
45 to 54 23.87 25.44 6.58% 29.48 24.21 -17.88% 27.49 28.27 2.84% 12.28 12.99 5.78%
55 to 64 21.86 16.92 -22.60% 25.88 31.95 23.45% 42.66 43.79 2.65% 12.89 11.26 -12.65%
Gender 0.6497 0.4688 0.1098 0.6763
Male 24.96 26.92 7.85% 38.89 36.18 -6.97% 48.50 38.54 -20.54% 15.91 17.43 9.55%
Female 75.04 73.08 -2.61% 61.11 63.82 4.43% 51.50 61.46 19.34% 84.09 82.57 -1.81%
Chronic Disease 0.0922 0.1988 0.1783 0.5177
No chronic disease 83.68 89.35 6.78% 82.73 78.31 -5.34% 78.77 68.57 -12.95% 91.41 90.37 -1.14%
At least 1 chronic disease 16.32 10.65 -34.74% 17.27 21.69 25.60% 21.23 31.43 48.05% 8.59 9.63 12.11%
Expansion Status 0.9384 0.8661 0.1890 0.9804
Non-expansion 34.48 34.97 1.42% 37.99 37.07 -2.42% 48.96 39.74 -18.83% 39.82 40.00 0.45%
Expansion 65.52 65.03 -0.75% 62.01 62.93 1.48% 51.04 60.26 18.06% 60.18 60.00 -0.30%
Insurance Status 0.5048 0.7274 0.2626 0.4209
Private 77.68 76.52 -1.49% 71.84 70.12 -2.39% 71.20 54.35 -23.67% 63.65 53.92 -15.29%
Medicaid  6.97 9.48 36.01% 7.27 10.62 46.08% 10.68 16.92 58.43% 22.22 26.75 20.39%
Medicare 3.71 1.34 -63.88% 5.00 5.23 4.60% 9.79 13.23 35.14% 2.10 2.92 39.05%
Self Pay 3.72 2.48 -33.33% 4.56 2.99 -34.43% 3.57 5.12 43.12% 4.41 6.94 57.37%
Other 7.93 10.18 28.37% 11.33 11.05 -2.47% 4.77 10.38 117.61% 7.62 9.47 24.28%
No/Low Risk High-Risk Diabetes Unknown
Change  
(%)
Change  
(%)
Change  
(%)
Change  
(%)
Note. Chi square calculated for pre-(2012-2013) vs. post-ACA (2014-2015) differences in outcomes by diabetes risk. 15-state group sample, survey weighted.
*p<0.05. **p<0.01. ***p<0.001
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Table AI-2.  
Descriptive Statistics by Diabetes Status for Non-expansion States.  
 
 
 
 
 
 
 
 
 
Pre-ACA Post-ACA p Pre-ACA Post-ACA p Pre-ACA Post-ACA p Pre-ACA Post-ACA p
n=276 n=195 n=630 n=460 n=150 n=102 n=732 n=544
Race/Ethnicity 0.8106 0.3754 0.6307 0.5404
Whites 71.71 66.89 -6.72% 61.14 55.27 -9.60% 65.81 55.55 -15.59% 52.93 44.26 -16.38%
Blacks 10.15 9.90 -2.46% 16.97 26.42 55.69% 14.31 21.46 49.97% 18.13 15.81 -12.80%
Hispanics 18.14 23.21 27.95% 21.89 18.32 -16.31% 19.88 22.99 15.64% 28.95 39.92 37.89%
Age 0.1910 0.3719 0.6023 0.8305
18 to 34 34.02 32.62 4.12% 20.80 23.42 12.60% 9.26 15.92 71.92% 63.31 66.43 4.93%
35 to 44 15.92 23.68 48.74% 22.49 23.74 5.56% 17.83 24.88 39.54% 12.55 13.00 3.59%
45 to 54 23.60 27.90 18.22% 29.31 22.16 -24.40% 29.29 28.67 -2.12% 12.37 11.41 -7.76%
55 to 64 26.46 15.79 -40.33% 27.40 30.68 11.97% 43.61 30.53 -29.99% 11.77 9.17 -22.09%
Gender 0.7015 0.2129 0.3867 0.9287
Male 22.97 20.61 -10.27% 38.58 31.70 -17.83% 48.92 39.93 -18.38% 14.83 15.41 3.91%
Female 77.03 79.39 3.06% 61.42 68.30 11.20% 51.08 60.07 17.60% 85.17 84.59 -0.68%
Chronic Disease 0.0636 0.1993 0.2264 0.9023
No chronic disease 82.20 91.87 11.76% 83.48 76.06 -8.89% 77.97 60.95 -21.83% 91.23 90.88 -0.38%
At least 1 chronic disease 17.80 8.13 -54.33% 16.52 23.94 44.92% 22.03 39.05 77.26% 8.77 9.12 3.99%
Insurance Status 0.0425 0.0464 0.3594 0.3538
Private 79.82 66.13 -17.15% 75.01 65.13 -13.17% 69.69 53.79 -22.82% 60.89 47.5 -21.99%
Medicaid  9.41 4.34 -53.88% 6.44 5.42 -15.84% 7.63 9.07 18.87% 24.11 35.26 46.25%
Medicare 3.02 2.49 -17.55% 7.46 2.96 -60.32% 15.10 13.64 -9.67% 3.20 3.14 -1.88%
Self Pay 1.93 3.81 97.41% 4.29 4.09 -4.66% 4.25 6.46 52.00% 5.64 3.51 -37.77%
Other 5.82 23.22 298.97% 6.80 22.4 229.41% 3.33 17.05 412.01% 6.15 10.61 72.52%
Note. Chi square calculated for pre-(2012-2013) vs. post-ACA (2014-2015) differences in outcomes by diabetes risk. Non-expansion group sample, survey weighted.
*p<0.05. **p<0.01. ***p<0.001
No/Low Risk High-Risk Diabetes Unknown
Change  
(%)
Change  
(%)
Change  
(%)
Change  
(%)
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Table AI-3.  
Descriptive Statistics by Diabetes Status for Medicaid Expansion States.  
Pre-ACA Post-ACA p Pre-ACA Post-ACA p Pre-ACA Post-ACA p Pre-ACA Post-ACA p
n=599 n=419 n=1,108 n=948 n=185 n=170 n=1,369 n=1,087
Race/Ethnicity 0.1510 0.5782 0.3979 0.8649
Whites 83.08 74.68 -10.11% 75.08 73.17 -2.54% 76.94 65.08 -15.41% 70.12 68.13 -2.84%
Blacks 5.75 5.39 -6.26% 13.80 11.59 -16.01% 13.13 15.04 14.55% 7.40 8.02 8.38%
Hispanics 11.17 19.93 78.42% 11.12 15.24 37.05% 9.93 19.87 100.10% 22.48 23.85 6.09%
Age 0.7831 0.1594 0.3350 0.8488
18 to 34 37.48 42.53 13.47% 26.32 20.54 -21.96% 17.54 10.58 -39.68% 57.24 55.89 -2.36%
35 to 44 19.07 15.82 -17.04% 19.14 21.36 11.60% 14.94 8.88 -40.56% 16.91 17.41 2.96%
45 to 54 24.01 24.12 0.46% 29.59 25.41 -14.13% 25.77 28.01 8.69% 12.21 14.04 14.99%
55 to 64 19.44 17.53 -9.83% 24.96 32.70 31.01% 41.75 52.53 25.82% 13.64 12.66 -7.18%
Gender 0.4626 0.9577 0.1604 0.6029
Male 26.01 30.31 16.53% 39.07 38.82 -0.64% 48.10 37.63 -21.77% 16.62 18.77 12.94%
Female 73.99 69.69 -5.81% 60.93 61.18 0.41% 51.90 62.37 20.17% 83.38 81.23 -2.58%
Chronic Disease 0.3918 0.5259 0.4420 0.4380
No chronic disease 84.47 88.00 4.18% 82.26 79.63 -3.20% 79.54 73.60 -7.47% 91.54 90.03 -1.65%
At least 1 chronic disease 15.53 12.00 -22.73% 17.74 20.37 14.83% 20.46 26.40 29.03% 8.46 9.97 17.85%
Insurance Status 0.0020 0.0071 0.2684 0.3936
Private 76.55 82.1 7.25% 69.89 73.05 4.52% 72.64 64.73 -10.89% 65.48 58.20 -11.12%
Medicaid  5.69 12.24 115.11% 7.78 13.68 75.84% 13.60 22.1 62.50% 20.97 21.07 0.48%
Medicare 4.07 0.72 -82.31% 3.50 6.56 87.43% 4.70 12.96 175.74% 1.37 2.78 102.92%
Self Pay 4.65 1.77 -61.94% 4.78 2.35 -50.86% 2.92 4.23 44.86% 3.59 9.23 157.10%
Other 9.05 3.17 -64.97% 14.10 4.36 -69.08% 6.15 5.99 -2.60% 8.59 8.71 1.40%
Note. Chi square calculated for pre-(2012-2013) vs. post-ACA (2014-2015) differences in outcomes by diabetes risk. Medicaid expansion group sample, survey weighted.
*p<0.05. **p<0.01. ***p<0.001
No/Low Risk High-Risk Diabetes Unknown
Change  
(%)
Change  
(%)
Change  
(%)
Change  
(%)
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APPENDIX AJ 
NAMCS LOGISTIC REGRESSION MODELS 
Table AJ-1.  
Multivariate Logistic Regression Models for the Pb (SCR) by Expansion Status and Race. 
 
 
Probability of being 
Screened
a
 (n=8,974)
Model 1 
(Odds 
Ratio)
95% CI
Model 2 
(Odds 
Ratio)
95% CI
Model 3 
(Odds 
Ratio)
95% CI
Model 4 
(Odds 
Ratio)
95% CI
Model 
5 (Odds 
Ratio)
95% CI
Model 6 
(Odds 
Ratio)
95% CI
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref
Post-ACA 1.02 (0.61, 1.70) 1.02 (0.60, 1.71) 0.91 (0.57, 1.46) 1.10 (0.39, 3.12) 0.83 (0.35, 1.98) 0.64 (0.30, 1.36)
Expansion Status
Non-expansion Ref Ref Ref Ref Ref
Medicaid Expansion 1.07 (0.57, 2.00) 1.13 (0.64, 1.99) 1.31 (0.87, 1.98) 1.25 (0.83, 1.89) 1.12 (0.72, 1.75)
Interaction Term
ACA*nonEXP Ref Ref Ref
ACA*EXP 0.74 (0.23, 2.36) 0.81 (0.27, 2.42) 1.17 (0.46, 2.98)
Race
Whites Ref Ref Ref Ref
Blacks 0.98 (0.69, 1.41) 1.33 (0.95, 1.87) 0.99 (0.66, 1.48) 0.64 (0.34, 1.19)
Hispanics 1.44 (0.87, 2.36) 1.44 (0.87, 2.40) 1.04 (0.74, 1.45) 0.95 (0.58, 1.56)
Interaction Term
ACA*whites Ref Ref
ACA*blacks 1.81 (0.94, 3.48) 3.15* (1.25, 7.93)
ACA*Hispanics 1.88 (0.82, 4.33) 3.29 (0.84, 12.79)
3-Way Interaction Term
b
whites*preACA*nonEXP Ref
B*Pre-ACA*EXP 2.00 (0.90, 4.42)
B*Post-ACA*EXP 0.88 (0.32, 2.43)
H*Pre-ACA*EXP 1.14 (0.58, 2.24)
H*Post-ACA*EXP 0.44 (0.11, 1.78)
Age
18 to 34 Ref Ref Ref Ref
35 to 44 0.98 (0.69, 1.41) 0.98 (0.69, 1.41) 0.98 (0.68, 1.40) 0.99 (0.71, 1.39)
45 to 54 1.15 (0.82, 1.61) 1.16 (0.83, 1.61) 1.16 (0.83, 1.62) 1.16 (0.83, 1.62)
55 to 64 1.65** (1.18, 2.32) 1.67** (1.19, 2.33) 1.68** (1.20, 2.34) 1.69** (1.21, 2.36)
Gender
Male Ref Ref Ref Ref
Female 0.85 (0.59, 1.22) 0.85 (0.59, 1.22) 0.84 (0.59, 1.21) 0.84 (0.59, 1.21)
Diabetes Risk
No/low Risk Ref Ref Ref Ref
High Risk 1.45* (1.05, 2.00) 1.45* (1.06, 2.00) 1.46* (1.06, 2.02) 1.46* (1.06, 2.01)
Diabetes 2.82*** (1.79, 4.44) 2.84** (1.81, 4.46) 2.82*** (1.79, 4.44) 2.82*** (1.77, 4.47)
Unknown 0.56* (0.34, 0.91) 0.56* (0.34, 0.91) 0.56* (0.35, 0.91) 0.56* (0.34, 0.91)
Chronic Disease
No Disease Ref Ref Ref Ref
At least 1 or more 1.17 (0.72, 1.90) 1.17 (0.73, 1.86) 1.19 (0.74, 1.91) 1.17 (0.74, 1.85)
Constant 0.13** (0.11, 0.16) 0.13** (0.08, 0.20) 0.10*** (0.06, 0.17) 0.09** (0.05,  0.15) 0.10** (0.06, 0.17) 0.11*** (0.06, 0.19)
F Statistic 0.95*** 0.94 9.71*** 8.91*** 7.82*** 6.59***
*p<0.05. **p<0.01. ***p<0.001
Note.  Logistic regressions for the Pb(SCR) by expansion status and race in 15-states (2012-2015); survey weighted data. Values indicate odds ratios . 
a
Diabetes Screening includes a glucose or HgbA1c test performed during a clinic visit using 2012-2015 data. 
b 
Three-way interaction term includes interactions between race, ACA and expansion status. Referernce group: whies living in non-expansion states, pre-ACA.  
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Table AJ-2. 
Multivariate Logistic Regression Models for the Pb(SCR) by Expansion Status and Diabetes 
Risk. 
 
 
 
Probability of being 
Screened
a
 (n=8,974)
Model 1 
(Odds 
Ratio)
95% CI
Model 
2 (Odds 
Ratio)
95% CI
Model 3 
(Odds 
Ratio)
95% CI
Model 4 
(Odds 
Ratio)
95% CI
Model 5 
(Odds 
Ratio)
95% CI
Model 6 
(Odds 
Ratio)
95% CI
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref
Post-ACA 1.02 (0.61, 1.70) 1.02 (0.60, 1.71) 0.91 (0.57, 1.46) 1.10 (0.39, 3.12) 1.15 (0.33, 3.97) 1.55 (0.54, 4.43)
Expansion Status
Non-expansion Ref Ref Ref Ref Ref
Medicaid Expansion 1.07 (0.57, 2.00) 1.13 (0.64, 1.99) 1.31 (0.87, 1.98) 1.30 (0.86, 1.96) 1.22 (0.52, 2.83)
Interaction Term
ACA*nonEXP Ref Ref Ref
ACA*EXP 0.74 (0.23, 2.36) 0.74 (0.23, 2.37) 0.44 (0.11, 1.77)
Diabetes Risk
No/low Risk Ref Ref Ref Ref
High Risk 1.45* (1.05, 2.00) 1.45* (1.06, 2.00) 1.38 (0.86, 2.23) 1.08 (0.56, 2.08)
Diabetes 2.82*** (1.79, 4.44) 2.84** (1.81, 4.46) 2.58** (1.47, 4.56) 2.14* (1.01, 4.49)
Unknown 0.56* (0.34, 0.91) 0.56* (0.34, 0.91) 0.70 (0.39, 1.24) 0.90 (0.44, 1.84)
Interaction Term
ACA*no/low risk Ref Ref
ACA*high risk 1.10 (0.59, 2.06) 1.00 (0.40, 2.53)
ACA*diabetes 1.18 (0.50, 2.80) 1.00 (0.34, 2.95)
ACA*unknown 0.55 (0.22, 1.43) 0.19* (0.04, 0.86)
3-Way Interaction Term
b
NoRisk*preACA*nonEXP Ref
HR*Pre-ACA*EXP 1.43 (0.57, 3.58)
HR*Post-ACA*EXP 1.78 (0.72, 4.38)
Dia*Pre-ACA*EXP 1.39 (0.48, 4.04)
Dia*Post-ACA*EXP 1.83 (0.50, 6.75)
UnK*Pre-ACA*EXP 0.64 (0.22, 1.84)
Unk*Post-ACA*EXP 3.65 (0.80, 16.64)
Race
Whites Ref Ref Ref Ref
Blacks 0.98 (0.69, 1.41) 1.33 (0.95, 1.87) 1.33 (0.95, 1.85) 1.32 (0.94, 1.84)
Hispanics 1.44 (0.87, 2.36) 1.44 (0.87, 2.40) 1.44 (0.87, 2.39) 1.46 (0.89, 2.41)
Age
18 to 34 Ref Ref Ref Ref
35 to 44 0.98 (0.69, 1.41) 0.98 (0.69, 1.41) 0.98 (0.68, 1.42) 0.98 (0.67, 1.43)
45 to 54 1.15 (0.82, 1.61) 1.16 (0.83, 1.61) 1.16 (0.83, 1.61) 1.15 (0.83, 1.60)
55 to 64 1.65** (1.18, 2.32) 1.67** (1.19, 2.33) 1.65** (1.19, 2.29) 1.65** (1.19, 2.29)
Gender
Male Ref Ref Ref Ref
Female 0.85 (0.59, 1.22) 0.85 (0.59, 1.22) 0.84 0.59, 1.20) 0.84 (0.59, 1.20)
Chronic Disease
No Disease Ref Ref Ref Ref
At least 1 or more 1.17 (0.72, 1.90) 1.17 (0.73, 1.86) 1.16 (0.73, 1.84) 1.16 (0.73, 1.84)
Constant 0.13** (0.11, 0.16) 0.13** (0.08, 0.20) 0.10*** (0.06, 0.17) 0.09** (0.05,  0.15) 0.09** (0.05, 0.16) 0.09*** (0.05, 0.18)
F Statistic 0.95*** 0.94 9.71*** 8.91*** 7.19*** 5.70***
*p<0.05. **p<0.01. ***p<0.001
a
Diabetes Screening: Glucose or HgbA1c test during visit (2012-2015).
b 
Three-way interaction term: Diabetes risk, ACA and expansion status. Reference group:no/low risk for diabetes individuals living in non-expansion states in the pre-
ACA period.
Note.  Logistic regressions for the Pb(SCR) by expansion status and diabetes risk in 15-states (2012-2015); survey weighted data. Values indicate odds ratios . 
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Table AJ-3. 
Multivariate Logistic Regression Models for the Pb(DPE) by Expansion Status and Race. 
 
 
 
 
 
Probability of 
Receiving Diabetes 
Prevention Education
a 
(n=8,974)
Model 1 
(Odds 
Ratio)
95% CI
Model 
2 (Odds 
Ratio)
95% CI
Model 3 
(Odds 
Ratio)
95% CI
Model 4 
(Odds 
Ratio)
95% CI
Model 5 
(Odds 
Ratio)
95% CI
Model 6 
(Odds 
Ratio)
95% CI
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref
Post-ACA 1.62* (1.05, 2.49) 1.62* (1.05, 2.50) 1.55 (0.98, 2.46) 2.54* (1.09, 5.92) 1.89 (0.95, 3.79) 1.42 (0.78, 2.59)
Expansion Status
Non-expansion Ref Ref Ref Ref Ref
Medicaid Expansion 0.83 (0.50, 1.38) 0.81 (0.48, 1.35) 1.29 (0.81, 2.08) 1.22 (0.76, 1.96) 1.19 (0.72, 1.95)
Interaction Term
ACA*nonEXP Ref Ref Ref
ACA*EXP 0.44 (0.17, 1.12) 0.49 (0.20, 1.20) 0.77 (0.37, 1.61)
Race
Whites Ref Ref Ref Ref
Blacks 0.89 (0.59, 1.35) 0.87 (0.58, 1.31) 0.54** (0.34, 0.86) 0.54 (0.28, 1.03)
Hispanics 0.93 (0.44, 1.97) 0.94 (0.45, 1.96) 0.60 (0.35, 1.04) 0.88 (0.29, 2.71)
Interaction Term
ACA*whites Ref Ref
ACA*blacks 2.20* (1.08, 4.49) 2.92* (1.09, 7.83)
ACA*Hispanics 2.05 (0.56, 7.57) 4.63 (0.71, 30.24)
3-Way Interaction Term
b
whites*preACA*nonEXP Ref
B*Pre-ACA*EXP 1.01 (0.40, 2.56)
B*Post-ACA*EXP 0.65 (0.24, 1.77)
H*Pre-ACA*EXP 1.19 (0.42, 3.37)
H*Post-ACA*EXP 0.23 (0.03, 1.53)
Age
18 to 34 Ref Ref Ref Ref
35 to 44 0.83 (0.55, 1.24) 0.83 (0.56, 1.23) 0.82 (0.56, 1.20) 0.84 (0.59, 1.18)
45 to 54 0.73 (0.50, 1.05) 0.74 (0.52, 1.05) 0.74 (0.52, 1.04) 0.73 (0.52, 1.03)
55 to 64 0.76 (0.52, 1.12) 0.78 (0.54, 1.11) 0.78 (0.55, 1.09) 0.79 (0.57, 1.09)
Gender
Male Ref Ref Ref Ref
Female 1.11 (0.87, 1.43) 1.11 (0.86, 1.42) 1.10 (0.86, 1.41) 1.10 (0.86, 1.41)
Diabetes Risk
No/low Risk Ref Ref Ref Ref
High Risk 1.44* (1.07, 1.92) 1.44* (1.07, 1.94) 1.45* (1.08, 1.94) 1.44* (1.07, 1.95)
Diabetes 1.69 (0.96, 2.97) 1.72 (0.97, 3.06) 1.70 (0.95, 3.05) 1.71 (0.95, 3.08)
Unknown 0.51* (0.27, 0.98) 0.51* (0.27, 0.96) 0.51* (0.27, 0.96) 0.50* (0.28, 0.88)
Chronic Disease
No Disease Ref Ref Ref Ref
At least 1 or more 0.89 (0.60, 1.32) 0.88 (0.58, 1.33) 0.89 (0.58, 1.36) 0.87 (0.57, 1.33)
Constant 0.16*** (0.13, 0.21) 0.18*** (0.13, 0.26) 0.22*** (0.14, 0.35) 0.16*** (0.09, 0.28) 0.19*** (0.11, 0.32) 0.20*** (0.11, 0.34)
F Statistic 4.73* 2.72 6.74*** 7.65*** 7.66*** 7.12***
*p<0.05. **p<0.01. ***p<0.001
a
Diabetes Prevention Education (DPE): at least 1 form of teaching (i.e. exercise, diet/nutrition or weight reduction) provided during visit using 2012-2015 data. 
b 
Three-way interaction term includes interactions between race, ACA and expansion. Reference: whites living in non-expansion states in the pre-ACA period.
Note.  Logistic regressions for the Pb(DPE) by expansion status and race in 15-states (2012-2015); survey weighted data. Values indicate odds ratios . 
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Table AJ-4. 
Multivariate Logistic Regression Models for the Pb(DPE) by Expansion Status and Diabetes 
Risk.  
 
 
  
Probability of 
Receiving Diabetes 
Prevention Education
a 
(n=8,974)
Model 1 
(Odds 
Ratio)
95% CI
Model 2 
(Odds 
Ratio)
95% CI
Model 3 
(Odds 
Ratio)
95% CI
Model 4 
(Odds 
Ratio)
95% CI
Model 5 
(Odds 
Ratio)
95% CI
Model 6 
(Odds 
Ratio)
95% CI
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref
Post-ACA 1.62* (1.05, 2.49) 1.62* (1.05, 2.50) 1.55 (0.98, 2.46) 2.54* (1.09, 5.92) 1.63 (0.72, 3.70) 0.61 (0.20, 1.86)
Expansion Status
Non-expansion Ref Ref Ref Ref Ref
Medicaid Expansion 0.83 (0.50, 1.38) 0.81 (0.48, 1.35) 1.29 (0.81, 2.08) 1.28 (0.79, 2.06) 0.75 (0.36, 1.52)
Interaction Term
ACA*nonEXP Ref Ref Ref
ACA*EXP 0.44 (0.17, 1.12) 0.45 (0.18, 1.11) 2.08 (0.58, 7.41)
Diabetes Risk
No/low Risk Ref Ref Ref Ref
High Risk 1.44* (1.07, 1.92) 1.44* (1.07, 1.94) 1.21 (0.88, 1.67) 0.92 (0.55, 1.55)
Diabetes 1.69 (0.96, 2.97) 1.72 (0.97, 3.06) 1.16 (0.63, 2.14) 0.67 (0.30, 1.50)
Unknown 0.51* (0.27, 0.98) 0.51* (0.27, 0.96) 0.33*** (0.18, 0.61) 0.15*** (0.07, 0.30)
Interaction Term
ACA*no/low risk Ref Ref
ACA*highrisk 1.40 (0.80, 2.46) 3.46* (1.18, 10.11)
ACA*diabetes 2.01 (0.73, 5.60) 3.14 (0.79, 12.48)
ACA*unknown 2.21 (0.62, 7.92) 14.91** (2.32, 95.60)
3-Way Interaction Term
no/low*preACA*nonEXP Ref
HR*Pre-ACA*EXP 1.51 (0.78, 2.91)
HR*Post-ACA*EXP 0.37 (0.13, 1.08)
DIA*Pre-ACA*EXP 2.45 (0.79, 7.57)
DIA*Post-ACA*EXP 1.28 (0.28, 5.82)
Unkn*Pre-ACA*EXP 3.32* (1.17, 9.40)
Unkn*Post-ACA*EXP 12.69* (0.02, 0.79)
Race
Whites Ref Ref Ref Ref
Blacks 0.89 (0.59, 1.35) 0.87 (0.58, 1.31) 0.87 (0.58, 1.31) 0.86 (0.59, 1.27)
Hispanics 0.93 (0.44, 1.97) 0.94 (0.45, 1.96) 0.93 (0.46, 1.90) 0.90 (0.47, 1.71)
Age
18 to 34 Ref Ref Ref Ref
35 to 44 0.83 (0.55, 1.24) 0.83 (0.56, 1.23) 0.83 (0.57, 1.21) 0.86 (0.61,1.22)
45 to 54 0.73 (0.50, 1.05) 0.74 (0.52, 1.05) 0.73 (0.52, 1.04) 0.74 (0.53, 1.04)
55 to 64 0.76 (0.52, 1.12) 0.78 (0.54, 1.11) 0.78 (0.55, 1.10) 0.76 (0.55, 1.07)
Gender
Male Ref Ref Ref Ref
Female 1.11 (0.87, 1.43) 1.11 (0.86, 1.42) 1.10 (0.86, 1.42) 1.11 (0.86, 1.43)
Chronic Disease
No Disease Ref Ref Ref Ref
At least 1 or more 0.89 (0.60, 1.32) 0.88 (0.58, 1.33) 0.87 (0.57, 1.32) 0.88 (0.59, 1.30)
Constant 0.16*** (0.13, 0.21) 0.18*** (0.13, 0.26) 0.22*** (0.14, 0.35) 0.16*** (0.09, 0.28) 0.21*** (0.12, 0.36) 0.29*** (0.16, 0.54)
F Statistic 4.73* 2.72 6.74*** 7.65*** 6.53*** 5.75***
*p<0.05. **p<0.01. ***p<0.001
a
Diabetes Prevention Education (DPE) includes at least 1 form of teaching (i.e. exercise, diet/nutrition or weight reduction) provided during a clinic visit in 2012-2015. 
b 
Three-way interaction term includes interactions between race, ACA and expansion status. Reference group:no/low risk for diabetes individuals living in non-expansion 
states in the pre-ACA period.
Note.  Logistic regressions for the Pb(DPE) by expansion and diabetes risk in 15-states (2012-2015); survey weighted data. Values indicate odds ratios . 
449 
 
Table AJ-5 
Logistic Regression for the Pb(SCR), Stratified by Diabetes Risk Status for Years 2012-2015. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Probability of being 
Screened
a 
Low Risk 
(n=1,489)
95% CI
Low Risk 
(n=1,489)
95% CI
Low Risk 
(n=1,489)
95% CI
High-Risk 
(n=3,146)
95% CI
High-Risk 
(n=3,146)
95% CI
High-Risk 
(n=3,146)
95% CI
Diabetes 
(n=607)
95% CI
Diabetes 
(n=607)
95% CI
Diabetes 
(n=607)
95% CI
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref Ref Ref Ref
Post-ACA 0.89 (0.43, 1.86) 1.51 (0.53, 4.35) 1.17 (0.42, 3.26) 1.03 (0.56, 1.90) 1.57 (0.42, 5.86) 0.92 (0.36, 2.38) 1.12 (0.51, 2.46) 1.33 (0.39, 4.55) 1.39 (0.33, 5.93)
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref Ref Ref. 1.59 (0.69, 3.65) Ref
Medicaid Expansion 0.78 (0.36, 1.66) 1.20 (0.48, 2.97) 1.15 (0.46, 2.83) 1.31 (0.61, 2.82) 1.86* (1.4, 3.32) 1.66 (0.95, 2.91) 1.37 (0.60, 3.11) 1.68 (0.71, 3.93)
Age
18 to 34 Ref Ref Ref Ref Ref Ref Ref Ref Ref
35 to 44 0.93 (0.33, 2.63) 0.90 (0.831, 2.59) 0.91 (0.33, 2.52) 1.01 (0.45, 2.30) 1.03 (0.46, 2.29) 0.98 (0.42, 2.25) 1.47 (0.44, 4.94) 1.48 (0.44, 5.00) 1.40 (0.40, 4.86)
45 to 54 0.74 (0.25, 2.22) 0.73 (0.23, 2.56) 0.72 (0.22, 2.33) 1.61* (1.08, 2.42) 1.64* (1.10, 2.44) 1.65* (1.11, 2.45) 1.33 (0.46, 3.86) 1.36 (0.47, 3.92) 1.33 (0.46, 3.88)
55 to 64 1.37 (0.58, 3.24) 1.4 (0.61, 3.23) 1.47 (0.67, 3.25) 2.52*** (1.59, 3.99) 2.57*** (1.62, 4.07) 2.56*** (1.61, 4.08) 0.96 (0.33, 2.76) 0.99 (0.36, 2.76) 1.00 (0.34, 2.92)
Gender
Male Ref Ref Ref Ref Ref Ref Ref Ref Ref
Female 0.63 (0.27 1.47) 0.62 (0.26, 1.46) 0.61 (0.26, 1.44) 0.77 (0.49, 1.21) 0.76 (0.48, 1.20) 0.74 (0.47, 1.17) 1.06 (0.63, 1.78) 1.07 (0.63, 1.80) 1.16 (0.68, 1.99)
Race
White Ref Ref Ref Ref Ref Ref Ref Ref Ref
Black 0.63 (0.20, 1.98) 0.63 (0.20, 2.01) 0.62 (0.18, 2.08) 1.77 (0.98, 3.18) 1.72* (1.03, 2.86) 1.15 (0.64, 2.05) 0.71 (0.19, 2.70) 0.71 (0.18, 2.73) 0.39 (0.12, 1.28)
Hispanic 1.87 (0.72, 4.87) 1.90 (0.75, 4.81) 1.10 (0.51, 2.39) 1.92 (0.80, 4.58) 1.96 (0.80, 4.80) 0.81 (0.42, 1.53) 0.65 (0.30, 1.40) 0.65 (0.30, 1.41) 1.18 (0.44, 3.20)
Chronic Disease
No Disease Ref Ref Ref Ref Ref Ref Ref Ref Ref
At least 1 or more 0.85 (0.44, 1.63) 0.87 (0.45, 1.66) 0.89 (0.46, 1.72) 1.07 (0.57, 2.02) 1.05 (0.58, 1.92) 1.08 (0.60, 1.94) 1.97 (0.93, 4.16) 1.95 (0.93, 4.10) 1.94 (0.93, 4.03)
Interaction Term
ACA*Non-expansion Ref Ref Ref Ref Ref Ref
ACA*Expansion 0.42 (0.10, 1.80) 0.44 (0.11, 1.82) 0.53 (0.12, 2.24) 0.64 (0.18, 2.28) 0.75 (0.15, 3.69) 0.72 (0.14, 3.65)
ACA*White Ref Ref Ref
ACA*Black 1.03 (0.08, 13.39) 2.17 (0.82, 5.75) 2.46 (0.30, 20.20)
ACA*Hispanic 2.56 (0.61, 10.73) 4.49* (1.12, 17.97) 0.36 (0.08, 1.67)
Constant 0.18*** (0.09, 0.38) 0.14*** (0.06, 0.35) 0.16*** (0.06, 0.38) 0.10*** (0.05, 1.17) 0.07*** (0.04, 0.14) 0.10*** (0.05, 0.18) 0.24* (0.06, 0.88) 0.21* (0.05, 0.84) 0.20* (0.05, 0.83)
F Statistic 1.68 1.67 1.67 3.89*** 3.46*** 3.57*** 0.97 0.89 1.04
*p<0.05. **p<0.01. ***p<0.001
Note.  Logistic regressions for the Pb(SCR) by expansion status and race in 15-states (2012-2015); survey weighted data. Values indicate odds ratios . 
a
Diabetes Screening: Glucose or HgbA1c test performed during a clinic visit from 2012-2015. 
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Table AJ-6.  
Logistic Regression for the Pb(DPE), Stratified by Diabetes Risk Status for Years 2012-2015.  
 
 
 
Probability of Receiving 
DPE
a 
Low Risk 
(n=1,489)
95% CI
Low Risk 
(n=1,489)
95% CI
Low Risk 
(n=1,489)
95% CI
High-Risk 
(n=3,146)
95% CI
High-Risk 
(n=3,146)
95% CI
High-Risk 
(n=3,146)
95% CI
Diabetes 
(n=607)
95% CI
Diabetes 
(n=607)
95% CI
Diabetes 
(n=607)
95% CI
ACA
Pre-ACA Ref Ref Ref Ref Ref Ref Ref Ref Ref
Post-ACA 1.00 (0.59, 1.73) 0.62 (0.20, 1.89) 0.47 (0.17, 1.34) 1.43* (1.01, 2.03) 2.11** (1.26, 3.54) 1.96* (1.11, 3.45) 2.04 (0.76, 5.53) 1.84 (0.50, 6.78) 2.05 (0.48, 8.74)
Expansion Status
Non-expansion Ref Ref Ref Ref Ref Ref Ref Ref Ref
Medicaid Expansion 1.10 (0.60, 2.02) 0.77 (0.37, 1.63) 0.73 (0.33, 1.53) 0.74 (0.52, 1.06) 1.07 (0.65, 1.75) 1.07 (0.66, 1.76) 1.90 (0.7, 5.11) 1.71 (0.56, 5.24) 1.77 (0.56, 5.59)
Age
18 to 34 Ref Ref Ref Ref Ref Ref Ref Ref Ref
35 to 44 0.70 (0.37, 1.31) 0.72 (0.38, 1.34) 0.67 (0.34, 1.29) 0.87 (0.58, 1.31) 0.89 (0.59, 1.32) 0.88 (0.60, 1.29) 0.39 (0.12, 1.26) 0.39 (0.12, 1.25) 0.38 (0.12, 1.24)
45 to 54 1.13 (0.62, 2.06) 1.15 (0.63, 2.10) 1.09 (0.63, 1.89) 0.71 (0.48, 1.05) 0.72 (0.49, 1.06) 0.73 (0.50, 1.08) 0.39 (0.15, 1.06) 0.39* (0.15, 0.99) 0.38* (0.15, 0.96)
55 to 64 1.09 (0.61, 1.92) 1.08 (0.61, 1.91) 1.07 (0.61, 1.88) 0.77 (0.50, 1.20) 0.78 (0.51, 1.21) 0.78 (0.51, 1.18) 0.43 (0.15, 1.22) 0.42 (0.16, 1.15) 0.42 (0.15, 1.16)
Gender
Male Ref Ref Ref Ref Ref Ref Ref Ref
Female 1.31 (0.70, 2.48) 1.33 (0.70, 2.52) 1.31 (0.70, 2.45) 0.90 (0.66, 1.23) 0.89 (0.65, 1.22) 0.90 (0.65, 1.23) 1.14 (0.61, 2.14) 1.14 (0.60, 2.17) 1.17 (0.62, 2.22)
Race
White Ref Ref Ref Ref Ref Ref Ref Ref Ref
Black 1.2 (0.38, 3.73) 1.19 (0.36, 3.94) 0.27* (0.08, 0.86) 0.92 (0.58, 1.46) 0.90 (0.58, 1.39) 0.55* (0.32, 0.93) 0.56 (0.21, 1.48) 0.56 (0.21, 1.47) 0.54 (0.16, 1.81)
Hispanic 0.84 (0.36, 1.94) 0.82 (0.37, 1.84) 0.78 (0.31, 1.99) 0.48* (0.27, 0.86) 0.49* (0.28, 0.88) 0.65 (0.34, 1.24) 0.83 (0.30, 2.25) 0.82 (0.30, 2.30) 1.17 (0.35, 3.84)
Chronic Disease
No Disease Ref Ref Ref Ref Ref Ref Ref Ref Ref
At least 1 or more 0.73 (0.30, 1.33) 0.71 (0.38, 1.31) 0.73 (0.39, 1.35) 0.80 (0.47, 1.36) 0.8 (0.46, 1.38) 0.79 (0.45, 1.39) 1.18 (0.55, 2.54) 1.19 (0.56, 2.55) 1.17 (0.55, 2.50)
Interaction Term
ACA*Non-expansion Ref Ref Ref Ref Ref Ref
ACA*Expansion 2.08 (0.58, 7.41) 2.34 (0.71, 7.74) 0.53 (0.26, 1.05) 0.54 (0.27, 1.09) 1.19 (0.19, 7.32) 1.13 (0.19, 6.85)
ACA*White Ref Ref Ref
ACA*Black 10.97* (1.68, 71.49) 2.17 (0.98, 4.81) 1.04 (0.18, 6.01)
ACA*Hispanic 1.13 (0.25, 5.09) 0.61 (0.21, 1.77) 0.60 (0.10, 3.68)
Constant 0.18*** (0.08, 0.39) 0.22** (0.09, 0.52) 0.25** (0.11, 0.57) 0.43** (0.27, 0.70) 0.34*** (0.21, 0.56) 0.35*** (0.22, 0.57) 0.31 (0.09, 1.09) 0.34 (0.09, 1.23) 0.31 (0.08, 1.24)
F Statistic 0.41 0.56 1.02 2.02* 2.01* 2.21** 1.03 0.94 1.05
*p<0.05. **p<0.01. ***p<0.001
a
Diabetes Prevention Education (DPE) includes at least 1 form of teaching (i.e. exercise, diet/nutrition or weight reduction) provided during a clinic visit using 2012-2015 data. 
Note.  Logistic regressions for the Pb(SCR) by expansion status and race in 15-states (2012-2015); survey weighted data. Values indicate odds ratios . 
451 
 
APPENDIX AK 
COMPARING ACTUAL ACA GAINS WITH EQUALIZING HEALTH INSURANCE 
GAINS BY INCOME  
Table AK-1.  
Comparing Actual ACA Gains with Equalizing Health Insurance Gains by Income.  
 
Table AK-2.  
Comparing Actual ACA Gains with Equalizing Health Insurance Gains by Income.  
 
 
U.S. Income Groups
>400% FPL 96,601 42.84 60,314,541 1.26 759,963 1.26 759,963 0
139-400% FPL 81,414 36.11 50,839,357 9.36 4,758,564 25.14 12,781,014 8,022,451
100-138% FPL 17,460 7.74 10,897,165 19.96 2,175,074 56.00 6,102,412 3,927,338
<100% FPL 29,996 13.30 18,725,103 23.82 4,460,319 74.36 13,923,986 9,463,667
Analytic Sub Sample
 47 States 224,441 100 140,790,245 - 12,153,921 - 33,567,376 21,413,456
Note. Calculation of remaining uninsured by income group for 47-state weighted sample.
a
Analytic Sample Total= 140,790,245 (47-state weighted analtyic sample).
b
Percent Change (INS): % change in insurance post vs. pre-ACA (Table 28).
c
Actual Change in INS: Total population* %Change INS.
d
Equalizing % Change: Percentage point change required to achieve 95.83% insured rate of the >400% FPL group.
e
Remaining Uninsured: Equalizing Actual Change- Actual Change in Insurance
Remaining 
Uninsured
e
%Change
b 
(INS)
Equalizing 
Actual Δ (INS) 
2012 
Sample (N)
%N
Total Pop
a
. 
(M)
Actual Δc 
(INS)
Equalizing 
%Change
d
U.S. Income Groups
>400% FPL 35,847 39.85% 22,340,976 1.13% 252,453
139-400% FPL 34,090 37.90% 21,247,754 8.64% 1,835,806
100-138% FPL 7,526 8.37% 4,692,446 17.62% 826,809 57.20 2,684,079 1,857,270
<100% FPL 12,486 13.88% 7,781,499 18.94% 1,473,816 48.20 3,750,683 2,276,867
Analytic Sub Sample
19 States 89,949 100% 56,062,676 - 4,388,884 - 6,434,762 2,045,878
Note. Calculation of remaining uninsured by income group for 19 non-expansion states weighted sample.
a
Analytic Sample Total= 140,790,245 (47-state weighted analtyic sample).
b
Percent Change (INS): % change in insurance post vs. pre-ACA (Table 28).
c
Actual Change in INS: Total population* %Change INS.
d
Equalizing % Change: Percentage point change required to achieve 95.83% insured rate of the >400% FPL group.
e
Remaining Uninsured: Equalizing Actual Change- Actual Change in Insurance
Equalizing 
Actual Δ (INS) 
Remaining 
Uninsured
Medicaid Not Available
2012 
Sample (N)
%N
Total Pop. 
(M)
%Change 
(INS)
Actual Δ 
(INS)
Equalizing 
%Change
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